Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AC091959.1		ENSG00000275740	"Novel readthrough transcript"		5	146203550-146339251	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"testis: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA035944, HPA036422"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nuclear speckles"		"HPA035944: AB_10670672, HPA036422: AB_10669987"	"unprognostic (6.42e-2)"	"unprognostic (7.72e-4)"	"unprognostic (2.05e-2)"		"unprognostic (4.95e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.24e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.12e-2)"	0.5	0.5	0.2	1.4	0.6	2.4	0.5	1.9	0.8	1.0	0.8	0.6	1.5	0.5	0.0	1.2	1.0	0.4	0.6	0.4	1.0	0.5	0.4	0.7	1.3	0.4	0.3	1.3	0.7	0.9	0.0	0.9	0.3	0.5	0.7	0.7	0.9	0.6	0.6	0.3	1.1	1.0	0.0	0.7	0.9	6.7	0.6	1.8	1.5	0.7	1.2	0.8	0.1	0.8	7.2	11.4	5.6	5.5	1.7	1.7	5.0	8.9	5.4	10.4	10.7	12.4	5.9	8.6	5.3	4.8	6.6	5.5	8.2	7.9	8.9	16.0	4.5	10.0	5.5	1.3	1.2	12.0	9.5	2.4	1.0	9.9	6.1	1.7	3.3	3.2	13.1	5.4	3.3	3.7	9.6	0.0	5.1	3.2	7.4	9.6	10.8	4.8	0.7	9.2	5.6	3.9	12.9	2.9	4.0	1.9	9.3	1.7	6.8	5.8	6.7	6.9	8.9	6.4	14.9	13.4	6.3	6.9	6.6	18.2	7.0	14.5	10.4	7.2	11.6	10.3	9.5	8.2	7.5	12.2	10.0	9.9	10.3	10.4	12.0	10.2	9.3	7.8	0.2	0.6	1.9	0.8	0.4	1.0	0.4	0.3	0.3	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184302-161199054	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 116.8;ovary: 95.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 80.3;Endothelial cells: 115.5;Fibroblasts: 88.8;Oligodendrocytes: 56.0;Sertoli cells: 52.6;Smooth muscle cells: 313.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.8;HUVEC TERT2: 14.4;SH-SY5Y: 7.9;TIME: 12.2;U-138 MG: 7.4;U-251 MG: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA		11000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978"	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	116.8	9.8	6.1	16.3	31.5	0.7	43.4	31.1	19.2	16.4	5.8	18.2	0.8	15.0	0.2	6.2	34.6	14.3	53.6	8.1	15.2	26.0	8.7	50.3	1.6	38.2	29.6	95.9	9.0	2.1	13.0	3.2	31.6	16.9	2.0	1.5	5.2	0.5	13.3	5.0	9.4	10.5	28.3	1.8	22.8	1.8	26.2	1.1	21.3	0.4	0.3	31.8	12.2	48.0	0.0	0.0	0.2	0.1	6.4	4.0	0.6	5.4	0.2	0.5	3.0	0.2	0.2	0.2	4.4	1.7	0.0	0.1	0.0	0.0	1.9	0.1	0.3	0.2	0.5	1.3	0.6	0.0	0.1	4.5	0.0	11.8	0.1	0.0	14.4	0.1	0.2	0.3	0.4	0.1	0.0	0.2	5.3	0.0	0.0	0.1	5.1	0.1	0.0	0.1	0.1	7.9	0.0	0.1	0.1	0.3	0.2	0.5	12.2	7.4	0.1	0.4	10.8	0.2	0.1	0.1	2.2	0.1	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.0	4.4	0.2	0.1	6.1	31.5	31.1	19.2	8.1	15.2	38.2	29.6	31.6	28.3	26.2	48.0	80.3	0.0	4.1	0.0	0.2	31.2	3.2	0.0	2.2	2.2	8.6	5.5	5.5	0.0	0.6	0.0	0.0	0.3	0.5	0.2	0.0	0.3	0.0	0.3	13.0	115.5	0.0	0.0	0.4	0.0	0.3	88.8	0.5	0.5	0.0	0.3	43.2	0.9	1.0	3.3	0.1	0.0	0.0	1.0	32.6	0.2	0.3	3.2	35.6	2.8	1.0	0.5	0.0	0.0	56.0	0.0	0.0	1.2	0.7	9.8	0.0	0.1	0.0	1.0	52.6	21.2	313.7	2.7	0.6	2.7	19.0	0.4	3.7	1.6	0.3	7.7
AKAP8L	"HAP95, NAKAP95"	ENSG00000011243	"A-kinase anchoring protein 8 like"	Q9ULX6	19	15380050-15419141	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042485, HPA042546"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear speckles"		"HPA042485: AB_2678019, HPA042546: AB_2678046"	"unprognostic (9.52e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (1.08e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-2)"	"prognostic favorable (8.04e-4)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (2.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.34e-3)"	27.2	32.8	25.1	4.0	25.5	32.3	26.9	26.0	32.2	34.8	21.8	32.7	2.5	23.5	11.9	23.4	31.8	7.5	41.5	24.4	25.3	29.3	28.8	33.5	9.4	24.1	24.4	36.2	22.5	11.1	40.4	9.3	24.7	32.3	5.8	37.4	23.2	6.3	60.5	34.5	24.0	6.4	25.0	31.5	24.7	48.8	25.8	20.6	33.9	24.1	10.8	26.8	28.1	26.1	25.4	25.8	32.3	17.2	32.3	34.0	18.8	21.0	25.1	34.0	30.9	41.5	35.2	23.2	38.8	23.4	31.8	29.9	51.2	28.3	29.8	39.8	44.2	40.3	21.9	34.0	57.3	38.8	26.6	29.6	52.0	27.2	35.3	31.3	25.4	38.0	51.3	41.9	21.3	34.3	39.0	32.6	31.9	32.0	41.9	46.6	22.8	25.2	28.7	8.5	37.2	23.5	26.2	28.3	37.5	42.4	20.8	42.2	30.4	20.5	15.4	34.4	36.7	60.1	48.0	49.5	19.2	39.8	23.5	0.1	1.8	1.7	0.9	0.8	1.8	1.7	0.8	1.0	1.5	2.3	1.3	1.2	3.5	0.5	1.0	1.4	2.8	0.8	25.1	25.5	26.0	32.2	24.4	25.3	24.1	24.4	24.7	25.0	25.8	26.1	34.7	6.4	15.9	55.5	39.1	31.6	48.2	22.6	26.2	60.9	34.6	29.3	7.7	17.2	30.0	35.0	77.2	35.6	47.3	22.5	25.4	32.6	34.6	52.7	33.7	29.8	25.6	114.9	59.1	31.8	28.6	26.0	50.0	42.6	13.9	69.6	17.5	17.0	16.3	79.1	45.1	22.0	26.4	18.6	32.8	9.9	26.4	31.3	26.6	19.7	24.0	42.0	30.9	29.7	38.5	32.5	19.9	29.3	38.2	33.2	13.6	17.3	32.1	83.2	26.3	27.8	45.2	83.3	63.9	26.4	39.2	62.4	44.0	60.2	18.3	40.2
ALYREF	"ALY, ALY/REF, BEF, REF, THOC4"	ENSG00000183684	"Aly/REF export factor"		17	81887835-81891586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"bone marrow: 148.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016281, HPA019799, HPA061282"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"CAB016281: AB_626667, HPA019799: AB_1844788, HPA061282: AB_2684464"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.89e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.55e-3)"	"unprognostic (6.58e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.74e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.09e-2)"	39.0	30.0	19.2	50.2	19.6	148.9	34.9	20.2	22.9	33.1	17.7	37.4	32.9	35.1	17.1	57.6	31.3	19.6	37.8	19.8	20.0	37.7	29.6	36.0	62.4	19.6	20.7	32.4	26.9	21.3	28.9	32.1	20.9	30.0	24.3	9.4	30.3	15.9	61.5	45.7	34.5	21.1	20.9	44.7	31.6	72.7	19.8	65.7	30.6	21.2	48.8	35.7	36.4	22.1	263.7	237.8	165.5	164.6	34.4	44.8	213.8	130.0	68.0	257.0	161.0	269.4	173.7	291.4	100.8	104.9	155.6	150.5	241.9	137.5	111.7	111.8	425.9	210.8	151.2	295.1	68.6	341.4	183.0	46.1	61.8	155.3	62.0	37.8	155.5	204.6	275.9	175.2	97.2	279.8	721.2	587.2	231.3	152.0	254.2	472.3	206.1	155.1	54.1	152.1	229.8	299.0	123.9	304.8	110.4	89.9	222.1	343.3	103.9	275.1	270.9	130.0	443.2	201.8	107.3	377.6	143.7	217.0	238.2	0.3	1.1	0.1	1.5	1.2	1.0	1.0	1.1	1.0	1.2	1.2	0.3	0.8	0.2	0.9	1.1	2.2	0.6	0.6	19.2	19.6	20.2	22.9	19.8	20.0	19.6	20.7	20.9	20.9	19.8	22.1	68.4	0.0	16.0	1.3	22.9	34.9	22.9	7.5	9.1	11.0	24.7	32.5	13.0	11.5	8.4	20.2	0.0	9.8	59.0	16.1	1.9	5.2	2.3	52.9	49.0	23.4	12.6	43.3	1.7	8.4	23.1	24.9	17.3	53.7	15.2	39.1	8.9	14.8	17.9	5.0	1.7	24.3	6.1	13.9	33.8	3.2	3.4	31.3	14.2	3.7	12.7	21.5	8.2	2.5	5.0	10.5	10.1	4.1	46.4	33.1	7.4	4.3	8.4	7.6	0.0	27.9	30.6	16.5	8.8	22.6	43.0	16.6	27.6	38.2	21.9	31.6
API5	"AAC-11, AAC11, API5L1"	ENSG00000166181	"Apoptosis inhibitor 5"	Q9BZZ5	11	43311963-43344529	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026598	Approved		Enhanced	"Nuclear speckles"		NA	NA		31000	"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA026598: AB_1844927"	"unprognostic (4.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.69e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (1.06e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.05e-2)"	37.6	33.1	29.2	43.4	31.1	35.3	45.7	38.5	37.4	39.3	25.9	44.3	42.8	42.1	34.5	44.6	36.6	32.4	28.2	32.0	30.6	49.1	57.7	34.8	53.5	29.2	28.5	35.1	45.9	46.6	19.0	29.9	30.8	40.4	46.6	44.1	39.0	39.5	37.1	40.0	45.5	46.6	32.8	40.3	41.1	26.8	29.9	62.1	51.4	35.9	57.2	44.2	27.6	38.6	90.2	93.0	119.4	75.2	82.7	82.4	82.9	83.8	89.4	116.3	110.2	69.4	38.8	106.4	67.2	90.2	86.9	107.7	143.2	99.7	160.6	122.4	134.9	96.5	53.0	60.8	74.8	165.6	88.9	64.2	104.6	59.0	102.9	72.4	98.9	65.8	160.3	93.9	82.1	57.0	141.2	71.1	214.6	111.1	86.0	145.2	126.3	85.3	89.5	103.8	95.5	64.2	100.7	88.7	81.4	88.4	109.1	76.6	86.5	102.0	78.3	139.8	144.5	77.5	122.7	172.1	88.8	95.0	62.3	61.3	47.3	51.5	66.5	64.5	75.1	61.7	64.8	69.3	62.1	60.4	66.3	68.7	9.9	116.3	67.3	40.0	61.4	88.4	29.2	31.1	38.5	37.4	32.0	30.6	29.2	28.5	30.8	32.8	29.9	38.6	26.4	16.0	27.3	30.0	35.9	43.8	16.6	21.6	47.3	23.8	27.8	17.8	14.4	31.5	28.0	20.2	10.4	30.4	31.8	20.1	31.3	21.3	13.6	23.5	25.8	26.2	24.0	48.0	40.2	19.7	30.4	28.3	35.2	28.2	32.3	25.9	22.1	48.0	26.3	28.6	33.5	27.5	12.2	33.6	28.8	6.5	18.6	30.0	32.0	27.2	41.7	21.1	17.5	25.1	45.4	24.9	19.8	20.3	44.2	24.0	29.4	37.3	20.8	19.0	6.6	28.9	31.1	28.4	26.6	43.1	51.9	38.9	33.8	26.6	31.4	19.2
BAZ2A	"KIAA0314, TIP5, WALp3"	ENSG00000076108	"Bromodomain adjacent to zinc finger domain 2A"	Q9UIF9	12	56595596-56636816	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005782, HPA063806"			Enhanced	"Nuclear speckles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA005782: AB_10601089, HPA063806: AB_2685128"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.43e-1)"	29.1	23.9	10.3	30.8	13.3	65.9	27.2	22.9	18.7	29.3	19.1	27.0	25.5	25.4	22.9	30.9	24.9	20.9	21.1	10.3	20.0	19.8	21.7	35.9	33.4	17.2	13.0	36.3	30.8	33.4	27.7	35.4	14.6	23.3	26.6	48.8	25.7	21.0	28.2	29.9	31.1	23.1	5.5	35.3	26.2	47.4	19.0	50.6	27.3	32.0	30.6	24.8	30.6	19.8	50.3	45.6	61.9	52.5	35.3	35.4	66.5	32.6	44.2	46.9	34.1	56.2	59.3	69.2	49.2	38.6	44.3	41.5	70.6	46.3	40.6	48.1	37.1	80.8	35.5	28.8	38.5	47.1	60.2	31.0	43.8	40.2	55.7	50.8	46.3	28.4	87.7	94.1	26.3	30.7	40.2	30.9	54.9	32.7	34.6	33.9	45.0	48.3	32.6	48.8	41.0	33.8	54.8	57.0	30.0	66.0	65.6	41.7	65.2	24.3	49.1	30.0	23.0	46.0	48.4	65.1	22.5	33.4	34.6	12.1	7.6	5.6	4.8	6.2	4.2	6.8	3.8	3.7	3.0	6.0	3.1	2.7	28.6	17.2	15.5	11.7	3.6	3.0	10.3	13.3	22.9	18.7	10.3	20.0	17.2	13.0	14.6	5.5	19.0	19.8	47.6	67.3	61.3	29.4	74.7	50.9	43.2	35.3	60.3	70.5	43.3	26.7	26.4	30.0	36.9	25.8	137.6	48.0	62.8	71.6	7.9	32.0	66.8	29.4	33.7	50.1	44.8	53.4	29.3	28.7	37.2	35.6	34.1	41.7	43.6	34.8	53.9	32.5	24.3	32.0	27.4	39.6	26.4	62.1	65.6	73.7	60.6	38.5	39.2	40.3	80.1	24.4	116.4	25.6	33.2	34.8	39.4	57.6	78.0	65.1	44.7	12.6	34.4	67.3	85.5	44.9	44.0	134.1	131.2	59.5	61.8	95.6	58.0	41.6	34.8	67.6
BCLAF1	"BTF, KIAA0164"	ENSG00000029363	"BCL2 associated transcription factor 1"	Q9NYF8	6	136256627-136289851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 135.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006484, HPA006669, HPA027770"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		21000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA006484: AB_2667600, HPA006669: AB_1078302, HPA027770: AB_1845484"	"prognostic unfavorable (1.64e-4)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.44e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.19e-3)"	24.4	22.3	14.3	26.9	17.3	135.0	32.9	23.6	18.6	21.4	19.7	29.5	18.8	23.2	24.0	24.3	21.3	14.8	16.7	15.9	19.2	21.5	27.4	24.6	28.2	11.1	12.9	24.4	25.5	33.4	18.0	21.3	12.0	21.2	28.4	34.8	21.2	20.5	27.5	21.8	21.1	28.3	14.7	24.8	27.9	21.3	16.7	35.2	30.4	24.3	32.9	23.0	19.3	19.3	82.4	70.0	162.5	136.2	50.4	42.6	82.3	153.0	94.4	100.6	106.5	100.4	54.4	172.7	92.8	117.9	112.8	78.0	183.5	101.1	125.5	95.1	114.2	213.7	96.0	110.3	58.6	362.6	131.0	58.3	49.2	142.8	88.6	37.2	90.9	77.6	193.6	82.3	107.0	97.4	145.3	40.2	120.2	55.2	72.0	130.3	203.2	76.4	76.3	155.0	137.2	94.5	150.0	71.3	60.4	60.6	66.9	71.5	125.7	79.2	116.7	95.9	151.2	69.5	134.8	227.9	47.2	113.3	94.2	32.6	27.1	42.1	32.4	33.2	32.7	36.6	29.9	28.1	42.3	32.9	37.7	34.5	57.9	49.5	35.3	24.7	25.5	24.5	14.3	17.3	23.6	18.6	15.9	19.2	11.1	12.9	12.0	14.7	16.7	19.3	165.3	205.1	178.7	68.9	174.3	68.2	118.9	99.5	104.2	129.7	86.9	71.5	88.4	65.8	131.6	57.0	210.6	111.9	173.3	86.3	33.2	96.8	12.6	157.2	173.5	117.5	118.9	134.6	80.5	65.2	99.4	138.0	128.0	169.8	156.4	130.5	74.3	60.0	74.0	102.6	82.6	106.0	93.6	92.5	88.9	13.8	122.1	121.8	69.4	56.2	136.9	91.6	118.4	63.3	93.4	77.5	81.4	109.4	197.8	128.6	83.3	42.9	147.1	139.9	111.7	259.8	130.7	102.2	129.7	121.4	71.2	128.3	174.8	154.8	101.6	123.8
BMP2K	"BIKe, DKFZp434K0614"	ENSG00000138756	"BMP2 inducible kinase"	Q9NSY1	4	78776342-78916365	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 242.9;granulocytes: 129.2;Hofbauer cells: 140.4;Microglial cells: 351.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 50.1;HEL: 73.6;HMC-1: 80.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026436, HPA026451, HPA026501"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear speckles"		"HPA026436: AB_10600102, HPA026451: AB_10600228, HPA026501: AB_10601341"	"unprognostic (7.96e-2)"	"unprognostic (3.68e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.18e-2)"	6.0	4.2	8.5	13.5	8.2	11.9	7.4	7.3	7.2	6.5	3.8	9.5	5.6	4.4	5.4	7.4	6.0	7.4	8.0	7.2	18.6	4.9	6.7	7.7	16.5	12.1	11.2	3.1	3.5	4.3	0.6	9.2	13.5	3.3	11.9	6.5	3.5	3.5	2.2	9.9	6.9	6.6	10.9	12.2	4.7	10.2	9.8	10.9	7.7	4.5	16.3	7.1	1.4	16.5	11.4	3.2	6.0	7.5	12.0	11.1	4.8	10.8	14.4	10.3	13.7	6.4	6.4	13.2	5.6	50.1	9.9	2.9	6.7	8.5	19.4	3.5	2.3	73.6	5.0	3.5	13.2	15.9	80.6	15.9	11.0	16.4	15.6	7.3	14.4	10.0	19.8	36.5	12.1	2.4	9.5	7.4	2.9	8.8	2.1	13.5	10.3	3.7	13.3	5.2	8.4	5.2	14.2	7.8	10.4	7.9	2.7	10.0	14.7	10.6	4.2	18.4	11.9	7.7	3.2	4.8	9.9	21.4	7.7	0.1	0.5	0.3	0.0	0.2	0.0	0.6	0.0	0.0	0.4	0.6	0.1	0.0	0.9	0.1	0.8	0.3	0.0	0.1	8.5	8.2	7.3	7.2	7.2	18.6	12.1	11.2	13.5	10.9	9.8	16.5	10.7	28.9	16.2	242.9	31.5	25.0	4.3	5.4	10.2	10.9	27.4	15.2	6.5	2.8	7.7	7.3	4.2	5.0	6.1	24.6	0.0	7.5	15.9	18.6	12.7	17.6	6.7	105.4	53.2	8.8	14.2	13.7	6.6	25.0	129.2	32.1	22.1	19.7	140.4	10.1	59.0	48.2	6.1	65.9	68.2	11.1	8.1	65.4	28.4	351.3	34.6	37.0	1.0	49.3	59.1	14.6	43.0	6.8	7.6	6.3	19.9	18.0	12.3	8.4	6.6	22.3	11.7	26.1	11.2	17.1	31.4	3.4	7.6	5.4	24.0	3.2
BPNT1		ENSG00000162813	"3'(2'), 5'-bisphosphate nucleotidase 1"	O95861	1	220057482-220090462	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 55.5;Proximal enterocytes: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 183.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048461	Approved		Approved	"Nuclear speckles"		NA	NA		420000	"Cluster 44: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"	"Nuclear speckles"		"HPA048461: AB_2680404"	"unprognostic (6.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.19e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (6.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-1)"	16.2	20.8	6.5	18.2	7.8	4.6	20.3	7.5	9.1	18.1	7.3	37.7	43.9	13.9	13.0	14.7	17.6	21.2	17.7	7.3	6.8	31.5	25.0	17.6	34.2	7.6	6.8	17.9	7.7	21.5	10.9	13.2	7.1	13.8	32.2	15.5	17.3	11.9	9.3	10.3	45.7	18.3	7.5	14.6	19.7	14.8	6.7	17.7	20.8	11.3	44.3	15.8	9.9	10.0	37.5	30.3	22.1	17.5	40.6	33.3	35.4	48.0	25.0	42.9	38.3	40.1	70.7	183.9	64.8	33.2	19.1	26.1	45.8	42.3	34.5	68.8	51.2	33.3	34.6	48.3	23.8	90.4	29.9	31.8	20.7	61.0	25.3	28.0	35.9	54.1	62.3	18.4	43.4	21.2	51.9	24.3	18.9	32.0	37.1	36.5	62.9	54.0	55.5	49.2	40.2	33.6	60.1	71.5	43.0	22.1	56.5	31.7	54.2	25.4	19.5	36.7	60.8	31.3	81.6	85.0	22.0	33.6	56.8	20.6	9.2	6.1	12.3	10.0	9.4	20.8	12.8	12.7	10.9	16.5	15.0	11.2	1.1	14.0	9.9	13.3	14.6	9.7	6.5	7.8	7.5	9.1	7.3	6.8	7.6	6.8	7.1	7.5	6.7	10.0	9.3	28.9	23.9	3.6	12.7	3.3	12.5	22.0	3.4	13.7	9.1	6.2	10.5	11.5	23.4	14.7	10.4	13.1	11.6	55.5	13.7	18.7	2.5	10.3	7.7	7.7	19.2	5.5	8.4	15.6	14.1	7.8	7.7	9.7	3.8	12.1	7.9	12.6	9.8	6.7	10.8	14.5	32.6	7.5	3.6	3.1	9.6	7.2	10.6	1.9	8.0	10.8	15.5	10.1	13.0	18.9	28.5	13.5	10.3	6.3	56.9	29.5	14.5	12.0	13.1	5.6	8.7	15.5	11.8	8.2	5.1	25.2	9.6	25.0	17.2	12.7
BRD1	"BRL, BRPF2"	ENSG00000100425	"Bromodomain containing 1"	O95696	22	49773283-49827512	"Predicted intracellular proteins"	"Erythrocyte maturation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000807, HPA001063"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"HPA000807: AB_1078298, HPA001063: AB_1078297"	"unprognostic (1.96e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.64e-3)"	"unprognostic (5.87e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.95e-3)"	11.4	7.3	3.1	8.1	3.0	15.0	10.8	12.0	5.0	12.5	3.6	14.7	11.7	15.8	2.8	12.8	13.7	7.7	7.5	3.4	3.2	5.4	6.9	10.0	9.4	3.2	2.8	16.0	13.2	8.5	11.2	8.3	2.9	8.7	5.8	6.1	12.1	8.0	16.7	23.2	12.0	6.7	1.5	12.0	11.5	30.7	3.2	14.0	10.2	8.9	7.6	11.8	12.3	4.5	12.7	12.7	22.8	12.8	9.2	8.2	19.3	13.7	9.3	14.2	11.1	19.3	8.3	13.3	7.9	11.4	5.2	17.9	14.7	9.8	6.1	13.4	26.6	13.2	20.3	11.8	17.8	30.5	18.2	12.2	15.1	8.3	10.5	10.3	10.4	15.9	15.3	14.3	7.3	20.8	23.0	15.9	15.7	9.4	10.1	33.6	19.9	13.9	5.5	18.2	14.6	25.8	17.6	22.7	18.4	10.5	10.6	24.9	12.9	13.1	14.1	9.9	12.7	16.8	4.3	18.9	9.3	10.7	11.8	0.3	0.6	0.7	0.5	0.2	1.0	0.4	0.8	1.0	0.4	0.7	0.8	1.0	0.6	0.8	2.9	0.9	0.3	0.5	3.1	3.0	12.0	5.0	3.4	3.2	3.2	2.8	2.9	1.5	3.2	4.5	25.9	22.4	27.6	16.3	13.8	15.8	5.7	7.1	8.6	26.6	14.0	14.7	8.4	5.7	12.7	3.7	29.2	6.7	76.8	13.3	0.0	6.7	7.5	32.4	37.1	13.9	16.2	8.2	25.3	9.3	6.6	17.2	14.8	47.7	10.1	28.3	14.3	12.3	6.7	33.7	22.2	13.9	4.1	13.3	14.0	6.7	11.8	15.4	12.4	16.9	11.2	13.8	7.2	19.1	21.9	9.5	8.7	13.9	43.1	9.1	10.6	3.2	11.3	36.1	0.0	25.4	20.1	42.6	19.7	10.7	18.5	10.1	40.6	26.4	11.3	9.0
BRD2	"BRD2-IT1, D6S113E, FSRG1, KIAA9001, NAT, RING3"	ENSG00000204256	"Bromodomain containing 2"	P25440	6	32968594-32981505	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042816	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA042816: AB_10794766"	"unprognostic (2.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.89e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-2)"	64.2	61.8	0.8	22.1	2.1	66.5	62.4	4.7	3.8	67.7	0.2	62.1	19.8	71.3	1.8	67.9	66.6	17.4	51.7	3.0	2.8	68.3	61.9	65.3	22.1	1.5	2.4	81.7	80.4	26.3	71.4	19.4	2.1	60.8	11.6	10.1	66.1	18.2	71.4	69.5	60.8	11.7	1.4	71.2	66.0	82.9	2.3	26.9	77.0	10.4	21.2	61.6	65.0	4.0	45.7	19.5	41.6	41.8	31.8	28.5	38.3	44.6	44.4	48.5	35.8	22.7	22.5	37.3	44.6	37.2	32.4	28.1	39.3	33.2	27.7	49.5	147.7	41.2	18.3	14.6	23.5	60.6	39.2	29.2	28.7	38.2	44.9	27.6	21.3	35.2	44.4	76.0	21.7	12.1	77.0	8.5	24.0	28.9	20.4	76.2	18.7	53.8	13.8	26.6	85.6	28.9	54.5	63.7	52.7	27.8	37.4	39.0	27.5	58.6	32.0	21.5	50.0	61.1	69.5	77.9	23.1	19.7	47.8	9.6	7.6	11.6	14.5	8.8	13.0	9.2	9.4	9.9	10.6	8.7	6.6	10.4	9.7	10.3	9.5	8.5	13.3	11.7	0.8	2.1	4.7	3.8	3.0	2.8	1.5	2.4	2.1	1.4	2.3	4.0	325.8	76.9	121.5	38.2	327.1	212.1	232.7	70.0	478.1	78.6	295.5	383.9	171.7	94.4	80.1	60.7	104.3	91.7	395.7	210.7	21.5	69.2	302.4	201.9	149.3	191.2	259.1	97.6	16.1	91.4	145.0	224.2	249.8	256.6	115.2	103.1	113.2	85.3	79.9	55.5	19.9	247.5	77.3	92.6	209.2	177.9	86.9	194.5	124.5	26.2	94.7	62.8	107.1	15.1	22.1	81.2	137.3	77.1	313.0	211.5	133.7	39.5	84.4	65.1	39.5	240.0	251.3	88.4	137.9	365.0	226.9	205.1	356.7	71.2	179.5	248.4
C11orf49	"FLJ22210, MGC4707"	ENSG00000149179	"Chromosome 11 open reading frame 49"	Q9H6J7	11	46936689-47164385	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 140.0;Excitatory neurons: 140.8;Inhibitory neurons: 112.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040051, HPA040280"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA040051: AB_10795412, HPA040280: AB_10795363"	"unprognostic (3.11e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.76e-2)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.34e-3)"	8.1	13.4	52.4	6.2	51.6	3.3	10.0	45.9	54.7	15.6	46.1	14.3	11.2	16.8	14.1	9.7	32.5	9.6	12.3	52.4	53.3	15.7	3.9	12.1	6.3	47.0	53.9	14.9	12.7	22.6	30.3	6.8	49.2	12.4	11.4	21.8	11.0	13.2	7.3	31.6	11.9	12.8	46.2	7.0	15.4	20.2	53.7	13.7	16.1	6.4	7.2	11.9	11.4	45.5	10.9	30.6	37.9	27.9	17.8	25.7	9.5	11.7	26.9	24.6	29.9	6.9	17.0	9.1	12.3	24.4	29.7	14.8	18.8	28.7	20.9	18.1	27.2	12.2	36.6	12.6	30.5	14.6	16.2	17.5	19.1	11.2	16.4	47.0	27.6	22.1	10.3	11.7	18.2	22.8	23.0	16.2	14.3	26.5	16.4	8.2	9.5	10.1	43.3	11.7	25.5	36.5	13.4	14.9	14.7	19.7	25.0	8.5	6.5	13.8	11.0	22.0	17.7	10.4	9.2	7.5	33.7	3.0	17.5	12.7	10.2	9.0	19.2	13.7	23.0	24.1	18.1	22.7	24.6	17.6	19.1	20.3	0.3	25.2	10.3	21.8	19.0	18.3	52.4	51.6	45.9	54.7	52.4	53.3	47.0	53.9	49.2	46.2	53.7	45.5	6.6	9.6	26.7	140.0	9.9	13.0	16.4	30.6	12.0	22.9	12.0	13.0	9.4	12.8	24.0	23.9	18.8	19.4	5.6	18.3	46.9	30.2	53.2	42.8	20.4	10.2	19.2	8.0	140.8	20.4	13.4	18.0	25.5	14.1	16.4	23.3	8.6	2.4	9.9	37.0	112.7	12.8	22.4	3.3	7.0	35.8	12.8	6.2	12.4	41.2	10.9	45.0	7.2	93.0	71.9	16.2	21.2	20.3	5.8	8.1	22.1	33.4	66.7	53.1	6.6	12.2	13.5	63.3	7.6	10.5	18.0	10.0	10.8	32.6	13.7	12.1
C12orf57	"C10, GRCC10"	ENSG00000111678	"Chromosome 12 open reading frame 57"	Q99622	12	6942978-6946003	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046182, HPA059163, HPA066043"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA046182: AB_2679572, HPA059163: AB_2683937, HPA066043: AB_2685603"	"unprognostic (5.89e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.20e-3)"	"unprognostic (8.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (8.74e-4)"	"unprognostic (4.25e-2)"	"prognostic unfavorable (2.32e-7)"	"unprognostic (1.47e-2)"	"unprognostic (3.26e-1)"	"unprognostic (6.81e-2)"	"unprognostic (8.39e-3)"	254.8	199.9	230.6	76.1	231.7	128.4	282.7	235.0	329.3	411.9	239.0	242.7	76.5	296.1	85.9	143.9	328.1	134.2	327.9	221.9	240.4	225.2	205.5	217.9	183.5	233.4	235.7	574.0	300.7	117.2	332.4	75.2	233.9	297.0	69.5	37.0	173.2	157.1	194.2	307.1	163.3	85.2	227.6	160.7	220.3	82.1	252.6	262.6	214.2	179.8	77.0	263.9	270.0	236.8	88.3	253.6	291.0	288.0	196.6	233.8	96.1	113.7	277.0	96.4	153.0	101.4	146.8	27.0	88.1	178.1	124.4	83.6	111.2	140.6	23.1	158.1	232.8	234.8	191.4	145.2	372.3	96.9	220.7	281.9	164.7	74.6	101.7	188.8	164.2	216.5	82.2	230.3	90.5	264.3	204.6	124.8	522.0	146.3	92.2	224.4	259.7	404.8	131.2	218.8	128.9	377.5	182.8	184.3	242.6	136.7	46.8	501.1	174.3	192.7	181.8	77.9	173.0	169.8	150.0	149.8	198.6	2.4	132.2	75.7	20.0	19.3	187.8	34.2	123.6	133.2	208.5	199.6	29.5	163.8	248.0	203.7	7.9	99.9	87.0	225.2	204.5	160.1	230.6	231.7	235.0	329.3	221.9	240.4	233.4	235.7	233.9	227.6	252.6	236.8	260.9	64.1	129.2	11.1	256.4	264.5	285.2	255.3	546.9	90.6	284.2	624.3	219.4	211.6	146.0	123.2	25.0	131.4	216.3	262.8	365.9	191.9	175.7	122.1	336.7	206.8	312.1	81.6	7.4	423.9	219.4	340.3	179.4	146.9	148.9	86.2	204.9	307.0	67.2	37.0	11.0	686.2	162.8	88.9	138.1	299.5	453.3	120.2	231.3	15.0	58.4	197.5	200.8	7.1	8.9	205.5	240.0	377.3	216.6	279.5	146.8	244.4	89.0	94.9	289.3	389.2	473.4	75.1	86.0	301.7	215.0	154.2	328.2	157.0	349.5	215.6
C16orf71	"DKFZp686H2240, FLJ43261"	ENSG00000166246	"Chromosome 16 open reading frame 71"	Q8IYS4	16	4734344-4749396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 22.5;testis: 74.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 37.1;Late spermatids: 62.0;Respiratory ciliated cells: 22.6;Spermatocytes: 122.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 4.6;U-2197: 5.0"					"Low region specificity"	"Detected in all"			HPA049468	Enhanced		Uncertain	"Nuclear speckles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA049468: AB_2680779"	"unprognostic (1.24e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.79e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.54e-5)"	"unprognostic (1.65e-1)"	0.7	1.3	1.0	0.7	1.4	0.2	0.7	2.2	1.6	1.4	9.2	0.8	0.6	1.0	2.7	0.7	22.5	1.4	0.8	1.5	1.4	1.8	1.3	2.8	0.4	4.5	5.7	1.2	1.1	0.9	4.1	0.2	2.6	1.1	0.3	1.7	1.2	0.7	1.0	0.5	0.4	0.8	3.3	0.4	0.8	74.0	1.5	0.6	2.0	1.1	0.4	0.7	0.5	1.6	0.3	2.0	0.4	1.1	2.6	1.1	0.8	1.1	0.9	0.9	1.1	0.9	0.8	0.0	1.0	1.6	2.6	0.9	0.9	1.1	0.2	0.4	0.6	0.2	1.5	0.1	0.8	0.9	0.3	0.3	0.2	3.4	0.9	0.7	0.4	0.8	0.7	0.5	0.9	4.6	0.2	0.8	0.6	1.3	1.0	0.3	0.4	1.4	2.3	0.4	3.0	1.1	1.1	0.9	0.3	0.7	4.0	0.2	0.4	0.7	0.8	5.0	0.5	2.0	1.7	0.5	0.4	0.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.3	1.1	0.0	0.1	1.0	1.4	2.2	1.6	1.5	1.4	4.5	5.7	2.6	3.3	1.5	1.6	0.1	0.0	1.1	1.0	0.1	0.0	0.2	1.0	0.6	0.9	0.6	0.5	1.2	0.0	3.9	0.0	4.2	0.3	0.2	0.2	0.0	0.6	37.1	15.6	0.6	0.2	0.0	0.0	1.0	0.0	0.1	0.3	3.6	0.6	0.0	0.2	0.0	0.3	0.2	0.0	0.9	0.1	0.0	0.0	0.0	62.0	1.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	1.5	0.0	0.1	0.0	2.4	22.6	1.7	0.0	0.2	0.7	122.1	7.2	0.5	0.0	0.1	0.2	0.3	0.3	0.0
C3orf62	FLJ43654	ENSG00000188315	"Chromosome 3 open reading frame 62"	Q6ZUJ4	3	49268596-49277232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"neutrophil: 40.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 40.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043328			Approved	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA043328: AB_10795613"	"prognostic favorable (3.93e-4)"	"unprognostic (4.87e-3)"	"unprognostic (3.70e-3)"	"unprognostic (2.35e-2)"	"unprognostic (9.51e-2)"	"prognostic favorable (9.72e-4)"	"prognostic unfavorable (5.20e-4)"	"prognostic favorable (8.88e-4)"	"unprognostic (1.28e-1)"	"unprognostic (9.40e-3)"	"prognostic favorable (8.15e-4)"	"unprognostic (7.23e-2)"	"unprognostic (3.27e-2)"	"prognostic favorable (3.29e-5)"	"unprognostic (2.46e-1)"	"unprognostic (4.79e-1)"	"prognostic favorable (1.62e-5)"	6.5	10.5	3.0	4.5	3.6	8.5	5.5	4.4	5.5	6.1	7.0	7.6	3.1	5.6	4.5	6.9	7.9	4.8	6.5	3.5	4.0	5.7	5.6	7.3	4.9	3.8	3.4	11.3	3.2	3.1	7.8	2.7	4.2	7.5	2.6	9.0	4.2	2.1	3.9	5.7	5.5	2.7	2.2	11.7	4.0	17.3	5.0	4.2	6.0	3.6	3.4	6.4	6.1	4.4	4.3	2.5	5.9	7.4	4.7	4.0	3.3	2.5	4.2	2.2	3.2	3.6	3.2	8.5	3.8	3.9	4.6	3.3	2.9	2.8	2.4	7.5	3.4	5.6	5.8	4.0	1.4	8.0	10.0	3.3	8.1	3.2	6.0	3.8	2.5	4.9	6.5	6.3	1.8	2.7	5.9	5.8	4.2	3.6	3.6	4.4	3.1	4.5	3.6	9.8	4.5	6.1	6.8	5.2	9.1	4.3	2.6	8.8	3.1	3.0	7.3	5.2	4.7	5.5	10.2	7.1	2.2	7.4	4.2	1.0	5.1	5.3	1.2	1.7	1.0	1.9	1.1	1.2	0.6	1.2	0.8	1.0	40.0	0.3	1.7	2.5	1.4	1.3	3.0	3.6	4.4	5.5	3.5	4.0	3.8	3.4	4.2	2.2	5.0	4.4	8.6	9.6	16.1	4.6	4.4	6.8	3.5	7.9	1.8	12.6	5.7	6.0	9.1	7.2	10.3	11.0	22.9	7.0	7.8	7.6	0.0	4.9	12.4	6.6	9.2	8.1	5.4	7.0	7.3	3.9	4.3	7.3	5.6	10.1	2.5	8.5	9.7	6.3	9.8	5.0	6.1	9.8	2.0	18.0	7.1	17.3	8.7	11.3	8.8	9.4	14.2	7.3	9.2	4.5	7.0	6.0	3.8	8.6	4.6	7.0	4.9	5.2	11.1	13.7	0.0	14.9	6.4	51.8	6.8	4.2	8.7	4.1	6.9	12.1	7.4	2.7
C6orf226	LOC441150	ENSG00000221821	"Chromosome 6 open reading frame 226"	Q5I0X4	6	42890265-42890821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA045350	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA045350: AB_10964640"	"prognostic favorable (1.93e-5)"	"unprognostic (2.21e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.17e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.50e-3)"	"prognostic favorable (5.13e-4)"	"unprognostic (2.24e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (4.63e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.82e-3)"	19.3	31.9	12.9	5.9	12.6	13.2	15.7	13.0	19.6	14.5	11.4	19.3	7.8	18.5	6.2	11.7	13.6	2.2	14.9	11.9	14.5	20.0	14.9	14.4	5.4	13.3	12.8	12.6	13.5	4.1	25.5	2.2	12.9	17.5	1.5	5.6	12.8	7.0	19.7	25.8	15.0	2.5	14.0	18.8	15.4	11.3	13.7	6.3	15.6	3.6	3.0	18.5	12.4	14.2	9.9	7.5	6.7	13.6	7.2	6.3	8.1	6.0	3.2	7.2	9.4	2.8	3.3	2.1	12.2	2.9	4.6	7.8	1.8	3.8	2.1	9.3	13.9	7.8	6.6	19.7	7.4	2.1	5.5	7.1	4.9	3.6	1.7	2.0	5.6	8.1	0.5	11.1	4.5	19.9	16.0	13.4	2.4	9.6	6.3	7.0	4.8	10.4	4.0	7.6	13.1	15.9	11.4	5.0	16.3	2.4	12.1	6.1	7.5	5.7	17.0	10.7	5.7	26.9	22.1	32.9	3.5	4.2	4.0	7.5	21.8	21.8	17.4	17.3	13.1	16.8	22.1	18.0	25.4	15.7	17.1	21.0	9.6	23.8	24.6	23.7	19.3	15.1	12.9	12.6	13.0	19.6	11.9	14.5	13.3	12.8	12.9	14.0	13.7	14.2	18.7	12.8	10.4	7.5	12.9	14.4	19.3	26.8	24.5	29.9	15.2	18.2	13.9	15.7	16.9	22.0	6.2	22.8	24.9	11.1	66.5	21.9	1.5	31.6	10.2	15.7	9.7	7.4	2.5	32.7	9.7	16.0	14.8	18.1	7.0	28.8	12.1	18.2	21.6	30.3	3.9	10.6	16.2	20.4	14.8	2.3	14.6	19.8	30.2	7.5	18.2	54.2	36.0	1.5	10.8	22.3	13.8	13.5	17.2	12.6	11.0	38.6	33.2	29.3	0.0	12.3	15.4	2.9	5.4	18.3	17.0	16.7	20.3	17.0	9.1	20.0
CBFA2T2	"MTGR1, ZMYND3"	ENSG00000078699	"CBFA2/RUNX1 partner transcriptional co-repressor 2"	O43439	20	33490075-33650036	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 128.3;Excitatory neurons: 114.7;Inhibitory neurons: 116.6;Oligodendrocytes: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 45.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060523, HPA072433"	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear speckles"		"HPA060523: AB_2684305, HPA072433: AB_2686520"	"unprognostic (6.51e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.85e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.89e-2)"	"prognostic favorable (6.93e-6)"	"unprognostic (7.83e-2)"	"unprognostic (1.39e-3)"	"unprognostic (9.40e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.12e-2)"	6.4	4.8	11.3	5.8	11.6	5.5	6.6	9.0	13.8	11.8	4.9	11.9	7.5	7.5	5.0	9.2	8.4	4.1	7.6	13.1	11.7	7.5	7.5	8.5	6.6	10.5	9.7	11.6	7.0	9.1	9.7	4.5	11.5	16.8	9.1	15.4	8.2	5.8	9.6	12.1	10.6	5.9	7.5	8.9	8.8	11.1	11.8	8.9	10.7	5.7	6.3	9.5	10.6	17.7	6.8	6.5	9.3	6.8	9.2	7.0	9.5	4.1	4.9	5.5	4.6	13.8	6.3	7.9	8.4	5.7	12.3	9.0	5.4	6.8	4.8	3.3	4.1	10.9	6.5	8.3	5.8	4.5	9.0	5.9	8.9	5.7	7.9	6.8	4.9	8.1	6.2	5.1	4.8	6.1	9.6	7.6	3.2	8.3	7.1	7.5	10.3	8.3	6.3	9.7	30.1	45.1	20.7	8.0	6.7	9.4	7.5	6.9	5.3	13.1	5.9	8.9	5.0	9.3	11.0	4.5	6.7	4.1	4.2	4.2	1.1	1.2	2.1	1.0	1.9	2.7	2.2	2.7	0.5	2.7	1.3	1.8	2.2	1.2	0.7	1.5	1.9	0.7	11.3	11.6	9.0	13.8	13.1	11.7	10.5	9.7	11.5	7.5	11.8	17.7	9.9	12.8	21.7	128.3	17.8	19.1	12.9	9.3	26.2	29.9	15.9	11.3	11.4	7.2	11.1	12.9	45.9	12.8	12.7	17.1	1.9	8.5	12.0	14.4	11.6	11.8	90.4	11.6	114.7	6.4	11.4	14.1	19.4	17.1	1.3	16.3	11.4	8.1	9.4	13.5	116.6	50.1	14.2	11.0	13.7	14.9	14.0	8.4	17.8	59.0	12.1	10.9	17.5	74.4	166.9	9.4	15.6	12.8	19.1	21.8	14.4	5.4	11.4	38.5	13.1	12.5	11.9	24.1	18.1	20.4	15.3	8.9	19.5	7.5	18.9	15.2
CBLL1	"FLJ23109, HAKAI, RNF188"	ENSG00000105879	"Cbl proto-oncogene like 1"	Q75N03	7	107743949-107761667	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021773, HPA026699"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA021773: AB_1846103, HPA026699: AB_1846104"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.16e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.71e-2)"	11.2	8.1	3.1	12.5	5.3	40.0	15.1	7.8	9.5	12.0	3.0	11.3	9.5	13.5	8.4	11.3	11.2	8.7	10.4	4.2	5.8	10.0	11.2	10.3	16.1	4.1	3.7	14.3	11.7	14.1	5.1	12.0	4.1	16.5	11.1	14.4	8.9	12.7	29.0	10.7	10.3	13.4	3.0	14.2	9.2	19.7	3.7	20.2	13.8	21.0	17.8	11.9	7.2	6.6	27.8	31.1	23.7	30.7	21.7	18.6	16.2	20.5	21.6	22.8	22.5	21.4	27.9	40.6	28.5	23.5	37.6	19.3	33.4	25.0	31.0	28.4	21.1	32.5	23.0	18.2	24.9	49.1	30.9	19.6	22.7	30.7	33.0	17.6	23.8	27.8	53.0	33.3	22.4	48.0	66.5	34.4	34.4	23.3	21.3	30.6	25.4	42.0	17.4	25.5	25.4	39.6	30.7	44.9	23.4	27.7	15.1	24.7	23.4	35.0	25.0	33.4	32.0	53.0	62.3	64.1	21.3	29.8	30.3	88.8	31.1	53.3	39.5	32.0	58.2	39.0	61.9	45.8	36.9	39.8	41.8	40.0	48.9	55.1	38.0	20.1	92.6	48.4	3.1	5.3	7.8	9.5	4.2	5.8	4.1	3.7	4.1	3.0	3.7	6.6	18.2	19.2	11.0	6.5	29.6	23.6	16.7	10.5	27.3	12.2	15.9	13.7	16.4	17.2	10.7	3.7	4.2	10.3	27.6	9.9	7.9	9.7	12.4	15.6	19.8	13.5	16.8	39.1	13.9	10.8	9.5	12.6	10.7	13.7	13.3	16.6	12.5	11.0	10.7	10.1	13.1	8.0	8.2	23.3	12.4	5.4	9.3	15.1	19.6	15.9	15.0	7.6	25.7	10.1	20.5	10.1	15.0	11.7	17.3	16.2	8.5	11.2	8.9	14.4	19.7	13.2	14.5	27.2	14.3	19.5	19.9	10.3	27.3	9.5	10.0	18.4
CCDC181	"C1orf114, FLJ25846"	ENSG00000117477	"Coiled-coil domain containing 181"	Q5TID7	1	169394870-169460669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 41.5;testis: 27.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 66.1;Cone photoreceptor cells: 66.7;Early spermatids: 289.9;Late spermatids: 69.3;Respiratory ciliated cells: 109.6;Rod photoreceptor cells: 89.4;Spermatocytes: 201.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"basophil: 1.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 7.1;GAMG: 7.4;NTERA-2: 13.8;SCLC-21H: 8.4;SH-SY5Y: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027189, HPA027275, HPA027281, HPA027312"	Enhanced		Uncertain	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"		"HPA027189: AB_10599252, HPA027275: AB_10602172, HPA027281: AB_10601452, HPA027312: AB_10601349"	"unprognostic (2.45e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.97e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.89e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.41e-2)"	0.4	2.5	7.4	0.5	7.9	0.5	0.4	8.4	11.9	3.1	14.2	0.7	0.2	3.6	1.9	0.4	12.3	3.6	1.9	7.7	10.3	6.2	0.1	1.8	0.2	8.0	9.0	6.3	3.8	12.1	18.2	0.1	7.6	2.0	0.2	41.5	0.4	2.0	0.2	0.6	0.4	2.0	7.5	0.1	1.6	27.6	8.9	0.4	0.5	0.3	0.1	1.2	1.0	7.1	0.2	0.3	7.1	0.1	0.2	0.2	0.2	0.1	0.0	1.8	3.7	0.1	0.2	0.1	0.1	0.0	7.4	0.1	0.3	0.0	0.3	0.2	1.6	1.8	0.2	0.0	0.0	2.0	0.1	0.7	0.0	0.4	0.0	0.1	0.1	5.7	0.1	0.1	1.3	0.1	4.5	0.0	13.8	0.1	0.0	0.0	5.9	0.1	1.1	0.0	8.4	9.9	0.0	0.3	0.5	3.7	0.0	0.0	0.5	1.4	4.4	0.2	6.4	2.1	2.0	0.0	2.8	0.1	5.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.4	7.9	8.4	11.9	7.7	10.3	8.0	9.0	7.6	7.5	8.9	7.1	0.2	3.2	4.7	6.8	0.0	0.0	0.2	2.7	0.6	66.1	0.8	0.4	6.3	0.0	22.5	9.2	66.7	0.0	0.2	0.1	15.6	1.2	289.9	47.0	1.9	1.5	19.2	2.1	16.2	1.6	0.0	3.1	0.0	1.7	1.3	4.5	0.7	0.0	0.1	25.2	13.1	0.0	6.1	0.0	0.0	69.3	3.1	0.5	0.0	5.6	0.0	23.5	0.0	8.5	3.9	0.7	0.0	10.5	0.0	0.1	0.0	16.2	109.6	89.4	6.6	13.1	3.4	201.8	41.1	0.4	0.0	0.1	0.4	4.0	0.0	0.5
CCNB3		ENSG00000147082	"Cyclin B3"	Q8WWL7	X	50202713-50351914	"Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 4.8;testis: 5.9"	"Cell type enhanced"	"Detected in some"		"Oligodendrocytes: 9.1;Sertoli cells: 13.1;Spermatocytes: 48.2;Spermatogonia: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.7;GAMG: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA000496			Approved	"Nuclear speckles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA000496: AB_1078605"	"unprognostic (1.57e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.48e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.63e-2)"	0.2	0.3	0.4	0.0	0.8	0.0	0.2	0.8	0.9	0.0	0.2	0.1	0.0	0.0	4.8	0.1	0.2	0.1	0.1	0.4	0.6	0.6	0.4	0.3	0.1	1.0	0.9	0.1	0.4	0.1	0.7	0.0	0.9	0.1	0.1	0.5	0.1	0.2	0.5	0.3	0.1	0.0	0.6	0.3	0.4	5.9	0.8	0.2	0.3	0.0	0.1	0.1	0.1	1.4	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	1.7	0.5	0.3	0.1	2.3	0.1	0.2	0.1	0.1	0.4	0.5	0.3	0.0	0.0	0.4	0.4	0.3	0.2	0.0	0.1	0.3	0.0	0.1	1.2	0.0	1.3	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.3	0.1	1.1	0.1	0.1	0.7	1.2	0.3	0.2	0.3	0.2	0.7	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.8	0.9	0.4	0.6	1.0	0.9	0.9	0.6	0.8	1.4	0.0	0.0	0.0	1.6	0.4	0.0	0.1	0.1	0.0	0.6	0.2	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	1.6	1.2	0.2	0.2	0.0	0.0	0.5	0.2	0.0	0.1	2.0	0.2	0.0	0.1	0.4	0.9	0.1	0.0	0.4	0.1	2.0	1.0	0.3	1.3	0.3	0.6	0.0	1.9	0.0	0.2	5.2	0.0	9.1	0.1	0.1	0.0	0.4	0.1	0.0	0.3	2.0	0.4	13.1	0.3	0.1	48.2	12.4	0.4	0.1	0.0	0.3	1.7	0.1	0.0
CCNJL	FLJ14166	ENSG00000135083	"Cyclin J like"	Q8IV13	5	160249083-160345396	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 23.4;Intestinal goblet cells: 28.5;Paneth cells: 26.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 18.6"	"Group enriched"	"Detected in some"	17	"neutrophil: 12.7;NK-cell: 4.2"	"Group enriched"	"Detected in many"	85	"granulocytes: 12.7;NK-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 49.8;RT4: 28.0;WM-115: 38.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049970	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear speckles"		"HPA049970: AB_2680974"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.60e-4)"	"unprognostic (1.26e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.10e-4)"	"prognostic favorable (8.02e-4)"	0.9	3.8	1.2	1.6	1.2	1.4	1.3	18.6	3.1	2.6	1.3	7.8	1.3	0.7	0.6	1.0	1.3	0.7	5.7	4.7	1.2	4.0	0.7	7.8	0.4	1.8	2.0	5.4	0.2	0.1	3.8	0.9	2.1	1.4	5.8	1.5	4.8	1.3	0.2	0.5	3.3	0.8	1.4	7.5	7.2	12.2	2.2	2.6	4.2	2.6	1.1	3.4	1.5	1.3	3.9	20.8	16.4	0.2	0.0	0.0	0.0	0.0	0.3	1.9	0.8	7.9	16.8	0.0	13.2	0.2	13.9	5.9	2.3	49.8	1.3	0.0	0.3	6.0	7.3	6.8	0.2	0.0	0.2	0.0	4.2	2.7	11.9	9.9	12.7	5.8	0.1	0.0	5.3	2.7	0.0	12.1	11.5	0.0	7.8	3.4	4.6	1.7	12.6	28.0	4.7	10.5	2.9	3.7	17.1	6.2	9.9	1.1	14.9	2.6	13.8	0.0	9.8	0.0	0.0	0.0	0.0	0.0	38.3	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	4.2	0.0	0.0	0.0	0.2	1.2	1.2	18.6	3.1	4.7	1.2	1.8	2.0	2.1	1.4	2.2	1.3	0.6	22.4	23.4	9.4	0.0	0.3	1.8	3.8	0.0	0.7	1.0	2.3	4.8	0.0	6.8	3.7	0.0	0.0	4.5	4.4	5.9	2.7	1.0	0.5	1.4	2.6	2.4	0.0	0.7	0.2	0.0	1.2	1.1	1.4	1.3	11.5	2.2	0.2	0.1	0.0	9.3	28.5	8.2	0.3	0.3	3.6	2.1	2.1	5.4	2.8	0.6	8.3	14.4	1.5	0.7	1.7	26.8	2.6	0.5	1.3	4.3	0.2	1.5	0.1	0.0	0.7	1.9	0.5	10.0	0.4	0.4	0.0	2.2	11.2	4.6	2.4
CDC25C	"CDC25, PPP1R60"	ENSG00000158402	"Cell division cycle 25C"	P30307	5	138285269-138338355	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.8;lymphoid tissue: 8.9;testis: 18.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 41.4;Late spermatids: 42.1;Spermatocytes: 53.6;Spermatogonia: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB003800, HPA066991"	Approved		Enhanced	"Nuclear speckles"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"CAB003800: AB_562081, HPA066991: AB_2685760"	"unprognostic (2.45e-3)"	"unprognostic (5.89e-3)"	"prognostic favorable (2.49e-4)"	"unprognostic (9.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.03e-6)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.06e-1)"	0.2	0.2	0.2	2.1	0.2	5.8	0.7	0.3	0.3	0.3	0.2	3.4	3.0	0.4	0.2	1.4	0.2	0.2	0.1	0.2	0.2	0.1	0.5	0.3	3.2	0.2	0.3	0.0	0.4	0.1	0.1	1.2	0.2	0.2	4.1	0.1	0.3	0.1	0.0	1.4	3.0	0.8	0.1	0.9	1.1	18.1	0.2	8.9	0.1	0.0	4.6	0.5	0.5	0.2	27.9	11.0	38.4	28.9	0.9	3.6	9.9	16.4	17.5	36.2	50.3	27.3	52.8	13.3	13.8	10.1	40.5	14.9	31.7	25.9	34.9	11.1	21.5	9.6	15.0	21.2	0.3	6.3	10.0	0.8	0.9	22.0	18.0	3.8	24.6	28.9	14.8	24.2	22.9	15.5	19.3	16.7	9.7	22.3	12.2	11.9	34.2	15.0	6.4	8.4	19.2	11.9	36.8	11.0	16.9	32.6	18.7	13.9	7.2	19.9	16.8	13.9	26.5	15.0	13.4	13.0	8.3	14.3	15.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.1	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.1	0.0	0.0	1.3	0.9	0.6	0.3	1.1	1.8	0.0	0.9	0.8	0.3	0.0	0.2	0.0	0.0	5.0	0.5	1.8	0.0	0.1	41.4	0.4	0.9	0.6	0.0	9.5	1.3	0.0	6.9	1.1	3.6	1.2	0.0	5.5	1.4	0.4	2.7	0.0	1.0	3.9	2.0	0.6	0.5	42.1	1.8	1.2	0.0	1.0	0.6	0.0	0.0	1.0	0.3	0.0	1.4	0.4	4.5	0.3	0.9	0.1	0.1	0.0	0.0	0.2	0.9	53.6	13.0	4.3	0.4	1.4	0.6	0.2	4.9	0.6
CDK11B	"CDC2L1, CDK11-p110, CDK11-p46, CDK11-p58"	ENSG00000248333	"Cyclin dependent kinase 11B"	P21127	1	1635225-1659012	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 174.6;Spermatogonia: 176.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA025061, HPA073626"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA025061: AB_1846407, HPA073626: AB_2686619"	"unprognostic (7.52e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (9.75e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.19e-2)"	"unprognostic (6.52e-3)"	31.8	29.0	20.6	17.6	20.8	43.0	30.0	18.1	20.9	32.4	16.6	46.1	25.6	35.9	5.8	30.3	31.6	9.9	39.6	18.3	20.2	28.2	32.1	41.0	19.5	21.2	19.8	33.4	35.0	8.9	30.5	10.6	20.7	31.7	9.4	9.0	28.4	12.7	85.9	39.3	44.6	10.4	20.4	47.7	34.5	49.8	20.8	13.2	30.8	17.8	10.6	37.9	30.8	21.6	47.2	36.4	21.9	17.4	17.8	12.0	30.6	43.7	18.8	24.0	20.8	41.3	43.7	40.8	43.9	18.7	16.9	35.4	18.6	22.0	18.4	36.3	40.4	43.9	68.9	36.1	24.1	50.4	44.3	16.1	15.8	26.2	19.9	14.1	24.5	42.3	51.9	26.9	14.4	31.0	47.9	42.5	38.9	13.8	43.7	46.9	43.4	33.5	12.7	16.6	28.3	36.4	40.3	36.7	42.3	15.0	25.2	33.4	37.4	29.8	33.0	22.7	43.0	60.5	58.7	85.6	37.4	55.9	23.2	7.2	3.3	5.3	6.1	2.8	2.7	3.3	3.8	3.6	2.8	3.7	4.1	3.1	13.8	4.4	3.2	5.1	3.2	1.6	20.6	20.8	18.1	20.9	18.3	20.2	21.2	19.8	20.7	20.4	20.8	21.6	35.2	19.2	43.1	13.7	42.9	14.4	19.5	10.2	25.6	32.0	22.2	18.3	42.9	30.0	31.7	27.6	20.9	27.7	44.7	86.6	9.8	33.3	39.7	28.1	34.2	32.3	28.8	25.0	14.1	35.2	31.5	25.1	48.9	36.3	55.6	24.1	25.7	38.6	20.5	15.2	12.3	73.8	10.2	30.1	14.5	25.6	28.9	33.9	5.4	15.0	36.3	20.5	76.2	10.1	18.2	37.4	93.3	26.7	54.7	19.6	95.4	19.2	29.4	42.4	52.6	25.9	31.0	174.6	176.5	27.5	17.3	44.6	48.9	16.5	56.9	15.9
CDYL	"CDYL1, DKFZP586C1622"	ENSG00000153046	"Chromodomain Y like"	Q9Y232	6	4706159-4955551	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Lyase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035578	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 52: Non-specific - Ribosome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"HPA035578: AB_2674685"	"unprognostic (1.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.38e-3)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.94e-1)"	14.0	6.0	6.9	10.2	6.8	20.0	11.5	5.0	6.7	15.0	4.9	13.0	7.0	15.2	10.5	16.8	10.6	8.4	10.4	6.0	6.4	7.2	5.6	8.9	12.1	6.6	6.2	9.9	7.5	12.4	5.1	18.2	6.0	7.6	13.2	6.7	9.0	11.9	19.5	17.8	9.0	14.5	5.6	9.6	9.2	9.0	6.7	9.3	9.7	12.7	12.9	15.6	13.0	6.9	23.7	22.1	30.1	25.5	23.3	15.9	34.4	23.1	17.9	21.3	22.9	18.0	17.2	5.3	22.1	17.6	33.3	19.8	24.2	28.2	24.9	16.4	20.2	20.9	21.0	16.4	28.5	27.9	21.7	12.5	49.8	25.0	37.5	12.9	20.6	19.2	37.9	16.2	10.8	22.9	14.8	25.9	32.6	17.9	21.3	19.0	26.2	43.7	14.7	20.5	25.5	15.4	28.5	24.9	36.9	86.5	15.0	26.3	28.1	25.2	21.6	18.5	26.8	33.7	57.8	18.4	8.3	17.7	28.1	5.3	1.3	0.6	1.5	0.6	1.1	1.0	1.1	1.2	1.6	1.1	0.7	1.1	0.4	1.6	0.8	6.8	0.1	1.3	6.9	6.8	5.0	6.7	6.0	6.4	6.6	6.2	6.0	5.6	6.7	6.9	32.7	19.2	9.4	28.7	18.4	37.3	23.9	11.9	10.8	16.7	31.2	35.8	18.8	14.3	12.0	14.7	22.9	12.9	64.5	44.7	15.6	10.8	62.8	26.9	43.2	22.9	32.3	41.5	52.3	10.4	22.0	18.7	6.1	60.3	5.7	24.3	18.9	11.7	10.5	45.4	41.5	26.6	6.1	17.3	57.9	74.9	5.9	28.1	8.8	101.2	22.7	25.4	19.6	54.3	64.1	16.8	41.8	8.2	22.3	30.1	4.6	10.7	12.1	25.7	6.6	29.7	20.9	10.4	25.3	9.8	41.9	63.8	17.5	10.9	22.6	56.9
CHTOP	"C1orf77, DKFZP547E1010, FOP, SRAG"	ENSG00000160679	"Chromatin target of PRMT1"	Q9Y3Y2	1	153633982-153646306	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028647, HPA030540"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA028647: AB_10602699, HPA030540: AB_2673516"	"unprognostic (2.72e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (9.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.30e-3)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (1.58e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic favorable (2.69e-4)"	42.4	44.8	48.1	36.5	54.1	62.5	44.2	54.7	56.0	52.5	48.3	44.2	30.3	45.2	36.2	50.3	47.5	21.9	63.3	47.8	51.1	66.5	54.8	39.3	46.6	51.9	50.7	55.2	63.4	35.9	48.7	33.4	52.2	48.4	32.7	59.9	44.4	29.6	124.4	52.6	46.8	30.5	50.0	65.4	47.9	37.6	49.6	65.7	55.8	68.4	44.4	45.1	47.9	63.5	74.3	63.9	106.2	65.0	45.2	33.1	84.3	51.2	47.0	71.3	61.2	71.6	72.9	83.5	75.6	48.0	46.6	66.8	103.4	74.7	46.9	97.8	95.7	65.5	102.2	60.0	56.1	101.8	78.8	38.5	84.8	69.0	97.5	59.2	57.7	89.4	82.1	62.2	54.1	94.3	109.8	102.6	123.6	106.9	79.1	67.5	65.0	92.5	69.8	100.5	64.3	74.5	54.6	77.8	91.6	69.9	83.7	138.6	50.0	47.7	70.4	60.7	83.8	86.2	77.8	95.5	50.1	81.9	56.8	84.9	42.9	40.9	46.0	44.8	46.2	46.2	45.3	45.3	54.4	43.3	45.2	41.0	30.8	35.1	43.0	41.7	51.9	46.4	48.1	54.1	54.7	56.0	47.8	51.1	51.9	50.7	52.2	50.0	49.6	63.5	46.4	32.1	37.3	32.3	50.1	63.0	103.6	59.7	37.5	40.8	45.6	33.5	74.1	57.2	43.5	53.3	33.3	91.7	47.7	49.2	50.9	69.5	34.9	50.6	42.6	54.2	60.3	81.9	16.1	64.8	121.9	47.1	42.3	63.4	46.3	59.7	43.9	41.2	69.7	43.7	17.6	56.4	42.7	48.9	38.2	18.0	44.7	40.9	35.6	14.0	69.3	44.0	52.5	16.6	40.1	61.3	58.1	42.2	48.2	101.8	48.4	49.0	33.2	57.5	19.7	34.9	59.7	125.2	115.2	46.5	61.7	128.6	45.7	57.9	52.3	110.2
CIR1	CIR	ENSG00000138433	"Corepressor interacting with RBPJ, CIR1"	Q86X95	2	174348022-174395712	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 187.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 187.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015784, HPA061442"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA015784: AB_1846782, HPA061442: AB_2732664"	"unprognostic (3.17e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (9.80e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (1.04e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.10e-3)"	"prognostic favorable (2.04e-5)"	26.7	23.8	36.3	23.4	38.1	67.3	35.9	38.5	61.1	26.6	39.5	27.7	25.8	27.4	43.5	20.3	28.3	23.4	28.7	36.0	37.3	25.9	27.5	26.7	31.1	36.8	37.0	33.7	24.9	27.4	25.1	29.8	36.6	26.2	26.3	23.6	24.9	26.0	30.7	30.5	26.7	20.7	35.9	35.0	25.5	31.4	36.3	32.3	29.0	25.2	29.5	24.0	24.2	40.1	20.4	11.4	26.5	21.2	36.3	50.4	39.2	32.9	46.5	32.3	39.5	21.5	30.7	14.1	30.3	32.4	28.3	24.0	22.1	23.4	38.6	26.1	29.1	29.4	17.8	34.9	35.1	35.2	26.0	41.7	41.9	35.5	26.5	55.6	32.4	24.9	30.7	30.8	31.0	19.5	44.1	55.6	24.5	33.2	31.6	24.7	38.1	42.2	38.4	32.1	30.7	36.1	22.7	28.7	52.9	45.7	21.6	51.6	33.6	26.1	19.0	24.9	17.3	34.6	31.4	5.2	37.4	18.2	23.3	71.0	33.8	55.9	28.4	31.7	28.4	41.2	32.2	30.5	21.4	40.5	33.4	30.9	187.8	45.3	33.9	39.5	37.2	28.3	36.3	38.1	38.5	61.1	36.0	37.3	36.8	37.0	36.6	35.9	36.3	40.1	82.0	118.6	79.8	30.0	80.8	28.6	52.2	118.6	39.3	51.7	40.6	66.8	61.4	61.5	101.2	42.3	31.3	72.7	116.5	69.1	119.3	67.3	201.5	192.2	79.7	58.7	51.4	102.5	30.4	78.7	58.1	69.9	30.1	79.6	81.6	59.1	75.7	58.6	63.8	45.4	33.7	81.9	85.5	93.0	30.3	43.4	107.2	75.3	33.8	22.5	108.2	85.7	111.2	30.2	37.3	57.7	79.8	82.4	49.1	37.5	91.6	114.0	202.3	56.2	72.3	71.4	72.1	219.5	54.7	25.4	32.0	116.0	80.5	62.6	53.5	45.7
COPS4	CSN4	ENSG00000138663	"COP9 signalosome subunit 4"	Q9BT78	4	83034447-83075818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036894, HPA042828"	Approved		Supported	"Nuclear speckles"		NA	NA		100000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA036894: AB_10670929, HPA042828: AB_2678191"	"unprognostic (1.82e-3)"	"unprognostic (1.01e-2)"	"prognostic favorable (4.14e-4)"	"unprognostic (7.97e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.21e-2)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.84e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-1)"	25.6	38.6	28.4	22.0	30.7	41.0	32.0	26.9	33.5	31.7	26.0	27.4	23.1	30.8	28.8	30.5	26.0	22.5	59.7	30.6	35.0	38.8	29.2	22.2	29.9	28.4	29.9	31.9	24.6	43.7	39.2	30.2	32.0	30.3	25.1	45.6	23.7	30.5	104.8	26.7	22.0	33.3	28.7	22.5	22.4	45.0	30.8	36.2	38.4	84.1	32.7	31.8	23.5	28.9	51.7	30.4	64.1	59.0	56.0	71.7	34.8	67.2	85.7	74.8	66.0	43.7	51.8	86.9	57.3	140.5	41.3	37.7	80.6	68.9	101.1	55.6	56.9	50.4	43.5	42.1	46.3	86.8	135.6	54.4	47.0	55.8	47.8	56.2	101.1	53.5	65.2	48.0	91.9	43.4	105.0	63.6	35.3	81.1	40.6	74.0	48.8	48.1	59.8	47.2	67.7	39.6	45.0	69.4	43.5	43.8	52.7	46.4	66.7	52.2	55.1	39.7	48.6	49.8	32.7	96.8	50.3	55.2	52.8	91.4	37.0	55.2	43.0	50.4	53.9	39.7	47.1	49.7	45.3	38.9	44.7	48.1	8.2	54.6	59.8	29.0	47.6	52.3	28.4	30.7	26.9	33.5	30.6	35.0	28.4	29.9	32.0	28.7	30.8	28.9	25.6	12.8	20.1	21.9	34.1	42.8	42.2	94.5	23.3	38.7	20.1	23.4	81.3	20.0	51.5	20.2	31.3	82.5	36.5	14.5	90.1	42.4	130.6	24.9	27.6	31.9	31.2	26.5	34.7	33.2	62.7	39.9	15.3	21.3	34.2	38.2	20.0	22.4	49.0	26.9	32.9	22.0	67.1	29.2	29.2	38.3	30.7	27.2	33.8	18.7	37.8	62.5	37.0	28.6	32.9	28.2	22.1	42.9	28.6	20.5	22.6	75.7	37.9	44.6	32.9	34.1	42.5	121.2	50.2	29.7	35.2	95.0	32.8	53.3	26.3	34.3
CRIP3	"bA480N24.2, TLP, TLP-A"	ENSG00000146215	"Cysteine rich protein 3"	Q6Q6R5	6	43299710-43308826	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 24.3;testis: 25.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Distal tubular cells: 9.8;Granulosa cells: 12.5;Late spermatids: 7.9;Oligodendrocyte precursor cells: 6.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	16	"myeloid DC: 44.6"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 44.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.8;HEK 293: 3.3;HeLa: 3.5;Hep G2: 6.5;NTERA-2: 5.7;RPMI-8226: 4.6;THP-1: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036198	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles"		"HPA036198: AB_10670791"	"unprognostic (8.35e-3)"	"unprognostic (4.14e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.49e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-3)"	"unprognostic (5.02e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.80e-4)"	0.8	0.6	10.1	1.7	10.2	2.6	0.9	11.3	16.5	2.4	8.1	1.1	2.0	1.3	1.6	0.7	2.0	0.6	24.3	10.1	10.4	5.3	10.4	0.6	5.4	9.4	9.4	2.1	1.6	2.1	2.3	0.2	9.4	5.7	0.4	2.5	0.8	8.0	0.4	1.8	3.5	0.6	9.0	7.9	0.8	25.7	10.0	1.6	2.0	0.0	5.9	1.1	1.4	10.4	0.0	0.8	0.2	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.2	0.0	0.1	0.6	2.8	0.1	0.0	0.0	3.3	0.0	3.5	6.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.6	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.7	0.9	0.0	1.7	0.0	2.3	0.0	0.0	44.6	2.6	0.0	0.0	0.8	0.3	2.3	0.4	0.0	1.8	10.1	10.2	11.3	16.5	10.1	10.4	9.4	9.4	9.4	9.0	10.0	10.4	0.2	0.0	0.0	9.4	2.8	0.6	0.3	0.0	0.0	0.9	0.1	0.8	3.2	5.7	0.1	0.0	0.0	0.0	0.1	0.3	9.8	1.1	3.9	1.1	0.2	0.2	0.0	0.8	4.7	0.2	0.0	0.2	0.0	0.1	0.0	12.5	0.0	2.9	0.2	0.0	3.5	0.1	0.0	0.9	3.4	7.9	1.2	0.7	0.0	1.0	1.4	0.5	1.0	6.6	3.4	0.3	0.1	0.0	0.1	0.1	0.7	4.5	0.3	0.8	0.0	0.3	0.4	5.3	1.6	0.0	0.0	0.0	0.3	1.0	0.4	0.1
CSRNP2	"C12ORF2, C12orf22, FAM130A1, PPP1R72, TAIP-12"	ENSG00000110925	"Cysteine and serine rich nuclear protein 2"	Q9H175	12	51061205-51083664	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018503, HPA019914"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA018503: AB_1845535, HPA019914: AB_2670315"	"unprognostic (8.67e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (1.10e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.74e-2)"	"prognostic favorable (2.78e-4)"	12.2	10.4	19.1	7.4	19.3	3.3	11.1	15.5	21.9	13.4	13.3	11.9	6.7	13.7	11.9	7.7	11.2	11.6	12.7	19.3	19.7	12.2	6.8	10.8	8.3	14.1	15.4	12.4	9.3	11.8	17.6	11.4	14.2	11.6	7.0	20.5	9.9	10.5	16.8	9.5	8.8	14.6	12.0	10.0	10.0	26.2	19.2	13.9	11.4	14.7	7.0	12.3	9.7	16.5	9.0	10.2	30.2	27.1	22.8	16.0	31.5	17.3	19.9	23.8	16.3	19.6	6.4	7.5	16.2	18.7	16.2	10.8	14.9	9.5	18.8	15.4	10.4	8.9	12.1	6.1	24.7	6.2	12.8	19.6	26.4	27.6	15.6	25.9	23.6	34.0	12.5	13.1	27.8	15.6	21.3	8.6	24.8	4.2	14.3	12.5	19.1	6.0	13.6	11.6	21.2	25.1	25.1	20.0	25.9	21.2	12.7	17.2	21.4	23.6	12.4	15.8	11.9	13.5	16.0	6.9	14.5	8.1	7.7	0.0	0.3	1.0	0.7	0.0	0.2	0.4	0.7	0.4	0.4	0.2	0.7	1.0	1.0	2.2	0.2	0.1	0.5	0.2	19.1	19.3	15.5	21.9	19.3	19.7	14.1	15.4	14.2	12.0	19.2	16.5	17.8	3.2	6.8	13.1	9.4	17.8	11.4	7.1	8.0	6.8	14.1	20.2	19.5	5.7	5.4	5.5	25.0	6.6	13.8	15.4	3.9	6.9	23.5	10.3	14.4	12.7	8.3	4.0	39.9	5.0	9.2	15.6	63.2	10.0	11.4	13.1	13.6	2.6	6.5	6.7	32.3	10.8	8.2	4.4	14.8	14.8	6.2	9.7	16.0	11.2	4.2	5.4	5.2	23.6	20.7	8.0	7.5	7.9	10.8	10.0	8.6	4.2	7.4	7.6	0.0	20.2	17.3	28.6	13.8	6.8	16.1	15.1	12.5	5.9	5.7	6.6
CWC25	"CCDC49, FLJ20291"	ENSG00000273559	"CWC25 spliceosome associated protein homolog"	Q9NXE8	17	38800441-38825355	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 28.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014874, HPA062997"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB014874: , HPA062997: AB_2684917"	"unprognostic (2.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.43e-3)"	"unprognostic (8.79e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.68e-3)"	13.3	12.6	7.9	9.9	8.9	62.2	12.3	8.5	9.7	11.6	8.8	11.1	10.3	10.3	5.4	12.5	11.9	7.6	9.0	8.2	8.5	11.6	16.2	13.0	12.6	8.7	8.5	11.2	12.6	7.2	11.0	6.7	8.5	11.7	6.1	8.6	10.9	4.5	12.7	17.4	13.1	6.8	8.0	16.8	11.6	18.4	8.5	14.2	11.3	7.1	9.0	10.9	11.5	9.4	11.2	13.1	8.2	14.1	10.9	7.1	8.3	11.5	7.9	12.0	11.0	8.4	11.7	12.7	7.8	9.2	9.2	25.3	8.2	7.7	14.5	12.0	8.7	9.9	14.9	10.4	10.8	25.2	15.6	8.4	12.3	11.8	9.7	12.7	9.8	13.5	15.5	15.0	10.2	6.2	26.4	25.6	8.5	8.2	6.4	20.0	12.1	11.4	12.0	10.7	9.3	8.2	10.7	7.6	13.8	12.2	12.0	19.8	10.2	10.8	9.9	14.3	17.9	11.9	9.3	18.8	11.4	12.1	10.9	18.0	4.1	10.6	4.6	3.9	4.0	4.5	4.3	4.8	3.5	6.0	4.9	3.7	28.7	5.9	8.1	1.7	2.9	3.0	7.9	8.9	8.5	9.7	8.2	8.5	8.7	8.5	8.5	8.0	8.5	9.4	50.7	57.7	69.5	10.4	54.2	63.9	61.2	45.9	39.9	37.2	40.8	31.2	18.3	21.5	46.3	23.9	83.4	35.1	60.6	56.6	29.4	27.5	118.4	63.8	51.7	45.3	41.8	34.5	10.0	23.6	35.2	43.8	52.0	100.2	58.9	23.8	37.9	27.2	28.6	26.9	7.9	51.9	26.4	27.0	37.9	31.9	37.3	38.2	26.6	5.6	38.7	30.1	41.2	5.5	8.1	29.3	70.9	34.6	43.2	51.4	61.5	27.2	41.9	43.4	39.5	57.0	45.7	93.9	33.6	30.5	76.7	79.1	54.6	28.8	32.6	72.4
CYP4V2	CYP4AH1	ENSG00000145476	"Cytochrome P450 family 4 subfamily V member 2"	Q6ZWL3	4	186191567-186213463	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sensory transduction, Vision"	"Monooxygenase, Oxidoreductase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 103.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.2;SK-MEL-30: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029122	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear speckles"		"HPA029122: AB_10601806"	"unprognostic (1.65e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.66e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.49e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (1.49e-7)"	"unprognostic (3.25e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	7.4	16.4	5.1	5.2	6.8	2.1	5.7	5.6	5.0	8.6	17.9	9.6	16.5	5.6	2.6	5.0	6.1	14.7	9.2	4.8	5.1	33.9	113.5	10.8	5.6	5.3	6.0	5.7	15.6	33.4	3.7	3.5	5.3	8.2	11.9	14.2	7.0	7.5	4.5	1.3	16.7	7.1	5.4	11.2	6.2	3.2	5.6	6.5	17.3	5.0	4.9	6.4	2.3	6.3	3.4	1.8	0.8	0.0	15.2	6.3	0.2	4.4	9.9	1.7	1.9	0.0	13.0	1.1	0.5	3.5	5.9	1.6	1.9	1.7	0.3	6.0	2.2	4.7	0.8	0.5	5.6	2.6	1.9	5.8	0.8	1.9	1.0	5.9	0.1	6.4	1.4	14.3	6.8	2.9	3.6	1.3	1.5	1.6	0.0	3.1	0.7	1.0	7.4	6.1	4.0	4.9	1.1	0.0	27.5	0.3	2.6	4.6	4.1	3.6	0.7	3.5	1.6	0.1	0.0	0.5	10.9	11.0	4.7	0.0	0.6	0.0	1.8	1.9	1.0	0.4	1.4	1.8	0.7	1.0	1.3	1.3	0.0	0.8	3.1	1.3	1.1	0.9	5.1	6.8	5.6	5.0	4.8	5.1	5.3	6.0	5.3	5.4	5.6	6.3	9.0	6.4	11.5	31.3	13.8	2.5	4.5	5.1	9.6	33.6	9.3	7.2	18.8	42.9	8.7	14.7	31.3	2.0	9.6	14.7	9.8	24.2	2.7	6.7	5.1	7.7	16.9	16.4	15.4	22.4	2.1	14.2	12.8	7.6	7.0	6.5	8.9	103.7	13.5	5.0	23.4	16.5	2.0	14.8	6.0	2.1	5.0	11.3	3.6	6.5	3.5	52.2	4.1	15.6	11.0	9.6	9.0	6.4	12.3	3.8	47.2	28.5	11.9	27.4	0.0	10.1	10.6	8.9	6.3	6.8	3.1	1.0	17.2	6.7	10.5	5.7
DAZAP2	KIAA0058	ENSG00000183283	"DAZ associated protein 2"	Q15038	12	51238724-51271362	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045940			Supported	"Nuclear speckles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA045940: AB_2679506"	"unprognostic (1.00e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.75e-3)"	"unprognostic (8.43e-2)"	"unprognostic (4.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.94e-9)"	"unprognostic (1.79e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.84e-3)"	136.4	115.7	112.2	187.5	125.3	613.5	154.0	136.6	124.4	150.5	109.8	206.2	194.9	131.6	122.5	129.9	180.5	168.0	202.1	105.1	125.9	251.4	198.4	193.2	220.6	132.7	119.8	114.1	116.5	227.3	30.7	79.5	134.4	152.8	215.5	75.2	140.7	171.8	113.5	121.4	200.5	148.4	129.8	224.3	174.3	52.7	116.5	213.2	209.8	106.7	241.5	190.3	76.3	151.5	159.8	209.0	95.4	92.2	201.1	171.5	57.6	104.6	208.9	187.7	162.8	155.9	239.0	153.2	262.2	209.9	130.0	147.8	134.2	178.4	189.2	167.3	160.2	227.1	129.7	91.0	216.4	265.5	350.2	220.5	252.1	175.3	147.2	207.2	234.8	118.8	141.6	303.1	155.4	252.6	219.8	145.6	19.6	109.2	58.7	123.2	144.7	165.3	244.9	260.2	103.3	101.0	159.3	137.9	121.3	56.7	190.5	382.7	195.7	111.1	102.4	136.9	132.6	231.5	237.5	158.6	161.2	175.0	66.9	2018.1	2144.1	3354.3	1055.9	1770.0	979.3	1090.7	962.8	1037.9	1354.1	1068.7	1063.1	918.3	3499.5	1045.4	1727.1	875.9	1420.3	4885.3	112.2	125.3	136.6	124.4	105.1	125.9	132.7	119.8	134.4	129.8	116.5	151.5	116.7	144.2	205.1	19.6	271.9	113.8	201.2	144.6	167.9	50.6	127.7	88.5	114.3	165.8	127.9	235.4	58.4	55.8	167.4	337.2	266.1	158.6	28.1	115.1	87.2	138.3	126.3	155.6	16.8	194.7	53.5	108.0	171.8	142.1	182.2	72.2	157.1	177.1	209.4	67.3	16.8	230.6	140.4	444.4	214.2	85.6	117.4	282.0	135.2	19.7	324.4	88.7	221.4	15.6	43.9	198.0	275.8	95.5	169.5	179.9	233.3	292.7	155.9	55.2	46.0	63.2	130.4	39.4	35.4	153.5	133.3	124.9	249.6	72.8	182.4	268.7
DDX17	P72	ENSG00000100201	"DEAD-box helicase 17"	Q92841	22	38483438-38507660	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, mRNA processing, mRNA splicing, RNA-mediated gene silencing, rRNA processing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024908, HPA063142"	Supported		Supported	"Nuclear speckles"	"Intracellular and membrane"	NA	NA		420000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB024908: , HPA063142: AB_2684949"	"unprognostic (1.46e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.24e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (6.06e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.51e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.19e-3)"	181.2	172.4	142.0	124.3	160.1	74.5	198.5	150.9	178.4	248.7	174.8	233.8	107.8	216.1	255.3	150.4	248.1	121.1	168.7	143.5	152.1	247.2	152.8	202.2	186.4	152.8	149.4	298.8	214.0	144.7	309.9	158.8	155.3	234.4	114.2	342.0	188.4	123.3	184.8	197.0	227.2	119.7	146.8	293.0	192.1	91.1	148.2	215.2	300.0	106.6	158.2	204.4	201.5	196.5	122.0	79.9	237.6	141.8	148.2	166.0	120.7	104.3	85.9	118.3	121.2	89.0	100.5	225.8	65.8	119.5	82.9	133.2	212.5	127.9	145.9	202.5	142.1	140.4	175.8	133.5	153.4	192.9	170.8	122.3	183.7	86.8	142.9	211.7	153.3	109.6	139.7	255.3	116.0	75.6	128.7	164.0	148.0	172.1	51.6	218.0	122.9	137.1	141.2	132.6	134.1	75.3	155.0	125.9	161.2	180.5	110.0	148.4	140.8	125.7	77.6	80.0	79.3	203.7	130.3	183.4	156.7	123.1	154.2	6.7	8.1	9.5	7.6	7.9	8.9	9.0	7.1	7.3	7.0	7.2	5.7	6.8	16.6	5.1	8.7	10.5	9.1	6.0	142.0	160.1	150.9	178.4	143.5	152.1	152.8	149.4	155.3	146.8	148.2	196.5	252.6	214.7	325.5	483.8	241.9	223.6	206.1	129.3	158.2	448.3	300.7	195.3	147.2	180.1	223.5	283.3	352.3	127.6	297.5	172.8	33.2	111.7	44.4	280.0	293.4	250.4	236.1	177.1	198.9	90.2	99.9	207.5	216.1	234.2	200.7	505.3	233.8	205.3	113.9	321.4	242.1	191.6	146.5	200.6	194.8	49.1	323.7	197.7	154.7	253.9	235.1	223.4	304.9	334.3	553.3	104.7	153.1	278.7	213.1	193.5	154.8	89.8	270.8	559.4	289.3	260.5	213.6	136.4	74.2	120.4	279.9	139.4	218.6	293.7	147.0	255.3
DDX39A	"BAT1L, DDX39, DDXL, URH49"	ENSG00000123136	"DExD-box helicase 39A"	O00148	19	14408798-14419383	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 147.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 308.4;Late spermatids: 283.3;Spermatocytes: 307.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055334	Approved		Approved	"Nuclear speckles"		NA	NA		200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"HPA055334: AB_2682787"	"unprognostic (1.31e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (1.50e-10)"	"unprognostic (1.55e-3)"	"unprognostic (8.57e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.38e-3)"	28.2	21.6	17.1	49.6	20.7	105.5	24.7	21.9	23.0	22.1	18.0	26.4	28.6	21.9	8.7	39.3	18.2	13.6	24.9	17.0	18.6	21.0	21.9	25.1	76.2	21.9	19.8	14.9	15.7	10.2	15.5	18.1	22.0	16.8	20.2	4.7	19.0	8.8	20.7	24.4	33.8	15.1	19.0	55.7	27.2	147.8	20.5	80.4	20.5	12.7	65.1	25.9	22.7	25.2	198.8	175.9	87.8	147.2	32.4	22.4	73.5	84.8	48.0	176.1	105.7	183.3	98.7	375.0	87.5	71.1	101.0	114.8	215.7	135.9	74.3	129.0	127.3	408.5	201.0	133.1	55.1	225.1	164.0	30.1	30.6	113.1	47.0	25.4	89.1	134.4	253.4	150.3	95.7	270.9	375.4	320.1	147.9	208.8	280.4	248.9	139.7	212.0	62.5	179.6	181.5	98.2	64.3	127.8	98.6	54.3	138.0	216.5	83.1	144.5	92.7	245.7	192.6	156.0	313.0	399.3	167.1	232.2	148.9	33.2	92.8	29.6	120.1	107.9	106.2	132.5	96.0	96.3	131.1	125.8	83.1	90.1	27.0	84.1	94.3	82.7	153.0	135.5	17.1	20.7	21.9	23.0	17.0	18.6	21.9	19.8	22.0	19.0	20.5	25.2	55.6	16.0	21.4	4.9	90.0	76.0	43.6	53.0	50.1	10.5	30.0	24.8	10.9	21.5	27.4	5.5	0.0	60.6	75.1	60.5	37.2	55.3	308.4	26.6	30.6	53.0	25.7	88.1	3.1	67.2	117.9	33.3	87.7	44.5	93.0	32.7	26.0	12.9	90.5	11.8	3.5	55.4	26.4	48.6	85.2	283.3	26.4	62.7	49.8	4.7	56.7	16.2	50.4	4.0	9.2	53.5	42.7	18.8	115.6	44.5	41.7	26.0	21.1	4.9	19.7	24.8	62.0	307.5	95.4	69.4	71.0	59.9	78.7	32.1	63.8	34.2
DDX39B	"BAT1, D6S81E, UAP56"	ENSG00000198563	"DExD-box helicase 39B"	Q13838	6	31530219-31542448	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 352.9;hTERT-HME1: 244.9;K-562: 255.5;NB-4: 254.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034012, HPA055334, HPA058450"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		270000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721"	"unprognostic (2.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.85e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.43e-5)"	130.5	138.3	11.9	23.7	12.3	5.5	125.0	12.8	13.1	147.7	12.0	126.6	3.0	127.6	103.5	105.9	133.9	6.2	141.8	11.4	12.4	123.0	125.9	117.5	34.5	14.4	12.5	173.0	187.5	7.9	125.0	14.6	12.6	141.8	16.6	34.3	103.1	30.3	181.6	104.3	134.1	9.5	13.5	178.1	117.0	59.8	12.0	40.1	133.4	60.4	26.4	118.6	113.2	14.6	9.0	130.9	37.7	19.7	121.4	78.1	24.7	9.6	11.5	28.8	25.4	13.3	17.8	24.3	75.0	145.0	106.3	16.5	42.8	223.1	26.7	8.1	352.9	19.9	14.3	28.7	13.2	35.1	18.8	129.0	117.8	28.9	244.9	131.0	18.3	157.0	255.5	7.1	24.1	6.3	22.7	254.1	17.2	18.3	13.0	17.9	41.6	10.8	143.5	11.8	18.4	151.2	26.3	9.0	15.6	35.7	6.5	36.5	10.3	3.7	13.9	3.6	26.7	68.2	78.9	229.9	2.3	39.5	16.6	2.5	6.4	4.8	4.8	7.6	6.4	4.2	6.9	6.7	9.3	6.2	10.2	8.8	4.3	5.2	4.6	7.7	7.1	5.6	11.9	12.3	12.8	13.1	11.4	12.4	14.4	12.5	12.6	13.5	12.0	14.6	31.5	22.4	36.9	0.0	43.9	14.4	41.9	13.2	35.9	21.3	21.8	15.7	4.0	5.7	22.2	3.7	22.9	13.9	58.1	15.2	5.9	9.7	1.4	23.0	37.8	26.5	17.3	26.3	0.0	8.2	11.8	28.0	64.2	32.4	37.2	58.3	13.2	6.9	9.8	15.2	0.0	11.7	12.2	14.8	14.4	2.6	16.1	34.9	8.8	0.0	17.1	8.5	66.9	0.0	0.0	10.4	11.7	11.7	44.5	23.0	17.5	5.1	31.5	27.2	26.3	57.9	35.2	6.4	6.7	44.2	13.5	17.0	50.3	79.6	12.7	33.9
DDX42	"RHELP, RNAHP, SF3b125, SF3B8"	ENSG00000198231	"DEAD-box helicase 42"	Q86XP3	17	63773603-63819317	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023447, HPA023571, HPA025941"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA023447: AB_1847560, HPA023571: AB_1847561, HPA025941: AB_1847562"	"unprognostic (3.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.26e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.55e-2)"	43.5	32.6	27.4	30.5	29.4	37.3	42.7	26.2	29.7	38.5	21.6	42.9	31.3	42.4	39.0	32.6	44.0	30.2	35.3	25.8	30.8	30.0	34.8	35.8	40.6	29.9	30.1	54.7	54.4	39.9	29.2	36.5	28.9	39.3	36.4	39.3	47.3	40.7	59.2	39.6	33.5	43.1	29.0	37.2	37.1	39.8	30.7	40.1	34.2	42.7	47.1	39.5	30.6	26.5	87.4	89.9	79.2	81.3	78.2	62.7	85.0	83.4	74.6	74.7	72.9	84.7	55.9	120.8	32.0	94.3	62.4	68.2	90.3	74.3	98.5	35.9	59.1	91.0	92.0	104.2	77.1	106.9	59.7	80.3	69.2	67.9	81.6	63.5	75.2	61.6	103.2	49.7	77.0	71.3	102.8	59.3	75.8	69.4	47.4	88.7	135.8	62.3	68.2	101.3	49.5	93.9	63.2	112.3	74.1	110.7	77.2	87.1	80.5	109.9	67.0	45.3	99.4	55.6	47.9	109.5	56.4	58.1	58.9	1.9	2.2	6.9	3.7	2.2	4.2	2.8	3.0	3.7	2.9	5.3	3.6	3.7	2.0	4.5	4.3	1.8	2.1	1.9	27.4	29.4	26.2	29.7	25.8	30.8	29.9	30.1	28.9	29.0	30.7	26.5	41.5	80.1	60.4	24.2	34.7	31.2	24.4	24.5	48.9	40.9	37.0	38.0	49.5	30.0	49.0	36.8	37.5	33.3	29.3	27.0	13.7	30.4	9.2	64.9	68.0	41.8	40.7	33.0	33.6	27.1	24.4	42.2	32.1	72.0	30.4	82.1	30.0	34.5	23.2	50.5	30.3	37.8	28.5	32.7	26.1	12.7	48.7	29.6	14.2	21.5	55.5	46.6	32.0	18.1	26.7	41.1	25.3	50.4	36.7	39.0	26.5	23.5	65.5	46.7	39.5	63.2	51.8	68.5	63.1	52.7	29.7	27.4	32.7	71.3	33.8	32.4
DGKZ	"DAGK5, DAGK6, DGK-ZETA, hDGKzeta"	ENSG00000149091	"Diacylglycerol kinase zeta"	Q13574	11	46332905-46380554	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 146.2"	"Cell type enhanced"	"Detected in all"		"NK-cells: 129.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	27	"amygdala: 46.5;basal ganglia: 75.1;cerebral cortex: 146.2;hippocampal formation: 133.8;white matter: 51.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051336	Enhanced	Supported	Supported	"Nuclear speckles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"		"HPA051336: AB_2681448"	"unprognostic (2.85e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.66e-3)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (1.48e-3)"	"unprognostic (7.75e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.84e-3)"	20.7	14.2	46.5	21.6	75.1	54.6	19.4	3.3	146.2	16.5	0.0	20.3	36.4	16.8	4.0	19.5	15.3	11.1	46.5	133.8	0.0	18.3	10.5	18.3	39.9	0.0	0.0	12.4	31.5	10.0	58.7	14.1	0.0	18.6	6.6	2.5	43.4	10.7	95.7	22.3	41.2	9.1	0.0	36.1	22.2	15.4	1.4	34.0	12.5	25.1	17.1	18.2	15.3	51.0	38.1	33.2	22.1	33.2	11.5	12.8	102.1	29.0	21.5	30.0	26.3	39.8	17.1	48.4	20.5	30.1	33.0	43.3	26.7	42.0	10.6	48.8	62.5	31.7	25.2	29.5	20.5	60.5	61.2	17.3	19.3	16.5	22.2	15.3	33.4	39.3	45.1	29.1	21.5	99.8	58.6	94.3	64.3	54.5	50.3	69.0	38.2	20.6	9.1	36.6	150.3	25.6	33.2	109.6	23.0	13.8	78.8	75.2	37.9	39.2	42.4	62.6	52.9	19.1	23.4	40.3	53.8	54.0	37.2	12.4	13.5	6.0	6.8	5.6	4.1	0.3	4.3	5.9	12.0	0.8	4.3	4.6	9.5	7.6	6.4	5.7	4.4	10.5	46.5	75.1	3.3	146.2	133.8	0.0	0.0	0.0	0.0	0.0	1.4	51.0	46.0	3.2	6.6	44.7	16.4	13.3	22.3	16.3	14.2	27.6	24.6	19.8	24.4	8.6	8.7	9.2	20.9	14.6	95.8	37.7	9.8	13.2	6.1	9.9	15.2	34.2	51.5	23.4	114.0	47.8	105.1	12.4	34.1	14.1	21.0	25.7	56.7	7.1	51.2	16.8	45.0	26.3	22.4	46.1	26.9	11.4	13.1	34.0	12.4	31.9	50.6	6.4	129.8	8.5	24.7	33.5	41.0	8.2	25.3	16.6	97.0	20.2	8.2	9.9	32.9	17.8	16.8	7.0	12.2	12.3	9.2	27.4	71.8	19.4	29.9	17.2
DHX15	"DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p"	ENSG00000109606	"DEAH-box helicase 15"	O43143	4	24517441-24584554	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047047	Approved		Enhanced	"Nuclear speckles"		NA	NA		130000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA047047: AB_2679916"	"unprognostic (4.46e-3)"	"unprognostic (2.47e-2)"	"prognostic favorable (5.74e-4)"	"unprognostic (3.35e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.77e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-3)"	40.3	35.7	17.0	51.2	23.2	78.5	50.7	30.5	22.6	41.3	29.4	48.8	36.8	44.5	30.2	43.9	38.5	35.6	33.3	18.4	20.9	45.7	44.7	37.1	60.2	20.9	20.3	43.8	47.7	52.1	21.6	55.0	22.0	39.5	57.9	40.1	37.7	35.9	43.0	42.1	37.9	48.0	20.8	40.0	44.7	33.5	20.2	79.8	40.0	42.2	70.9	65.6	34.7	29.0	135.0	129.1	209.4	104.6	100.6	97.4	124.7	153.0	133.9	157.8	155.5	132.0	158.5	245.4	91.8	126.2	183.7	109.8	272.1	184.1	243.7	90.6	129.0	213.3	134.7	107.3	59.2	222.3	140.9	82.2	108.4	154.3	103.1	100.8	133.9	113.4	203.4	96.2	181.3	101.3	293.7	148.2	228.4	133.4	115.8	190.4	245.3	114.6	187.1	190.2	179.0	111.9	118.7	112.8	109.1	149.0	123.8	113.7	123.5	132.8	87.5	101.6	181.4	72.1	130.2	289.3	89.1	177.9	161.8	57.5	29.6	28.5	28.8	30.8	39.7	28.7	32.0	33.7	39.0	29.9	33.2	32.2	13.9	37.1	38.5	25.8	38.6	28.5	17.0	23.2	30.5	22.6	18.4	20.9	20.9	20.3	22.0	20.8	20.2	29.0	51.2	76.9	57.4	40.1	53.4	98.7	68.3	58.0	56.3	30.2	50.1	36.7	28.1	35.8	70.6	27.6	22.9	72.7	44.9	79.8	37.2	59.3	32.6	61.7	53.2	53.6	60.5	58.9	51.4	41.8	69.7	55.5	79.5	97.3	57.0	47.4	42.8	48.4	44.7	26.9	50.8	69.3	36.7	46.9	53.2	16.5	39.4	50.2	48.0	49.6	48.0	24.4	34.0	61.3	99.1	57.1	41.2	40.3	51.0	73.1	33.2	34.8	55.6	32.1	26.3	59.6	69.4	72.9	46.3	60.4	100.0	88.2	49.3	34.0	71.2	89.4
DLX2	TES-1	ENSG00000115844	"Distal-less homeobox 2"	Q07687	2	172099438-172102900	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 3.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 6.5;Early spermatids: 6.9;Gastric mucus-secreting cells: 5.6;Inhibitory neurons: 10.0;Melanocytes: 5.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"hypothalamus: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"AN3-CA: 79.7;HEK 293: 50.8"	"Region enhanced"	"Detected in many"		"olfactory bulb: 29.4"	"Region enriched"	"Detected in many"	5	"olfactory bulb: 23.2"	HPA056965			Approved	"Nuclear speckles"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"		"HPA056965: AB_2683291"	"unprognostic (8.12e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.60e-3)"	"unprognostic (3.03e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.69e-10)"	"unprognostic (9.38e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.95e-3)"	0.0	0.3	1.4	0.0	1.1	0.1	0.2	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	79.7	0.5	0.3	2.2	4.3	1.0	0.7	0.2	0.5	0.2	0.0	2.4	2.0	3.8	4.1	2.6	0.3	0.2	0.1	50.8	1.3	8.8	2.0	0.2	0.4	0.3	0.0	3.7	0.1	0.5	0.3	0.0	2.0	0.6	0.0	0.5	0.2	0.1	0.6	0.1	0.0	1.1	0.0	0.4	0.0	0.1	0.1	2.8	0.0	2.1	1.2	5.0	1.3	0.6	0.4	0.4	5.5	0.0	3.0	0.5	0.1	0.1	0.5	4.7	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.1	0.0	0.9	0.4	3.0	0.0	0.0	0.0	0.0	0.5	0.1	1.4	0.0	0.0	0.0	1.3	1.8	0.2	0.9	0.6	0.0	3.1	3.6	0.4	0.0	0.2	0.0	0.0	0.4	6.5	1.0	0.0	0.0	6.9	1.6	0.3	0.5	0.0	0.0	0.1	0.0	0.3	0.2	5.6	1.1	0.0	0.0	0.0	0.0	0.5	0.0	10.0	1.1	0.0	0.0	0.3	0.1	0.0	1.8	5.4	1.0	0.0	0.2	0.0	0.0	0.1	0.0	1.2	0.0	0.4	0.1	1.3	0.0	0.1	0.0	0.0	0.3	1.5	0.9	0.7	1.6	0.0	0.4	1.5	0.2	0.6	0.0
DNMT3L	MGC1090	ENSG00000142182	"DNA methyltransferase 3 like"	Q9UJW3	21	44246339-44262216	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.9"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 20.8;Proximal tubular cells: 29.1"	"Cancer enriched"	"Detected in some"	90	"testis cancer: 46.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BEWO: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055234, HPA066780"	Approved		Approved	"Nuclear speckles"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA055234: AB_2682750, HPA066780: AB_2685719"							"unprognostic (1.05e-4)"			"unprognostic (1.91e-1)"			"unprognostic (2.73e-9)"	"unprognostic (2.77e-1)"	"unprognostic (5.28e-2)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	1.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	20.8	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1
DPCD	"DKFZP566F084, RP11-529I10.4"	ENSG00000166171	"Deleted in primary ciliary dyskinesia homolog (mouse)"	Q9BVM2	10	101570560-101609662	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 132.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 579.4;Late spermatids: 1068.7;Respiratory ciliated cells: 329.7;Spermatocytes: 313.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 20.2;intermediate monocyte: 22.2;myeloid DC: 29.6;non-classical monocyte: 9.5"	"Group enriched"	"Detected in all"	14	"dendritic cells: 29.6;monocytes: 22.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036603, HPA036604"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"		"HPA036603: AB_2675212, HPA036604: AB_10673503"	"unprognostic (1.22e-2)"	"unprognostic (1.73e-3)"	"unprognostic (4.66e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.90e-1)"	"unprognostic (9.13e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.83e-2)"	"unprognostic (7.54e-2)"	10.5	18.7	35.1	8.7	37.2	11.8	19.4	31.5	42.0	21.8	55.1	17.3	6.8	16.7	41.3	20.4	73.3	15.5	29.6	37.4	39.1	30.9	10.4	14.0	6.2	36.2	37.1	23.5	14.7	49.3	49.5	10.6	36.5	16.1	13.5	55.8	21.2	15.7	19.2	13.2	7.1	18.0	33.3	4.5	14.4	132.4	39.7	6.6	33.0	18.3	8.2	14.4	14.9	33.4	97.1	53.4	37.9	77.2	35.2	61.7	15.6	44.5	53.6	59.4	55.1	38.8	51.4	9.0	74.6	42.7	25.2	54.0	55.4	65.3	61.2	23.0	57.5	11.3	49.8	56.7	20.3	58.8	8.1	42.3	54.8	72.0	56.1	153.7	50.8	14.0	32.4	12.6	45.1	122.9	0.0	48.1	28.7	26.9	41.6	0.0	51.8	20.5	92.6	25.3	37.1	63.3	36.5	23.4	31.3	34.1	71.2	23.9	35.5	27.3	24.9	55.7	62.3	37.9	45.9	16.9	94.7	13.7	11.7	0.0	20.2	1.0	1.8	22.2	1.7	1.3	1.4	1.4	29.6	0.7	1.5	1.8	0.9	1.6	9.5	4.1	0.6	8.1	35.1	37.2	31.5	42.0	37.4	39.1	36.2	37.1	36.5	33.3	39.7	33.4	6.9	35.3	12.4	4.9	2.1	9.7	29.5	89.2	9.6	16.4	25.4	29.5	33.7	30.0	56.6	49.7	18.8	24.6	0.9	10.5	95.9	63.3	579.4	136.5	23.5	11.1	23.9	14.1	7.7	27.5	16.7	21.2	10.2	20.2	1.3	19.2	11.4	10.9	24.0	11.8	6.2	12.5	52.9	4.4	14.6	1068.7	23.6	8.7	16.0	3.7	6.9	27.8	2.1	4.0	1.4	33.9	12.4	27.8	5.6	18.6	3.5	117.3	329.7	49.1	0.0	12.4	29.0	313.8	77.4	8.7	14.2	10.7	2.9	25.3	22.1	23.9
E2F7		ENSG00000165891	"E2F transcription factor 7"	Q96AV8	12	77021248-77065569	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.0;lymphoid tissue: 8.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 46.9;Endometrial ciliated cells: 17.2;Late spermatids: 70.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"midbrain: 5.8;pons: 6.4;thalamus: 11.3"	HPA064866			Supported	"Nuclear speckles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA064866: AB_2685374"	"unprognostic (1.21e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.14e-5)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.67e-5)"	"unprognostic (1.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-1)"	0.2	0.1	0.2	1.1	0.2	5.0	0.2	0.0	0.3	0.3	0.3	0.9	0.7	0.2	0.0	1.4	0.6	0.7	0.2	0.2	0.2	0.1	0.2	0.3	1.5	0.7	0.8	0.1	0.2	0.1	0.5	1.0	0.4	0.2	1.5	0.2	0.2	0.1	0.0	1.1	0.8	0.3	0.6	0.3	0.6	2.9	0.2	8.3	0.1	0.1	1.6	0.6	0.5	0.2	20.1	9.4	25.7	10.1	0.8	2.5	31.1	27.6	29.8	14.2	17.0	12.8	6.6	11.2	5.4	5.5	29.5	15.1	15.5	29.8	27.1	4.4	10.4	9.8	27.3	7.3	5.9	8.5	8.8	0.8	7.7	37.4	22.9	8.3	14.2	19.0	10.4	8.9	29.5	10.1	31.9	0.1	18.1	6.7	21.9	23.0	22.2	6.2	3.5	16.8	16.3	10.7	22.9	7.9	6.5	10.9	12.6	8.7	39.3	53.5	26.8	23.0	36.7	9.5	5.8	7.1	19.3	3.8	34.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.2	0.2	0.0	0.3	0.2	0.2	0.7	0.8	0.4	0.6	0.2	0.2	0.1	0.0	0.5	2.3	0.5	0.3	1.0	1.4	4.6	0.0	0.6	0.9	2.1	0.0	2.2	0.0	0.0	1.8	0.4	1.5	0.0	0.3	46.9	17.2	0.8	1.5	0.0	7.4	0.4	1.1	3.1	0.8	6.1	3.1	4.5	6.3	0.0	0.0	0.9	0.0	0.2	1.2	2.0	0.3	1.2	70.2	0.3	1.3	0.0	3.7	0.0	1.6	0.0	0.5	0.0	12.0	0.1	0.7	6.9	1.7	0.0	0.0	3.1	0.1	0.0	0.0	1.2	1.2	2.1	6.3	0.6	0.3	0.8	0.4	2.1	4.3
EPC2	DKFZP566F2124	ENSG00000135999	"Enhancer of polycomb homolog 2"	Q52LR7	2	148644440-148787569	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 125.7;Oligodendrocytes: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036759	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA036759: AB_10672365"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.83e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.91e-2)"	16.4	14.0	9.6	13.5	10.9	50.3	17.2	22.0	13.4	18.2	7.8	12.4	9.7	25.5	14.1	12.2	15.3	15.3	15.5	9.9	11.3	12.9	12.7	14.6	18.0	9.6	9.9	31.9	9.8	12.1	9.9	18.5	9.9	16.2	13.9	14.0	11.5	15.5	15.9	11.7	10.5	19.1	9.7	15.9	12.0	14.2	11.5	23.1	19.3	18.5	15.9	15.6	14.0	14.5	9.2	7.0	23.8	14.8	15.7	19.5	17.9	15.9	21.4	25.3	21.2	14.1	12.0	19.8	7.8	18.7	10.9	12.1	20.7	12.7	31.1	17.6	15.4	38.9	11.0	19.8	16.0	29.7	22.7	20.5	22.1	25.8	25.3	15.6	15.9	15.9	20.9	33.4	16.0	14.7	20.2	19.8	24.3	8.7	13.6	20.7	22.1	18.2	12.7	25.6	32.5	23.6	19.6	12.0	29.8	16.6	7.7	25.8	19.2	20.2	17.7	14.0	13.6	20.3	17.0	25.0	16.0	17.4	21.9	0.1	0.9	1.2	0.9	0.7	1.3	0.8	1.4	0.8	0.9	0.8	1.5	1.1	4.5	0.3	2.0	1.0	1.4	0.5	9.6	10.9	22.0	13.4	9.9	11.3	9.6	9.9	9.9	9.7	11.5	14.5	24.2	25.6	13.6	60.1	21.1	14.0	26.4	4.8	4.0	19.6	15.4	17.1	22.0	8.6	15.1	9.2	6.2	11.3	27.5	8.4	3.9	9.1	28.5	23.5	25.9	17.0	18.0	15.8	79.2	8.8	11.7	20.7	8.6	27.3	6.3	15.6	7.9	5.0	8.6	8.4	75.3	9.2	2.0	16.1	10.2	5.5	23.9	17.7	12.4	70.3	11.3	14.1	20.6	125.7	99.3	9.3	9.1	23.0	10.7	20.3	6.3	6.7	9.8	15.7	13.1	44.4	25.4	19.3	18.6	7.8	15.6	20.1	25.2	16.3	8.1	23.6
EPG5	"hEPG5, KIAA1632"	ENSG00000152223	"Ectopic P-granules autophagy protein 5 homolog"	Q9HCE0	18	45847609-45967329	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 53.1;Oligodendrocytes: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"LHCN-M2: 55.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031689	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"		"HPA031689: AB_10609997"	"unprognostic (3.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.11e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.66e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (4.04e-5)"	"unprognostic (5.71e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.18e-1)"	6.6	6.8	5.8	4.4	6.0	13.8	6.8	6.3	6.2	7.1	5.1	5.8	3.2	6.1	5.8	7.1	6.0	3.2	8.4	6.2	5.3	6.6	6.0	8.8	5.7	5.1	8.1	8.9	6.3	6.9	7.6	4.5	5.3	5.9	4.0	8.6	6.0	3.7	8.6	10.1	6.0	4.1	4.5	9.5	5.6	4.8	5.8	8.4	9.3	6.7	5.9	5.4	6.6	6.3	5.3	4.1	4.1	3.0	13.8	16.6	4.1	33.2	13.7	18.7	19.4	1.2	3.9	5.4	2.0	25.0	22.5	4.9	5.5	6.6	23.7	4.5	2.3	4.2	4.7	4.2	13.1	7.2	10.4	11.2	6.0	20.6	14.0	16.5	9.4	4.7	3.7	2.8	55.8	3.7	3.2	6.9	2.0	1.9	2.5	3.0	5.1	3.8	8.8	7.3	4.4	3.4	5.9	2.4	7.0	5.8	3.4	5.1	23.0	23.2	4.9	3.4	9.2	5.7	4.3	3.0	9.9	6.2	7.7	0.4	0.7	0.7	1.5	0.7	1.4	0.4	0.9	0.8	0.5	0.6	0.7	0.9	0.8	0.4	0.6	0.6	0.5	0.3	5.8	6.0	6.3	6.2	6.2	5.3	5.1	8.1	5.3	4.5	5.8	6.3	8.8	19.2	10.5	24.5	9.0	10.3	4.6	6.8	8.0	16.7	11.9	8.3	17.1	10.0	7.4	11.0	25.0	7.6	15.7	5.8	1.9	6.5	4.6	9.0	9.8	9.3	8.3	11.4	53.1	3.6	4.4	7.8	6.1	16.9	7.0	14.4	13.6	10.3	12.2	13.5	46.5	6.9	6.1	16.0	6.2	3.0	12.5	11.5	14.2	40.3	16.6	6.5	27.8	40.2	51.4	7.8	6.5	11.7	10.0	9.1	6.2	8.3	10.5	17.4	13.1	9.8	6.7	8.4	7.1	5.9	13.2	9.0	15.4	9.8	6.5	9.4
EPHB6	HEP	ENSG00000106123	"EPH receptor B6"		7	142855061-142871094	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 66.0;skin 1: 65.8"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 226.6;Sertoli cells: 105.2;Suprabasal keratinocytes: 118.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"MOLT-4: 39.6;RT4: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035784			Uncertain	"Nuclear speckles"	"Intracellular and membrane"	NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear speckles"		"HPA035784: AB_2674781"	"unprognostic (1.90e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (7.08e-3)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (2.53e-3)"	"unprognostic (3.15e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (4.68e-5)"	9.2	0.7	26.9	1.8	42.0	2.2	3.6	9.7	66.0	18.6	9.2	2.6	0.0	8.9	2.3	10.6	13.5	1.5	3.2	27.7	14.4	4.0	1.5	4.0	2.3	12.9	14.1	7.9	12.4	0.9	2.4	0.4	12.9	14.3	0.1	2.8	5.7	7.3	1.4	65.8	5.0	1.6	12.6	4.3	3.3	5.0	16.7	14.5	9.4	0.7	2.3	7.8	18.5	48.7	0.2	0.0	0.0	0.8	7.5	3.0	0.0	0.9	0.8	0.2	0.1	1.0	2.3	0.0	0.0	0.1	0.0	8.8	0.4	0.0	0.0	2.0	0.3	0.6	0.0	0.3	1.2	9.7	0.4	1.7	0.8	3.0	0.0	0.1	0.5	5.2	2.1	0.0	0.1	0.2	39.6	5.8	6.8	1.4	3.6	0.8	0.0	0.0	0.0	71.7	0.0	0.0	3.3	2.0	0.0	1.5	6.1	0.4	0.0	0.0	2.6	0.0	0.0	0.0	0.6	0.0	0.0	3.5	0.0	0.0	0.8	0.4	0.0	0.3	0.3	1.6	1.1	0.6	0.5	0.3	1.4	0.7	0.5	0.0	0.1	0.0	1.0	0.7	26.9	42.0	9.7	66.0	27.7	14.4	12.9	14.1	12.9	12.6	16.7	48.7	1.9	3.2	1.7	6.2	12.5	54.4	30.7	13.3	42.1	12.1	1.8	6.7	3.0	45.8	10.0	7.3	2.1	0.2	1.9	0.1	5.9	28.2	0.9	5.7	20.0	2.8	1.8	8.6	65.1	6.8	0.0	15.6	6.1	7.2	0.0	3.2	1.8	3.5	4.2	0.0	43.4	0.1	0.0	13.2	10.4	8.3	30.1	8.9	12.4	8.4	7.1	226.6	5.2	5.5	4.6	32.4	0.1	9.8	1.6	11.0	0.0	0.6	4.9	6.6	105.2	31.5	20.5	0.5	7.2	40.0	118.5	0.3	14.0	0.7	0.1	22.2
ERCC8	"CKN1, CSA"	ENSG00000049167	"ERCC excision repair 8, CSA ubiquitin ligase complex subunit"	Q13216	5	60866454-60945073	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cockayne syndrome, Deafness, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.3;Excitatory neurons: 51.8;Inhibitory neurons: 47.9;Oligodendrocyte precursor cells: 44.2;Oligodendrocytes: 57.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029328			Approved	"Nuclear speckles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA029328: AB_2673000"	"unprognostic (5.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.10e-3)"	"unprognostic (9.68e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.75e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.31e-3)"	"unprognostic (7.19e-2)"	3.4	3.1	2.3	1.6	2.4	2.0	3.1	3.1	3.2	2.5	1.5	2.6	1.7	3.0	1.4	2.8	2.4	1.9	3.2	2.3	1.7	4.0	3.2	2.2	1.6	1.9	1.8	2.7	2.7	3.0	2.5	2.1	2.1	2.2	2.4	2.7	2.7	2.1	3.0	2.4	2.2	2.3	1.4	2.6	2.5	4.1	2.0	2.8	2.9	2.9	2.2	2.5	2.6	2.9	4.8	4.9	7.3	9.5	6.0	4.2	8.2	7.6	6.4	8.9	9.2	6.9	8.6	7.3	9.4	4.2	14.4	4.0	10.6	7.4	11.1	7.6	6.0	5.3	7.3	7.7	5.0	4.9	4.5	6.5	6.5	6.1	7.5	3.3	9.9	8.8	8.0	4.2	5.2	8.1	6.9	8.0	6.5	2.8	3.1	11.0	9.6	9.1	4.7	5.9	6.1	11.3	8.6	3.6	6.5	7.6	11.2	3.6	3.8	3.8	7.4	7.6	10.1	5.5	11.9	12.7	5.9	10.1	8.3	0.5	4.2	0.9	3.1	3.4	2.5	2.7	2.4	2.8	7.1	1.8	2.8	3.2	0.7	2.2	1.4	3.5	3.3	2.1	2.3	2.4	3.1	3.2	2.3	1.7	1.9	1.8	2.1	1.4	2.0	2.9	3.4	3.2	4.6	28.4	6.6	2.9	3.1	6.9	9.6	0.0	4.9	5.5	4.1	7.2	3.3	16.5	0.0	7.7	4.2	1.6	15.6	5.0	47.3	4.3	7.2	3.9	0.0	10.5	51.8	5.2	9.2	5.2	5.1	3.1	5.7	8.1	3.9	5.0	6.4	0.0	47.9	3.8	4.1	7.1	5.5	11.2	4.7	6.5	7.2	20.6	7.9	0.0	6.2	44.2	57.4	5.2	2.2	3.0	11.1	3.8	2.0	7.1	6.3	0.0	0.0	4.0	4.6	22.5	9.2	10.4	4.3	3.4	6.5	8.9	4.4	3.5
ESX1	"ESX1L, ESXR1"	ENSG00000123576	"ESX homeobox 1"	Q8N693	X	104250038-104254933	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 8.9"	"Cell type enriched"	"Detected in some"	25	"Spermatogonia: 98.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"TIME: 24.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051992, HPA073330"	Enhanced		Supported	"Nuclear speckles"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA051992: AB_2681684, HPA073330: "															"unprognostic (1.87e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	98.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
EXOSC7	"EAP1, hRrp42p, KIAA0116, p8, RRP42, Rrp42p"	ENSG00000075914	"Exosome component 7"	Q15024	3	44975241-45036066	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036182, HPA057980"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA036182: AB_10673346, HPA057980: AB_2683571"	"unprognostic (1.69e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.67e-3)"	"prognostic favorable (2.69e-4)"	"unprognostic (4.33e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.20e-1)"	17.5	44.1	9.5	12.5	9.5	17.2	18.4	10.0	10.4	23.5	10.7	15.3	11.6	20.4	7.0	27.2	17.0	9.1	27.0	9.5	10.9	22.2	18.1	15.0	19.6	10.4	9.8	19.0	18.6	20.1	17.3	15.4	10.1	15.9	10.8	5.9	17.5	15.9	43.8	44.6	13.2	11.2	9.7	15.3	20.0	23.2	10.5	20.2	19.9	36.4	16.8	22.7	22.2	9.8	61.5	55.7	44.9	37.3	45.9	50.0	40.5	26.2	42.2	56.0	57.7	93.3	47.8	77.4	40.3	45.6	42.6	33.9	55.9	72.2	46.0	52.3	49.2	67.5	64.5	91.5	88.7	95.3	26.5	44.1	45.6	61.2	123.6	36.5	54.8	84.9	107.4	37.8	40.3	63.2	68.6	167.9	54.3	55.2	78.4	33.8	41.7	117.7	51.0	85.5	20.9	31.4	37.0	31.6	39.7	38.4	46.7	77.9	39.3	28.8	43.0	48.3	71.7	47.1	47.5	92.6	42.4	131.6	26.2	6.8	41.3	7.6	38.8	41.5	43.6	71.3	44.6	40.2	66.0	59.7	51.8	41.4	2.1	58.3	31.5	40.2	47.7	45.4	9.5	9.5	10.0	10.4	9.5	10.9	10.4	9.8	10.1	9.7	10.5	9.8	25.0	35.3	30.1	16.0	23.2	61.8	68.8	97.2	47.3	29.5	23.9	43.2	39.0	21.5	46.5	35.0	18.8	67.8	22.1	8.6	135.0	51.7	3.9	23.7	34.8	24.0	13.1	19.6	19.9	46.7	62.4	32.7	23.0	21.7	15.2	33.0	18.2	28.6	46.5	20.2	22.5	19.3	79.3	14.2	22.6	8.3	47.8	17.4	26.6	8.4	20.6	37.6	33.0	10.6	14.0	41.7	10.3	41.0	19.4	74.8	17.7	47.4	34.3	23.4	13.1	25.7	53.9	53.7	66.3	35.5	74.2	63.1	26.2	52.2	24.3	56.3
FAM107A	"DRR1, TU3A"	ENSG00000168309	"Family with sequence similarity 107 member A"	O95990	3	58564117-58627610	"Predicted intracellular proteins"	"Cell cycle, Growth regulation, Stress response"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 1923.8;choroid plexus: 1389.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 196.3;Astrocytes: 81.9;Endothelial cells: 121.3;Hepatic stellate cells: 150.6;Muller glia cells: 125.0"	"Cancer enriched"	"Detected in many"	6	"glioma: 110.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC diff: 20.7;HUVEC TERT2: 64.9"	"Low region specificity"	"Detected in all"							HPA055888	Enhanced		Supported	"Nuclear speckles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"		"HPA055888: AB_2682957"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.80e-3)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.73e-2)"	"unprognostic (7.82e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.95e-3)"	73.2	7.5	1824.7	8.3	1801.2	0.3	58.6	1490.8	1923.8	34.5	1389.1	36.9	5.4	36.3	53.3	29.2	87.0	16.0	140.4	1745.7	1736.7	45.0	5.5	93.2	3.1	1611.9	1644.5	11.8	23.3	5.9	109.6	29.4	1613.0	80.5	16.0	85.1	40.6	38.0	26.3	23.3	45.2	42.5	1564.5	25.7	37.7	5.7	1698.7	43.9	51.4	32.8	8.6	68.9	41.6	1770.4	0.0	0.0	0.9	0.0	20.7	1.3	0.3	0.1	0.0	0.1	0.2	0.0	0.1	0.1	5.8	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1.4	0.0	0.1	0.1	0.3	64.9	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.2	0.0	3.6	0.3	0.2	0.2	0.1	0.1	0.0	0.1	1.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1824.7	1801.2	1490.8	1923.8	1745.7	1736.7	1611.9	1644.5	1613.0	1564.5	1698.7	1770.4	196.3	6.4	5.5	81.9	0.5	2.2	50.8	0.3	2.2	5.2	2.3	1.3	26.5	4.3	3.2	38.6	52.1	0.1	0.4	0.0	9.8	1.1	14.5	23.2	2.4	121.3	3.6	2.7	1.4	0.2	0.0	18.4	0.0	39.3	1.3	5.9	150.6	1.6	0.0	3.3	5.3	0.0	0.0	2.2	3.7	32.4	32.9	1.9	5.4	14.0	0.0	125.0	0.0	2.0	0.6	0.3	0.0	11.7	1.3	7.3	0.2	4.5	2.3	50.2	6.6	6.6	10.4	0.7	0.4	0.4	2.7	0.0	1.0	0.5	0.0	2.2
FAM120C	"CXorf17, FLJ20506, ORF34"	ENSG00000184083	"Family with sequence similarity 120C"	Q9NX05	X	54068324-54183281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 33.2;Oligodendrocytes: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047677	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear speckles"		"HPA047677: AB_2680118"	"unprognostic (4.70e-2)"	"unprognostic (2.58e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (4.48e-4)"	"unprognostic (1.86e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.28e-2)"	3.1	3.7	8.3	1.8	9.9	3.4	2.9	8.1	8.9	3.9	2.3	2.9	1.3	3.7	5.1	3.5	3.5	1.7	2.6	7.5	9.0	3.0	3.1	2.4	2.9	11.3	9.2	4.6	2.6	4.0	4.3	2.2	8.7	3.3	1.7	5.8	2.7	3.1	5.9	3.2	2.4	2.8	9.3	3.4	2.1	2.6	9.0	4.1	3.4	2.9	3.1	3.3	3.4	11.0	4.0	7.2	3.6	8.3	8.2	5.9	6.7	3.8	6.3	5.7	6.1	3.4	4.2	5.6	2.5	3.3	8.4	10.7	10.6	2.8	5.0	4.4	11.6	3.0	11.3	5.6	3.7	2.7	3.0	4.1	3.5	5.0	5.8	6.6	3.6	5.7	3.2	4.5	4.6	10.9	4.5	10.8	6.8	2.3	15.9	5.3	5.8	5.9	4.7	2.2	5.0	5.0	9.8	7.4	2.7	8.8	8.8	2.4	6.5	5.0	6.5	6.6	3.1	5.4	5.6	4.2	5.7	8.2	6.1	0.0	1.4	0.1	1.3	0.8	1.1	2.6	1.2	1.0	2.5	2.1	1.3	1.5	0.0	0.9	0.3	3.1	0.4	0.9	8.3	9.9	8.1	8.9	7.5	9.0	11.3	9.2	8.7	9.3	9.0	11.0	4.5	3.2	2.6	21.9	7.8	5.9	5.4	5.0	15.4	10.5	5.5	3.7	5.7	8.6	2.5	0.0	4.2	8.9	4.6	0.8	9.8	3.0	0.1	7.0	7.2	5.5	4.8	7.4	18.1	2.7	5.5	5.5	3.1	7.7	2.5	9.2	5.3	6.1	4.1	6.7	19.0	1.1	2.0	3.2	4.7	0.7	6.5	5.3	1.8	10.3	3.5	5.1	8.2	33.2	32.9	1.5	1.6	4.9	3.0	3.3	0.8	5.6	3.9	8.6	0.0	9.0	5.4	2.0	6.9	12.0	4.7	2.5	5.6	8.7	2.5	3.4
FAM227B	"C15orf33, FLJ32800"	ENSG00000166262	"Family with sequence similarity 227 member B"	Q96M60	15	49326962-49620929	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Early spermatids: 41.0;Oligodendrocytes: 55.1;Spermatocytes: 48.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA049774, HPA061695"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA049774: AB_2680873, HPA061695: AB_2684588"	"unprognostic (1.19e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.28e-4)"	"unprognostic (3.32e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.57e-3)"	"unprognostic (6.32e-3)"	"unprognostic (6.41e-2)"	"unprognostic (7.48e-5)"	"unprognostic (2.70e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.76e-1)"	1.1	5.1	4.2	1.9	5.1	1.5	6.6	4.2	5.2	4.7	4.6	4.3	2.8	6.3	7.3	3.5	7.7	3.4	7.3	3.9	4.8	7.7	7.5	2.7	4.8	4.8	5.0	9.9	6.4	5.6	6.4	1.3	5.2	5.7	2.8	7.9	5.3	5.1	7.9	3.9	2.3	3.9	4.9	2.8	3.6	10.4	4.5	6.8	7.4	8.9	4.4	3.5	2.2	6.3	0.8	0.7	5.1	2.8	1.5	3.0	0.6	2.1	2.8	3.2	5.1	0.7	2.4	1.5	4.9	3.5	3.7	0.8	1.8	3.1	3.7	3.7	1.5	3.2	1.3	1.7	4.2	1.5	1.3	3.1	4.0	1.8	2.0	6.2	3.0	7.7	5.4	2.4	7.1	3.5	3.2	1.3	2.0	1.2	1.3	2.7	4.5	8.1	4.8	1.0	3.8	5.3	1.9	2.5	6.2	3.7	3.1	1.1	2.2	2.2	1.7	3.0	1.3	12.2	9.8	4.8	2.4	3.9	2.4	5.8	0.2	1.7	3.4	0.5	4.5	2.8	3.5	4.6	0.3	3.5	5.8	5.6	0.3	2.7	0.6	3.4	3.4	2.0	4.2	5.1	4.2	5.2	3.9	4.8	4.8	5.0	5.2	4.9	4.5	6.3	1.1	9.6	4.8	39.5	5.8	2.8	5.4	5.4	3.4	4.3	6.2	7.6	10.8	1.5	9.4	3.7	0.0	1.7	3.3	1.3	25.4	3.9	41.0	19.1	3.1	2.8	8.4	2.1	12.8	3.2	1.5	3.7	3.6	3.2	3.8	1.8	1.8	4.1	0.6	5.0	12.1	1.8	6.1	0.6	2.0	21.1	4.1	2.0	3.6	5.6	0.6	11.7	4.1	16.1	55.1	2.5	1.6	3.0	6.1	2.6	1.9	12.5	21.3	8.0	0.0	4.7	2.0	48.7	13.2	2.5	4.3	0.4	5.7	6.3	2.2	2.6
FAM71A	FLJ32796	ENSG00000162771	"Family with sequence similarity 71 member A"	Q8IYT1	1	212624474-212626775	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	105	"testis: 78.7"	"Group enriched"	"Detected in many"	50	"Early spermatids: 1174.2;Late spermatids: 453.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028462, HPA060344"	Enhanced		Approved	"Nuclear speckles"		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA028462: AB_10601904, HPA060344: "																		0.4	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.1	78.7	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.8	0.0	3.7	0.0	0.1	0.5	1.7	4.4	0.6	0.1	3.5	6.7	0.0	4.3	3.3	0.0	0.0	2.6	0.3	1.9	0.0	0.7	1174.2	7.2	2.8	1.6	1.2	0.0	0.0	1.2	1.5	1.8	9.7	16.0	1.3	0.0	1.8	0.4	1.2	0.0	0.0	2.8	0.0	0.0	0.3	453.8	5.3	2.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	2.8	2.6	0.6	2.5	0.4	0.0	1.5	0.0	0.0	3.2	2.7	3.9	2.4	0.8	0.1	2.9	0.8	0.1	2.0	0.5
FBXL4	"FBL4, FBL5"	ENSG00000112234	"F-box and leucine rich repeat protein 4"	Q9UKA2	6	98868535-98948006	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029140, CAB033362"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear speckles"		"CAB033362: AB_2103974, HPA029140: AB_10611967"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.62e-1)"	5.8	8.0	5.9	5.3	8.4	5.1	7.7	7.6	5.5	7.0	5.5	6.2	5.9	6.9	11.2	5.3	7.7	6.6	5.9	4.6	7.1	13.1	15.7	5.9	6.1	8.0	8.3	8.2	9.4	12.7	4.8	6.8	8.4	8.0	6.9	5.1	9.9	6.6	9.4	5.7	5.8	6.2	7.2	5.3	7.4	4.1	7.4	9.0	12.2	7.2	6.4	5.7	5.3	11.0	5.7	9.0	7.6	10.2	12.5	22.8	8.2	12.7	10.7	7.3	10.3	4.1	10.7	13.1	11.5	10.6	12.8	8.1	8.8	9.2	11.1	21.4	7.2	9.3	6.2	9.4	9.7	11.5	8.9	13.0	16.4	6.6	18.4	20.4	9.5	10.2	12.6	10.1	13.4	5.6	4.3	5.5	4.0	7.5	5.5	14.6	5.2	10.7	13.9	8.2	9.5	7.7	6.7	8.9	12.2	9.2	6.6	8.2	13.3	8.4	3.7	11.9	9.3	3.4	3.4	5.5	10.5	10.4	10.2	18.4	4.7	13.0	4.6	4.5	6.1	7.1	4.6	4.6	3.8	5.7	5.9	5.6	5.9	4.3	6.0	2.5	6.1	3.9	5.9	8.4	7.6	5.5	4.6	7.1	8.0	8.3	8.4	7.2	7.4	11.0	12.2	19.2	11.9	42.7	14.2	9.7	8.2	9.0	12.0	14.9	9.1	8.3	16.2	5.7	8.8	36.8	22.9	10.1	9.5	9.8	19.6	9.7	5.4	10.6	14.5	10.8	7.2	20.2	46.9	11.0	10.7	13.7	14.3	7.9	8.9	20.8	11.4	19.4	8.9	10.1	58.3	13.7	8.2	12.3	6.4	2.1	19.0	11.8	5.4	41.2	14.9	10.6	12.3	97.0	94.4	7.5	9.8	12.8	8.8	13.9	12.5	11.8	11.3	13.3	13.1	12.7	10.0	4.1	6.4	12.4	8.5	9.9	9.3	16.9	10.4	8.2
FBXO34	"Fbx34, FLJ20725"	ENSG00000178974	"F-box protein 34"	Q9NWN3	14	55271344-55370053	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 165.2;Late spermatids: 219.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052592	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"HPA052592: AB_2681877"	"unprognostic (6.19e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.47e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.87e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.20e-13)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	9.0	7.9	7.8	11.9	10.7	17.2	12.6	6.5	14.9	12.3	7.1	27.3	14.4	11.0	15.9	33.5	15.0	13.3	13.1	14.4	6.2	18.3	12.0	15.2	12.8	4.6	5.8	11.6	10.5	11.6	6.5	10.0	4.7	12.9	26.8	16.0	17.5	11.6	31.2	12.2	15.1	11.7	4.9	13.9	18.1	24.8	6.7	17.0	22.7	44.7	15.8	16.4	16.1	7.5	30.1	17.2	13.5	12.3	17.3	14.1	14.8	14.9	25.4	22.1	25.5	15.7	37.8	24.0	12.1	12.9	14.4	29.0	17.5	15.0	28.3	14.8	10.2	25.2	10.4	9.7	13.4	30.5	23.8	11.5	21.6	15.4	15.4	17.2	17.0	25.8	19.9	18.8	14.3	20.2	24.0	21.6	8.0	26.3	13.3	25.5	33.1	13.4	20.3	34.2	14.9	16.2	18.0	17.9	14.8	16.3	21.5	19.5	13.0	19.3	24.9	10.5	11.8	9.1	8.2	27.1	13.7	16.4	11.3	9.4	11.2	2.5	9.9	7.5	11.8	7.0	10.1	10.8	11.1	7.0	8.8	9.3	6.1	13.2	14.0	5.1	6.9	8.7	7.8	10.7	6.5	14.9	14.4	6.2	4.6	5.8	4.7	4.9	6.7	7.5	16.2	22.4	31.6	22.9	27.3	21.0	32.9	18.5	15.9	36.7	15.6	12.7	21.5	7.2	32.5	18.4	22.9	13.9	57.8	63.7	17.6	22.8	165.2	27.1	17.4	24.1	26.4	52.8	109.1	30.3	4.7	14.7	31.1	28.9	17.2	21.1	9.3	7.8	9.9	37.0	75.5	30.0	30.5	13.5	24.3	219.1	23.0	27.8	12.4	46.9	12.6	14.1	24.7	35.2	20.7	18.0	35.3	16.6	27.4	31.2	20.0	17.0	34.5	32.4	6.6	24.2	19.3	34.1	16.3	20.7	24.3	27.0	44.1	11.4	29.3	63.2
FEV	Pet-1	ENSG00000163497	"FEV transcription factor, ETS family member"	Q99581	2	218981087-218985184	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 70.8"	"Cell type enriched"	"Detected in some"	32	"Enteroendocrine cells: 744.9"	"Group enriched"	"Detected in some"	10	"pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4"	"Group enriched"	"Detected in many"	7	"midbrain: 70.8;pons: 20.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HMC-1: 35.5;SH-SY5Y: 43.8"	"Region enhanced"	"Detected in single"		"midbrain: 1.9"	"Group enriched"	"Detected in some"	5	"midbrain: 4.8;pons: 2.7"	HPA067679		Supported	Supported	"Nuclear speckles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear speckles"		"HPA067679: AB_2685884"			"unprognostic (4.58e-1)"		"unprognostic (1.60e-1)"					"unprognostic (7.21e-2)"	"prognostic favorable (4.85e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"			0.1	2.3	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	1.2	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	6.2	70.8	0.0	1.3	0.0	2.6	0.0	20.1	2.2	1.8	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.1	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.6	0.6	0.1	6.2	70.8	20.1	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	744.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.2	6.0	0.0	0.0	3.4	1.2	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.1
FIBP	FGFIBP	ENSG00000172500	"FGF1 intracellular binding protein"	O43427	11	65883740-65888531	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 608.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011729	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA011729: AB_1848579"	"unprognostic (1.70e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.10e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.89e-2)"	34.1	48.4	48.0	26.8	49.0	32.2	33.0	48.0	55.1	31.1	41.8	30.8	30.4	35.9	29.4	35.6	37.2	22.3	56.8	51.0	50.5	48.3	37.1	31.6	35.6	53.3	47.6	28.6	39.0	32.8	31.2	25.1	54.3	30.6	27.3	19.8	27.9	24.6	53.6	45.7	35.3	30.9	46.6	43.3	37.7	64.9	49.9	40.3	35.9	56.1	42.9	29.7	28.3	47.8	61.0	86.9	48.3	118.6	72.8	91.2	35.9	54.8	110.9	74.3	62.0	36.1	83.1	79.7	98.2	124.1	35.9	65.2	48.5	121.0	48.1	93.7	62.2	77.3	84.1	54.7	99.8	100.7	64.4	73.8	68.3	54.1	114.4	60.0	93.7	61.5	27.4	139.4	98.9	198.2	78.9	88.0	47.8	61.5	130.7	104.9	45.6	196.3	88.5	79.6	87.8	80.4	60.3	110.6	110.5	32.5	113.0	58.1	86.3	79.7	66.4	130.9	40.3	73.8	87.6	48.4	101.1	73.6	30.7	123.5	121.2	98.9	71.1	136.9	74.4	100.7	67.2	64.9	164.7	83.1	52.7	57.0	20.4	101.1	150.0	84.1	100.6	109.4	48.0	49.0	48.0	55.1	51.0	50.5	53.3	47.6	54.3	46.6	49.9	47.8	55.8	12.8	28.0	4.9	57.0	47.3	51.7	105.7	38.7	47.7	66.9	85.6	44.7	42.9	55.7	44.1	31.3	79.4	41.1	61.6	93.9	114.2	176.7	45.3	59.8	52.6	93.5	39.1	7.1	149.3	125.7	50.3	37.2	39.6	67.2	68.6	45.3	36.5	115.0	42.1	7.3	49.2	57.0	75.3	75.9	608.0	36.1	67.9	51.6	3.7	129.3	47.1	101.0	3.5	5.6	98.9	68.8	39.5	60.1	56.1	185.8	150.1	54.9	52.8	19.7	39.2	77.2	100.5	84.0	51.5	52.1	71.8	54.6	79.6	58.8	61.5
FNBP4	KIAA1014	ENSG00000109920	"Formin binding protein 4"	Q8N3X1	11	47716494-47767443	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039485, HPA040029"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA039485: AB_2676536, HPA040029: AB_2676808"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (5.58e-3)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.60e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (6.35e-4)"	"prognostic unfavorable (1.91e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (7.23e-5)"	38.0	34.4	5.8	12.1	6.1	19.6	36.6	9.9	7.4	46.7	8.4	35.4	8.9	38.9	9.4	33.8	40.6	8.2	29.9	5.7	6.8	29.5	31.3	39.1	15.9	5.9	6.2	48.8	39.2	7.5	29.2	9.6	5.8	36.3	8.8	14.9	32.7	8.2	51.0	40.5	42.8	9.0	5.3	50.6	31.6	16.5	6.4	14.0	42.8	7.0	14.2	34.2	40.2	7.8	10.6	8.5	17.7	12.5	10.0	11.6	12.0	12.3	12.7	11.1	12.9	8.4	14.0	23.2	6.0	14.0	9.3	21.2	15.8	10.0	16.4	18.2	24.1	17.5	28.1	14.3	14.1	19.5	16.6	14.2	16.4	9.7	22.0	16.2	13.1	14.1	19.2	19.2	10.7	9.7	30.0	22.6	16.7	9.4	7.8	21.2	16.8	12.9	10.9	12.8	7.9	13.1	18.5	15.2	10.5	13.2	12.3	9.1	14.4	13.1	13.8	19.0	17.3	18.6	13.4	26.1	9.5	11.9	9.1	3.8	2.1	3.4	3.7	1.5	2.9	5.1	2.6	2.6	1.3	5.4	2.7	2.9	2.0	1.8	2.2	5.6	3.9	0.9	5.8	6.1	9.9	7.4	5.7	6.8	5.9	6.2	5.8	5.3	6.4	7.8	65.0	51.3	71.7	82.6	114.7	70.9	112.5	45.9	112.7	95.1	57.0	49.0	38.2	27.1	63.6	25.8	108.4	48.9	122.0	46.1	5.9	39.9	5.5	94.3	121.9	59.7	36.5	59.1	86.7	37.8	37.4	70.6	89.2	165.4	57.6	95.5	48.2	27.0	28.4	67.3	93.6	46.5	34.6	37.2	58.3	8.0	89.5	59.2	39.2	71.2	62.1	28.1	83.4	100.5	108.3	50.8	39.4	62.1	102.4	120.8	36.6	11.3	60.5	103.2	46.0	70.5	61.6	37.3	28.1	96.0	69.9	82.9	105.7	93.4	42.6	168.0
FNDC1	"bA243O10.1, dJ322A24.1, FNDC2, KIAA1866"	ENSG00000164694	"Fibronectin type III domain containing 1"	Q4ZHG4	6	159169400-159272108	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 14.2;thyroid gland: 20.3"	"Group enriched"	"Detected in some"	4	"Fibroblasts: 28.7;Smooth muscle cells: 11.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.5"	"Group enriched"	"Detected in many"	6	"cerebral cortex: 5.4;hippocampal formation: 8.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;fHDF/TERT166: 2.9;SuSa: 3.1"	"Region enhanced"	"Detected in many"		"olfactory bulb: 7.0"	"Region enhanced"	"Detected in many"		"spinal cord: 10.3"	"HPA030962, HPA030963"	Approved		Approved	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA		14000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"		"HPA030962: AB_10696212, HPA030963: AB_2673676"	"unprognostic (4.59e-2)"	"unprognostic (9.17e-3)"	"unprognostic (7.62e-2)"	"prognostic favorable (6.10e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.93e-6)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.76e-3)"	5.4	0.5	0.5	1.9	0.3	0.0	2.1	0.1	5.4	6.5	0.2	12.9	2.5	2.2	0.0	1.1	0.6	14.2	3.9	8.7	0.3	0.6	0.7	1.6	2.8	0.1	1.0	1.2	1.1	0.3	0.2	0.9	0.0	0.4	1.8	0.1	0.9	0.8	2.1	0.9	4.2	11.7	0.3	0.5	0.4	0.4	0.4	0.1	20.3	9.6	2.4	1.0	1.6	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	5.4	8.7	0.3	0.1	1.0	0.0	0.3	0.4	1.2	2.6	0.0	0.6	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.1	0.5	2.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.3	0.4	4.7	0.7	0.0	0.0	0.2	0.0	0.2	28.7	0.0	0.3	0.0	0.1	1.4	0.0	0.2	0.0	1.7	0.0	0.0	0.0	3.1	0.0	0.3	0.2	1.8	2.8	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	3.0	11.5	1.1	1.4	0.0	1.4	0.1	0.5	0.1	0.0	0.0
FYTTD1	"DKFZp761B1514, UIF"	ENSG00000122068	"Forty-two-three domain containing 1"	Q96QD9	3	197737179-197787596	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054474, HPA074880"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"HPA054474: , HPA074880: "	"unprognostic (3.61e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (2.33e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.69e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.74e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.15e-1)"	29.7	20.9	12.1	27.1	12.6	39.2	26.6	16.1	14.6	24.8	9.1	19.9	16.7	30.4	19.6	43.9	19.1	24.4	41.3	12.1	14.9	25.7	28.9	23.6	32.4	12.4	13.9	27.5	36.4	28.7	12.6	33.5	13.0	25.1	21.6	33.8	18.2	28.8	92.6	27.1	19.3	34.9	12.8	26.3	18.2	41.1	13.3	34.1	29.6	67.0	37.7	33.6	16.9	14.9	104.5	22.6	43.7	41.7	50.1	55.3	13.4	50.0	50.8	75.4	61.4	35.3	34.8	66.4	177.1	59.3	40.0	36.7	55.5	51.0	79.8	14.5	24.9	99.8	32.9	16.1	48.9	75.1	46.5	40.0	64.6	40.8	58.3	52.1	60.4	36.8	45.9	139.0	67.6	86.9	82.2	18.1	9.6	45.1	41.2	74.9	53.6	47.4	54.8	67.3	82.4	35.7	76.8	60.0	56.4	31.8	141.2	39.1	54.0	38.5	38.1	49.0	53.6	83.5	137.2	79.3	40.8	106.4	40.6	59.2	26.9	26.5	32.4	31.8	40.7	20.0	30.7	35.9	29.9	18.9	33.4	32.2	8.5	64.6	31.0	16.9	30.2	45.7	12.1	12.6	16.1	14.6	12.1	14.9	12.4	13.9	13.0	12.8	13.3	14.9	60.6	35.3	27.2	14.7	78.5	82.3	46.6	24.3	42.7	35.1	47.0	34.4	109.7	25.8	30.1	47.8	31.3	24.4	63.9	19.0	90.1	35.5	21.7	27.3	58.9	55.2	56.4	25.2	23.7	36.1	27.5	53.7	30.1	42.6	66.6	29.4	36.4	50.7	38.0	45.4	19.6	23.7	28.5	48.6	67.8	18.3	32.0	54.8	51.6	22.5	108.6	41.8	82.4	19.6	23.0	34.3	16.5	37.2	65.4	74.5	17.1	51.1	44.6	45.2	39.5	45.8	63.1	96.3	90.7	54.0	91.1	50.1	60.7	51.9	20.0	63.6
GADD45A	"DDIT1, GADD45"	ENSG00000116717	"Growth arrest and DNA damage inducible alpha"	P24522	1	67685201-67688334	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, Growth arrest"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 240.5"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 858.9;Basal prostatic cells: 2807.1;Glandular and luminal cells: 982.6;Urothelial cells: 1740.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 48.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 48.4;T-cells: 18.6"	"Cell line enhanced"	"Detected in all"		"HHSteC: 365.9;hTERT-HME1: 577.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053420			Supported	"Nuclear speckles"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"		"HPA053420: AB_2682144"	"unprognostic (1.36e-2)"	"unprognostic (3.29e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.76e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.21e-2)"	"prognostic favorable (8.06e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.93e-1)"	122.0	15.9	21.0	20.0	24.7	136.2	83.7	19.2	27.5	65.6	22.3	29.6	24.8	69.5	23.3	39.2	42.3	44.2	62.2	20.8	24.0	147.2	164.9	75.0	13.7	34.7	26.8	49.6	20.2	19.5	19.1	22.2	24.6	25.6	21.2	19.0	32.4	36.9	240.5	57.9	32.2	38.3	18.6	26.8	53.2	12.3	25.3	30.7	73.8	26.4	16.8	50.4	44.4	28.7	138.6	9.7	22.3	7.5	44.8	43.9	219.8	239.5	122.6	88.5	96.7	50.8	25.3	61.1	71.4	42.0	206.6	85.3	3.0	219.6	164.5	44.9	23.6	75.7	24.0	51.8	365.9	22.5	7.5	76.7	117.8	107.7	577.7	41.5	61.0	15.2	165.6	109.9	104.5	4.8	7.2	27.3	29.8	19.3	96.3	16.4	177.2	67.9	44.2	110.5	102.7	17.1	51.9	15.2	158.3	79.7	2.6	23.2	61.6	85.7	111.6	89.3	165.7	267.3	54.9	106.8	37.8	11.1	86.3	23.6	5.7	48.4	6.3	2.8	5.3	2.3	4.4	5.3	2.6	1.5	1.2	2.0	8.2	6.5	2.0	4.1	18.6	8.7	21.0	24.7	19.2	27.5	20.8	24.0	34.7	26.8	24.6	18.6	25.3	28.7	402.5	64.1	19.0	6.8	51.2	858.9	2807.1	273.2	225.3	45.1	56.7	100.6	190.5	47.1	155.8	103.0	10.4	24.6	85.1	175.3	236.7	264.4	1.6	410.7	250.6	176.6	131.7	116.2	6.1	253.6	117.8	177.0	87.7	982.6	44.5	18.9	74.6	110.1	18.6	26.9	7.0	99.6	122.1	23.5	290.6	4.0	38.2	94.7	158.3	7.5	273.2	30.3	12.3	6.6	1.0	367.3	202.0	64.7	116.8	786.2	101.4	530.0	135.1	72.8	52.6	136.0	201.6	3.7	18.8	365.2	390.8	17.6	139.5	88.6	70.3	1740.4
GAS1		ENSG00000180447	"Growth arrest specific 1"	P54826	9	86944362-86947506	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Growth arrest"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 105.4"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 127.1;Muller glia cells: 90.3;Skeletal myocytes: 213.7"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 30.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.2;ASC diff: 29.3;BJ hTERT+: 59.8;HSkMC: 41.1;RH-30: 91.1"	"Low region specificity"	"Detected in all"							"CAB024164, HPA036085, HPA066902"	Approved		Approved	"Nuclear speckles"		NA	NA		27000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"		"CAB024164: AB_2107950, HPA036085: AB_2674932, HPA066902: AB_2685746"	"unprognostic (2.78e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.97e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (1.96e-5)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (3.59e-2)"	81.5	6.4	3.6	16.6	4.4	0.2	38.3	3.5	4.4	27.1	16.1	27.6	2.2	105.4	15.2	5.8	60.7	10.5	27.1	3.2	2.7	12.5	2.2	7.8	6.8	3.8	3.8	45.1	11.2	1.9	8.4	22.1	3.6	22.6	2.3	3.3	13.1	9.6	12.2	22.2	9.3	43.4	3.4	3.6	16.3	1.8	3.8	7.1	15.9	9.3	3.1	22.5	27.1	6.8	0.0	0.0	7.5	44.2	29.3	10.9	0.8	8.8	59.8	2.9	2.6	0.0	0.1	0.0	0.5	15.8	0.3	0.6	0.0	0.3	1.2	5.2	17.8	0.0	25.0	0.0	14.9	0.1	0.7	41.1	6.3	1.0	5.3	0.0	0.0	0.9	0.0	0.0	12.6	0.0	0.0	0.4	9.5	0.3	0.1	9.6	91.1	0.0	0.4	0.0	1.0	4.0	12.9	0.0	14.1	4.8	0.1	0.2	0.1	13.0	3.6	0.9	3.0	0.0	0.0	0.0	0.4	0.6	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.4	3.5	4.4	3.2	2.7	3.8	3.8	3.6	3.4	3.8	6.8	15.8	0.0	0.6	2.0	0.4	25.9	7.5	10.9	10.2	8.3	3.9	28.3	5.5	0.0	3.1	14.7	10.4	21.5	7.8	0.1	9.8	0.5	0.1	2.4	36.6	5.6	0.0	0.4	1.2	0.4	3.7	127.1	1.1	2.0	0.0	2.1	22.9	0.3	5.8	5.0	2.6	0.3	0.0	1.0	15.4	0.9	32.3	2.2	17.8	1.9	0.2	90.3	7.2	8.5	4.4	0.2	0.0	12.4	2.1	4.5	0.0	2.6	0.7	3.2	39.5	213.7	15.4	0.3	1.3	1.0	12.5	4.5	2.1	0.8	0.2	0.4
GCNT1	"C2GNT, NACGT2, NAGCT2"	ENSG00000187210	"Glucosaminyl (N-acetyl) transferase 1"	Q02742	9	76419850-76651203	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 49.9;parathyroid gland: 84.1;stomach 1: 39.0;thyroid gland: 21.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 93.8;Kupffer cells: 42.2;Proximal enterocytes: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 21.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 46.2;HSkMC: 39.4;U-2197: 33.9"	"Group enriched"	"Detected in all"	6	"cerebellum: 7.6;olfactory bulb: 24.9"	"Low region specificity"	"Detected in all"			"HPA003522, HPA003523, HPA031151"	Uncertain		Supported	"Nuclear speckles"		NA	NA		84000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"		"HPA003522: , HPA003523: , HPA031151: AB_10602904"	"unprognostic (3.14e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (5.53e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.96e-4)"	4.0	0.8	1.8	5.0	2.2	5.1	4.6	4.8	1.7	10.6	1.3	8.7	49.9	5.9	0.7	1.8	1.5	2.9	1.2	2.0	0.9	0.9	1.9	4.2	6.7	1.0	1.0	0.7	2.1	84.1	0.9	2.9	1.0	6.3	9.3	0.1	3.8	1.3	0.3	1.1	32.3	4.8	1.0	7.3	39.0	1.6	1.5	3.0	21.5	0.7	4.7	2.2	0.8	1.4	4.7	0.4	0.3	0.1	5.5	26.5	6.7	18.8	8.4	15.0	10.5	4.7	1.1	3.3	1.8	14.1	2.9	4.0	9.5	7.8	16.6	2.3	1.6	8.2	0.4	0.8	46.2	6.0	2.7	39.4	2.0	14.5	15.5	12.2	13.9	4.1	0.0	3.2	15.1	7.1	3.2	9.7	8.8	11.9	1.1	5.3	9.3	1.6	17.5	8.3	2.0	0.0	2.3	2.5	0.1	6.6	0.0	4.1	5.6	9.3	5.9	33.9	8.4	4.7	0.9	0.0	18.7	10.1	2.3	6.1	3.2	21.6	1.5	7.8	0.5	1.9	1.7	1.5	5.8	10.2	0.3	1.1	1.1	5.8	7.3	2.8	2.5	2.1	1.8	2.2	4.8	1.7	2.0	0.9	1.0	1.0	1.0	1.0	1.5	1.4	2.9	0.0	1.7	2.0	8.3	0.9	5.0	34.4	0.6	0.0	8.8	4.2	1.0	0.0	15.6	3.7	0.0	2.1	10.7	16.6	0.0	1.0	20.1	15.1	4.2	5.1	27.6	17.9	11.8	24.3	27.1	3.4	93.8	24.6	10.8	0.6	6.4	0.3	8.1	0.0	1.7	21.3	16.2	42.2	8.5	12.9	0.0	18.6	1.8	15.0	6.7	0.1	8.2	0.5	0.8	12.9	14.5	1.2	2.2	6.8	40.7	1.4	17.0	0.4	0.0	0.9	1.8	1.8	3.3	1.0	0.3	19.0	10.6	0.2	38.4	1.5
GPATCH2	"CT110, FLJ10252, GPATC2, Pfa1, PPP1R30"	ENSG00000092978	"G-patch domain containing 2"	Q9NW75	1	217426992-217631090	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 171.0;Rod photoreceptor cells: 144.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027181, HPA027322"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear speckles"		"HPA027181: AB_10602601, HPA027322: AB_1848645"	"unprognostic (3.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (9.99e-6)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.41e-2)"	4.1	4.2	3.5	4.1	4.0	3.2	7.1	3.0	4.8	5.9	6.3	4.3	4.9	6.5	5.9	5.5	5.0	6.1	3.5	4.3	5.1	5.2	4.9	4.2	5.1	2.9	3.2	4.8	3.9	6.9	4.4	6.3	3.1	6.9	4.6	5.7	3.7	5.3	6.6	4.4	4.8	5.1	3.2	4.8	4.8	6.2	4.5	6.3	6.6	2.9	5.6	6.1	4.1	3.8	8.4	9.4	9.9	7.8	8.6	8.7	8.2	7.7	9.4	10.5	9.9	8.3	10.6	8.9	7.6	6.7	6.5	9.7	11.2	9.1	12.2	6.6	6.4	5.9	7.9	5.3	10.6	9.0	6.7	7.7	13.0	12.3	20.0	9.1	7.3	9.8	14.7	0.1	7.7	7.9	12.2	6.4	18.0	6.7	10.2	5.9	22.7	10.7	7.4	17.9	11.6	16.5	13.7	12.5	10.7	15.5	11.7	8.7	7.5	9.8	6.8	13.9	7.2	9.0	6.8	8.4	7.4	5.9	7.1	4.1	3.1	1.1	2.6	1.9	1.8	2.6	3.0	1.8	3.4	2.8	2.7	2.4	0.4	2.7	2.9	5.0	2.9	1.5	3.5	4.0	3.0	4.8	4.3	5.1	2.9	3.2	3.1	3.2	4.5	3.8	17.5	12.8	15.9	43.8	19.4	15.6	16.1	13.4	14.8	55.4	27.2	27.9	14.4	21.5	15.3	18.4	171.0	20.8	24.5	22.4	13.7	20.4	62.6	41.3	36.4	20.5	20.8	12.0	113.1	18.0	22.2	23.0	19.4	24.0	9.5	32.9	20.7	12.4	15.7	50.5	60.5	21.5	18.3	9.2	9.2	22.8	19.9	16.6	5.4	39.4	17.2	27.7	28.8	46.3	47.1	15.0	17.2	23.0	24.5	17.5	17.9	18.1	22.3	144.2	19.7	36.8	20.2	53.3	23.8	12.9	19.5	21.6	20.0	41.4	23.1	19.0
GTF2H2	"BTF2, BTF2P44, p44, T-BTF2P44, TFIIH"	ENSG00000145736	"General transcription factor IIH subunit 2"	Q13888	5	71032670-71067689	"Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 18.5;RPTEC TERT1: 19.1"									HPA047001			Supported	"Nuclear speckles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA047001: AB_2679899"	"unprognostic (7.40e-3)"	"unprognostic (4.71e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.22e-3)"	"unprognostic (3.74e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.62e-1)"	3.1	2.9	0.6	1.1	0.7	1.1	2.8	1.1	1.7	3.9	0.4	4.6	0.2	3.8	2.0	2.6	3.4	1.2	2.7	0.6	0.9	3.6	3.4	2.8	4.8	0.8	0.9	3.4	4.3	1.1	2.6	0.9	1.0	2.3	1.0	1.7	2.8	0.6	3.5	1.9	2.9	5.1	0.6	2.8	2.9	3.7	0.9	1.4	3.5	0.0	0.3	2.6	3.0	1.2	4.8	0.0	4.2	0.0	11.0	12.8	13.9	0.5	0.2	0.3	0.7	12.0	0.4	18.5	8.4	10.2	6.1	3.1	0.6	0.1	0.3	15.0	14.0	8.7	0.2	0.9	12.3	0.4	0.0	0.0	2.7	0.4	0.0	2.4	0.0	0.1	0.2	3.3	0.0	7.3	5.6	6.0	0.1	0.1	0.0	6.6	2.6	11.1	19.1	0.0	0.4	4.6	12.1	1.4	11.5	0.3	7.7	8.0	4.2	5.3	1.1	0.7	8.7	0.2	0.8	4.7	0.1	0.8	10.1	0.2	0.5	0.2	0.6	0.3	0.2	0.5	0.7	0.5	0.3	0.8	0.7	0.5	2.1	0.3	0.3	0.3	0.0	0.3	0.6	0.7	1.1	1.7	0.6	0.9	0.8	0.9	1.0	0.6	0.9	1.2	6.9	16.0	27.0	6.8	17.6	16.6	23.5	17.5	7.4	23.3	14.9	8.1	16.7	28.6	18.7	12.9	39.6	37.3	9.6	8.4	46.9	19.1	5.4	17.0	17.7	12.6	12.0	15.2	10.0	20.5	17.5	14.6	7.1	17.7	6.3	25.5	14.6	12.5	15.0	25.2	10.2	5.9	14.2	15.0	9.9	7.0	24.2	11.0	14.2	4.7	7.9	10.6	9.2	9.0	11.0	16.7	7.5	13.2	14.6	23.7	8.9	22.5	22.7	39.7	26.3	14.1	12.5	60.3	55.9	6.9	12.5	9.6	15.3	15.5	9.1	18.7
GTF2H2C		ENSG00000183474	"GTF2H2 family member C"	Q6P1K8	5	69560191-69595221	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 10.1"	"Cell line enhanced"	"Detected in many"		"U-266/84: 37.5"									HPA047001			Approved	"Nuclear speckles"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA047001: AB_2679899"	"unprognostic (3.70e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.33e-2)"	"unprognostic (8.59e-3)"	"unprognostic (5.34e-2)"	"unprognostic (7.12e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.55e-1)"	7.4	6.9	3.0	4.0	3.6	2.9	7.2	4.6	4.4	9.0	2.0	8.0	1.4	8.2	3.0	5.4	8.2	1.7	6.1	3.2	3.2	13.0	11.3	8.3	4.0	3.7	3.5	8.6	10.6	2.8	6.4	1.5	4.0	6.0	2.0	4.4	6.8	2.3	6.0	4.9	7.2	3.7	2.4	7.9	7.2	9.8	3.3	3.8	9.9	1.3	1.1	7.1	6.8	6.8	8.0	5.8	4.6	5.7	2.7	3.9	6.5	13.2	5.1	8.7	10.0	8.6	4.8	19.7	15.3	4.0	3.1	3.2	6.9	7.5	13.5	20.2	11.0	21.8	4.7	9.0	4.3	13.6	6.7	1.5	2.0	4.7	3.9	3.5	2.7	8.5	16.1	10.5	0.8	8.2	17.8	6.5	7.2	0.7	4.3	6.5	19.5	19.0	10.5	7.5	6.4	13.0	17.9	4.8	9.3	3.8	6.4	8.7	12.7	7.3	4.5	5.2	18.0	7.4	37.5	14.7	7.4	16.6	13.3	10.1	1.6	2.1	0.9	1.4	1.7	1.5	1.0	1.6	1.3	1.7	1.2	2.4	5.0	1.5	1.2	1.4	1.8	1.2	3.0	3.6	4.6	4.4	3.2	3.2	3.7	3.5	4.0	2.4	3.3	6.8	4.9	9.6	10.9	6.8	14.3	3.6	4.9	8.6	6.8	10.6	7.5	3.9	8.2	14.3	10.4	14.7	12.5	4.9	4.9	5.9	9.8	7.1	16.2	15.7	10.3	6.3	2.4	12.4	9.6	5.7	2.9	8.1	8.6	15.4	0.0	7.7	7.9	6.9	4.3	18.5	10.5	4.1	14.2	6.3	3.3	17.8	9.0	7.6	3.6	5.6	3.5	6.5	13.4	5.5	9.8	5.9	4.0	11.7	8.7	6.1	5.8	14.2	10.8	14.6	0.0	3.2	7.1	32.5	23.5	7.2	4.1	1.4	7.1	6.7	5.4	7.4
GTF2H4	"P52, TFB2, TFIIH"	ENSG00000213780	"General transcription factor IIH subunit 4"	Q92759	6	30908207-30914106	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 12.5;Gastric mucus-secreting cells: 9.7;granulocytes: 7.0;Plasma cells: 9.2;Squamous epithelial cells: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA074336			Supported	"Nuclear speckles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA074336: AB_2686679"	"unprognostic (7.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.79e-4)"	"unprognostic (7.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.66e-4)"	"unprognostic (7.74e-3)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.53e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.07e-2)"	12.6	11.1	5.4	6.6	6.6	4.7	11.4	6.2	7.0	12.8	4.8	12.0	1.8	12.8	1.9	14.4	10.6	2.2	9.3	5.6	6.3	14.6	21.5	10.1	5.6	5.2	5.8	12.2	11.0	6.8	13.4	3.5	4.9	10.5	4.0	1.1	8.6	3.5	13.2	9.7	10.4	1.9	6.0	11.9	12.4	11.9	6.3	8.7	13.5	3.8	3.7	11.7	11.7	8.1	20.5	15.0	15.9	16.5	16.0	11.6	17.7	3.3	5.3	5.8	9.6	14.9	9.1	12.3	8.0	21.1	11.1	16.6	10.7	21.4	10.6	18.6	2.5	10.0	11.5	13.8	10.1	0.0	17.0	18.5	20.5	9.8	0.0	10.3	6.1	9.1	35.2	11.3	11.4	25.0	22.5	16.9	18.5	10.4	6.1	28.5	0.0	11.8	20.7	11.4	9.2	4.5	0.8	11.5	8.8	9.8	16.2	13.7	6.8	15.5	21.5	16.4	28.6	11.1	13.1	9.3	8.9	16.8	7.0	1.8	1.1	0.9	0.8	1.2	0.3	1.3	1.2	1.3	2.5	0.6	1.2	2.2	0.0	1.1	0.6	1.2	2.1	0.3	5.4	6.6	6.2	7.0	5.6	6.3	5.2	5.8	4.9	6.0	6.3	8.1	0.6	0.0	0.0	4.2	4.0	0.4	0.1	0.4	12.5	0.7	1.1	0.8	0.0	1.5	0.1	0.0	2.1	0.4	0.5	0.4	1.9	0.6	0.1	1.1	1.0	1.8	0.0	4.2	4.6	0.6	0.4	1.4	9.7	1.0	7.0	0.8	0.7	1.1	0.3	0.0	3.3	0.0	0.0	1.2	1.2	0.0	0.9	1.5	1.8	1.9	0.3	0.5	0.0	3.5	2.8	0.0	1.2	0.7	9.2	0.1	0.1	0.9	0.8	0.3	0.0	0.4	1.9	1.4	0.4	13.8	1.0	0.3	3.5	0.4	0.6	0.1
H1-4	"H1.4, H1e, H1F4, H1s-4, HIST1H1E"	ENSG00000168298	"H1.4 linker histone, cluster member"	P10412	6	26156329-26157115	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 52.3;brain: 53.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 11.2;Cytotrophoblasts: 8.0;dendritic cells: 18.6;Extravillous trophoblasts: 11.3;Hofbauer cells: 7.7;Plasma cells: 6.7;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 53.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 10.5;U-266/70: 12.5;U-266/84: 15.1;U-87 MG: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011506, HPA055907"	Supported		Supported	"Nuclear speckles"		NA	Yes		8300000	"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"CAB011506: AB_470256, HPA055907: AB_2682966"	"unprognostic (6.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.72e-13)"	"unprognostic (4.54e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.18e-2)"	1.7	0.3	0.4	0.3	2.4	52.3	2.7	53.8	26.5	3.2	7.3	1.7	0.3	0.5	0.3	1.2	0.7	0.4	0.6	2.8	11.7	2.1	1.1	1.2	2.5	11.8	0.0	1.8	1.8	0.3	1.9	0.9	3.2	2.5	0.4	0.0	3.0	0.2	0.4	4.1	2.7	0.1	5.0	1.4	1.4	1.4	5.5	2.7	0.9	0.1	0.5	0.9	2.8	11.4	2.6	0.3	0.5	5.5	0.1	0.0	6.6	0.0	0.4	1.2	0.9	0.1	1.6	1.3	0.7	0.1	0.5	1.2	0.3	0.7	0.5	1.8	1.6	0.9	0.5	0.4	0.1	0.8	1.1	0.1	0.3	0.3	0.6	0.1	0.5	1.4	4.4	7.0	0.2	0.5	8.6	7.8	2.0	0.8	0.8	4.0	1.3	10.5	0.3	0.0	4.0	0.9	3.3	0.8	1.2	0.6	1.1	2.8	0.5	2.5	3.8	1.5	2.6	12.5	15.1	6.1	12.6	2.3	1.2	257.4	43.0	106.3	66.4	42.1	76.6	73.6	52.1	61.6	49.0	119.6	39.4	37.1	60.4	70.7	39.5	48.6	56.9	31.4	0.4	2.4	53.8	26.5	2.8	11.7	11.8	0.0	3.2	5.0	5.5	11.4	3.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	8.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	11.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.3	1.8	0.0	0.0	0.0
HAS2		ENSG00000170961	"Hyaluronan synthase 2"	Q92819	8	121612116-121641440	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 22.7;urinary bladder: 20.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 54.1;Fibroblasts: 62.1;Langerhans cells: 28.9;Melanocytes: 30.2;Smooth muscle cells: 30.7;Urothelial cells: 89.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HBF TERT88: 157.8;hTEC/SVTERT24-B: 153.8;LHCN-M2: 206.5;U-138 MG: 396.9;U-251 MG: 123.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052060			Approved	"Nuclear speckles"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"		"HPA052060: AB_2681712"	"unprognostic (7.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.57e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-7)"	"unprognostic (1.47e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-3)"	22.7	0.3	0.6	9.0	0.5	0.1	5.3	0.6	0.5	0.7	0.1	4.1	2.8	0.8	1.2	1.6	1.7	7.8	4.0	0.5	1.5	1.1	2.9	3.7	1.6	1.6	2.1	0.2	0.9	0.2	0.3	2.3	1.3	1.1	5.6	0.0	1.0	0.2	0.5	2.3	5.2	3.9	1.1	0.1	2.0	1.8	1.3	0.8	0.7	0.9	0.9	20.5	0.6	0.9	0.3	2.8	0.0	0.4	4.7	11.8	0.0	23.5	17.3	29.9	51.2	0.2	0.4	0.1	0.0	20.8	0.0	4.2	0.0	0.0	157.8	0.1	0.6	0.0	0.6	0.0	19.9	0.0	0.0	31.0	0.0	153.8	14.1	0.7	0.0	0.0	0.0	0.0	206.5	0.3	0.0	0.0	0.4	0.0	3.4	0.0	26.6	0.0	0.0	2.0	0.0	0.4	10.0	0.0	5.6	9.0	0.2	0.3	0.0	396.9	1.4	37.7	123.7	0.0	0.0	0.0	8.5	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.6	0.5	0.5	1.5	1.6	2.1	1.3	1.1	1.3	0.9	2.2	0.0	0.0	0.0	0.0	16.3	54.1	1.8	0.6	0.0	0.1	0.4	1.2	0.0	0.2	3.7	0.0	0.2	0.2	1.6	0.0	0.9	19.0	0.1	3.5	7.2	1.2	0.0	0.1	0.0	0.0	62.1	1.1	0.1	13.4	0.0	0.7	0.0	0.3	0.0	0.2	2.3	0.0	0.0	28.9	3.4	1.8	0.7	30.2	0.0	0.0	0.0	0.0	16.1	0.2	1.6	1.9	0.0	0.0	11.0	0.0	0.1	0.0	0.0	0.0	6.9	30.7	0.3	0.1	0.6	11.9	0.1	1.5	0.0	3.9	89.3
HBP1		ENSG00000105856	"HMG-box transcription factor 1"	O60381	7	107168961-107202522	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 332.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020225, CAB032824"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles"		"CAB032824: AB_2114615, HPA020225: "	"unprognostic (9.00e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.43e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.49e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.70e-5)"	"unprognostic (7.39e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.26e-2)"	58.4	49.8	13.2	15.0	18.3	49.0	52.4	17.1	14.8	50.1	15.2	45.9	16.3	53.1	20.0	54.4	40.0	19.9	39.8	13.0	14.7	26.7	37.8	40.1	17.3	19.2	16.1	51.1	34.9	29.0	24.2	24.6	19.2	35.4	17.8	16.5	46.6	22.5	86.4	70.9	34.9	22.1	15.0	34.0	38.0	57.1	14.9	23.6	36.8	39.6	19.9	43.4	51.5	25.7	9.0	10.1	18.8	12.2	38.7	36.1	8.8	15.6	35.1	11.2	19.6	3.6	23.5	8.7	20.4	21.8	23.3	11.4	7.7	9.7	13.9	6.5	7.0	6.0	16.7	6.9	22.1	4.3	17.3	42.3	28.3	10.9	13.3	37.7	37.0	8.8	11.3	21.2	14.5	14.8	7.3	13.6	11.8	12.8	11.5	6.9	13.8	22.4	19.9	11.1	7.3	22.0	18.4	26.7	25.9	25.9	8.3	13.2	35.8	14.7	11.4	22.7	4.7	24.6	31.9	9.0	14.4	9.2	15.3	142.1	59.5	80.0	37.5	61.7	35.8	35.6	39.5	36.5	40.3	34.6	45.2	38.5	146.2	53.8	64.1	20.5	55.6	91.8	13.2	18.3	17.1	14.8	13.0	14.7	19.2	16.1	19.2	15.0	14.9	25.7	67.9	22.4	39.7	37.2	72.9	108.2	77.6	56.2	91.6	29.7	83.1	54.7	22.1	31.5	51.6	33.1	8.4	46.1	95.5	56.1	45.0	50.5	175.9	56.8	45.8	51.8	54.2	59.5	32.6	32.3	26.1	76.8	50.4	93.3	50.7	25.7	35.3	36.8	28.9	42.1	35.2	41.3	85.5	49.8	81.8	332.7	54.0	67.8	74.7	49.6	46.3	33.4	37.0	40.2	91.4	33.7	46.6	57.9	70.2	82.8	55.1	45.3	37.6	29.2	46.0	91.4	70.0	53.0	38.0	55.3	133.0	210.4	94.8	42.6	28.1	89.9
HP1BP3	HP1-BP74	ENSG00000127483	"Heterochromatin protein 1 binding protein 3"	Q5SSJ5	1	20740266-20787323	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028215, HPA054295"	Supported		Supported	"Nuclear speckles"		NA	Yes		30000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA028215: AB_10601021, HPA054295: AB_2682440"	"unprognostic (3.90e-3)"	"unprognostic (6.83e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.43e-2)"	87.9	78.9	62.2	76.2	75.1	141.7	80.1	69.6	76.5	143.6	62.1	107.9	71.3	116.5	63.0	94.8	96.7	75.3	75.7	64.5	66.6	83.5	66.5	84.1	91.4	68.1	64.4	135.6	74.4	98.1	60.9	85.9	67.5	81.3	88.2	96.4	83.0	74.3	113.9	86.9	93.8	100.3	61.3	89.2	83.1	54.5	68.7	134.5	106.3	78.7	90.3	93.9	114.2	107.6	207.3	106.1	261.6	157.5	152.3	172.8	157.3	230.2	182.4	156.7	163.1	97.6	232.0	208.2	113.4	176.6	108.4	171.9	136.7	125.5	199.8	306.5	124.7	296.2	230.5	85.4	98.1	209.7	181.7	135.1	90.6	159.0	208.5	193.0	160.5	245.1	169.9	251.8	180.1	64.2	323.5	93.0	69.3	152.6	126.3	250.4	255.0	219.2	113.6	66.6	175.0	180.0	279.8	112.9	181.2	132.9	117.3	138.7	196.4	176.2	164.2	180.7	139.2	144.0	194.2	246.7	150.2	213.0	204.0	102.4	55.3	202.6	57.1	45.0	59.7	70.8	61.9	62.1	52.2	58.4	80.4	54.5	66.1	63.3	54.9	59.5	71.6	49.0	62.2	75.1	69.6	76.5	64.5	66.6	68.1	64.4	67.5	61.3	68.7	107.6	129.4	150.6	156.2	96.9	112.1	130.4	137.4	81.6	159.9	117.8	116.6	108.7	161.4	94.4	94.5	104.8	54.2	87.6	144.7	105.6	154.6	87.0	40.8	85.3	184.6	136.8	103.7	214.6	98.3	93.4	70.7	161.9	98.8	128.2	137.8	131.8	129.2	101.0	72.6	80.8	93.7	113.4	83.4	100.7	104.1	22.3	172.7	116.9	113.8	130.2	111.2	119.5	127.7	142.7	189.9	113.0	90.1	162.5	162.0	124.6	91.7	110.7	54.6	97.6	157.8	145.2	148.3	141.3	110.1	201.8	134.5	92.9	151.9	116.2	115.3	118.4
HPD	"4-HPPD, 4HPPD, GLOD3, PPD"	ENSG00000158104	"4-hydroxyphenylpyruvate dioxygenase"	P32754	12	121839527-121863596	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 2530.4"	"Group enriched"	"Detected in some"	9	"Hepatocytes: 1373.6;Proximal tubular cells: 2144.0"	"Cancer enriched"	"Detected in many"	100	"liver cancer: 540.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 7.8"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 7.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;granulocytes: 7.8"	"Cell line enriched"	"Detected in some"	31	"Hep G2: 516.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038321, HPA038322"	Enhanced		Uncertain	"Nuclear speckles"		NA	NA		26000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA038321: AB_2675957, HPA038322: AB_10670778"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.14e-3)"	"unprognostic (9.72e-3)"	"unprognostic (8.61e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.34e-1)"	2.3	5.3	0.6	0.7	0.4	0.9	4.6	3.2	0.6	2.0	119.0	1.2	0.1	4.1	0.7	0.7	6.4	1.1	3.5	7.8	0.5	531.0	2530.4	2.0	0.3	1.5	1.0	4.7	3.9	0.1	1.1	0.3	0.8	2.3	0.5	0.3	0.2	7.3	2.2	0.2	0.9	1.4	0.6	2.3	1.9	10.2	3.5	0.1	0.7	0.1	0.1	3.7	1.9	1.0	0.3	0.9	0.6	0.6	0.3	0.6	0.6	0.0	0.1	0.0	0.0	0.2	0.5	0.2	0.6	1.1	0.2	0.4	0.2	0.0	0.0	0.3	0.8	1.2	5.4	516.4	11.5	1.8	16.4	3.6	0.3	0.0	0.0	1.3	0.0	0.5	0.8	0.0	1.3	1.3	0.2	0.4	9.9	0.4	0.0	0.3	1.6	0.5	0.0	1.4	0.1	0.1	1.5	0.1	0.1	6.9	1.1	0.9	0.2	0.0	0.3	0.1	0.1	0.8	0.6	0.7	0.2	1.2	0.0	0.0	0.6	7.8	0.0	0.8	0.0	0.1	0.1	0.1	1.0	0.1	0.2	0.2	3.9	0.0	1.3	3.8	0.0	0.3	0.6	0.4	3.2	0.6	7.8	0.5	1.5	1.0	0.8	0.6	3.5	1.0	0.0	0.0	0.0	0.7	15.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	55.8	0.0	92.0	0.0	0.8	0.0	0.0	193.7	0.5	38.0	0.1	0.0	2.6	0.0	80.2	1.0	16.2	0.3	0.4	0.0	0.1	0.0	0.0	38.9	1373.6	0.3	0.0	1.0	0.0	0.0	37.8	0.3	121.0	2.5	10.8	0.0	0.0	0.4	0.0	0.0	1.5	0.7	0.2	0.0	5.3	0.0	0.0	0.0	2144.0	0.0	0.0	0.0	2.0	0.2	1.8	1.4	0.0	0.0	1.1	8.0	7.1	0.0	0.0
HSF4	CTM	ENSG00000102878	"Heat shock transcription factor 4"	Q9ULV5	16	67164681-67169945	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 38.5;Excitatory neurons: 30.9;Horizontal cells: 43.7;Inhibitory neurons: 30.0;Leydig cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 17.1;T-47d: 12.9;U-266/70: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048584			Supported	"Nuclear speckles"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear speckles"		"HPA048584: AB_2680452"	"unprognostic (1.90e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (9.20e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.48e-2)"	"unprognostic (8.74e-3)"	12.4	23.7	43.6	1.3	44.3	1.8	12.7	44.6	69.2	17.9	39.2	10.1	4.8	12.4	4.8	11.0	21.1	3.6	20.0	44.6	43.7	17.1	20.3	8.7	1.6	45.0	41.9	19.8	35.9	4.3	30.1	3.3	46.4	28.3	1.8	5.6	19.0	1.9	25.9	14.5	6.1	2.1	41.3	6.0	14.4	7.0	43.3	1.1	17.9	4.1	1.1	18.8	10.9	45.8	1.6	1.1	0.0	1.1	0.5	3.0	5.2	0.5	0.6	0.2	0.0	2.4	3.5	0.1	2.5	1.1	0.7	5.9	0.4	0.7	0.2	2.3	2.2	0.6	4.5	3.1	2.3	0.3	4.4	1.3	4.8	0.2	2.5	17.1	0.9	4.0	1.5	5.1	2.3	1.5	0.8	1.8	0.1	3.4	3.2	2.0	1.7	8.7	4.4	2.5	3.5	7.6	4.9	3.0	7.8	2.1	12.9	4.5	0.9	1.6	1.6	6.4	1.5	22.3	3.7	1.5	4.9	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.6	44.3	44.6	69.2	44.6	43.7	45.0	41.9	46.4	41.3	43.3	45.8	2.6	3.2	7.7	38.5	1.1	3.1	3.4	2.9	4.6	10.8	9.1	7.7	5.3	4.3	2.7	3.7	2.1	1.0	0.7	2.9	0.0	1.0	0.5	4.1	2.8	1.6	1.2	0.0	30.9	1.3	0.6	6.0	14.8	7.0	1.3	2.3	2.9	5.7	21.9	43.7	30.0	3.0	2.0	0.8	2.5	1.8	32.9	4.6	10.6	5.6	1.5	8.8	0.0	4.0	15.2	1.4	3.5	22.2	1.5	4.0	0.4	2.4	4.8	11.4	0.0	5.4	3.2	0.4	2.3	3.6	3.4	0.7	0.9	1.9	2.9	2.0
HSPB3	HSPL27	ENSG00000169271	"Heat shock protein family B (small) member 3"	Q12988	5	54455699-54456377	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Stress response"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"heart muscle: 406.9;skeletal muscle: 217.2;tongue: 218.9"	"Cell type enriched"	"Detected in some"	18	"Cardiomyocytes: 398.1"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 86.3;fHDF/TERT166: 39.1;HSkMC: 16.3;LHCN-M2: 12.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA062124			Supported	"Nuclear speckles"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"		"HPA062124: AB_2684690"		"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-3)"		"unprognostic (1.13e-1)"	"unprognostic (4.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-2)"		"unprognostic (2.73e-1)"	"unprognostic (2.82e-2)"		"unprognostic (7.15e-2)"	1.4	0.2	4.6	0.1	5.6	0.2	2.1	4.0	7.5	0.9	4.1	5.2	0.2	7.5	0.4	16.5	3.0	0.2	406.9	6.3	7.2	0.4	0.1	2.8	0.0	4.1	4.0	1.0	0.1	0.0	3.6	0.1	4.4	8.6	2.1	1.6	6.7	0.8	217.2	2.2	0.9	10.4	4.1	0.7	0.9	1.8	4.1	0.7	0.3	218.9	0.0	3.7	0.8	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	86.3	0.1	0.1	0.4	0.0	0.0	0.3	39.1	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	16.3	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.6	5.6	4.0	7.5	6.3	7.2	4.1	4.0	4.4	4.1	4.1	6.4	0.0	0.0	0.0	0.3	0.0	6.4	0.4	3.2	0.0	0.1	0.0	0.0	398.1	0.0	0.3	0.0	0.0	0.1	0.0	10.5	0.0	0.0	0.1	0.7	0.2	3.5	0.0	0.0	4.3	0.0	0.0	14.4	0.0	1.3	0.0	0.1	0.0	0.0	0.1	1.7	6.5	0.0	0.0	0.0	4.9	0.4	0.6	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.5	6.6	21.3	7.2	0.4	0.0	0.0	5.3	0.1	0.2	0.1	0.3	0.3
IK	"RED, RER"	ENSG00000113141	"IK cytokine"	Q13123	5	140647058-140662480	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 438.7;Endometrial ciliated cells: 510.8;Respiratory ciliated cells: 732.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048798	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 16: U-266 - Nucleosome"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"		"HPA048798: AB_2680525"	"unprognostic (9.90e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (2.32e-7)"	"unprognostic (1.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.83e-1)"	73.9	64.0	53.4	68.7	56.6	135.4	66.9	64.4	70.8	70.0	62.3	76.1	55.4	73.9	74.4	77.0	143.5	53.4	74.2	54.2	68.6	67.0	68.6	69.5	89.9	60.6	60.6	78.8	48.3	74.3	55.8	64.9	59.9	60.3	70.3	90.4	65.2	66.2	136.5	73.4	67.9	64.6	57.0	71.6	60.5	107.7	57.6	114.0	72.6	83.0	96.0	69.6	68.1	62.3	119.1	132.5	114.4	163.2	125.7	106.4	133.4	139.0	146.7	151.6	153.2	184.1	133.4	138.9	167.4	145.4	172.3	120.9	168.2	190.1	175.4	198.1	136.6	130.4	213.2	117.8	129.6	214.6	136.9	117.2	124.4	151.5	136.8	112.0	132.7	114.9	144.3	121.1	137.3	110.0	184.1	216.8	74.5	100.3	134.2	145.5	160.7	141.4	117.7	109.2	103.6	112.3	171.5	155.6	172.9	97.9	181.3	171.8	141.2	126.2	87.9	106.2	167.8	181.8	294.1	188.4	141.8	162.4	94.5	353.1	136.5	240.3	188.3	157.1	168.9	197.4	202.7	194.3	139.0	191.5	212.7	199.1	229.4	198.8	193.0	131.2	284.4	247.0	53.4	56.6	64.4	70.8	54.2	68.6	60.6	60.6	59.9	57.0	57.6	62.3	110.7	163.5	134.9	10.1	102.8	46.1	86.4	127.5	61.5	75.3	40.0	57.7	126.7	80.1	177.1	86.5	29.2	115.2	139.9	69.2	121.3	106.4	438.7	510.8	124.9	91.4	34.1	137.6	7.6	99.6	99.6	82.6	50.0	107.2	132.2	68.0	54.3	74.7	70.6	53.8	8.2	66.4	97.6	56.8	58.8	55.0	98.2	80.2	56.9	8.4	107.4	116.1	151.4	8.5	7.4	110.1	67.3	83.8	76.9	50.5	80.4	120.8	732.0	97.3	72.3	96.0	115.7	311.3	145.0	65.3	45.5	132.8	128.5	93.0	65.5	66.9
ISY1	"fSAP33, KIAA1160"	ENSG00000240682	"ISY1 splicing factor homolog"	Q9ULR0	3	129127415-129161063	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006312, HPA016995"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (2.20e-2)"	"prognostic favorable (2.46e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (4.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	18.7	13.7	9.1	19.0	9.0	51.6	17.0	9.8	9.6	20.2	7.5	21.6	15.4	19.5	15.1	22.2	15.5	17.4	21.4	8.8	9.1	15.0	10.8	14.1	32.0	9.2	9.3	19.7	15.8	11.2	8.8	22.1	8.9	13.3	16.9	10.4	15.0	12.3	34.9	20.3	16.2	20.3	8.2	18.2	14.9	12.4	8.8	22.7	14.9	21.3	30.1	18.3	19.4	8.9	53.7	20.5	29.6	41.6	35.1	36.4	34.5	39.3	35.0	46.1	44.2	40.6	39.3	67.3	41.3	32.6	40.0	44.8	56.3	31.8	64.9	65.0	26.5	78.0	35.2	32.8	32.7	121.2	53.4	22.9	21.7	40.6	62.3	28.7	37.7	43.2	57.1	33.5	25.2	54.2	73.8	67.1	32.3	55.9	31.3	64.9	67.3	47.5	17.3	33.5	46.8	35.3	72.7	15.7	41.9	16.0	30.3	99.1	45.2	33.5	33.4	49.8	41.6	40.1	26.1	131.9	30.8	69.4	39.0	79.8	57.6	94.2	54.8	56.4	61.4	56.1	55.8	58.7	62.8	50.7	61.0	55.0	90.7	84.8	51.2	54.5	73.5	56.5	9.1	9.0	9.8	9.6	8.8	9.1	9.2	9.3	8.9	8.2	8.8	8.9	26.5	25.6	23.4	0.0	27.4	27.4	16.5	21.3	20.5	19.7	17.0	15.6	19.7	21.5	21.8	9.2	22.9	44.1	38.5	15.8	23.5	26.7	2.8	11.9	23.0	25.3	9.0	29.0	0.0	28.0	41.2	21.8	12.8	21.0	45.6	25.8	26.0	12.3	34.8	20.2	0.0	16.7	16.2	21.1	25.6	1.8	16.1	23.9	10.6	0.0	43.7	20.7	46.4	0.0	0.0	24.4	15.3	16.1	24.1	17.4	18.8	23.2	14.8	19.0	19.7	18.8	20.9	57.4	42.6	20.0	35.8	45.8	32.9	18.7	20.5	16.9
ISY1-RAB43		ENSG00000261796	"ISY1-RAB43 readthrough"		3	129087575-129161036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.5;granulocytes: 1.3;Oligodendrocytes: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA006312, HPA016995"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (1.09e-1)"	"unprognostic (5.42e-2)"			"unprognostic (1.52e-1)"	"unprognostic (9.05e-3)"		"unprognostic (2.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-1)"		"unprognostic (5.67e-2)"	"unprognostic (1.87e-1)"	7.6	7.2	2.4	10.1	2.8	7.1	7.5	2.4	5.7	7.3	2.5	7.6	3.9	8.1	4.4	5.2	6.9	4.2	5.7	2.3	2.9	7.8	9.6	9.4	8.1	2.5	2.6	9.4	7.2	8.8	5.6	6.5	3.2	7.6	7.4	2.7	6.6	8.3	3.9	5.5	6.7	7.7	2.1	9.2	6.8	5.1	2.7	16.7	7.6	3.7	9.0	7.6	4.6	3.5	26.1	5.7	12.9	11.9	15.8	9.3	5.6	12.2	28.5	19.4	23.6	3.0	13.1	0.9	17.7	22.0	22.2	9.8	5.1	20.4	11.9	9.9	1.0	2.4	2.5	10.2	27.1	10.8	12.9	21.5	10.7	12.1	7.7	19.2	25.4	23.7	4.2	9.9	16.9	10.8	16.3	7.7	9.1	27.7	6.7	13.7	5.6	9.1	20.8	9.9	0.9	5.8	5.8	13.1	18.9	10.7	6.5	10.3	21.0	9.4	7.9	13.5	5.6	14.3	7.0	4.4	10.7	1.1	13.3	0.1	0.5	0.1	0.6	0.2	0.6	0.0	0.6	0.8	0.2	0.1	0.8	0.7	0.6	0.6	0.4	0.2	0.4	0.6	2.4	2.8	2.4	5.7	2.3	2.9	2.5	2.6	3.2	2.1	2.7	3.5	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ITPKC	"IP3-3KC, IP3KC"	ENSG00000086544	"Inositol-trisphosphate 3-kinase C"	Q96DU7	19	40717112-40740860	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 96.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 151.4;Glandular and luminal cells: 139.3;Squamous epithelial cells: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050760, HPA053003"	Approved		Supported	"Nuclear speckles"		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA050760: AB_2681227, HPA053003: AB_2682011"	"unprognostic (4.27e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.31e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (4.91e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.32e-1)"	45.3	13.9	11.2	10.8	9.6	3.5	29.4	9.4	10.7	32.6	11.6	16.8	11.7	18.6	4.7	96.7	25.0	23.0	19.3	10.0	10.7	18.8	17.7	41.8	6.0	15.0	11.5	12.9	22.8	10.3	22.0	10.3	11.6	27.1	6.8	5.5	31.1	10.5	18.4	51.0	16.9	16.3	10.8	14.5	26.3	6.0	15.2	8.7	17.2	8.9	13.9	22.4	42.0	9.3	12.9	12.0	7.3	11.5	32.2	27.8	11.6	7.5	15.7	7.6	6.7	17.3	13.1	3.5	8.5	9.7	5.7	13.3	7.3	32.6	3.1	6.7	7.5	2.7	4.5	12.3	31.8	3.0	3.6	38.8	46.4	7.2	26.5	10.3	18.9	5.0	10.6	6.1	7.5	15.7	4.4	4.5	3.7	29.4	5.4	4.7	3.6	4.9	12.0	21.5	5.2	6.5	7.6	30.5	7.2	8.4	14.1	7.6	12.2	4.9	7.3	3.3	5.1	3.5	0.9	3.7	7.6	3.1	5.4	0.9	0.7	0.4	0.8	0.3	0.3	0.3	0.6	0.4	0.3	0.7	0.4	0.5	0.3	0.2	0.5	0.5	0.6	0.4	11.2	9.6	9.4	10.7	10.0	10.7	15.0	11.5	11.6	10.8	15.2	9.3	75.4	86.6	35.2	6.5	2.7	60.4	72.4	17.4	39.9	10.0	88.4	44.4	4.1	7.2	29.7	3.7	0.0	7.7	2.8	57.7	1.9	13.9	2.1	67.5	23.2	26.4	16.7	3.2	7.4	12.3	5.5	20.1	151.4	139.3	3.8	4.3	25.7	6.8	2.9	5.0	6.0	27.2	2.0	7.8	9.6	2.2	11.8	6.8	19.6	6.5	3.1	3.7	3.1	9.0	3.5	23.2	50.8	7.5	1.2	65.3	28.7	4.4	29.4	6.2	0.0	7.1	10.1	1.9	2.0	160.8	53.4	16.8	5.2	4.6	18.0	98.6
KDM6B	"JMJD3, KIAA0346"	ENSG00000132510	"Lysine demethylase 6B"	O15054	17	7834217-7854796	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Inflammatory response"	"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 393.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 3.6;neutrophil: 8.9"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 8.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037988	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"HPA037988: AB_10672502"	"unprognostic (3.43e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.89e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.85e-1)"	33.6	13.3	3.1	20.0	2.4	35.5	12.6	12.5	22.9	12.2	3.4	15.4	14.3	14.0	3.4	13.6	17.1	15.6	17.7	3.2	4.5	14.6	15.2	27.4	8.0	4.8	3.2	29.7	17.1	7.9	21.8	6.8	3.3	14.5	4.1	6.2	12.0	6.2	12.4	16.4	17.5	5.5	1.4	20.7	17.7	16.1	5.0	16.4	15.9	8.2	4.6	19.8	12.4	6.2	4.9	7.0	12.5	19.0	4.6	3.4	16.2	3.8	5.4	2.7	2.8	9.3	3.6	11.4	4.5	3.0	3.9	12.2	5.8	5.1	1.6	4.7	4.5	5.3	6.7	6.2	13.0	7.2	15.6	5.3	8.0	6.1	5.1	7.2	4.8	11.8	8.8	4.8	1.2	7.7	10.6	6.5	6.4	4.9	3.9	11.9	2.9	3.2	5.1	7.7	6.6	21.4	4.8	11.5	10.3	7.3	6.4	8.9	2.3	4.0	7.1	7.0	5.5	5.6	1.2	3.9	5.3	4.2	8.1	3.6	0.6	1.1	0.3	0.4	0.3	0.3	0.2	0.1	0.3	0.5	0.3	0.4	8.9	0.1	0.2	0.7	0.1	0.4	3.1	2.4	12.5	22.9	3.2	4.5	4.8	3.2	3.3	1.4	5.0	6.2	135.5	25.6	33.6	6.2	158.8	214.4	122.2	30.8	156.0	45.2	113.7	70.9	10.8	42.9	32.4	7.3	31.3	15.1	127.6	47.8	1.9	28.0	29.2	88.2	67.1	80.5	79.9	8.4	9.0	25.1	15.9	85.4	73.4	181.6	178.6	44.8	34.2	22.7	23.4	38.7	10.9	62.5	18.3	50.4	393.1	10.7	16.4	219.2	56.9	4.7	25.6	13.2	9.2	5.5	1.9	58.4	49.1	13.9	70.7	99.6	53.9	9.8	20.5	17.1	19.7	181.2	83.0	20.1	19.3	138.1	188.0	52.0	104.1	22.0	46.2	86.6
KIF22	"Kid, KNSL4, OBP-1, OBP-2"	ENSG00000079616	"Kinesin family member 22"	Q14807	16	29790719-29805384	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.5;lymphoid tissue: 73.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 288.7;Hepatocytes: 565.5;Proximal tubular cells: 194.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048213, HPA075670"	Enhanced		Supported	"Nuclear speckles"		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear speckles"		"HPA048213: AB_2680316, HPA075670: "	"unprognostic (3.71e-2)"	"prognostic favorable (3.87e-8)"	"unprognostic (1.86e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	9.2	7.0	9.5	19.7	9.9	88.5	13.4	8.1	10.4	10.5	6.9	22.6	16.6	8.2	8.6	22.3	12.3	6.4	10.8	9.5	8.9	11.2	8.3	8.5	34.1	8.4	8.3	8.2	7.3	33.8	9.2	15.7	8.3	24.9	20.6	8.9	10.5	12.0	8.4	32.8	16.9	8.0	8.9	18.6	11.8	28.3	9.4	73.0	26.0	11.0	34.7	10.1	13.3	9.3	89.3	103.9	120.6	87.6	8.0	11.9	104.8	65.8	52.1	123.1	113.9	97.9	103.3	130.6	60.4	34.4	61.2	90.0	118.9	67.5	57.4	84.8	100.4	72.4	115.1	119.0	2.7	79.1	76.0	6.7	17.7	68.5	51.3	17.1	67.2	144.7	109.4	104.1	65.5	186.5	173.1	196.1	101.8	65.7	59.6	237.9	110.6	122.4	44.9	45.0	99.8	65.4	48.5	94.7	33.1	39.4	84.8	105.2	29.8	63.8	66.6	57.7	72.6	96.6	105.3	141.4	41.9	129.0	83.3	58.7	14.1	39.5	49.7	21.1	37.3	30.4	50.0	53.1	14.7	27.3	40.0	38.4	6.2	31.5	18.3	9.6	56.5	40.5	9.5	9.9	8.1	10.4	9.5	8.9	8.4	8.3	8.3	8.9	9.4	9.3	13.9	32.1	115.4	5.5	23.0	30.8	25.8	56.7	52.9	27.5	56.5	56.4	288.7	57.2	38.5	69.9	25.0	81.7	20.1	44.2	62.6	16.6	9.9	29.5	18.9	29.2	41.4	85.2	4.8	50.1	85.4	50.1	25.0	31.1	43.6	29.5	49.2	565.5	46.3	6.7	6.1	39.5	34.6	47.7	40.4	8.5	15.5	36.7	35.6	4.7	38.6	69.8	29.9	4.0	5.3	17.3	44.0	12.8	49.9	26.1	18.0	194.0	29.7	20.5	13.1	23.7	34.2	50.9	61.6	41.4	27.6	76.9	34.2	12.2	42.3	22.5
KLHDC7A	FLJ38753	ENSG00000179023	"Kelch domain containing 7A"	Q5VTJ3	1	18480930-18485974	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 8.4;kidney: 19.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 5.7;Collecting duct cells: 9.2;Endometrial ciliated cells: 4.4;Gastric mucus-secreting cells: 5.6;Hepatocytes: 7.6;Proximal tubular cells: 9.9;Respiratory ciliated cells: 5.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.4;CAPAN-2: 10.4;EFO-21: 5.2;NTERA-2: 5.7;RPTEC TERT1: 11.5;RT4: 9.5;T-47d: 10.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA056616	Uncertain		Approved	"Nuclear speckles"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA056616: AB_2683193"	"unprognostic (4.63e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (7.81e-9)"	"unprognostic (4.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (1.88e-4)"	0.5	0.0	0.0	0.0	0.0	0.0	4.5	0.7	0.1	2.3	8.4	0.6	0.4	0.0	0.2	1.3	0.8	1.0	0.0	0.5	0.0	19.5	4.7	1.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.0	0.4	0.7	0.0	1.7	1.1	0.0	0.0	0.3	0.0	0.0	0.0	4.9	0.2	0.1	0.0	1.6	0.0	0.0	3.2	0.3	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.1	10.4	0.0	5.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.1	0.0	0.2	0.0	0.0	11.5	9.5	2.8	0.0	0.0	0.8	0.0	1.0	10.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.3	0.5	0.0	0.0	1.7	0.4	1.2	5.7	2.2	9.2	0.0	0.1	0.0	0.3	1.9	2.0	0.4	4.4	0.3	0.1	0.0	0.0	0.0	2.2	0.1	0.1	5.6	3.0	0.0	0.1	0.0	7.6	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	1.1	0.0	9.9	5.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.6
LHX4	Gsh4	ENSG00000121454	"LIM homeobox 4"	Q969G2	1	180230264-180278984	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 15.4"	"Group enriched"	"Detected in some"	12	"Bipolar cells: 98.6;Cone photoreceptor cells: 52.1;Early spermatids: 43.0;Late spermatids: 73.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 4.5;BEWO: 10.5;HeLa: 4.9"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.3"	"Region enhanced"	"Detected in single"		"spinal cord: 1.9"	HPA055705			Approved	"Nuclear speckles"		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear speckles"		"HPA055705: AB_2682892"	"unprognostic (2.83e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.86e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.76e-5)"	"unprognostic (9.39e-4)"	"unprognostic (1.47e-1)"	"unprognostic (2.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.72e-3)"	"unprognostic (4.07e-8)"	"unprognostic (3.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.44e-3)"	"unprognostic (7.83e-3)"	0.5	0.6	0.3	0.8	0.2	0.6	0.6	1.8	0.3	0.9	0.0	0.9	0.8	0.8	0.0	0.7	0.8	0.4	0.4	0.2	0.1	0.9	0.5	0.6	0.7	0.3	0.6	1.1	1.4	0.0	1.4	0.9	0.7	0.7	0.3	15.4	0.8	0.0	0.5	1.0	1.0	0.0	0.0	0.9	0.7	1.8	0.1	0.0	1.1	0.0	0.0	0.7	0.9	0.2	1.0	4.5	1.1	2.3	0.0	0.0	10.5	1.2	0.3	0.3	0.1	0.8	1.9	1.1	0.3	0.0	0.4	1.9	2.1	0.0	0.5	0.6	1.7	0.8	4.9	0.5	0.0	1.2	1.3	0.0	0.0	0.0	0.0	0.4	0.0	1.1	1.3	0.4	0.0	2.3	0.6	2.2	0.9	0.3	0.2	0.7	2.8	0.4	0.0	0.9	1.1	0.9	1.2	0.9	0.4	0.9	2.5	0.2	1.4	1.0	1.8	1.0	0.7	0.7	0.3	0.9	0.3	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	1.8	0.3	0.2	0.1	0.3	0.6	0.7	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.6	0.0	98.6	0.4	0.0	0.7	0.0	0.1	0.0	52.1	0.5	0.5	2.2	0.0	0.0	43.0	0.5	0.8	0.2	0.0	0.0	0.3	0.0	0.5	0.1	0.0	1.1	0.0	0.3	0.0	0.0	0.1	5.0	0.3	0.5	0.0	0.0	0.0	73.9	0.6	0.3	0.0	0.0	0.0	2.6	0.0	0.5	0.4	0.0	0.1	0.0	0.2	0.0	0.4	1.6	0.1	5.4	0.0	1.2	0.2	0.3	0.6	0.0	0.0	0.1	0.1	0.4	0.3	0.0
LIN52	C14orf46	ENSG00000205659	"Lin-52 DREAM MuvB core complex component"	Q52LA3	14	74084796-74201235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.5;Inhibitory neurons: 65.4;Oligodendrocyte precursor cells: 60.3;Oligodendrocytes: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000900, HPA001777"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"		"HPA000900: AB_2135058, HPA001777: AB_2666431"	"unprognostic (2.34e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.90e-3)"	"prognostic favorable (6.60e-4)"	"prognostic unfavorable (6.08e-5)"	"unprognostic (2.48e-3)"	"unprognostic (9.34e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-1)"	8.0	7.8	8.4	5.4	8.4	3.5	6.3	8.8	10.1	5.8	7.8	4.5	6.5	7.0	5.7	4.9	5.5	4.9	10.2	8.3	10.0	19.3	6.6	5.0	6.1	9.2	8.9	8.5	3.4	6.8	5.7	5.0	9.3	6.4	5.7	10.7	3.9	5.6	5.6	3.8	5.8	6.8	7.9	5.1	4.3	7.5	8.9	10.7	5.1	10.0	6.3	5.8	3.9	8.5	10.5	7.7	26.8	12.8	15.5	6.6	10.5	17.5	16.7	23.0	25.7	14.0	9.6	5.9	5.3	8.6	9.2	9.2	20.4	6.9	35.1	49.1	8.1	9.1	8.9	20.0	16.6	9.4	12.7	8.2	7.7	12.2	15.9	6.3	11.0	18.6	9.7	27.8	11.4	13.4	14.9	12.3	7.7	13.8	12.3	19.0	25.1	9.6	6.0	6.2	19.0	15.5	16.4	12.0	13.7	9.9	16.3	13.5	6.3	10.8	20.3	11.5	14.8	18.2	41.8	13.2	12.5	10.7	18.4	6.2	6.4	20.6	10.7	6.6	16.6	8.7	9.3	10.7	8.6	9.4	13.7	12.5	3.2	11.4	4.8	7.9	13.9	10.1	8.4	8.4	8.8	10.1	8.3	10.0	9.2	8.9	9.3	7.9	8.9	8.5	5.6	9.6	9.0	39.8	10.4	4.8	3.2	3.2	11.4	8.8	7.6	5.3	10.0	10.0	6.6	5.5	8.4	6.3	8.8	3.5	7.9	3.1	0.8	5.9	6.6	7.4	3.0	16.4	47.5	2.4	5.2	8.1	6.1	6.7	2.5	9.0	6.4	12.2	6.3	16.8	65.4	6.0	4.1	4.3	3.7	1.6	5.3	4.5	0.0	26.2	6.6	10.8	10.3	60.3	60.4	2.4	5.0	9.8	27.3	3.3	10.9	22.4	6.2	7.5	6.6	8.1	6.4	16.3	10.4	10.3	5.5	8.8	8.2	3.7	4.7	1.4
LMNA	"CMD1A, HGPS, LGMD1B, LMN1, LMNL1, MADA, PRO1"	ENSG00000160789	"Lamin A/C"	P02545	1	156082573-156140081	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cardiomyopathy, Charcot-Marie-Tooth disease, Congenital muscular dystrophy, Disease variant, Emery-Dreifuss muscular dystrophy, Limb-girdle muscular dystrophy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 1533.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 85.1;T-reg: 83.2"	"Group enriched"	"Detected in all"	8	"dendritic cells: 85.1;granulocytes: 23.9;T-cells: 83.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004022, HPA006523, HPA006660"	Supported		Supported	"Nuclear speckles"		NA	NA		5700000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"CAB004022: AB_2136278, HPA006523: , HPA006660: AB_1079231"	"unprognostic (2.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.90e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.44e-2)"	280.2	174.8	17.6	64.9	27.1	58.1	231.5	24.1	20.6	221.7	33.0	183.3	72.8	271.4	14.5	256.2	173.8	92.1	221.7	15.8	23.1	120.9	93.2	188.5	18.2	30.3	25.2	178.2	81.8	21.3	76.9	53.0	26.1	125.3	38.2	4.7	176.1	42.8	190.0	364.3	136.8	78.8	21.0	84.1	160.6	61.9	30.9	15.3	147.4	23.8	22.9	168.7	217.6	41.8	518.8	269.7	26.2	72.4	119.5	238.7	169.4	607.3	379.6	221.3	146.8	68.3	311.9	2.8	338.7	417.9	94.6	515.4	31.4	227.8	70.3	188.6	50.8	175.4	168.4	130.8	124.0	25.7	412.9	133.0	92.0	154.8	134.7	120.2	207.5	0.7	82.8	21.9	205.8	193.1	1.0	67.8	32.1	202.9	706.0	1.6	195.9	137.7	128.9	105.6	33.8	114.9	414.3	154.2	427.4	56.2	230.1	74.2	727.9	241.6	233.0	389.1	393.3	39.5	10.5	4.9	449.2	24.8	760.4	23.9	8.3	0.4	2.8	2.1	2.5	2.4	17.8	7.3	85.1	0.2	0.2	0.7	2.1	3.7	0.2	0.3	83.2	14.6	17.6	27.1	24.1	20.6	15.8	23.1	30.3	25.2	26.1	21.0	30.9	41.8	353.5	262.8	350.0	16.0	179.1	610.5	1235.3	446.2	531.6	7.2	542.5	374.9	94.1	191.6	320.3	161.8	47.9	478.8	239.8	614.1	109.5	429.3	38.6	215.4	209.4	386.0	431.5	70.4	9.9	360.2	387.8	622.1	505.1	270.5	1181.8	145.5	277.7	103.1	343.0	13.5	15.1	601.2	177.0	60.6	1533.4	45.4	288.6	409.0	859.2	10.3	20.4	37.2	3.1	17.1	20.1	513.0	384.1	287.3	331.3	340.6	262.6	125.0	170.5	17.8	203.8	1028.4	766.8	107.4	42.2	404.1	602.4	680.9	472.3	111.6	513.8	942.6
LUC7L3	"CRA, CREAP-1, CROP, FLJ11063, hLuc7A, LUC7A, OA48-18"	ENSG00000108848	"LUC7 like 3 pre-mRNA splicing factor"	O95232	17	50719565-50756219	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018475, HPA018484, HPA020017"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		15000	"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA018475: AB_1847247, HPA018484: AB_1847248, HPA020017: AB_1847249"	"unprognostic (3.90e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.18e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (7.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (5.35e-5)"	86.8	108.2	128.2	91.1	134.2	75.9	96.4	165.6	193.2	172.2	131.4	163.3	99.4	144.8	88.1	98.3	157.5	63.8	102.8	126.1	138.7	112.7	90.8	119.0	132.4	131.3	128.4	223.5	111.6	63.6	172.0	78.5	132.5	141.3	75.1	175.8	94.8	73.4	151.9	105.3	131.2	65.8	124.6	133.6	113.7	73.7	133.5	84.1	144.0	43.2	88.4	130.1	136.5	148.4	176.7	114.3	222.8	143.1	91.5	87.9	105.5	162.8	63.0	77.0	92.1	214.5	132.4	212.5	171.1	65.2	87.5	148.8	149.4	67.5	132.2	226.6	242.5	251.5	445.3	174.9	50.5	223.4	136.0	84.2	94.5	84.2	48.7	193.7	79.9	164.9	202.9	188.0	99.1	99.1	221.4	218.0	146.2	125.3	83.4	238.2	208.4	224.0	105.5	109.8	158.1	163.2	96.8	121.5	179.3	192.6	196.3	164.9	113.7	170.9	146.3	72.8	171.5	167.8	191.7	265.1	108.1	152.5	123.9	49.1	32.3	32.6	32.0	24.0	28.2	67.3	35.7	27.6	21.2	55.4	37.1	30.5	47.8	23.3	19.8	64.7	29.6	12.1	128.2	134.2	165.6	193.2	126.1	138.7	131.3	128.4	132.5	124.6	133.5	148.4	129.7	150.6	194.2	231.8	177.8	216.2	200.9	99.4	200.3	512.3	121.1	129.5	111.5	70.1	148.3	93.8	229.4	104.8	237.1	130.8	74.3	102.6	18.9	111.1	171.8	151.9	207.8	191.2	121.5	85.3	108.5	149.8	99.4	144.8	148.0	364.8	94.2	83.1	76.4	380.2	145.9	151.8	81.4	87.4	122.5	48.4	394.5	105.1	96.0	107.7	184.2	207.8	197.8	181.5	239.1	86.5	158.0	355.0	134.5	151.2	157.8	56.2	130.1	402.2	236.7	204.5	172.3	122.2	159.3	135.7	177.0	99.9	162.8	253.1	141.7	191.7
MAML3	"CAGH3, GDN, KIAA1816, MAM2, TNRC3"	ENSG00000196782	"Mastermind like transcriptional coactivator 3"	Q96JK9	4	139716753-140154184	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 125.6;Microglial cells: 355.1;Oligodendrocytes: 150.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 16.8"	"Immune cell enhanced"	"Detected in many"		"basophil: 12.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.2;NK-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 15.0;SCLC-21H: 15.7;SH-SY5Y: 23.9;WM-115: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037717	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"		"HPA037717: AB_10794323"	"unprognostic (1.83e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.83e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.89e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (7.60e-5)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.88e-1)"	3.3	3.4	1.5	2.4	0.9	3.2	3.4	16.8	2.1	5.0	0.1	3.8	4.8	6.7	5.3	5.9	5.5	4.1	2.0	2.2	2.8	2.0	2.6	3.8	2.6	3.4	2.3	8.6	6.8	3.3	4.5	5.0	3.4	4.9	3.9	1.7	5.9	4.5	1.7	7.8	4.5	6.0	2.4	3.3	3.4	3.0	2.2	6.0	4.3	2.1	2.3	3.6	5.1	2.2	0.5	8.1	5.4	2.7	2.1	4.4	4.9	1.0	4.4	0.5	0.3	3.2	2.2	1.8	0.4	0.8	0.3	0.1	2.1	1.8	0.3	0.0	1.2	5.9	1.9	0.3	0.4	2.8	8.7	4.3	1.5	0.1	0.9	3.3	15.0	0.1	1.6	0.0	0.3	0.9	0.5	1.2	1.4	3.6	3.5	3.5	0.5	3.6	2.5	11.2	15.7	23.9	0.0	4.2	5.5	4.2	2.3	0.8	13.1	0.6	1.3	0.1	1.7	2.9	3.5	0.1	0.8	9.2	20.2	12.2	1.5	2.9	0.0	1.1	0.1	0.0	0.0	0.0	1.5	0.4	0.4	0.4	3.6	3.4	0.9	1.2	0.0	1.2	1.5	0.9	16.8	2.1	2.2	2.8	3.4	2.3	3.4	2.4	2.2	2.2	21.2	3.2	11.5	39.5	3.1	8.0	8.1	4.2	7.4	4.6	12.6	9.3	3.0	11.5	8.7	5.5	18.8	5.8	3.9	13.6	5.9	5.1	3.6	12.6	9.4	11.7	14.9	9.4	60.2	5.1	7.3	5.3	8.6	19.9	19.6	34.4	13.2	17.5	7.5	11.8	125.6	12.1	2.0	22.6	13.3	9.0	4.1	19.6	3.6	355.1	18.3	3.1	1.0	7.5	150.8	3.0	14.0	3.8	2.1	5.7	8.2	6.1	7.2	3.7	0.0	2.9	13.7	0.5	2.2	19.0	13.5	8.2	5.3	8.5	11.0	8.9
MAMSTR	"FLJ36070, MASTR"	ENSG00000176909	"MEF2 activating motif and SAP domain containing transcriptional regulator"	Q6ZN01	19	48712725-48719725	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 32.4;skeletal muscle: 88.9;tongue: 22.6"	"Cell type enhanced"	"Detected in many"		"Theca cells: 10.1"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 7.0"	"Region enhanced"	"Detected in many"		"cerebellum: 7.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 7.2;RH-30: 16.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049765			Approved	"Nuclear speckles"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	"Nuclear speckles"		"HPA049765: AB_2680870"	"unprognostic (6.00e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.50e-3)"	"unprognostic (4.34e-4)"	"unprognostic (2.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.39e-2)"	4.6	32.4	1.7	0.8	2.0	0.3	1.8	7.9	3.7	6.2	0.0	2.5	0.6	8.0	1.4	3.5	8.0	1.0	4.0	2.0	0.2	2.4	0.4	1.4	0.6	0.6	0.8	8.7	1.9	3.0	3.8	1.6	0.9	2.4	0.7	0.5	2.9	1.9	88.9	2.1	1.2	4.6	0.2	6.1	1.6	9.2	0.6	0.5	1.2	22.6	0.6	2.0	4.6	1.2	0.5	1.3	1.4	3.5	2.7	4.5	1.3	4.8	3.8	2.3	3.6	1.4	0.9	0.7	0.2	4.4	1.3	1.0	0.1	0.8	0.9	0.5	1.6	0.3	0.6	7.2	1.4	0.1	0.9	2.8	0.9	3.2	0.4	3.1	0.8	1.3	0.3	0.9	1.5	0.6	1.1	0.5	0.1	1.1	1.0	1.3	16.6	0.4	0.2	0.3	1.5	2.8	0.7	0.3	0.3	0.3	0.5	0.0	0.3	4.7	0.8	3.8	0.6	1.0	0.6	0.5	1.7	0.5	0.9	0.0	0.2	0.5	1.6	0.4	1.0	1.3	1.7	1.6	0.4	2.1	1.6	1.5	0.2	0.3	0.4	1.3	0.8	0.3	1.7	2.0	7.9	3.7	2.0	0.2	0.6	0.8	0.9	0.2	0.6	1.2	2.4	0.0	0.0	2.6	1.3	0.9	1.8	1.5	4.6	1.8	1.4	2.2	2.9	0.0	2.3	1.8	2.1	0.8	0.5	0.6	5.9	1.7	0.8	0.8	3.5	3.8	0.0	1.3	2.9	1.0	2.9	4.9	1.1	1.6	0.0	6.1	4.6	0.3	1.1	0.0	2.0	0.7	2.0	0.3	2.2	1.7	5.6	1.6	7.2	0.0	1.2	5.3	2.1	1.5	1.2	0.5	0.0	6.0	1.5	0.6	1.1	0.6	0.4	2.9	0.0	5.1	4.7	0.7	1.6	2.4	0.9	1.0	1.8	10.1	0.8	1.6
MAST3	KIAA0561	ENSG00000099308	"Microtubule associated serine/threonine kinase 3"	O60307	19	18097793-18151692	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 62.6;Oligodendrocytes: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035061, HPA035062"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA035061: AB_10670585, HPA035062: AB_10671508"	"unprognostic (5.94e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (1.93e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (7.01e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-3)"	4.9	4.8	49.9	9.2	53.4	14.4	3.7	0.0	62.1	9.4	0.0	7.3	9.6	5.3	4.7	3.3	7.1	3.1	3.7	61.6	0.0	7.6	14.5	9.1	11.2	5.3	1.9	7.1	20.2	5.0	15.5	2.6	4.3	5.6	4.3	1.0	4.8	3.9	3.0	7.3	12.4	3.0	0.0	19.2	4.5	3.6	13.7	4.2	4.5	1.6	10.1	3.7	4.9	47.4	3.5	5.1	2.3	10.2	6.7	5.4	5.5	3.5	2.2	2.4	3.4	5.2	4.7	9.0	5.1	3.5	2.6	1.9	3.4	2.0	1.7	7.7	4.2	4.1	5.7	8.3	5.6	2.2	13.2	6.2	5.7	3.6	1.4	3.2	1.1	6.1	4.3	5.8	2.8	6.3	4.7	7.3	2.4	7.7	6.2	12.6	2.0	6.6	1.9	1.5	3.8	6.2	4.9	2.8	2.1	1.6	3.2	5.1	4.0	3.0	3.2	13.1	1.5	6.2	9.0	8.0	6.7	11.6	2.9	0.3	6.2	14.8	11.7	8.0	8.4	5.9	6.3	4.7	3.2	5.9	4.9	8.4	32.9	8.1	14.7	15.4	7.6	6.1	49.9	53.4	0.0	62.1	61.6	0.0	5.3	1.9	4.3	0.0	13.7	47.4	2.6	6.4	9.4	5.5	13.5	0.5	0.8	2.8	2.8	3.0	2.6	2.8	1.5	7.2	3.6	9.2	2.1	0.5	19.0	30.0	3.9	2.9	9.3	2.8	5.4	3.8	2.4	1.3	62.6	10.5	1.5	3.4	7.7	1.5	2.5	3.0	4.6	16.3	7.7	0.0	6.1	8.5	0.0	21.7	6.3	30.8	4.1	13.3	5.4	19.7	19.6	0.9	32.0	8.0	63.7	7.1	7.9	6.8	5.1	1.2	16.7	8.8	4.2	0.7	0.0	2.1	3.0	0.6	3.9	2.3	2.3	0.4	11.0	5.3	13.0	0.6
MBD4	MED1	ENSG00000129071	"Methyl-CpG binding domain 4, DNA glycosylase"	O95243	3	129430947-129440179	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002031	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear speckles"		"HPA002031: AB_1079319"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (2.18e-4)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.73e-6)"	"unprognostic (9.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.35e-2)"	18.6	18.4	16.8	34.0	18.4	44.2	21.6	19.6	20.7	33.2	16.8	19.3	23.7	23.3	24.8	16.4	19.3	21.3	25.3	17.0	17.4	25.4	38.0	22.9	66.5	17.5	17.2	30.3	22.9	18.1	19.3	19.7	17.7	18.7	22.9	19.6	19.5	17.8	25.8	23.7	27.5	19.7	17.3	39.2	27.8	17.3	18.4	30.0	19.3	22.3	74.0	18.5	17.5	20.6	46.2	27.4	32.5	36.5	36.8	32.8	37.5	39.0	36.9	36.7	43.3	33.8	30.1	64.6	31.1	24.5	33.7	40.7	25.2	24.1	44.2	37.0	16.6	38.9	32.0	24.6	58.7	71.2	49.2	39.1	33.8	31.2	27.4	36.5	35.1	37.2	43.9	47.1	27.5	43.3	41.4	50.0	28.7	38.8	23.5	38.7	19.2	44.7	40.9	22.7	36.5	20.3	49.3	25.3	42.5	28.0	32.3	62.5	23.6	34.5	26.3	37.6	26.2	31.9	20.9	111.9	29.4	40.1	29.2	80.3	25.0	35.2	31.1	23.1	24.0	116.5	33.2	30.9	21.0	110.8	40.6	33.3	43.0	28.9	30.0	25.2	31.5	25.6	16.8	18.4	19.6	20.7	17.0	17.4	17.5	17.2	17.7	17.3	18.4	20.6	36.5	19.2	52.9	15.3	111.2	17.3	32.5	38.4	29.6	37.0	26.7	29.6	35.9	27.1	36.4	44.1	18.8	49.2	61.4	22.4	45.0	32.1	19.8	49.6	41.2	33.5	33.6	46.3	18.1	69.0	46.2	35.6	55.0	45.0	58.9	33.1	31.4	32.1	71.8	21.9	12.8	27.5	40.7	41.8	24.7	10.6	32.9	48.0	21.4	24.4	62.9	21.2	54.6	14.1	22.0	39.3	23.4	36.5	75.5	31.1	29.4	55.5	39.5	46.3	39.5	39.6	30.9	49.5	71.6	30.4	19.6	37.1	54.2	33.2	26.3	35.6
MECOM	"EVI1, KMT8E, MDS1, MDS1-EVI1, PRDM3"	ENSG00000085276	"MDS1 and EVI1 complex locus"	Q03112	3	169083499-169663775	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 73.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 184.8;Collecting duct cells: 125.0;Gastric mucus-secreting cells: 111.1;Glandular and luminal cells: 107.7;Microglial cells: 346.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 55.5;RPTEC TERT1: 71.2;RT4: 119.6;TIME: 53.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046537	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA046537: AB_2679689"	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.27e-3)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.37e-3)"	16.0	0.9	7.3	7.3	7.2	1.4	12.3	8.5	7.3	21.3	2.4	24.9	19.8	17.3	4.4	13.5	23.4	8.3	13.0	4.9	6.3	41.3	1.4	25.5	1.5	9.1	7.2	2.3	23.3	1.7	4.2	17.4	8.9	6.9	30.0	1.8	8.8	8.0	4.3	2.6	10.2	8.0	4.1	6.2	73.3	3.0	8.1	2.0	5.7	12.0	5.3	30.4	7.5	6.3	25.8	0.7	0.9	0.2	3.7	2.7	1.1	3.7	4.2	1.1	2.2	10.7	26.1	0.9	39.1	0.6	5.5	13.4	10.2	15.7	3.1	1.4	16.6	16.7	7.6	1.1	0.4	0.3	5.1	5.7	2.2	1.0	12.1	12.0	55.5	1.4	13.0	1.8	10.3	9.8	0.9	0.4	1.7	13.5	6.6	9.8	13.1	0.3	71.2	119.6	1.0	3.1	1.3	6.7	0.3	1.5	7.1	1.1	53.4	9.7	6.6	2.5	16.9	1.4	0.7	0.9	4.8	1.0	1.6	0.9	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.4	0.5	1.6	0.1	0.0	7.3	7.2	8.5	7.3	4.9	6.3	9.1	7.2	8.9	4.1	8.1	6.3	80.2	60.9	184.8	16.0	0.6	2.2	33.3	29.4	10.2	0.0	1.2	0.9	11.4	2.8	69.6	125.0	0.0	1.1	0.1	25.5	52.8	1.6	10.4	71.9	5.8	70.5	19.9	7.4	10.3	75.4	0.2	4.8	111.1	107.7	9.5	0.8	69.3	0.2	0.0	0.0	9.1	29.0	20.3	0.6	1.9	3.2	0.3	2.6	1.8	346.6	1.0	0.0	0.0	6.0	13.8	49.8	19.3	0.0	0.3	13.9	6.2	0.7	53.2	0.1	0.0	1.4	5.7	3.0	1.2	39.4	1.4	0.4	1.3	0.5	53.9	45.4
MORF4L1	"Eaf3, HsT17725, MEAF3, MORFRG15, MRG15"	ENSG00000185787	"Mortality factor 4 like 1"	Q9UBU8	15	78810487-78898139	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042360, HPA062010"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA042360: AB_10794275, HPA062010: AB_2684655"	"unprognostic (5.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.61e-3)"	"unprognostic (8.61e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-3)"	272.8	306.3	183.9	237.6	193.6	427.6	241.5	197.6	285.5	283.8	188.9	270.1	169.4	305.1	213.0	201.1	257.9	256.5	396.6	187.9	240.5	332.2	258.9	243.4	251.8	232.8	221.6	318.2	165.5	263.6	175.1	300.9	223.4	228.7	225.7	265.5	195.9	282.7	559.3	140.5	187.4	331.5	205.4	217.4	186.9	588.7	220.1	297.6	270.2	425.2	279.6	266.2	184.3	227.9	362.0	480.3	863.5	355.4	603.2	620.4	453.2	644.3	636.0	570.7	554.0	436.9	532.7	446.7	517.2	649.1	376.0	442.1	1054.3	432.8	534.3	446.0	420.3	493.5	483.5	406.5	617.9	410.4	424.3	436.7	482.5	323.1	447.6	550.1	689.1	309.7	526.3	398.2	659.2	335.3	392.9	301.6	930.7	472.9	208.5	431.8	673.0	431.0	459.2	488.1	443.6	457.7	578.1	367.2	825.7	871.1	441.7	533.9	543.1	667.2	471.6	359.0	549.6	256.4	770.6	499.2	412.3	647.4	501.4	118.5	195.0	197.5	123.0	188.4	149.4	172.7	176.9	141.6	225.5	163.7	241.9	174.2	154.9	145.1	155.8	214.4	214.2	318.6	183.9	193.6	197.6	285.5	187.9	240.5	232.8	221.6	223.4	205.4	220.1	227.9	374.2	301.3	249.0	38.2	300.0	418.1	624.1	724.2	256.6	104.5	236.1	198.9	372.2	286.0	512.3	290.6	62.6	611.9	309.4	173.4	686.7	545.5	740.6	377.8	352.6	391.1	275.2	298.0	69.6	312.8	815.0	468.2	153.4	282.5	465.8	179.5	372.3	328.6	379.1	200.2	68.5	263.6	451.6	310.9	601.3	504.6	389.5	325.7	501.6	52.5	450.8	322.0	306.9	40.2	80.0	407.4	185.5	464.9	232.0	489.8	178.6	805.1	582.5	97.5	315.5	368.3	500.6	1322.3	467.9	185.3	370.4	663.0	338.2	279.9	199.0	597.1
MRTFB	"FLJ31823, MKL2, MRTF-B"	ENSG00000186260	"Myocardin related transcription factor B"	Q9ULH7	16	14071319-14266773	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 43.9;Cardiomyocytes: 26.9;Cytotrophoblasts: 9.9;Endothelial cells: 9.6;Extravillous trophoblasts: 10.0;Smooth muscle cells: 14.9;Syncytiotrophoblasts: 10.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	170	"amygdala: 9.4;basal ganglia: 15.1;cerebral cortex: 21.4;hippocampal formation: 21.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011286	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA011286: AB_1853973"	"unprognostic (2.00e-1)"	"unprognostic (5.28e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.62e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (6.20e-4)"	"unprognostic (5.22e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.96e-2)"	21.4	7.3	9.4	8.6	15.1	3.8	18.3	0.0	21.4	19.0	0.0	9.9	9.7	14.9	9.1	14.5	14.0	13.3	11.8	21.7	0.0	8.4	5.9	13.2	7.6	0.0	0.0	7.1	12.1	22.2	4.9	21.7	0.0	15.5	10.8	8.6	11.6	15.2	11.9	16.6	7.9	15.6	0.0	5.1	10.1	17.5	0.0	10.3	16.9	14.5	8.1	11.3	12.2	0.0	17.6	17.8	17.8	13.2	5.9	11.0	8.0	4.9	13.3	7.4	10.6	7.7	16.4	9.4	12.4	8.4	9.3	13.8	12.9	14.4	13.5	23.1	7.0	6.0	13.6	13.3	8.2	4.2	5.4	8.4	14.6	12.8	8.3	7.8	14.7	12.2	7.9	9.7	5.6	15.1	13.4	2.8	6.0	4.7	4.8	20.5	13.7	8.1	7.3	17.3	6.2	10.8	23.9	10.2	4.9	8.2	18.0	3.5	9.4	15.3	14.9	4.4	6.4	6.6	8.8	8.4	16.6	7.1	11.7	0.2	0.5	0.0	1.1	0.7	1.7	3.7	1.9	0.9	0.7	1.5	2.4	1.3	0.3	1.1	0.8	1.7	0.9	0.6	9.4	15.1	0.0	21.4	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	9.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	10.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	10.4	0.4	0.0	0.0	0.0
MSX2	"CRS2, FPP, HOX8, MSH, PFM, PFM1"	ENSG00000120149	"Msh homeobox 2"	P35548	5	174724582-174730896	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 25.8;placenta: 33.6;urinary bladder: 17.5"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 162.6;Endometrial ciliated cells: 65.7;Glandular and luminal cells: 62.2;Syncytiotrophoblasts: 233.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 18.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"BEWO: 322.0"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.2"	"Low region specificity"	"Detected in many"			HPA005652	Uncertain		Supported	"Nuclear speckles"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear speckles"		"HPA005652: AB_1079418"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.08e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-4)"	"unprognostic (7.64e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.12e-6)"	"unprognostic (1.43e-2)"	2.1	0.3	0.7	0.5	1.0	0.0	8.1	4.3	1.1	2.7	1.1	0.9	0.3	6.8	0.0	0.6	0.9	0.9	1.6	1.2	1.4	0.3	0.0	0.8	0.1	7.8	1.3	0.2	0.4	25.8	0.3	33.6	4.1	2.5	0.1	0.0	0.8	0.8	1.9	6.9	0.8	1.4	5.4	0.8	2.8	5.6	1.3	0.1	0.7	1.8	0.1	17.5	1.8	5.4	0.4	4.0	1.1	3.2	0.0	0.0	322.0	2.2	3.6	0.7	0.1	56.6	23.0	0.0	8.6	0.2	19.6	6.2	17.6	6.4	0.2	0.0	10.7	0.0	1.4	0.0	2.4	0.0	3.0	3.7	4.5	3.1	3.5	0.0	0.0	0.0	0.0	0.0	5.0	27.7	0.0	0.4	2.5	38.3	8.5	0.0	8.8	0.1	4.0	35.3	0.0	2.5	0.0	43.0	2.9	69.6	25.7	0.2	0.0	1.1	5.5	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	4.3	1.1	1.2	1.4	7.8	1.3	4.1	5.4	1.3	5.4	1.5	0.0	0.0	2.3	0.0	9.6	2.4	0.1	3.4	0.2	15.8	18.9	1.7	0.0	0.1	0.0	0.0	162.6	0.2	0.3	0.0	0.6	0.2	65.7	4.9	0.7	0.0	0.0	0.0	0.0	13.9	5.3	5.1	62.2	4.5	0.1	0.4	0.0	11.3	0.0	0.0	1.9	0.0	0.6	2.9	0.6	0.0	1.0	1.8	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.3	1.9	0.1	0.1	0.0	0.0	8.9	4.8	1.4	4.5	2.0	11.4	233.8	1.0	0.6	1.2	9.8
MYADM		ENSG00000179820	"Myeloid associated differentiation marker"	Q96S97	19	53864763-53876435	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 207.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056301			Approved	"Nuclear speckles"		NA	NA		27000	"Cluster 52: Eosinophils - Transcription"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"HPA056301: "	"unprognostic (5.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.21e-3)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavorable (7.71e-7)"	"unprognostic (2.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.14e-3)"	179.4	25.7	21.5	66.5	20.2	196.3	82.4	3.1	21.6	97.4	24.6	155.6	48.9	248.6	22.2	76.8	146.5	124.6	92.3	16.7	22.2	19.8	46.4	110.7	37.2	16.9	24.7	73.4	101.1	31.1	17.9	89.6	13.7	75.0	39.9	3.6	48.8	100.9	36.7	45.2	63.8	180.9	6.4	42.5	79.5	28.4	17.3	37.1	57.8	21.1	15.2	104.6	64.8	18.8	28.8	231.6	29.2	23.3	96.2	66.0	45.3	145.9	105.9	57.0	58.7	94.4	84.1	2.6	53.7	187.4	61.6	56.4	14.6	56.7	48.5	34.9	34.2	38.0	35.8	75.6	219.2	78.4	131.3	72.3	12.7	73.4	10.5	93.4	52.0	14.9	41.5	68.7	36.4	32.0	21.4	60.9	27.9	104.3	65.3	82.1	31.0	13.3	63.8	3.0	0.4	43.8	1.2	44.6	14.1	58.4	44.4	66.8	105.5	125.8	44.5	17.0	66.2	44.7	29.9	0.6	78.4	37.1	2.1	74.3	48.1	165.5	20.9	27.1	19.6	5.4	13.4	15.2	59.5	7.1	12.5	11.0	207.4	17.8	23.5	22.3	5.4	20.0	21.5	20.2	3.1	21.6	16.7	22.2	16.9	24.7	13.7	6.4	17.3	18.8	125.9	163.5	59.1	2.9	138.9	103.0	173.3	73.1	96.8	4.1	141.0	105.8	67.1	97.2	91.5	20.2	4.2	46.2	143.3	43.8	0.0	106.6	2.7	97.0	164.1	117.2	202.4	35.7	9.1	51.8	243.9	279.7	83.1	195.5	347.6	27.0	182.8	18.5	73.5	10.1	8.3	203.9	24.4	120.4	217.2	2.2	90.1	180.3	60.5	11.2	68.0	4.0	19.6	7.1	13.9	71.4	54.7	116.6	189.9	56.6	2.7	0.5	57.0	1.4	151.2	340.1	199.0	35.9	14.5	19.7	59.8	49.5	221.5	20.5	93.8	75.0
NCBP3	"C17orf85, ELG, HSA277841"	ENSG00000074356	"Nuclear cap binding subunit 3"	Q53F19	17	3802158-3846246	"Predicted intracellular proteins"	"Antiviral defense, mRNA capping, mRNA processing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008959, HPA013195"	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA008959: AB_2668184, HPA013195: AB_2668800"	"unprognostic (1.39e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.64e-1)"	"unprognostic (5.68e-2)"	"unprognostic (5.36e-2)"	9.4	8.2	8.1	7.9	10.2	17.1	8.8	8.8	9.6	11.3	7.7	10.0	8.4	8.3	3.5	9.6	10.7	4.9	9.4	8.5	9.2	8.5	6.9	8.1	6.5	8.7	9.7	10.8	12.0	5.8	6.8	7.1	9.7	8.5	5.8	10.4	9.4	4.3	8.8	11.8	10.3	5.8	8.6	10.8	9.4	16.8	9.1	13.9	8.4	3.3	5.4	9.5	9.4	15.2	12.4	15.8	14.3	10.6	7.3	5.3	7.0	8.3	5.6	11.4	7.2	6.3	4.7	10.9	7.3	8.8	5.4	22.2	10.8	10.9	14.5	13.6	14.9	8.9	7.7	7.0	6.1	5.4	12.6	8.2	4.6	10.9	11.5	9.1	9.6	16.0	11.2	11.1	8.5	4.1	19.7	9.6	13.1	5.6	5.9	33.8	11.3	7.1	5.9	6.3	5.2	11.2	17.4	5.9	11.9	11.6	9.1	11.2	9.8	6.5	8.9	10.3	18.2	5.9	6.0	9.3	8.3	9.6	10.3	0.9	2.0	2.6	2.2	1.3	1.9	1.7	1.8	3.0	1.3	1.1	3.0	2.5	2.8	1.4	0.8	2.1	3.2	1.2	8.1	10.2	8.8	9.6	8.5	9.2	8.7	9.7	9.7	8.6	9.1	15.2	45.1	51.3	41.2	0.0	31.2	0.0	26.8	0.0	26.2	44.8	32.2	27.3	0.0	22.8	24.1	25.8	35.5	93.6	59.5	13.1	13.7	24.8	13.5	49.8	63.2	27.8	10.9	21.7	0.0	23.5	21.0	31.1	29.6	48.2	24.0	56.7	29.6	21.5	23.3	33.7	0.0	16.6	0.0	29.9	0.0	17.0	24.8	28.3	0.0	0.0	36.7	20.9	46.4	0.0	0.0	26.8	16.9	18.8	37.7	28.6	20.3	18.2	35.0	45.4	32.9	42.4	27.8	48.0	50.6	30.9	0.0	99.3	34.3	34.1	19.4	28.4
NR4A2	"HZF-3, NOT, NURR1, RNR1, TINUR"	ENSG00000153234	"Nuclear receptor subfamily 4 group A member 2"	P43354	2	156324437-156342348	"Cancer-related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 129.3;bone marrow: 130.8;ovary: 129.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 511.7;dendritic cells: 410.4;Langerhans cells: 782.3;Macrophages: 577.5;T-cells: 465.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.0;HMC-1: 10.9;SK-MEL-30: 8.1;U-266/70: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000543, CAB010481"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"CAB010481: AB_2298676, HPA000543: AB_1854631"	"unprognostic (4.26e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.14e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.11e-1)"	40.0	129.3	4.3	24.5	44.1	130.8	15.6	36.2	8.8	18.3	5.9	9.5	2.9	15.0	1.7	11.4	28.2	32.7	36.6	15.1	3.6	19.2	20.2	18.8	6.3	3.2	9.2	129.2	9.2	8.8	54.0	5.2	2.8	25.6	18.7	5.3	19.2	15.5	11.6	12.8	7.8	14.5	0.9	4.6	19.9	5.6	2.5	9.7	15.2	7.8	1.4	50.9	14.0	6.4	0.9	1.3	0.5	1.8	3.2	0.7	0.9	1.1	5.5	0.4	1.3	0.0	3.3	0.0	1.2	0.4	0.4	1.6	2.6	0.7	0.4	1.3	1.4	1.0	16.0	0.0	0.6	0.7	10.9	0.6	1.2	0.4	0.4	2.1	0.3	0.0	1.6	1.0	1.1	1.9	0.0	0.8	2.1	1.5	0.8	0.2	0.7	3.3	0.6	0.8	2.7	0.1	2.6	4.1	8.1	0.3	0.2	1.0	0.7	2.9	0.8	0.7	0.4	14.2	1.8	0.0	5.3	1.0	7.0	1.9	1.7	2.4	1.0	0.3	0.5	0.4	0.3	0.5	1.9	0.3	0.5	0.2	6.5	0.0	0.7	0.0	0.4	0.5	4.3	44.1	36.2	8.8	15.1	3.6	3.2	9.2	2.8	0.9	2.5	6.4	70.7	25.6	124.7	7.8	511.7	218.6	25.8	87.5	298.7	11.8	120.8	160.1	11.9	17.2	58.3	71.7	50.1	4.7	410.4	35.0	0.0	13.1	36.7	209.6	33.9	111.9	206.4	12.0	5.8	9.1	6.5	164.9	103.9	349.7	349.3	4.3	45.0	6.8	125.1	0.0	0.8	95.4	42.7	161.1	782.3	37.2	4.1	577.5	241.9	5.6	7.9	1.6	3.1	4.0	2.3	11.7	41.9	0.7	203.5	49.1	25.9	0.4	54.6	33.4	13.1	63.0	169.8	1.8	3.3	230.2	213.7	9.9	465.1	34.4	57.5	29.5
NR5A2	"B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1, LRH1"	ENSG00000116833	"Nuclear receptor subfamily 5 group A member 2"	O00482	1	200027614-200177420	"Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 17.8;liver: 38.6;pancreas: 61.1"	"Cell type enriched"	"Detected in many"	5	"Granulosa cells: 276.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"A549: 25.0;CACO-2: 6.2;HAP1: 14.9;HMC-1: 6.4;HUVEC TERT2: 20.4"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	"Not detected"	"Not detected"			"HPA005455, HPA017067"	Approved		Uncertain	"Nuclear speckles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles"		"HPA005455: AB_1078140, HPA017067: AB_1844767"	"unprognostic (7.47e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-7)"	"unprognostic (5.48e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.37e-1)"	5.4	0.4	0.5	2.6	0.2	0.9	3.7	0.5	0.3	3.4	0.2	11.9	17.4	3.3	1.4	0.9	2.2	8.0	1.0	0.3	2.8	0.7	38.6	2.7	2.1	0.7	0.6	1.0	61.1	0.4	0.1	0.4	0.8	1.6	13.1	0.2	0.5	0.8	1.1	1.1	17.8	4.3	0.4	0.2	1.3	0.8	0.8	0.5	0.9	0.7	1.4	1.8	1.2	0.7	0.0	25.0	0.0	0.1	0.0	0.2	0.6	0.0	0.4	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.7	0.7	14.9	0.0	0.0	3.3	1.1	0.0	0.3	2.7	0.5	0.1	6.4	0.1	0.0	0.0	0.1	0.0	20.4	0.1	0.0	0.3	0.0	0.6	0.0	0.4	0.9	0.0	0.3	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	1.7	4.7	0.3	0.1	1.0	0.2	0.1	0.2	3.4	2.3	2.6	0.3	0.2	0.1	3.2	0.4	0.4	0.2	0.2	0.2	0.3	0.3	0.3	0.1	0.4	0.4	0.3	1.5	0.5	0.2	0.5	0.4	0.1	0.5	0.2	0.5	0.3	0.3	2.8	0.7	0.6	0.8	0.4	0.8	0.7	23.7	0.0	1.7	0.3	0.2	1.9	0.1	0.0	0.0	0.2	0.2	0.0	9.9	32.9	0.0	0.0	0.0	0.0	0.3	37.5	0.0	38.2	0.4	0.3	0.3	32.4	4.9	2.7	0.4	54.5	0.0	0.8	0.0	0.2	13.3	276.2	38.6	38.5	0.1	0.0	0.6	13.8	0.0	4.9	1.5	0.3	0.6	0.6	0.0	0.0	3.1	0.0	0.0	1.0	0.3	22.0	21.8	0.0	1.2	0.3	49.9	0.0	0.8	0.3	0.0	0.5	6.1	0.1	0.1	0.0	1.4	0.0	0.3	0.1	32.3	0.2
NSL1	"C1orf48, DC8, DKFZP566O1646, MIS14"	ENSG00000117697	"NSL1 component of MIS12 kinetochore complex"	Q96IY1	1	212726153-212791782	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045761, HPA053721"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA045761: AB_2679444, HPA053721: AB_2682240"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.44e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.66e-2)"	16.7	14.5	13.8	19.4	16.9	19.1	11.2	17.1	17.5	12.8	15.0	13.3	17.5	14.5	8.0	15.3	13.9	15.0	24.9	13.4	14.9	16.0	19.3	12.5	27.0	18.0	14.9	16.8	12.5	13.9	11.0	17.6	17.5	12.8	10.1	12.6	13.9	10.0	22.5	8.8	17.5	13.1	17.3	19.4	11.7	13.5	14.8	22.7	15.0	15.6	16.7	13.6	10.1	21.3	39.7	44.3	45.0	43.3	18.9	19.5	59.4	32.5	22.1	38.7	33.2	37.3	42.2	55.6	29.4	18.7	21.6	28.4	35.6	29.9	20.1	102.9	33.6	37.0	31.2	61.8	21.7	62.5	34.9	20.2	14.6	39.6	19.8	17.8	28.8	62.9	83.0	45.7	24.6	23.1	80.6	24.6	82.9	20.6	32.8	69.2	68.1	61.5	31.3	19.8	41.1	57.0	46.0	22.3	55.7	33.3	65.6	44.9	33.3	39.4	34.1	36.4	54.5	26.4	76.3	73.8	33.7	42.2	50.7	21.8	49.3	63.1	35.9	62.3	43.0	59.0	38.8	39.2	55.6	47.4	46.7	41.9	49.6	45.3	64.3	53.8	51.2	60.7	13.8	16.9	17.1	17.5	13.4	14.9	18.0	14.9	17.5	17.3	14.8	21.3	39.4	16.0	20.7	25.5	43.5	14.8	21.2	51.4	31.3	34.1	22.8	26.8	22.4	31.5	28.1	18.4	14.6	64.0	40.9	14.7	43.0	32.2	29.2	19.9	29.0	32.0	21.7	50.7	50.2	21.1	62.2	28.9	13.3	15.1	15.2	31.6	29.6	27.9	61.6	33.7	50.1	14.1	30.5	68.2	28.5	15.2	34.8	44.6	19.6	33.7	56.0	37.1	35.0	36.2	68.9	22.7	15.9	32.7	26.7	10.5	32.5	58.5	25.6	32.7	59.2	30.2	32.6	48.7	65.5	22.7	16.2	20.9	36.6	27.0	18.5	10.3
PARN	DAN	ENSG00000140694	"Poly(A)-specific ribonuclease"	O95453	16	14435700-14632728	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006314, CAB011673, HPA012010"	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB011673: AB_778216, HPA006314: AB_1079567, HPA012010: AB_1854976"	"unprognostic (2.54e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.09e-2)"	16.6	20.2	10.8	13.9	12.1	9.2	15.9	11.7	11.4	17.2	12.0	19.3	11.8	19.1	24.7	15.6	16.0	13.4	14.8	10.6	14.0	12.7	16.4	14.2	21.2	11.7	11.9	16.4	16.5	21.1	16.3	15.6	11.9	16.1	16.8	7.0	15.3	17.1	16.8	17.9	16.1	18.0	11.3	15.7	16.2	18.1	12.6	21.6	20.6	9.7	23.4	19.3	16.0	13.5	28.0	39.9	17.6	22.9	32.9	33.2	20.3	24.4	32.4	29.8	28.3	21.9	28.7	56.2	63.1	32.3	25.3	30.4	46.7	32.3	41.0	42.9	29.4	28.8	24.2	53.2	35.5	46.0	36.2	32.5	38.5	32.0	43.1	25.5	22.5	32.6	28.5	29.9	32.5	44.9	36.7	33.1	26.0	28.2	16.7	56.2	36.1	57.1	23.1	17.1	18.7	16.9	53.4	29.6	36.3	28.6	31.6	28.0	21.2	31.5	15.8	16.4	26.9	32.5	31.0	63.5	34.6	30.8	35.8	8.9	8.0	15.8	8.6	13.2	7.7	16.0	10.4	12.4	13.6	9.4	14.2	14.4	6.2	15.0	15.6	8.3	19.1	7.1	10.8	12.1	11.7	11.4	10.6	14.0	11.7	11.9	11.9	11.3	12.6	13.5	18.0	32.1	39.1	37.9	26.2	7.1	7.8	9.7	21.6	13.0	13.4	14.0	22.3	7.2	11.8	11.0	8.4	29.2	24.7	13.6	11.7	14.2	14.1	15.2	20.5	15.2	14.9	20.4	48.0	12.9	23.2	19.5	21.9	21.7	2.5	19.2	11.7	15.6	14.8	8.4	48.2	14.3	6.1	14.2	5.8	6.3	21.1	18.2	10.6	54.4	35.8	10.3	52.5	38.2	72.4	15.2	10.6	17.7	23.0	7.1	12.2	10.8	19.2	10.8	19.7	13.1	15.0	70.5	70.5	20.0	8.2	22.4	21.5	20.1	13.4	4.8
PASD1	CT63	ENSG00000166049	"PAS domain containing repressor 1"	Q8IV76	X	151563675-151676739	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	161	"testis: 16.1"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 19.3;Spermatogonia: 57.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 0.7;testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 34.8;HMC-1: 55.3;U-266/84: 27.8"	"Not detected"	"Not detected"							"HPA011122, HPA011152"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA011122: AB_1854990, HPA011152: AB_1854991"										"unprognostic (3.34e-1)"					"unprognostic (1.02e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	55.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.3	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	19.3	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PHYHD1	MGC16638	ENSG00000175287	"Phytanoyl-CoA dioxygenase domain containing 1"	Q5SRE7	9	128920966-128942041	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 119.3;Muller glia cells: 139.3;Proximal tubular cells: 161.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 13.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 13.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.5;ASC TERT1: 32.7;BEWO: 50.6;HSkMC: 28.3;RPTEC TERT1: 78.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012115			Approved	"Nuclear speckles"		NA	NA		36000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA012115: AB_1859448"	"unprognostic (1.18e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (6.38e-10)"	"unprognostic (1.10e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.83e-3)"	28.2	25.7	41.9	3.2	39.9	8.4	34.6	37.9	40.8	39.8	41.7	24.4	2.3	33.8	38.3	25.6	28.5	13.2	35.1	36.3	46.9	49.9	78.7	23.1	4.5	48.1	51.9	39.1	70.2	15.6	15.5	9.6	46.5	36.8	3.8	41.8	40.0	30.0	29.3	43.7	12.4	15.4	48.1	14.7	33.4	7.2	47.9	6.8	43.0	12.8	4.6	25.9	25.6	48.7	0.2	0.5	0.4	0.8	46.5	32.7	50.6	3.7	0.0	3.4	6.0	1.8	0.5	0.7	0.4	3.0	0.3	0.7	0.4	0.3	2.9	0.5	5.4	0.1	6.7	18.0	15.1	0.8	0.6	28.3	1.0	0.4	0.2	0.2	0.3	0.3	0.3	1.2	24.3	0.4	0.5	0.7	17.0	0.2	0.2	20.5	9.7	0.3	78.9	0.7	1.1	0.4	0.5	0.3	0.3	11.4	4.7	0.6	1.3	0.7	2.1	0.7	0.5	0.4	0.9	20.7	0.3	0.4	0.7	1.3	0.2	0.2	1.3	0.3	0.3	2.8	0.4	0.5	1.7	0.7	1.8	1.9	0.8	2.2	0.4	13.0	0.3	0.5	41.9	39.9	37.9	40.8	36.3	46.9	48.1	51.9	46.5	48.1	47.9	48.7	8.5	32.1	34.3	51.6	3.7	22.0	63.2	26.8	57.5	9.4	40.0	46.9	19.8	10.0	31.0	33.1	29.2	58.8	3.4	0.7	119.3	11.4	0.4	27.0	26.0	9.5	1.2	12.0	1.2	15.8	30.0	34.5	7.7	53.8	0.0	42.8	31.8	82.2	10.7	3.3	0.8	2.4	4.1	3.2	5.5	4.2	68.6	3.1	12.4	5.6	0.1	139.3	4.1	1.0	0.7	14.2	0.5	66.2	2.6	19.3	0.0	161.5	14.6	67.5	52.6	48.1	17.8	0.9	3.9	32.7	24.3	30.9	2.7	44.6	1.4	35.0
PLEKHN1	DKFZP434H2010	ENSG00000187583	"Pleckstrin homology domain containing N1"	Q494U1	1	966482-975865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 54.9;skin 1: 46.0;vagina: 24.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 29.6;Pancreatic endocrine cells: 38.5;Prostatic glandular cells: 37.9;Squamous epithelial cells: 19.2;Urothelial cells: 52.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 15.1;HaCaT: 26.0;SK-BR-3: 16.6"					"Not detected"	"Not detected"			HPA031742	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"		"HPA031742: AB_10670704"	"unprognostic (2.72e-3)"	"unprognostic (8.05e-3)"	"unprognostic (9.03e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (9.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	0.4	1.6	0.0	0.7	0.1	0.4	1.7	0.0	0.1	11.5	0.0	0.6	0.9	0.4	0.3	54.9	0.9	0.7	0.2	0.0	0.0	2.1	0.9	1.1	0.3	0.0	0.0	0.1	1.1	0.5	0.3	0.4	0.0	3.6	0.1	0.0	10.2	1.2	2.1	46.0	0.8	0.1	0.0	1.2	2.0	0.4	0.1	0.1	0.7	0.0	1.6	7.5	24.2	0.0	15.1	1.4	0.0	1.0	0.1	0.7	2.5	6.8	1.7	4.1	1.1	2.0	11.3	0.0	3.2	3.0	5.7	26.0	0.2	4.5	0.7	5.0	1.0	0.0	5.6	3.3	0.6	0.3	0.2	0.2	3.8	2.9	1.6	3.7	0.5	0.0	0.3	4.0	0.2	8.3	0.0	0.3	0.5	2.4	11.0	0.1	0.0	5.6	4.3	4.2	0.1	0.1	7.5	16.6	1.0	0.4	3.2	0.0	3.2	5.3	2.3	0.5	4.6	3.2	0.1	0.1	6.8	2.5	3.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.2	1.1	0.0	1.9	4.6	29.6	5.0	1.8	0.5	3.8	1.8	0.9	0.0	6.4	0.0	0.0	7.1	1.0	1.9	0.0	13.8	0.0	3.0	1.1	0.7	0.0	0.0	0.0	14.0	2.0	0.9	3.1	8.2	0.0	0.0	0.7	0.3	1.1	3.3	0.0	0.0	8.2	0.3	1.4	0.0	0.0	0.9	1.8	0.0	1.9	0.2	0.0	0.0	0.0	38.5	3.3	0.0	2.5	37.9	0.0	0.1	5.2	0.2	0.0	0.2	1.0	0.0	0.7	19.2	17.3	9.9	2.8	0.0	0.1	52.9
PNN	memA	ENSG00000100941	"Pinin, desmosome associated protein"	Q9H307	14	39175183-39183220	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001378	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA001378: AB_1079648"	"unprognostic (9.28e-3)"	"unprognostic (5.07e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.91e-1)"	"unprognostic (7.38e-3)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.30e-2)"	57.8	60.6	42.7	68.0	46.6	135.9	60.2	50.6	48.1	82.2	77.8	83.1	56.5	81.5	129.5	74.0	77.0	41.8	54.9	42.9	51.4	87.6	124.8	61.4	87.6	47.5	45.1	84.5	78.5	40.8	90.7	53.8	47.2	83.8	63.1	76.0	65.6	48.4	59.9	67.7	90.5	48.0	43.9	103.6	70.7	58.5	47.1	65.6	88.4	27.0	69.5	69.2	73.3	50.9	152.4	72.0	193.2	94.0	45.5	37.4	141.4	116.6	35.4	82.4	81.2	112.3	232.6	229.1	72.7	53.2	69.7	156.4	153.3	85.5	138.5	105.1	109.0	158.6	243.7	246.0	39.1	201.0	107.6	55.8	73.5	80.1	65.1	115.5	57.3	119.0	149.1	128.2	65.8	122.6	145.5	170.3	126.6	76.2	114.3	188.4	137.0	64.2	65.6	219.3	93.8	50.5	126.2	90.5	69.1	133.2	114.4	117.5	92.7	115.9	90.9	52.7	142.2	102.5	87.8	194.0	59.5	167.3	70.6	9.2	13.7	22.0	17.0	11.4	16.1	22.2	12.1	10.9	11.8	25.5	17.2	16.6	27.6	15.4	16.4	22.1	14.2	6.1	42.7	46.6	50.6	48.1	42.9	51.4	47.5	45.1	47.2	43.9	47.1	50.9	105.6	192.3	125.0	40.8	170.5	126.2	244.5	84.4	153.1	203.1	77.5	87.5	63.4	61.5	164.8	60.7	56.3	113.2	230.9	129.3	35.2	89.4	59.0	155.0	178.9	127.9	136.2	121.1	33.1	58.3	100.0	117.1	101.9	289.4	142.5	273.5	69.3	67.8	62.3	153.1	35.6	96.6	71.2	69.3	72.5	53.7	156.3	93.9	49.8	25.3	89.2	138.0	193.6	41.2	54.6	76.7	126.3	151.6	116.7	172.1	82.9	28.9	111.7	172.4	151.2	166.2	161.3	212.8	149.3	145.0	112.0	99.6	170.6	211.8	123.7	245.4
POLR3B	"C128, FLJ10388, RPC2"	ENSG00000013503	"RNA polymerase III subunit B"	Q9NW08	12	106357748-106510198	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036466	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA036466: AB_10671842"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	4.5	8.7	3.1	4.8	4.4	5.2	5.0	4.3	4.6	4.7	3.7	5.3	4.2	4.6	5.2	8.6	5.1	3.6	5.8	3.4	2.9	6.8	9.0	4.7	4.1	2.2	2.3	7.5	4.9	11.1	2.4	6.7	2.3	5.6	5.7	6.2	4.7	4.0	6.5	11.0	3.4	5.4	2.7	3.3	5.4	6.1	3.2	4.7	6.0	8.3	5.6	4.9	4.3	3.6	16.2	7.6	16.4	7.8	13.9	13.1	22.9	21.9	13.0	15.2	11.6	14.0	4.4	20.6	7.7	14.2	5.6	14.8	19.5	19.2	18.5	16.6	13.1	15.7	10.1	12.0	9.2	26.1	17.0	11.7	13.4	15.1	17.3	10.3	11.5	9.8	24.5	6.5	11.2	12.0	19.1	8.7	17.8	11.9	28.5	11.6	9.8	13.5	8.6	21.8	17.3	9.6	13.6	18.2	13.4	10.8	17.0	7.9	11.0	8.3	10.0	13.6	13.1	8.1	22.4	30.3	3.8	15.9	9.2	5.6	2.0	1.5	2.0	2.2	2.7	2.1	2.2	2.2	2.6	1.3	3.0	1.9	1.3	2.1	2.2	0.9	2.7	1.7	3.1	4.4	4.3	4.6	3.4	2.9	2.2	2.3	2.3	2.7	3.2	3.6	2.4	0.0	9.2	14.4	4.7	1.8	1.7	4.5	4.6	6.0	3.4	3.7	10.3	2.8	7.0	5.5	6.2	11.0	3.8	3.8	1.9	5.1	7.1	3.9	7.0	3.3	4.2	3.8	22.3	4.6	9.3	4.4	9.2	3.9	5.1	4.8	3.6	11.0	3.1	3.3	24.1	5.6	2.0	1.6	0.3	5.2	3.7	2.4	3.6	9.4	1.0	2.4	2.1	17.1	22.4	3.8	1.1	4.9	4.9	1.5	1.7	3.4	7.2	7.2	6.6	6.9	4.1	16.5	10.9	8.9	3.0	7.4	4.1	7.2	5.1	1.2
POMP	"C13orf12, HSPC014, UMP1"	ENSG00000132963	"Proteasome maturation protein"	Q9Y244	13	28659104-28678959	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Ichthyosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026995	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"		"HPA026995: AB_1845546"	"unprognostic (2.00e-1)"	"unprognostic (3.56e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.15e-1)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (2.71e-3)"	"unprognostic (2.50e-2)"	"unprognostic (9.90e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.83e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.70e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.81e-2)"	78.9	71.6	77.5	62.9	78.5	66.4	66.7	82.1	101.1	45.1	77.8	66.6	57.0	44.4	78.9	68.7	43.4	46.2	126.3	78.1	83.6	94.1	110.9	65.6	65.4	82.2	83.4	32.9	46.6	51.7	41.7	100.3	83.2	46.6	66.3	56.2	45.1	50.7	175.6	48.5	58.4	57.2	83.6	61.2	54.9	70.0	81.0	64.6	51.4	114.6	70.1	74.0	46.9	86.3	103.4	124.9	129.9	153.1	145.3	161.3	120.3	232.1	203.8	225.5	179.5	245.7	228.7	181.7	136.3	178.6	241.7	150.3	170.7	179.3	307.5	137.7	131.9	171.7	130.1	191.1	203.0	209.6	136.0	131.2	181.9	162.5	149.5	122.3	181.6	139.7	222.2	72.5	291.5	182.5	178.4	295.6	226.1	319.0	146.1	169.6	199.3	122.2	259.6	160.7	152.1	117.1	104.0	147.4	162.2	161.5	103.1	238.5	166.2	108.7	111.2	172.3	195.5	61.5	118.5	255.3	129.2	139.8	243.6	146.4	155.3	101.7	99.9	210.8	88.7	136.4	101.6	113.2	190.8	137.6	71.8	101.9	135.1	95.3	213.9	223.4	132.3	165.2	77.5	78.5	82.1	101.1	78.1	83.6	82.2	83.4	83.2	83.6	81.0	86.3	527.4	131.4	114.2	17.3	218.5	409.8	345.1	1106.2	124.1	110.1	194.3	229.9	806.2	204.5	523.9	239.1	54.2	660.4	255.5	410.0	600.7	566.3	1156.6	266.7	235.8	486.2	228.7	271.5	23.4	699.5	974.0	281.8	128.9	293.0	207.3	181.6	434.1	538.7	780.7	97.6	22.4	315.0	585.9	431.0	673.7	533.7	201.0	407.1	300.6	29.0	612.6	294.7	228.6	13.6	26.1	755.1	414.0	233.6	228.1	443.5	491.8	922.5	472.8	121.8	322.1	193.8	494.6	625.5	240.3	230.1	416.3	972.4	202.7	234.7	335.5	494.3
PPIE	"CyP-33, MGC111222, MGC3736"	ENSG00000084072	"Peptidylprolyl isomerase E"	Q9UNP9	1	39692182-39763914	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA019357, HPA020131"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA019357: AB_2670131, HPA020131: AB_1847405"	"unprognostic (2.94e-1)"	"unprognostic (4.32e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.41e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (5.05e-5)"	"unprognostic (5.86e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.00e-1)"	26.0	27.9	22.3	16.1	22.9	18.5	26.8	22.7	26.5	31.4	20.2	41.1	18.3	33.8	24.9	31.8	35.0	18.1	33.3	22.3	22.8	33.0	33.7	23.3	27.2	22.6	22.0	36.7	40.2	23.8	27.7	20.7	22.9	32.3	22.5	20.9	26.2	23.6	43.1	29.5	29.2	25.4	23.7	32.7	31.7	41.8	22.3	20.6	29.1	30.3	28.2	36.4	29.5	24.6	24.5	34.4	37.2	25.7	40.9	36.9	14.3	40.8	42.7	58.7	56.4	32.8	64.8	68.4	52.2	47.9	34.5	32.8	57.1	52.3	68.8	41.1	38.4	75.6	37.4	9.7	50.9	68.4	36.3	32.8	47.2	53.9	21.0	42.0	54.5	52.8	74.8	39.5	46.6	24.7	34.2	42.1	39.9	49.7	31.5	41.4	28.4	38.4	37.8	37.2	47.7	42.3	43.8	31.5	28.4	49.7	40.9	155.8	35.8	36.3	35.3	48.4	57.1	55.8	66.4	52.5	27.0	86.4	52.3	38.3	62.8	32.6	83.9	64.8	82.8	107.5	89.4	83.8	74.1	109.2	103.5	82.4	6.0	123.2	70.0	63.8	101.3	122.5	22.3	22.9	22.7	26.5	22.3	22.8	22.6	22.0	22.9	23.7	22.3	24.6	28.2	32.1	36.7	10.7	37.0	24.9	43.1	69.8	23.9	25.9	30.3	47.5	31.8	21.5	62.1	33.1	14.6	62.5	39.3	22.8	66.5	57.5	29.2	34.6	27.7	28.7	28.8	38.3	7.7	48.4	59.3	34.0	16.3	23.4	55.2	44.1	37.9	31.1	56.1	23.5	8.8	32.9	40.7	33.4	26.9	76.3	29.8	30.0	39.2	8.4	46.8	34.0	58.7	8.0	13.6	40.0	24.1	45.1	31.7	32.0	39.3	69.8	63.4	29.7	59.2	23.3	40.1	76.1	51.4	24.5	26.3	34.8	36.6	36.3	35.9	32.9
PQBP1	"MRX2, MRX55, MRXS3, MRXS8, RENS1, SHS"	ENSG00000102103	"Polyglutamine binding protein 1"	O60828	X	48890197-48903143	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001880	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"		"HPA001880: AB_1079671"	"unprognostic (7.25e-2)"	"prognostic favorable (1.48e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.68e-7)"	"unprognostic (2.68e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-3)"	38.8	50.6	35.5	25.6	36.9	46.0	39.3	38.1	44.2	47.9	31.1	50.0	39.2	42.5	22.7	48.6	41.0	24.2	43.0	36.7	40.2	41.7	61.0	35.6	31.1	38.8	37.3	58.4	62.8	28.1	50.5	18.2	38.6	42.2	20.4	21.5	43.2	28.3	65.0	52.0	42.2	25.3	38.4	45.2	52.1	13.8	39.0	38.6	38.6	32.3	29.0	39.2	43.2	40.0	100.6	124.3	64.5	63.2	58.2	40.8	48.8	57.3	67.1	116.8	70.7	146.3	45.0	91.8	46.2	40.0	88.1	79.9	110.6	42.6	43.5	80.8	95.2	78.1	94.6	109.5	55.9	95.5	69.8	50.7	81.4	96.8	95.5	46.5	67.0	35.9	75.7	169.0	50.1	167.5	41.5	94.3	60.3	69.3	139.6	66.7	63.0	209.4	75.5	66.2	95.7	49.4	75.3	82.6	66.5	48.0	103.5	68.9	58.6	51.1	92.2	65.6	77.4	99.9	106.5	69.5	29.0	88.0	53.8	41.8	81.9	53.1	56.4	79.1	74.7	83.9	78.2	56.2	96.9	70.4	81.5	74.9	23.4	76.1	73.0	86.9	114.3	84.5	35.5	36.9	38.1	44.2	36.7	40.2	38.8	37.3	38.6	38.4	39.0	40.0	37.0	41.7	65.9	6.2	65.4	111.8	86.1	99.5	85.4	36.7	76.9	97.2	39.0	54.3	68.6	31.3	12.5	58.5	53.4	85.1	49.0	59.9	6.2	37.5	38.6	54.5	70.1	38.7	4.4	95.8	56.1	53.9	39.8	54.3	70.5	36.6	43.5	45.0	70.2	18.5	3.9	68.2	77.3	72.2	113.5	4.9	69.9	56.2	88.9	3.7	96.6	47.4	55.6	3.5	4.8	73.7	123.6	43.6	105.9	54.2	151.1	108.5	51.6	27.7	39.5	64.4	69.8	2.7	17.7	69.5	117.3	54.6	62.9	67.0	67.9	69.3
PRCC	RCCP1	ENSG00000143294	"Proline rich mitotic checkpoint control factor"	Q92733	1	156750610-156800815	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017151, HPA019463, HPA019481"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear speckles"		"CAB017151: , HPA019463: AB_1855672, HPA019481: AB_1855673"	"unprognostic (6.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (3.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (8.99e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.02e-2)"	31.9	31.8	43.4	29.7	45.2	41.9	31.4	44.5	50.4	32.4	42.3	36.6	27.0	34.5	23.1	39.7	29.7	23.0	37.6	45.7	42.0	36.7	34.2	29.6	36.3	43.3	42.8	30.9	29.0	34.7	28.1	29.0	43.7	33.5	22.5	26.6	30.4	24.1	63.4	43.2	30.9	27.3	41.3	37.4	31.8	27.0	43.3	37.5	31.0	34.4	30.7	32.6	32.2	46.9	79.1	67.3	51.6	59.5	42.5	33.8	89.8	53.8	52.8	59.3	50.8	106.2	65.0	80.6	90.4	43.1	34.1	80.3	74.7	57.0	45.3	101.6	97.4	59.1	47.4	68.4	52.5	81.9	66.6	48.1	64.7	51.5	46.6	45.7	55.2	52.5	99.7	72.1	41.8	140.2	94.1	94.6	124.9	108.9	82.0	81.6	45.7	108.7	62.5	74.0	91.6	163.4	57.0	140.6	92.4	84.4	102.7	129.8	51.1	59.3	61.9	66.0	89.6	184.6	298.5	124.1	58.7	52.2	56.1	46.9	28.6	57.4	27.5	29.9	26.5	24.0	24.7	30.0	32.5	27.6	24.0	25.2	27.7	30.2	37.1	38.9	27.1	26.0	43.4	45.2	44.5	50.4	45.7	42.0	43.3	42.8	43.7	41.3	43.3	46.9	22.2	9.6	16.4	12.7	32.0	52.4	38.2	52.1	46.1	19.8	31.1	24.4	13.0	18.6	29.4	20.2	22.9	63.1	36.0	27.2	21.5	39.4	13.5	21.4	21.9	30.2	34.3	16.6	15.9	32.2	63.4	28.7	24.5	23.2	17.1	28.9	25.4	16.0	44.0	28.6	14.4	26.9	40.7	22.6	27.4	10.4	30.4	28.4	21.4	9.4	44.9	16.9	30.9	18.1	25.4	35.5	34.2	28.6	48.8	43.8	29.8	29.9	21.5	19.8	32.9	32.2	29.2	43.3	46.2	39.6	51.3	101.1	30.3	32.4	29.4	39.2
PRDM7	ZNF910	ENSG00000126856	"PR/SET domain 7"	Q9NQW5	16	90056566-90092072	"Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 1.0"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 6.3;Spermatocytes: 14.3;Spermatogonia: 5.1"	"Cancer enriched"	"Detected in single"	30	"melanoma: 3.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"REH: 3.8;SK-MEL-30: 2.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059944	Approved		Uncertain	"Nuclear speckles"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA059944: AB_2684174"	"unprognostic (3.98e-1)"	"unprognostic (8.89e-2)"		"unprognostic (8.02e-3)"	"unprognostic (8.26e-2)"		"unprognostic (9.01e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.46e-1)"		"unprognostic (5.73e-1)"	"unprognostic (5.52e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.03e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.2	14.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRPF19	"hPSO4, NMP200, PRP19, PSO4, SNEV, UBOX4"	ENSG00000110107	"Pre-mRNA processing factor 19"	Q9UMS4	11	60890547-60906585	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012448, HPA038051, HPA059070"	Supported		Enhanced	"Nuclear speckles"		NA	NA		71000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"CAB012448: AB_2170868, HPA038051: AB_2675807, HPA059070: AB_2683896"	"unprognostic (5.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.37e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.41e-3)"	46.1	70.6	89.8	49.8	87.9	67.0	48.8	73.7	100.2	57.4	60.2	54.5	42.9	55.4	34.2	81.7	57.3	29.4	47.9	91.3	94.1	50.4	77.2	34.6	64.1	92.0	80.7	66.6	69.4	79.8	79.3	42.9	92.9	62.1	51.8	46.1	56.5	48.2	75.2	80.3	49.5	47.9	75.6	54.3	54.3	30.5	81.1	78.5	43.4	38.9	73.7	58.7	55.9	84.5	197.5	147.0	161.8	116.2	92.7	80.8	155.6	102.4	137.5	200.2	149.0	162.7	141.1	280.5	145.2	98.2	120.2	179.0	229.2	184.6	153.4	207.0	153.4	232.4	111.3	184.9	134.2	308.6	161.1	86.3	137.0	154.4	171.9	58.7	158.7	167.4	248.2	155.3	99.5	270.6	328.9	249.5	292.6	150.5	197.7	285.8	165.5	227.5	101.7	127.5	142.3	172.9	126.6	208.3	178.0	73.1	225.8	170.2	101.9	89.6	147.2	161.8	171.2	147.2	223.3	287.9	111.6	208.6	138.6	4.2	7.8	2.0	2.4	3.8	1.7	0.9	1.8	1.7	3.6	2.4	2.2	2.0	0.5	1.8	2.3	3.9	1.7	1.0	89.8	87.9	73.7	100.2	91.3	94.1	92.0	80.7	92.9	75.6	81.1	84.5	15.8	19.2	23.7	10.1	26.7	42.1	35.2	40.2	33.0	32.0	24.6	19.4	17.6	20.0	28.6	27.6	10.4	94.7	16.2	20.4	27.4	48.5	21.6	21.4	19.7	27.3	39.0	45.2	19.8	51.6	90.2	24.9	23.4	28.4	22.8	25.4	20.0	46.1	46.3	62.2	22.2	40.0	32.6	23.0	21.6	3.6	37.0	19.3	26.6	11.2	41.2	25.4	21.6	10.1	11.8	33.4	27.7	38.7	31.9	40.4	27.8	27.9	17.8	25.3	46.0	22.4	22.6	25.2	38.0	37.4	41.6	40.6	24.8	24.8	55.1	26.3
PRPF4	"HPRP4, HPRP4P, PRP4, Prp4p, SNRNP60"	ENSG00000136875	"Pre-mRNA processing factor 4"	O43172	9	113275642-113294009	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021794, HPA022248"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA021794: AB_1855772, HPA022248: AB_1855773"	"unprognostic (1.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (1.95e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (6.76e-3)"	"unprognostic (2.18e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-2)"	11.6	14.7	9.2	15.2	9.5	15.1	13.4	10.3	10.9	11.2	8.6	11.1	9.9	13.5	19.4	14.9	12.3	10.3	11.0	9.4	9.5	15.4	16.2	9.4	15.6	8.9	8.9	14.8	14.4	25.4	12.2	12.5	9.2	13.3	12.3	13.1	11.2	11.1	18.1	14.6	9.8	13.2	9.0	11.6	10.3	11.6	9.1	16.9	10.2	15.2	17.6	16.7	11.3	9.6	36.6	61.3	40.3	44.4	27.8	28.6	40.4	56.1	28.1	60.2	44.2	60.4	33.4	76.5	32.5	30.3	62.2	81.8	84.9	48.8	66.2	54.2	32.1	39.1	50.4	43.7	25.2	68.0	34.2	20.7	32.7	63.1	59.9	22.6	28.9	41.8	67.5	40.9	51.2	57.3	65.1	47.9	63.9	94.2	66.5	59.4	95.9	51.4	26.0	28.9	52.7	35.5	82.9	44.0	26.0	32.0	68.3	35.0	29.8	49.1	37.3	63.0	72.4	52.1	153.1	73.3	37.6	42.9	63.8	27.4	16.2	16.1	14.7	19.4	17.1	17.1	14.4	13.3	20.4	17.4	14.5	14.6	5.2	18.4	24.6	13.4	14.6	14.8	9.2	9.5	10.3	10.9	9.4	9.5	8.9	8.9	9.2	9.0	9.1	9.6	15.7	9.6	18.4	6.8	23.7	15.7	17.6	10.4	18.8	22.9	12.7	14.6	12.9	12.8	15.2	18.4	18.8	27.7	26.6	5.8	25.4	18.6	17.2	17.5	24.7	12.6	17.5	20.0	8.6	16.9	34.5	16.4	10.2	21.9	19.0	21.5	6.4	9.9	18.4	28.6	8.3	13.0	10.2	13.5	17.8	13.0	11.5	20.5	5.4	2.8	27.3	22.7	18.6	4.0	5.7	15.5	9.6	10.9	15.7	20.6	8.1	16.9	14.3	24.1	0.0	16.9	17.5	28.6	21.0	21.4	18.8	21.5	20.0	24.7	14.0	16.9
PRPF40A	"FBP-11, FBP11, FLAF1, FLJ20585, FNBP3, HIP10, HYPA, NY-REN-6, Prp40"	ENSG00000196504	"Pre-mRNA processing factor 40 homolog A"	O75400	2	152651593-152717997	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038272, HPA038273"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA038272: AB_2675923, HPA038273: AB_10671526"	"unprognostic (1.81e-1)"	"unprognostic (2.91e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.62e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.05e-2)"	16.7	16.7	9.0	24.7	9.8	45.0	21.5	14.3	10.4	16.8	9.4	24.2	23.0	18.6	15.7	27.6	18.0	17.4	15.3	8.7	10.3	18.9	21.7	17.4	30.4	10.4	8.7	18.9	19.7	24.0	10.5	22.2	10.9	18.4	20.9	16.7	16.6	15.0	22.8	21.0	23.0	17.4	9.9	20.7	22.2	25.5	8.7	31.5	24.6	20.0	28.1	27.1	15.1	12.3	63.4	62.9	68.9	70.8	39.1	51.8	95.5	61.8	55.2	86.0	78.9	120.0	57.8	130.9	88.0	62.7	49.2	63.8	90.8	74.3	91.6	72.4	78.6	121.8	55.7	79.9	50.7	135.4	81.6	41.7	61.9	113.8	127.3	52.4	67.5	60.8	133.2	60.6	52.9	38.4	57.2	63.4	102.9	41.2	75.8	110.4	73.3	86.9	43.7	99.8	82.2	56.0	73.9	53.5	67.6	50.6	46.8	85.4	79.1	90.3	56.6	51.9	81.4	38.8	67.7	130.6	57.9	78.2	56.1	87.6	70.1	91.7	66.7	86.5	62.3	65.5	62.1	60.7	79.4	70.3	65.5	58.8	61.1	70.4	101.1	84.8	58.8	80.1	9.0	9.8	14.3	10.4	8.7	10.3	10.4	8.7	10.9	9.9	8.7	12.3	98.5	112.2	118.5	48.3	120.3	141.0	120.0	117.9	101.3	65.0	73.6	70.6	64.4	55.8	122.1	53.3	73.0	123.1	123.7	67.2	49.0	110.0	150.3	101.0	126.6	97.4	78.3	105.6	56.4	111.5	155.9	96.4	74.9	121.0	123.4	111.0	53.9	72.5	109.2	60.6	53.3	81.5	87.5	95.7	114.5	36.4	69.3	125.5	55.2	44.0	184.1	62.7	107.1	44.7	71.3	128.3	86.8	79.7	112.1	131.7	69.5	75.7	152.6	75.2	98.6	104.8	132.1	239.0	121.4	141.6	151.7	132.2	119.9	164.9	103.7	148.4
PRPF4B	"KIAA0536, PR4H, Prp4"	ENSG00000112739	"Pre-mRNA processing factor 4B"	Q13523	6	4021267-4064983	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020638	Approved		Supported	"Nuclear speckles"		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA020638: AB_1855774"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (8.68e-3)"	"unprognostic (3.41e-2)"	"unprognostic (4.45e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.50e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.63e-3)"	"prognostic favorable (6.82e-5)"	9.1	7.2	4.8	11.3	5.4	27.3	8.1	7.5	6.7	5.8	5.2	8.6	10.2	9.9	10.1	8.4	4.4	6.1	5.0	4.7	5.1	4.2	4.3	6.8	14.2	5.4	5.5	8.4	6.8	4.2	3.3	7.6	5.3	6.3	8.6	15.9	8.4	5.5	16.3	13.3	9.0	5.6	4.9	11.2	8.1	3.8	5.5	8.8	6.5	4.5	10.0	6.7	7.0	6.9	6.0	3.9	14.4	12.1	8.3	7.3	12.3	7.7	3.4	4.7	5.2	6.9	7.1	8.1	5.7	5.1	4.8	12.8	10.1	6.8	7.1	4.4	11.1	6.7	19.1	11.5	3.6	11.2	10.6	5.7	6.9	5.4	6.6	11.0	5.1	6.5	11.6	3.1	7.4	2.7	7.2	26.3	6.0	3.8	4.3	9.9	6.1	11.2	8.4	10.2	7.9	7.3	4.7	3.9	5.5	16.9	9.6	7.9	7.3	11.2	6.5	4.3	8.2	7.5	7.9	6.9	3.2	7.6	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.4	7.5	6.7	4.7	5.1	5.4	5.5	5.3	4.9	5.5	6.9	122.4	109.0	103.2	35.6	110.5	83.5	64.0	43.1	69.4	88.6	80.4	49.5	79.1	61.5	75.1	97.5	89.6	61.8	151.3	94.9	72.4	64.4	15.6	115.9	143.5	85.8	75.3	79.1	42.8	56.8	49.9	78.7	88.2	113.4	90.5	96.2	61.1	85.8	41.1	106.0	49.8	88.8	50.8	71.6	49.4	20.6	98.8	71.4	35.6	49.6	97.4	81.2	118.4	50.8	68.1	62.8	61.5	89.1	101.9	62.8	55.5	89.5	71.7	184.0	59.2	105.3	85.8	66.1	76.5	66.7	91.4	63.6	106.2	93.1	87.7	65.2
PRPF6	"ANT-1, bB152O15.1, C20orf14, hPrp6, Prp6, RP60, SNRNP102, TOM, U5-102K"	ENSG00000101161	"Pre-mRNA processing factor 6"	O94906	20	63981132-64033100	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047106	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA047106: AB_10963084"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.16e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (5.39e-3)"	44.0	32.2	33.6	30.8	37.4	33.3	40.1	44.9	37.1	38.5	34.5	39.9	30.0	43.5	27.9	38.9	49.3	27.2	39.0	32.9	34.7	35.3	29.8	32.1	40.9	37.7	35.5	50.6	44.2	37.2	36.7	30.9	37.1	34.5	25.9	36.4	38.3	36.4	64.6	58.3	38.1	29.7	34.6	40.9	37.3	41.0	35.5	44.4	36.2	37.1	40.5	40.5	36.2	46.8	72.8	86.5	62.3	66.3	69.5	48.6	81.5	56.1	62.8	167.9	74.6	233.6	86.2	90.9	133.4	74.5	107.1	110.0	101.2	116.1	88.7	44.0	59.0	76.8	112.7	213.3	76.7	105.3	102.3	55.2	81.4	77.5	89.2	59.9	63.3	83.7	76.2	76.6	56.8	89.2	106.8	131.0	55.4	114.4	106.7	116.0	53.0	87.3	64.4	71.9	61.8	72.4	108.6	110.0	74.1	43.2	108.0	135.5	90.1	96.2	55.1	77.4	104.6	63.7	66.5	94.6	70.3	62.5	76.3	90.8	59.7	73.7	67.0	62.7	93.3	67.1	82.3	72.5	58.6	58.4	95.8	80.9	50.3	130.5	77.8	54.5	79.7	92.3	33.6	37.4	44.9	37.1	32.9	34.7	37.7	35.5	37.1	34.6	35.5	46.8	60.7	60.9	62.6	19.2	69.3	38.4	45.3	50.7	63.2	81.6	54.2	59.8	70.5	34.3	71.6	62.5	37.5	72.5	53.2	43.8	82.2	59.3	49.1	70.3	66.8	55.7	52.7	43.5	12.5	56.7	47.6	51.2	38.7	62.0	91.2	49.0	63.9	55.2	46.3	42.1	14.8	60.6	57.0	44.8	34.1	28.7	58.1	49.9	48.0	5.6	79.7	86.5	57.7	12.5	17.8	65.9	43.9	52.6	67.8	33.5	58.0	65.8	87.7	112.7	59.2	68.2	61.9	120.6	118.9	59.8	46.3	94.5	60.0	32.6	47.7	34.3
PYROXD1	"DKFZp762G094, FLJ22028"	ENSG00000121350	"Pyridine nucleotide-disulphide oxidoreductase domain 1"	Q8WU10	12	21437615-21471250	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 179.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038319, HPA038320"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA038319: AB_10669522, HPA038320: AB_2675956"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.70e-4)"	7.9	10.0	3.8	9.2	4.3	9.3	10.4	5.1	5.4	7.1	5.3	11.9	13.9	7.1	8.6	8.3	7.1	8.7	10.7	3.7	5.2	16.8	12.3	8.6	10.6	5.4	5.2	6.6	13.4	10.4	5.2	5.9	5.3	9.9	11.2	14.0	11.9	5.9	12.4	10.0	16.0	6.4	4.7	7.9	12.8	5.8	4.2	7.5	15.6	9.6	8.5	7.6	6.1	5.4	9.3	3.5	5.2	5.8	3.7	6.8	11.8	14.5	6.7	5.2	4.0	4.5	8.6	10.2	6.0	11.0	4.4	11.3	5.8	11.4	5.8	12.1	5.1	11.8	9.2	5.7	17.2	17.7	12.0	11.3	13.5	3.3	14.3	6.7	7.8	11.0	5.8	4.2	10.7	5.9	8.3	24.3	8.6	8.2	6.5	1.4	11.2	11.2	16.3	9.2	1.7	13.1	6.7	12.2	27.0	7.1	14.5	20.8	11.2	6.2	5.9	13.5	13.4	6.4	4.8	12.7	25.4	13.1	7.5	1.2	0.8	0.6	1.7	1.5	1.9	1.2	2.0	2.1	0.8	0.9	1.6	1.7	0.3	1.6	2.7	1.1	1.6	0.9	3.8	4.3	5.1	5.4	3.7	5.2	5.4	5.2	5.3	4.7	4.2	5.4	12.5	12.8	28.4	12.7	18.3	6.6	10.2	10.7	8.0	21.8	15.1	10.8	11.7	27.1	13.6	27.6	25.0	15.4	22.9	40.0	23.5	24.7	179.8	26.0	13.0	9.4	20.4	13.3	14.0	33.4	14.2	10.4	19.9	21.1	25.3	8.6	8.9	21.2	16.2	8.4	17.0	21.3	12.2	21.8	5.8	32.6	10.5	18.1	5.4	17.8	15.6	14.5	17.5	13.0	34.2	41.2	25.1	6.4	19.5	12.0	39.4	43.8	28.6	28.2	13.1	15.0	13.8	49.7	18.8	14.5	7.7	19.4	20.1	10.6	20.6	14.1
RADX	"CXorf57, FLJ10178, FLJ14191"	ENSG00000147231	"RPA1 related single stranded DNA binding protein, X-linked"	Q6NSI4	X	106611930-106679439	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3;pituitary gland: 20.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 12.3;Extravillous trophoblasts: 4.7;Syncytiotrophoblasts: 22.6"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 1.8;NK-cells: 1.0;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 37.2;RT4: 39.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA000896, HPA001010, HPA001374"	Uncertain		Supported	"Nuclear speckles"		NA	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear speckles"		"HPA000896: AB_1078880, HPA001010: , HPA001374: AB_2666288"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-3)"	"unprognostic (4.85e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.23e-3)"	1.0	7.2	6.1	1.4	5.6	0.6	1.4	2.5	4.5	3.7	1.7	1.2	1.1	3.2	2.1	1.0	3.8	0.6	1.1	3.4	27.3	2.5	1.4	2.4	3.3	4.5	4.9	6.7	1.9	0.8	20.3	3.6	6.1	0.8	0.8	1.8	0.8	1.2	1.8	2.5	1.8	0.9	3.6	2.3	2.6	3.9	20.6	2.3	3.0	1.0	2.1	2.5	1.9	5.3	7.2	0.0	7.2	10.1	4.0	3.4	10.8	0.3	1.4	0.0	0.1	1.6	1.5	15.0	0.0	0.8	7.7	2.0	18.6	3.2	0.0	0.0	37.2	5.0	0.0	0.4	0.2	0.0	3.2	2.0	2.2	0.5	1.3	1.9	0.0	13.1	0.2	19.1	1.6	0.0	14.0	0.0	6.5	4.8	1.1	0.0	6.7	0.0	3.1	39.9	11.8	0.0	0.7	0.2	4.3	5.5	1.8	0.2	0.0	3.1	2.6	0.0	4.5	6.8	3.1	18.5	5.5	0.0	5.3	0.0	0.0	0.0	1.5	0.0	1.1	1.8	1.3	1.0	0.0	1.3	1.6	1.3	0.1	1.0	0.0	0.1	0.5	0.4	6.1	5.6	2.5	4.5	3.4	27.3	4.5	4.9	6.1	3.6	20.6	5.3	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	12.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	22.6	1.0	0.0	0.0	0.0
RALGAPB	"DKFZp781M2411, KIAA1219, RalGAPbeta"	ENSG00000170471	"Ral GTPase activating protein non-catalytic subunit beta"	Q86X10	20	38472816-38578859	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051454	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA051454: AB_2681490"	"unprognostic (1.06e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.51e-2)"	"prognostic favorable (7.25e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	9.6	10.6	7.6	12.1	9.5	12.3	16.1	13.4	10.8	12.1	14.3	11.9	12.1	12.0	12.7	13.9	10.9	10.7	10.5	9.6	9.4	14.4	8.5	11.1	12.2	8.7	8.0	11.6	11.7	24.2	10.5	14.3	8.5	14.4	13.3	18.7	10.8	12.7	12.1	13.7	11.9	12.9	7.6	11.1	12.4	20.8	9.7	17.6	18.1	14.4	14.9	15.3	9.3	9.8	25.3	23.4	23.8	17.5	22.5	25.9	25.3	20.3	23.6	24.8	24.3	42.3	18.6	23.7	18.9	23.7	36.5	29.2	22.6	30.8	34.8	13.6	9.6	36.2	21.0	24.3	21.3	29.6	18.4	18.5	39.1	29.3	32.0	19.7	32.9	20.0	26.8	22.9	24.2	16.5	34.1	12.5	17.5	24.9	30.1	19.4	34.0	15.9	16.5	46.7	25.1	27.6	44.9	59.8	37.4	27.2	34.8	15.0	39.2	49.9	19.9	28.6	20.8	26.6	34.9	21.1	36.1	14.2	22.5	1.2	0.9	2.4	1.2	0.7	1.6	1.3	1.7	1.5	1.4	1.0	1.5	1.2	1.7	2.0	1.3	0.9	0.8	0.6	7.6	9.5	13.4	10.8	9.6	9.4	8.7	8.0	8.5	7.6	9.7	9.8	23.1	22.4	17.1	47.7	18.6	13.9	7.4	12.4	17.1	24.4	19.5	12.3	20.0	10.0	17.7	31.3	27.1	10.4	23.4	26.9	3.9	9.4	11.8	24.3	20.2	17.4	12.6	14.9	63.3	9.3	7.8	15.7	30.5	28.8	16.5	19.4	23.2	12.1	9.7	20.2	66.0	16.1	16.2	17.7	11.6	8.7	16.8	14.7	10.6	49.6	15.1	10.0	16.5	58.3	81.0	15.2	20.4	18.8	16.7	16.1	26.9	9.0	20.9	18.3	13.1	16.8	13.5	31.8	24.0	19.7	18.0	15.2	19.4	15.9	15.8	14.2
RBBP6	"P2P-R, PACT, SNAMA"	ENSG00000122257	"RB binding protein 6, ubiquitin ligase"	Q7Z6E9	16	24537693-24572863	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA replication, Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 143.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032866, HPA041725, HPA043544"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"CAB032866: AB_2177791, HPA041725: AB_2677639, HPA043544: AB_2678543"	"unprognostic (1.04e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-2)"	27.1	25.0	22.9	21.1	23.8	143.6	25.9	33.1	29.9	27.8	21.7	31.5	15.0	33.6	26.3	23.2	32.4	25.5	23.9	22.8	23.5	24.3	26.8	27.9	29.7	24.2	22.8	38.8	22.2	21.8	28.1	31.7	24.4	26.0	20.4	51.1	21.4	19.9	29.7	34.6	26.0	24.1	23.9	29.4	25.6	45.5	24.4	26.6	27.2	25.7	23.5	25.3	24.7	27.7	35.4	18.4	42.5	44.4	31.9	32.9	45.9	28.1	26.1	25.1	27.3	20.5	28.3	49.6	20.3	24.4	28.7	33.3	46.2	24.8	41.9	26.9	35.7	41.9	57.1	58.6	24.7	57.5	23.7	28.8	33.7	33.2	38.9	28.6	36.9	42.2	54.5	43.8	29.7	36.5	45.5	51.2	48.7	24.0	17.3	62.8	42.5	43.3	24.7	31.7	33.4	28.5	39.7	35.1	52.3	47.0	27.4	49.7	32.3	31.0	22.8	27.0	30.8	37.7	40.9	60.9	25.1	36.5	26.1	7.1	1.2	2.0	2.0	2.0	2.2	2.0	2.1	1.5	0.9	1.7	1.8	2.0	2.5	3.5	1.1	3.7	1.7	0.6	22.9	23.8	33.1	29.9	22.8	23.5	24.2	22.8	24.4	23.9	24.4	27.7	139.1	86.6	115.3	47.3	125.7	100.7	103.5	40.8	223.1	67.1	145.6	160.8	147.0	44.3	56.5	27.6	100.1	46.3	88.9	71.5	25.4	48.8	307.5	109.8	123.7	93.7	82.0	83.1	52.5	47.6	57.6	127.1	121.8	203.1	51.3	127.8	64.2	59.5	38.4	62.2	53.4	76.0	28.5	53.5	70.2	41.9	72.4	101.5	62.2	54.4	54.0	53.1	52.5	61.3	58.7	56.4	32.8	58.6	173.7	99.9	54.5	23.9	52.0	61.4	52.6	247.0	112.9	100.3	45.8	161.0	101.7	101.5	110.2	105.3	69.3	111.9
RBM10	"DXS8237E, GPATC9, GPATCH9, KIAA0122, S1-1, ZRANB5"	ENSG00000182872	"RNA binding motif protein 10"	P98175	X	47145221-47186813	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034972, HPA057372"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"		"HPA034972: AB_10602919, HPA057372: AB_2683421"	"unprognostic (9.07e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (7.83e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.86e-6)"	"unprognostic (1.18e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.20e-3)"	23.7	31.1	28.5	19.9	28.8	32.5	23.9	32.6	36.4	33.3	26.6	28.8	18.1	29.5	12.4	34.2	31.5	12.1	30.8	28.5	28.4	30.0	32.2	23.9	25.1	28.2	27.9	40.6	32.2	15.9	38.0	17.3	28.3	33.8	11.3	14.8	23.6	15.6	26.5	27.1	27.8	12.5	26.6	33.9	26.4	12.8	29.3	23.6	33.1	12.4	15.9	28.3	29.9	31.9	50.1	52.5	48.9	58.8	25.7	21.0	57.3	36.8	21.4	37.2	35.8	46.4	39.8	60.1	22.0	25.6	47.5	47.7	64.9	46.1	20.4	61.6	59.0	45.1	65.1	48.8	37.5	46.0	52.1	27.7	22.0	61.2	49.8	26.5	40.4	56.5	38.3	47.0	23.0	74.9	84.8	78.2	81.9	37.1	58.0	74.0	41.0	62.2	27.7	42.9	58.6	44.5	56.0	41.6	35.6	29.3	50.9	45.7	35.8	43.7	54.9	47.8	39.5	48.4	42.9	49.5	38.8	32.8	62.3	13.5	8.1	11.4	12.7	10.7	12.0	11.2	10.2	10.8	9.2	11.1	10.0	9.7	7.5	9.9	15.8	10.7	12.7	9.3	28.5	28.8	32.6	36.4	28.5	28.4	28.2	27.9	28.3	26.6	29.3	31.9	17.4	41.7	36.9	22.5	21.6	11.1	22.4	15.0	22.8	26.7	16.5	16.8	36.6	21.5	28.8	9.2	14.6	34.2	21.3	32.2	11.7	20.5	1.3	23.6	20.1	19.6	35.8	14.9	14.8	17.7	28.5	20.2	31.6	31.5	24.1	29.1	16.8	23.3	19.7	21.9	15.4	31.5	10.2	14.2	10.0	2.7	18.0	15.4	16.0	8.4	19.9	14.7	20.6	15.1	18.1	19.8	20.8	25.6	22.5	18.7	23.1	14.3	28.8	27.0	0.0	21.4	21.8	10.7	8.7	23.4	10.5	46.1	23.8	19.7	34.2	18.1
RBM14	"COAA, DKFZp779J0927, SIP, SYTIP1"	ENSG00000239306	"RNA binding motif protein 14"	Q96PK6	11	66616626-66629934	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006628	Supported		Supported	"Nuclear speckles"		NA	NA		31000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 43: Testis - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA006628: AB_1078546"	"unprognostic (6.96e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.56e-3)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (4.21e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (9.38e-3)"	"unprognostic (8.59e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.94e-1)"	26.9	32.0	39.9	25.0	40.2	32.6	24.1	52.6	48.0	37.2	48.5	29.4	15.7	30.8	19.1	33.9	37.6	10.7	33.2	40.1	38.9	50.6	40.4	27.3	28.3	39.4	40.6	45.1	34.1	17.5	34.5	19.6	39.4	36.3	18.2	35.8	25.3	14.6	29.7	28.4	29.1	15.6	37.1	40.4	30.1	44.0	39.6	25.7	28.4	11.6	29.2	30.4	28.6	48.6	83.0	77.9	55.9	43.2	25.3	16.8	97.0	45.0	16.4	40.8	24.0	79.2	60.6	130.9	49.2	21.9	45.0	69.0	63.4	36.5	43.3	63.9	68.7	81.7	67.1	71.2	14.1	71.5	70.0	11.8	13.3	41.9	23.3	24.1	31.0	38.2	98.6	83.9	40.2	70.3	122.4	79.4	107.2	69.0	85.7	125.3	65.4	67.3	34.2	71.5	67.0	61.9	78.0	55.9	33.9	45.9	77.3	63.5	50.5	49.4	97.9	40.5	72.6	49.8	75.2	109.0	41.8	68.9	120.1	19.7	24.3	27.3	27.9	26.1	27.2	21.3	24.1	26.8	33.6	21.8	24.3	28.2	9.0	21.7	27.2	21.3	23.1	34.0	39.9	40.2	52.6	48.0	40.1	38.9	39.4	40.6	39.4	37.1	39.6	48.6	12.6	9.6	17.0	0.0	27.4	38.1	45.7	20.7	15.4	24.8	19.1	16.3	16.3	18.6	17.2	14.7	29.2	56.3	32.7	17.7	17.6	26.5	37.3	18.1	16.5	21.3	21.6	23.1	0.0	18.4	54.4	20.1	9.7	17.5	19.7	20.4	22.5	24.5	29.0	11.8	0.0	20.9	24.4	16.0	30.2	27.0	17.1	20.1	12.4	0.0	25.4	18.1	34.0	0.0	0.0	19.3	21.7	16.1	20.7	26.9	19.0	12.2	23.2	49.4	6.6	15.1	21.5	53.9	40.1	20.9	31.1	69.2	29.0	13.7	25.2	32.6
RBM25	"fSAP94, NET52, RNPC7, S164, Snu71"	ENSG00000119707	"RNA binding motif protein 25"	P49756	14	73058532-73123899	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003025, HPA070713"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA003025: AB_1079748, HPA070713: AB_2686302"	"unprognostic (1.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.85e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (4.22e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.09e-4)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.73e-1)"	31.4	23.2	14.7	36.0	16.2	72.6	30.7	21.5	20.9	28.7	17.2	28.9	23.4	31.4	22.7	28.9	29.5	21.2	22.2	14.5	19.3	20.8	21.2	30.3	40.0	14.9	13.7	31.1	33.2	22.7	25.3	26.7	16.1	22.5	24.0	41.9	31.4	19.8	41.1	33.3	29.9	23.2	12.5	29.7	27.7	28.5	15.9	36.4	29.3	21.9	33.4	28.1	29.8	20.7	97.8	55.6	86.9	66.6	38.1	44.6	76.5	78.4	54.6	59.5	65.2	74.5	61.2	116.7	40.5	54.0	45.1	72.3	100.9	47.2	101.6	73.8	53.3	98.2	43.2	57.7	24.1	87.5	60.0	32.4	33.3	69.7	56.7	51.1	60.0	42.4	102.7	47.6	65.2	73.3	114.4	51.1	73.8	59.6	60.1	97.4	94.8	57.1	49.0	67.4	58.5	55.8	98.5	64.4	35.0	52.2	92.7	37.9	77.2	87.5	85.5	47.3	79.7	50.2	96.0	141.5	39.1	61.3	61.2	17.4	17.2	16.6	19.9	19.2	18.7	22.3	15.8	16.9	18.2	23.7	16.6	17.6	20.3	27.2	17.5	28.7	19.2	11.7	14.7	16.2	21.5	20.9	14.5	19.3	14.9	13.7	16.1	12.5	15.9	20.7	177.8	230.8	319.9	94.7	226.2	227.4	194.3	109.8	198.6	253.8	136.2	139.2	131.5	77.2	191.8	92.0	268.9	151.8	268.4	137.5	17.6	111.0	71.1	160.4	295.6	170.2	155.2	149.3	115.4	122.6	183.5	185.1	146.8	223.2	247.8	183.3	95.3	98.3	113.1	180.0	99.3	146.3	54.9	110.8	180.8	29.2	157.8	169.9	81.8	71.2	176.9	131.2	155.5	84.9	134.1	132.9	111.0	137.7	233.2	236.5	86.3	32.9	137.0	263.0	72.3	234.2	213.4	213.8	212.9	196.7	236.7	185.4	242.9	161.0	162.5	235.1
RBM26	"ARRS2, C13orf10, FLJ20957, PPP1R132, PRO1777, SE70-2, ZC3H17"	ENSG00000139746	"RNA binding motif protein 26"	Q5T8P6	13	79311824-79406477	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 251.4;Oligodendrocytes: 253.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040252	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA040252: AB_10672895"	"unprognostic (5.55e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.18e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (3.46e-4)"	"prognostic unfavorable (5.87e-6)"	"unprognostic (8.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic favorable (8.20e-4)"	21.7	26.0	17.1	28.5	21.8	37.2	25.6	32.0	30.1	24.9	13.7	21.0	18.6	28.2	28.1	20.9	24.2	17.5	18.8	19.5	18.3	20.3	21.1	21.5	40.4	14.2	14.4	32.8	27.9	19.2	30.2	24.2	15.0	21.2	21.9	40.9	23.7	18.6	26.0	32.4	28.5	20.3	13.8	33.7	25.0	30.0	16.7	29.9	25.4	19.4	34.2	20.8	21.5	22.2	55.3	29.1	70.1	35.9	30.7	32.2	38.1	37.0	30.9	37.5	38.7	39.1	45.9	82.1	29.5	27.3	24.7	51.4	53.0	36.3	54.2	49.6	56.3	63.4	68.0	35.8	23.9	119.9	48.6	21.9	29.6	38.6	53.3	34.4	39.8	50.5	49.0	26.8	41.9	18.7	73.3	63.3	43.6	49.3	16.9	72.9	57.5	43.8	34.9	31.4	53.2	35.6	31.8	38.2	23.4	42.4	34.4	99.0	38.0	31.8	31.7	25.9	38.0	38.5	36.0	100.0	51.6	66.0	38.6	3.8	1.4	2.8	2.9	2.0	3.0	3.7	2.8	2.7	0.8	5.5	4.2	3.7	2.0	2.3	1.5	2.6	3.3	1.0	17.1	21.8	32.0	30.1	19.5	18.3	14.2	14.4	15.0	13.8	16.7	22.2	50.2	57.7	83.5	148.9	80.9	34.7	35.1	25.0	47.8	63.7	36.5	31.0	42.1	35.8	35.6	25.8	73.0	34.3	72.4	34.8	9.8	25.4	49.2	29.0	59.9	43.3	49.1	41.9	251.4	26.0	31.5	41.6	32.1	36.6	55.8	75.9	60.0	40.3	32.9	57.2	170.8	39.2	32.6	53.7	23.0	27.3	65.0	41.6	16.0	137.7	58.0	37.9	56.7	217.6	253.0	27.0	31.5	47.4	65.8	51.1	28.4	19.6	37.7	72.0	52.6	71.3	43.1	102.3	78.1	47.3	35.5	23.0	54.8	57.7	37.5	33.7
RBM27	"ARRS1, KIAA1311, Psc1, ZC3H20"	ENSG00000091009	"RNA binding motif protein 27"	Q9P2N5	5	146203605-146289223	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA035944, HPA036422"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA035944: AB_10670672, HPA036422: AB_10669987"	"unprognostic (8.18e-2)"	"unprognostic (3.17e-1)"	"unprognostic (6.04e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.04e-3)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (4.73e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.67e-3)"	"unprognostic (4.09e-3)"	7.3	5.4	4.1	8.4	4.2	19.5	9.4	7.0	4.9	8.3	4.0	7.8	7.5	9.3	8.0	7.3	7.4	5.9	7.0	3.9	4.8	8.0	10.6	6.7	11.7	3.5	4.5	10.9	6.0	8.9	3.6	9.2	4.0	7.6	8.3	9.4	6.3	6.4	7.2	7.2	7.3	7.6	4.3	9.4	8.6	10.1	4.6	12.6	10.9	9.2	11.3	9.3	5.9	4.9	15.0	12.1	15.3	24.8	13.1	12.5	17.7	10.9	12.3	15.7	17.2	21.3	18.9	31.7	8.4	12.5	21.5	15.3	23.1	25.2	27.7	24.3	10.2	21.7	12.9	14.9	14.4	34.3	24.1	11.7	13.0	16.9	29.9	12.1	14.2	14.9	24.3	18.7	15.0	13.5	25.0	17.4	21.2	16.5	13.6	22.2	23.7	21.9	16.0	16.6	19.1	13.1	22.5	21.7	17.8	15.6	25.3	18.7	13.5	16.6	17.6	12.5	17.8	17.7	18.1	36.6	12.5	24.7	15.7	1.7	0.8	1.6	1.4	1.3	1.6	1.2	1.4	1.6	1.1	1.4	1.8	1.5	1.2	1.8	1.5	1.3	1.5	0.7	4.1	4.2	7.0	4.9	3.9	4.8	3.5	4.5	4.0	4.3	4.6	4.9	12.7	16.0	17.6	20.5	13.1	66.2	9.5	52.6	6.2	11.2	13.0	8.6	17.3	5.7	32.3	14.7	10.4	9.2	17.6	10.1	1.9	7.8	32.4	15.1	11.8	15.7	10.8	11.8	32.2	6.8	8.3	17.0	11.2	13.9	22.1	12.2	11.4	12.1	11.2	15.2	31.4	13.8	30.5	20.4	40.6	6.6	11.5	14.1	19.6	28.1	16.9	8.4	12.3	28.6	43.8	11.5	8.7	14.7	7.3	17.4	9.9	7.9	36.8	8.7	0.0	16.5	24.1	31.4	13.2	12.0	62.1	9.7	15.7	9.8	12.5	19.7
RBM8A	"BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP"	ENSG00000265241	"RNA binding motif protein 8A"	Q9Y5S9	1	145917714-145927678	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 735.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018403	Supported		Supported	"Nuclear speckles"		NA	NA		100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA018403: AB_1858908"	"unprognostic (3.81e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.79e-3)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (3.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-3)"	86.1	74.9	37.2	105.4	39.1	214.7	82.3	38.7	43.0	69.6	35.6	70.5	70.1	67.7	49.3	163.6	62.2	58.0	73.0	36.8	41.7	81.6	77.5	72.8	126.4	39.7	39.8	72.0	59.9	78.4	65.8	85.3	40.8	66.4	56.4	45.0	79.2	48.2	214.9	92.0	69.2	57.7	42.1	81.6	67.5	71.3	40.0	120.7	68.8	100.1	123.7	112.8	80.4	43.9	377.0	300.7	268.8	215.7	94.6	92.2	330.0	224.3	150.7	315.0	230.1	400.0	277.4	342.0	344.9	155.3	166.5	252.5	289.3	245.3	257.0	305.6	275.7	264.2	229.2	299.8	133.6	446.6	222.6	102.2	180.8	283.0	300.3	137.4	238.1	291.9	405.2	314.7	246.2	1033.8	452.3	352.2	463.7	323.9	518.4	394.4	234.6	341.2	203.2	355.6	274.6	335.7	334.5	169.7	316.5	231.0	318.0	534.3	247.3	252.3	324.0	250.9	626.0	352.2	603.4	502.6	226.4	264.9	223.2	464.6	316.5	513.6	337.2	363.9	322.1	444.3	317.6	346.4	318.0	389.6	296.1	328.3	363.7	389.8	361.3	498.4	386.3	582.7	37.2	39.1	38.7	43.0	36.8	41.7	39.7	39.8	40.8	42.1	40.0	43.9	289.1	70.5	132.4	8.1	251.0	332.9	396.7	475.4	244.2	66.3	168.5	184.7	78.0	98.7	262.8	88.3	54.2	376.2	276.0	125.3	187.9	224.1	243.7	148.0	134.3	206.0	158.9	149.2	10.8	223.2	506.3	174.1	80.5	152.8	244.0	136.8	120.3	124.4	204.3	35.3	9.1	127.6	313.3	100.3	265.2	54.4	102.2	170.7	208.1	9.4	197.7	120.3	165.8	6.0	16.1	245.4	159.8	85.4	174.9	259.6	119.5	204.1	195.1	86.3	98.6	213.7	208.1	212.0	168.9	208.1	318.0	735.5	282.1	139.7	141.7	393.0
RFXAP		ENSG00000133111	"Regulatory factor X associated protein"	O00287	13	36819222-36829104	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	SCID	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA032035			Approved	"Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA032035: AB_2674120"	"unprognostic (2.03e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.14e-3)"	"unprognostic (4.45e-3)"	"unprognostic (1.15e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.94e-1)"	"prognostic favorable (4.18e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (2.81e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.99e-3)"	4.3	3.4	3.8	5.0	4.2	6.0	4.7	6.8	5.2	6.3	2.5	5.1	3.1	6.8	5.1	3.0	5.8	4.1	3.5	3.9	3.5	3.3	2.6	4.3	6.7	3.3	3.7	7.0	4.6	6.2	4.6	3.7	3.5	5.2	4.1	5.5	4.8	3.8	4.3	3.5	4.4	5.8	4.0	5.1	4.2	6.5	3.4	8.3	5.8	3.0	5.4	4.0	3.8	4.3	7.4	1.8	10.4	14.7	3.8	5.2	6.7	5.9	6.2	10.9	6.7	5.2	5.9	32.3	4.8	5.4	9.6	6.7	10.8	3.6	12.2	24.4	17.9	15.5	8.6	10.2	6.9	28.7	10.9	4.8	6.3	5.3	4.0	3.1	8.3	24.4	9.0	6.4	3.3	3.6	28.8	20.5	11.1	6.4	3.2	24.9	19.3	9.8	4.6	4.5	8.5	10.6	5.7	3.8	4.7	6.3	3.9	16.9	6.5	2.8	6.1	9.8	5.5	6.0	5.3	24.2	7.9	19.6	4.5	0.0	0.0	0.5	0.2	0.0	0.1	0.3	0.1	0.2	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.3	0.2	0.0	3.8	4.2	6.8	5.2	3.9	3.5	3.3	3.7	3.5	4.0	3.4	4.3	6.6	3.2	3.9	11.1	10.4	3.6	3.3	2.5	7.4	14.5	4.9	4.4	3.6	1.5	2.7	3.7	2.1	6.4	11.1	2.0	15.6	4.2	5.3	4.3	7.5	7.0	7.2	16.0	26.4	5.5	2.8	9.8	4.6	3.0	10.2	10.9	7.9	2.2	3.1	23.5	27.5	2.8	2.0	1.9	7.4	4.1	11.1	4.1	7.2	7.5	5.5	20.8	17.5	11.1	23.9	2.8	2.5	10.9	6.4	1.5	3.3	1.4	2.2	18.0	6.6	13.1	10.0	20.1	25.8	2.8	2.0	1.2	11.7	8.2	3.6	0.8
RNF112	"BFP, ZNF179"	ENSG00000128482	"Ring finger protein 112"	Q9ULX5	17	19411125-19417276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 8.1;Bipolar cells: 6.6;Excitatory neurons: 19.6;Inhibitory neurons: 11.6;Muller glia cells: 7.6;Oligodendrocyte precursor cells: 13.6;Sertoli cells: 6.6"	"Cancer enriched"	"Detected in some"	8	"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.2;fHDF/TERT166: 6.2;SCLC-21H: 6.0;SH-SY5Y: 10.6;U-87 MG: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015970	Enhanced		Approved	"Nuclear speckles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA015970: AB_1859103"	"unprognostic (1.16e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.43e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.31e-9)"	"unprognostic (1.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.24e-1)"	2.2	5.4	20.2	1.5	21.9	0.1	1.9	33.8	25.0	3.2	7.2	9.4	1.8	3.0	4.5	1.7	3.2	2.8	3.6	24.7	16.8	3.9	1.0	2.8	0.7	12.7	14.2	2.4	1.3	0.0	5.5	0.5	14.0	12.3	2.8	1.5	1.2	2.0	1.3	1.9	6.9	2.2	12.9	3.0	2.5	2.3	16.6	0.2	2.2	1.3	0.2	8.4	3.2	23.2	0.0	0.0	0.1	0.4	1.4	5.2	0.2	0.3	1.2	0.1	0.0	0.2	0.0	0.0	0.1	6.2	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	4.2	0.0	0.1	2.1	0.2	0.2	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.4	0.1	0.2	0.2	0.0	0.0	6.0	10.6	0.1	0.0	0.0	1.4	0.1	0.1	0.1	0.0	0.3	0.6	0.0	0.1	0.0	0.0	34.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	21.9	33.8	25.0	24.7	16.8	12.7	14.2	14.0	12.9	16.6	23.2	1.1	0.0	0.0	8.1	0.0	1.0	0.0	0.2	0.0	6.6	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.2	0.3	0.5	0.0	0.0	19.6	0.0	0.0	3.3	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	11.6	0.2	0.0	0.6	0.4	0.2	0.0	0.3	0.0	4.7	0.1	7.6	1.0	13.6	3.3	0.0	1.4	3.8	0.0	0.2	0.5	0.0	0.1	0.7	6.6	1.4	1.5	1.7	0.7	0.3	1.0	0.3	0.2	0.0	0.1	0.1
RPL3L		ENSG00000140986	"Ribosomal protein L3 like"	Q92901	16	1943974-1957606	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 943.6;tongue: 422.7"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 134.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049136	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"		"HPA049136: AB_2680648"	"unprognostic (2.53e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.27e-4)"	"unprognostic (6.38e-4)"	"unprognostic (4.36e-2)"	"unprognostic (3.48e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.32e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.60e-2)"	0.3	0.4	0.9	0.2	0.6	1.7	1.4	1.7	0.8	0.0	1.0	0.2	0.6	0.3	0.4	8.5	0.1	0.5	174.0	0.5	0.4	0.4	0.3	0.2	0.4	0.1	0.0	0.3	11.5	0.0	0.1	0.2	0.1	4.2	0.0	1.2	6.9	0.1	943.6	0.7	0.5	0.0	0.0	0.4	0.2	6.4	0.1	0.1	0.4	422.7	0.1	0.2	0.1	1.0	1.1	1.2	0.3	1.1	0.0	0.0	0.7	0.5	0.0	0.0	0.0	4.0	2.1	0.6	0.7	0.0	1.0	1.1	0.1	0.1	0.0	0.5	0.6	0.4	0.9	1.4	0.0	0.3	0.4	0.1	0.1	0.1	0.1	0.7	0.0	0.7	0.4	2.8	0.0	0.6	0.8	1.0	0.6	1.2	2.5	0.4	0.3	0.9	0.1	0.4	1.6	0.5	0.5	1.4	0.6	0.7	0.7	0.6	0.6	0.6	1.4	0.8	0.4	1.2	0.6	0.5	0.8	0.2	0.2	0.5	0.2	0.3	0.3	0.3	0.2	0.4	0.2	0.3	0.1	0.4	0.3	0.3	1.2	0.2	0.3	0.4	0.1	0.1	0.9	0.6	1.7	0.8	0.5	0.4	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.2	0.0	0.0	0.1	0.6	134.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	7.9	0.0	0.1	1.3	0.0	5.3	0.1	0.0	0.2	2.9	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	23.7	2.2	0.7	2.4	0.0	0.4	0.0	0.2	0.1	0.1	0.5
RSRC1	"BM-011, MGC12197, SFRS21, SRrp53"	ENSG00000174891	"Arginine and serine rich coiled-coil 1"	Q96IZ7	3	158105855-158545730	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044792	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA044792: AB_10794502"	"unprognostic (1.06e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (7.40e-5)"	"unprognostic (5.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.84e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.48e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.15e-1)"	18.5	17.1	13.2	11.8	12.0	15.1	16.4	16.9	17.2	16.0	6.2	14.8	8.7	14.2	11.6	12.7	10.7	10.2	16.0	8.0	12.7	15.9	16.5	10.6	13.7	14.5	15.5	12.8	15.6	15.6	11.6	11.8	12.6	13.1	13.5	18.7	13.5	12.3	19.3	12.9	10.2	13.8	11.0	11.8	12.1	11.3	17.6	13.2	17.0	11.0	14.2	13.6	13.4	13.8	73.6	37.3	24.1	32.1	60.7	41.4	34.1	36.2	29.3	37.8	41.5	51.8	56.8	68.6	66.9	42.9	47.2	32.8	48.4	31.8	58.3	107.6	40.4	71.0	30.4	41.3	9.3	61.5	43.2	32.3	30.0	32.4	29.1	43.4	17.7	38.8	45.4	50.2	31.6	63.7	43.2	41.5	21.4	44.3	33.4	54.7	45.4	86.1	29.5	23.8	47.4	51.7	40.7	26.6	44.6	27.1	59.2	51.7	20.3	52.6	31.6	63.3	69.4	41.0	51.0	72.6	48.5	79.5	61.2	40.4	36.3	20.3	25.1	38.6	25.9	49.5	25.6	24.3	22.0	45.5	23.9	25.7	25.4	17.7	37.2	62.3	22.4	12.9	13.2	12.0	16.9	17.2	8.0	12.7	14.5	15.5	12.6	11.0	17.6	13.8	36.0	32.1	23.1	51.6	51.1	37.3	36.1	32.3	15.4	78.1	39.4	28.7	44.9	45.8	27.0	82.8	33.3	37.5	41.1	33.2	74.3	52.6	49.9	32.8	48.4	35.5	33.0	68.8	71.3	60.5	52.8	47.5	26.0	29.9	76.5	44.0	32.2	74.5	38.3	63.9	82.4	54.9	40.7	45.6	67.6	11.0	46.3	42.4	44.4	80.6	50.0	52.2	44.3	46.3	142.2	45.8	34.2	35.7	35.4	27.7	21.8	67.8	29.7	95.6	19.7	34.8	49.5	39.5	40.4	27.4	27.4	29.6	37.4	39.8	35.9	29.3
RTN2	"NSP2, NSPL1, SPG12"	ENSG00000125744	"Reticulon 2"	O75298	19	45485294-45497055	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 509.8;tongue: 207.7"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 134.3;Extravillous trophoblasts: 145.7;Skeletal myocytes: 73.2;Syncytiotrophoblasts: 120.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 6.2;eosinophil: 2.6;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	10	"dendritic cells: 1.6;granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"RH-30: 44.3;RT4: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034941, HPA034948"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nuclear speckles"		"HPA034941: AB_10671358, HPA034948: AB_2674375"	"unprognostic (3.08e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.68e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (4.34e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.03e-1)"	9.9	13.6	21.4	3.4	25.7	1.7	12.0	15.9	43.6	5.9	7.8	21.8	2.8	15.2	2.5	12.1	4.6	7.9	21.9	24.7	22.0	7.1	3.9	8.2	4.7	27.3	19.3	1.9	4.8	10.1	7.6	19.2	27.0	17.0	2.2	5.7	22.3	10.6	509.8	9.1	8.7	7.3	14.1	11.2	7.9	1.6	25.1	1.1	4.9	207.7	2.0	12.4	7.8	29.0	3.8	5.2	8.6	6.7	14.4	17.6	16.9	8.5	20.0	5.2	9.9	10.4	3.2	3.3	11.4	9.3	4.2	7.2	5.6	4.1	1.7	7.9	8.2	23.0	3.9	7.8	6.2	1.4	25.0	19.5	2.2	2.3	4.2	9.2	9.6	0.9	12.9	6.2	15.6	2.9	0.0	4.3	6.3	17.0	6.8	3.6	44.3	18.8	3.0	45.0	24.1	23.1	1.7	40.7	13.2	8.0	32.3	9.1	8.6	14.7	4.4	0.4	1.9	3.5	8.7	7.7	3.9	5.2	7.7	6.2	0.1	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.3	1.6	0.0	0.2	21.4	25.7	15.9	43.6	24.7	22.0	27.3	19.3	27.0	14.1	25.1	29.0	9.8	3.2	8.1	2.6	0.8	6.4	27.7	8.9	6.8	10.4	18.4	21.1	4.6	4.3	4.6	3.7	6.2	134.3	2.9	0.9	0.0	21.3	0.3	2.1	7.0	15.3	11.4	1.7	21.0	6.8	145.7	14.0	3.1	3.4	16.5	4.2	18.9	3.1	27.3	23.5	13.3	2.2	12.2	12.9	12.0	0.4	5.6	10.7	23.2	1.9	6.5	9.1	1.0	4.5	2.1	13.1	0.3	6.8	2.5	13.0	0.3	0.3	1.3	13.6	13.1	73.2	12.3	0.5	3.9	2.3	3.4	120.1	1.0	16.4	0.7	23.2
S100PBP	"FLJ12903, S100PBPR"	ENSG00000116497	"S100P binding protein"	Q96BU1	1	32816767-32858875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.8;Spermatocytes: 109.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027242, HPA027328"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA027242: AB_2672174, HPA027328: AB_2672221"	"unprognostic (4.29e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.44e-2)"	"prognostic favorable (5.22e-5)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (1.61e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.71e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	9.5	10.9	12.1	10.0	19.4	14.2	9.6	13.3	14.1	14.3	13.9	10.8	6.1	12.2	10.1	7.2	12.5	10.0	7.0	10.7	16.1	7.9	8.8	9.2	15.7	14.2	14.1	16.9	6.9	6.5	11.1	10.9	13.7	10.0	7.6	14.0	8.9	8.5	7.0	8.4	11.3	10.9	12.0	15.6	8.2	34.5	15.1	18.7	11.6	8.1	14.9	10.0	10.2	17.6	11.7	15.0	32.2	17.8	15.0	21.0	16.6	22.3	15.7	20.5	22.7	9.5	18.6	36.5	17.2	14.8	19.7	18.3	31.7	13.1	25.2	18.6	10.6	45.7	31.1	12.1	17.6	21.1	18.0	15.2	12.3	19.5	23.9	27.9	21.8	30.8	27.5	27.2	25.0	6.8	32.6	19.0	38.2	7.9	11.7	29.7	34.5	31.3	9.3	7.6	15.0	14.6	22.9	6.6	24.9	49.2	13.8	13.0	11.4	28.3	18.9	24.3	14.7	40.2	39.2	36.5	13.8	22.2	15.9	7.5	3.6	6.5	6.6	2.0	7.9	8.7	5.2	7.1	3.8	5.4	3.6	5.2	4.6	18.7	1.7	11.3	5.5	3.8	12.1	19.4	13.3	14.1	10.7	16.1	14.2	14.1	13.7	12.0	15.1	17.6	18.3	12.8	21.0	32.3	20.0	10.5	10.4	12.5	26.2	21.2	18.0	16.1	6.0	18.6	13.6	20.2	35.5	14.8	32.6	7.7	13.7	11.0	7.8	13.0	20.6	15.4	8.4	23.1	17.9	5.0	17.0	15.5	12.8	13.1	14.5	29.1	21.4	11.5	15.2	18.5	23.9	7.8	8.2	19.3	9.6	6.9	19.0	14.5	5.4	48.7	10.6	13.1	33.0	51.8	78.8	6.6	4.4	17.7	29.2	9.7	12.6	5.9	9.8	25.0	26.3	12.5	16.6	109.9	74.4	17.6	7.1	6.2	22.0	12.3	9.9	6.5
SAP130	FLJ12761	ENSG00000136715	"Sin3A associated protein 130"	Q9H0E3	2	127941217-128028120	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.5;Late spermatids: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034664			Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA034664: AB_10603238"	"unprognostic (2.17e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	9.1	8.6	8.8	8.7	8.5	21.7	8.2	8.5	10.2	10.5	5.1	10.3	8.3	10.4	9.2	10.4	9.6	7.2	8.5	8.1	10.8	7.2	8.3	8.0	10.0	6.4	7.9	11.2	8.7	12.4	14.5	9.0	7.1	8.7	9.7	8.6	9.1	7.9	11.9	12.9	9.8	10.2	6.1	8.5	9.7	47.3	8.0	14.8	8.8	13.0	12.6	9.5	10.3	8.8	35.3	18.9	35.3	28.6	22.9	15.7	38.5	22.0	21.4	33.4	26.2	45.1	14.4	29.4	19.3	25.0	17.4	24.0	39.3	22.7	34.5	16.3	25.2	29.2	16.7	35.9	27.5	25.5	22.2	14.8	16.7	44.1	27.5	17.6	27.0	24.4	35.9	21.1	28.2	39.3	35.6	20.0	36.6	20.7	21.1	24.3	29.0	19.6	17.9	30.7	18.5	22.3	23.2	21.7	13.6	22.1	16.4	17.3	23.2	32.1	34.5	30.1	23.6	29.3	31.2	34.3	26.4	17.0	21.0	2.3	4.2	4.6	5.3	2.7	4.0	2.0	3.8	3.5	3.4	5.0	2.7	3.1	14.0	3.6	8.6	6.2	2.7	3.8	8.8	8.5	8.5	10.2	8.1	10.8	6.4	7.9	7.1	6.1	8.0	8.8	5.4	0.0	10.9	29.0	7.9	7.9	2.3	3.2	5.7	5.2	6.5	5.3	15.2	2.8	3.1	1.8	8.4	11.9	9.4	13.1	0.0	4.9	71.5	4.6	8.6	6.2	6.7	11.6	25.4	4.7	12.8	5.2	8.6	8.7	1.3	5.3	5.3	5.8	7.8	8.4	28.9	7.0	4.1	8.4	6.3	44.2	8.4	7.0	5.4	16.9	4.9	5.0	6.2	26.2	31.0	6.1	7.8	8.2	13.2	4.9	6.5	3.4	4.0	5.8	6.6	4.4	5.5	31.0	17.9	9.2	10.4	19.3	7.6	3.7	7.8	4.3
SARNP	"CIP29, Hcc-1, THO1"	ENSG00000205323	"SAP domain containing ribonucleoprotein"	P82979	12	55752463-55817724	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Translation regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030902, HPA030903"	Supported		Supported	"Nuclear speckles"		NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA030902: AB_10669872, HPA030903: AB_10964180"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-4)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.03e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.31e-6)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.19e-1)"	48.0	59.1	52.9	45.8	53.7	88.8	58.0	56.4	88.2	52.6	55.0	53.7	31.1	48.2	57.2	61.9	42.3	34.8	81.5	53.4	60.8	62.5	49.4	46.4	67.2	54.8	56.8	48.5	31.6	45.7	43.7	55.1	55.3	48.0	53.6	31.6	39.4	47.7	98.9	43.3	38.5	53.4	53.5	47.9	44.1	55.4	55.8	83.0	41.6	84.0	84.5	59.8	48.3	56.2	118.8	106.6	251.5	107.9	114.9	162.9	119.7	160.5	126.2	196.7	163.6	151.4	129.1	191.3	108.7	131.8	77.2	66.5	223.7	158.2	209.8	151.2	140.5	192.5	181.6	132.9	166.9	162.0	142.4	121.1	115.7	129.0	99.7	206.0	210.4	169.1	141.3	137.9	198.0	100.5	204.1	257.8	221.4	107.0	97.8	186.5	131.6	159.3	265.9	133.0	108.2	87.8	138.1	88.1	144.8	143.3	134.1	216.3	146.1	79.0	79.3	101.3	128.3	87.0	122.8	258.5	94.9	163.8	101.9	246.1	137.9	218.7	110.5	156.2	101.1	125.3	115.8	119.0	153.7	114.0	91.7	103.0	107.2	134.2	138.8	146.8	170.6	153.9	52.9	53.7	56.4	88.2	53.4	60.8	54.8	56.8	55.3	53.5	55.8	56.2	14.7	32.1	35.6	27.7	26.6	25.2	24.5	24.0	46.1	11.2	12.9	9.9	0.2	10.0	41.0	22.0	16.7	16.1	17.9	11.8	25.4	28.8	16.3	9.1	8.8	16.5	14.9	34.1	32.8	29.8	19.8	30.5	33.6	11.4	27.8	8.9	8.9	7.4	14.6	8.4	33.8	13.3	24.4	19.2	36.3	35.9	18.0	25.1	21.4	27.2	32.4	10.6	16.5	37.7	46.6	32.1	13.1	17.3	37.0	14.8	14.8	19.1	45.2	10.0	6.6	12.6	23.3	36.4	32.8	50.9	26.6	16.8	29.9	12.2	11.5	20.4
SCAND1	"RAZ1, SDP1"	ENSG00000171222	"SCAN domain containing 1"	P57086	20	35953617-35959472	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 241.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071335			Approved	"Nuclear speckles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"		"HPA071335: "	"unprognostic (3.88e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.15e-3)"	"unprognostic (3.53e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.48e-2)"	67.4	92.4	25.8	20.2	24.5	44.3	66.2	30.2	51.7	54.9	34.4	61.5	35.4	62.4	4.7	63.1	58.1	5.3	72.6	27.5	31.9	96.0	117.9	51.7	13.8	39.8	29.6	61.1	76.8	9.7	69.6	9.5	28.7	83.7	3.9	2.7	61.0	11.1	85.0	69.4	61.8	5.5	26.8	78.5	66.4	56.7	28.2	10.3	65.7	6.3	4.9	55.5	49.5	26.4	57.0	41.6	14.6	30.1	8.0	9.0	102.2	38.1	14.5	16.0	18.3	37.2	41.0	44.2	96.8	5.7	20.4	52.3	3.3	17.3	1.8	15.8	93.3	105.9	23.5	86.2	28.1	33.7	41.8	16.9	14.3	13.0	2.9	8.9	26.3	42.9	47.7	34.4	9.9	58.6	95.5	241.1	52.9	20.3	162.5	70.8	48.6	73.6	16.4	22.7	78.8	114.4	63.7	100.4	89.2	2.0	67.8	62.7	52.2	54.5	49.7	53.3	37.5	99.6	55.0	64.2	63.8	35.7	42.3	401.5	267.5	274.6	149.3	191.8	120.8	172.0	149.7	134.2	208.6	192.2	124.2	120.8	241.8	149.4	196.2	278.5	224.0	213.7	25.8	24.5	30.2	51.7	27.5	31.9	39.8	29.6	28.7	26.8	28.2	26.4	114.4	32.1	61.9	11.1	115.7	60.0	164.0	188.6	96.2	67.6	118.8	112.0	43.1	133.0	126.9	165.5	43.8	158.3	123.3	410.8	311.0	241.4	336.3	159.6	98.0	123.0	281.3	131.1	5.5	337.3	159.7	105.6	159.0	127.2	69.7	122.4	185.6	292.4	205.9	52.2	7.1	269.8	201.4	197.4	91.5	79.8	118.7	134.5	104.9	6.5	202.2	154.6	148.3	7.1	14.3	283.0	418.6	100.1	137.2	162.4	378.8	596.9	149.1	88.0	111.7	83.9	117.4	96.0	38.2	110.3	75.0	163.8	131.0	153.8	200.8	217.3
SETD1A	"KIAA0339, KMT2F, Set1"	ENSG00000099381	"SET domain containing 1A, histone lysine methyltransferase"	O15047	16	30957754-30984664	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020646, HPA058376"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA020646: AB_1856752, HPA058376: AB_2683695"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.18e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.94e-1)"	10.2	10.0	6.0	7.3	5.5	20.1	10.0	8.4	8.3	11.0	3.0	13.0	6.6	13.0	2.8	9.0	10.5	4.1	8.5	5.5	5.5	8.4	10.4	8.2	8.6	5.6	5.4	12.4	10.6	8.0	11.9	5.0	5.4	10.2	3.3	3.1	9.3	6.1	15.1	12.3	10.5	6.3	4.1	11.8	10.0	20.8	6.0	10.0	11.8	7.1	5.1	10.2	9.3	6.9	13.1	24.4	15.9	19.4	8.7	6.3	18.0	13.6	10.6	11.9	10.1	20.2	12.8	34.2	15.2	13.0	12.0	16.4	15.0	14.6	9.3	18.5	56.1	16.0	47.1	23.2	8.9	26.6	26.2	11.0	11.3	17.1	10.8	9.2	9.3	19.5	32.3	19.0	6.4	27.2	32.3	27.7	23.4	9.0	15.4	48.7	15.9	21.9	7.6	13.9	17.6	18.1	18.7	15.1	10.8	8.7	16.2	22.1	12.8	17.7	17.1	11.6	14.9	28.0	36.2	32.4	14.3	22.9	13.5	0.0	0.1	0.6	0.2	0.3	0.3	0.0	0.2	0.2	0.1	0.5	0.1	0.2	0.0	0.2	0.1	0.6	0.1	0.2	6.0	5.5	8.4	8.3	5.5	5.5	5.6	5.4	5.4	4.1	6.0	6.9	7.8	3.2	9.2	9.1	8.8	15.7	5.1	3.8	15.4	8.1	9.5	8.3	3.9	5.7	4.0	7.3	6.2	4.6	11.4	6.8	0.0	4.2	3.1	6.1	8.2	9.9	10.3	6.7	6.4	4.2	3.7	7.8	6.1	8.6	3.8	9.5	7.5	9.1	6.5	13.5	6.1	7.9	2.0	4.7	7.1	2.9	9.9	5.5	8.8	6.5	4.7	4.8	7.2	2.5	5.7	5.4	4.8	11.7	7.9	8.3	5.1	2.8	4.0	5.2	6.6	10.8	7.8	17.5	23.3	15.7	12.9	2.9	8.6	10.3	6.9	4.8
SETD4	"C21orf18, C21orf27"	ENSG00000185917	"SET domain containing 4"	Q9NVD3	21	36034541-36079389	"Predicted intracellular proteins"	"Inflammatory response"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 54.3;Spermatocytes: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024073, HPA035405"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA024073: AB_1856755, HPA035405: AB_2674612"	"unprognostic (4.23e-1)"	"unprognostic (5.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.05e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.17e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.60e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.99e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.28e-2)"	8.8	9.3	9.1	6.9	9.9	8.4	9.1	9.4	10.4	10.2	15.8	9.5	11.4	9.7	11.1	10.9	10.8	7.8	10.1	9.4	10.5	9.7	7.2	8.4	8.7	9.0	8.3	9.7	7.8	10.0	8.9	9.0	9.5	10.2	9.4	9.6	10.0	7.9	9.8	13.6	9.3	10.9	8.4	8.5	9.9	23.1	9.9	11.1	10.1	8.8	10.9	9.9	10.7	12.1	13.3	9.2	13.6	17.3	6.5	7.9	21.9	17.1	15.0	17.3	11.5	19.2	11.5	7.1	11.9	7.8	13.3	9.7	10.3	10.2	15.0	12.7	12.4	19.2	16.2	12.6	15.9	18.3	10.7	8.3	17.2	11.7	15.0	9.8	13.1	9.6	25.5	12.7	10.7	14.3	12.3	26.3	28.2	11.3	11.6	18.2	10.0	17.3	18.9	9.3	11.2	17.9	17.4	18.5	17.6	11.7	16.3	15.2	11.0	15.0	5.6	9.4	15.9	20.3	31.7	11.2	15.6	24.9	13.2	5.9	12.5	11.3	8.1	10.0	9.0	16.2	10.3	8.8	14.6	13.2	7.3	8.6	9.5	11.0	10.2	15.6	13.0	7.7	9.1	9.9	9.4	10.4	9.4	10.5	9.0	8.3	9.5	8.4	9.9	12.1	9.7	9.6	7.0	11.1	10.8	12.1	11.3	18.6	15.4	13.3	9.0	8.9	9.2	7.2	13.7	9.2	31.3	16.3	13.4	7.9	5.9	12.7	54.3	16.8	10.9	9.3	3.6	7.2	17.4	8.2	9.6	10.4	8.6	8.7	11.4	17.0	7.5	5.5	10.6	3.3	19.2	13.4	26.4	6.9	5.1	10.4	9.6	5.0	10.6	4.7	8.0	7.6	14.4	19.6	19.8	10.0	9.4	10.1	6.2	11.2	20.7	10.3	23.8	21.0	6.6	8.9	9.0	63.1	20.8	13.2	9.1	9.4	8.1	14.8	11.3	11.3
SF3B1	"Hsh155, Prp10, PRPF10, SAP155, SF3b155"	ENSG00000115524	"Splicing factor 3b subunit 1"	O75533	2	197388515-197435079	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050275	Approved		Enhanced	"Nuclear speckles"		NA	NA		94000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA050275: AB_2681071"	"unprognostic (6.86e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	183.8	173.9	101.7	132.7	112.4	304.8	180.7	120.5	126.1	222.8	136.8	170.9	110.4	195.8	200.0	136.8	183.8	123.2	135.7	98.2	100.8	135.4	168.5	162.8	203.0	105.7	101.9	226.5	200.7	154.9	147.8	165.3	111.0	163.2	147.3	138.4	180.4	133.2	172.4	156.5	231.6	116.5	107.5	287.8	169.2	91.4	104.9	221.9	167.8	144.8	199.3	154.4	167.1	135.8	134.9	105.4	288.6	155.9	222.8	219.2	237.8	172.6	196.7	163.2	205.9	233.0	147.2	247.5	116.6	193.1	165.8	133.7	273.4	151.2	271.8	196.5	154.8	237.5	257.4	294.3	155.4	270.1	198.6	232.1	163.0	175.9	209.3	278.6	205.9	171.0	210.2	174.0	192.3	134.2	251.1	285.6	231.4	167.5	163.8	234.4	197.9	182.9	245.8	286.4	154.2	186.7	174.7	118.2	139.2	345.1	115.2	242.5	186.8	126.9	109.4	123.3	145.8	168.7	238.8	342.0	123.7	174.8	146.5	49.8	50.4	57.5	54.5	51.7	55.4	46.1	46.2	50.9	60.5	44.1	48.7	49.2	60.8	56.7	52.5	37.5	71.3	56.2	101.7	112.4	120.5	126.1	98.2	100.8	105.7	101.9	111.0	107.5	104.9	135.8	175.6	179.5	222.9	92.4	187.4	119.0	172.0	127.1	125.7	103.4	96.4	83.3	129.2	72.9	194.0	92.0	73.0	116.8	224.1	90.1	56.7	104.8	9.2	123.9	191.0	143.1	110.5	109.0	55.5	94.8	102.3	151.6	132.0	179.0	246.9	171.1	107.1	74.4	100.6	94.2	59.7	108.1	89.5	124.7	144.1	20.6	120.2	166.1	76.5	75.9	163.9	111.1	116.4	87.0	121.1	112.0	68.3	104.6	195.6	103.8	84.2	70.5	221.5	98.5	118.3	159.5	227.9	104.6	100.5	94.3	118.8	142.7	216.2	119.4	91.4	156.1
SF3B2	"Cus1, SAP145, SF3b1, SF3b145"	ENSG00000087365	"Splicing factor 3b subunit 2"	Q13435	11	66050729-66069308	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045028	Supported		Enhanced	"Nuclear speckles"		NA	NA		130000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA045028: AB_10965174"	"unprognostic (1.48e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.10e-2)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (8.43e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (4.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.60e-2)"	116.0	96.0	117.5	80.4	127.1	144.6	109.0	119.4	139.5	123.3	125.1	97.4	70.7	111.6	95.5	96.6	112.3	55.2	94.7	117.9	120.4	107.1	112.0	104.3	99.0	124.2	118.9	136.1	137.4	88.9	137.2	80.6	121.3	99.2	77.0	96.5	91.3	73.8	108.1	116.9	98.5	80.0	121.4	113.9	102.9	145.2	124.0	109.4	115.2	54.6	114.0	108.3	104.7	136.9	226.9	177.3	189.0	178.9	184.3	163.5	153.1	168.4	210.5	234.9	176.8	149.8	188.9	212.5	185.7	186.7	249.5	202.9	263.2	177.8	208.8	170.2	143.5	223.3	164.2	245.5	187.8	229.7	171.5	137.9	174.0	242.5	287.8	171.3	172.7	180.5	215.2	348.7	191.4	309.8	257.5	343.2	196.1	166.2	163.9	235.6	162.9	299.0	192.3	186.0	147.8	218.0	165.9	175.9	257.0	136.3	217.2	147.1	156.7	206.9	178.0	229.0	194.3	267.5	337.0	270.8	229.6	151.6	191.9	152.1	96.2	167.9	135.3	117.2	131.1	106.8	120.3	128.2	98.5	110.2	116.7	116.8	130.2	116.3	160.1	78.8	131.8	147.5	117.5	127.1	119.4	139.5	117.9	120.4	124.2	118.9	121.3	121.4	124.0	136.9	86.5	128.2	131.0	18.6	144.3	111.3	148.9	165.9	129.1	94.9	69.1	65.0	68.5	98.7	141.5	66.2	89.6	195.9	131.8	114.3	92.0	172.2	278.2	119.5	103.2	104.4	82.5	113.6	19.2	214.8	183.7	117.6	95.8	92.0	120.8	119.0	80.7	72.4	124.9	107.7	19.3	112.4	130.2	103.6	115.0	78.5	120.2	103.8	65.8	10.3	195.6	122.1	155.5	12.1	28.9	158.9	96.3	130.1	198.3	136.6	101.1	108.1	214.7	109.4	78.9	106.1	153.7	220.1	172.0	103.2	99.0	186.6	145.5	118.7	122.3	130.8
SF3B4	"Hsh49, SAP49, SF3b49"	ENSG00000143368	"Splicing factor 3b subunit 4"	Q15427	1	149923317-149927803	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028578, HPA064660"	Approved		Approved	"Nuclear speckles"		NA	NA		36000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA028578: AB_10601601, HPA064660: AB_2685314"	"unprognostic (2.43e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (9.26e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (3.11e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.74e-7)"	"unprognostic (9.63e-2)"	"unprognostic (6.54e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	35.6	36.8	27.9	42.3	28.4	74.3	31.6	30.1	35.8	36.0	29.3	55.8	39.6	48.5	37.5	45.1	51.8	33.8	28.9	28.6	30.4	29.9	27.1	36.8	48.5	31.1	28.3	47.5	34.6	53.4	26.0	40.1	28.7	32.3	44.2	20.8	40.1	47.9	22.5	62.4	40.1	46.7	28.0	39.4	32.4	46.4	29.1	58.0	39.1	26.9	57.6	50.3	33.4	29.8	153.0	144.1	119.4	110.9	75.5	58.4	172.0	119.0	118.2	188.0	143.0	152.0	125.6	144.2	87.1	139.7	103.0	154.3	150.9	158.2	161.8	95.3	110.7	130.0	77.3	112.8	121.7	156.6	163.5	74.7	122.6	184.0	84.5	59.0	94.6	126.7	116.6	119.6	172.9	456.6	203.9	148.9	199.4	175.9	146.1	157.9	106.4	157.6	137.4	128.2	79.6	147.6	109.8	151.1	92.5	141.4	229.9	205.1	78.3	154.9	170.0	122.9	222.8	169.0	259.4	161.2	124.2	133.8	147.5	70.5	81.1	130.5	84.0	109.8	87.4	80.2	79.6	90.4	71.3	73.1	74.3	71.9	111.2	104.7	120.0	84.6	100.1	67.5	27.9	28.4	30.1	35.8	28.6	30.4	31.1	28.3	28.7	28.0	29.1	29.8	30.4	16.0	13.4	4.2	39.9	54.2	47.5	83.2	65.4	20.0	34.3	41.4	3.9	21.5	41.2	23.9	4.2	80.8	54.2	42.2	60.7	64.3	80.3	38.9	30.4	30.6	26.0	34.3	4.1	51.6	77.5	31.8	27.0	44.5	39.3	32.9	16.8	14.7	53.0	8.4	4.8	40.0	59.0	24.7	42.5	13.3	45.1	34.9	24.9	3.7	61.8	27.5	44.3	4.5	7.0	62.3	35.9	29.3	38.6	32.2	28.5	43.0	49.8	15.9	46.0	30.8	64.6	64.0	51.5	47.0	51.3	94.7	44.9	27.9	36.7	43.8
SGK1	SGK	ENSG00000118515	"Serum/glucocorticoid regulated kinase 1"	O00141	6	134169246-134318112	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1007.1"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 1238.4;Proximal enterocytes: 789.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 43.4;eosinophil: 170.2;neutrophil: 91.6"	"Group enriched"	"Detected in all"	8	"granulocytes: 170.2;monocytes: 43.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 298.1;RPTEC TERT1: 469.5;SK-MEL-30: 319.7;TIME: 373.9;U-266/84: 358.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022085, CAB025148, HPA051251"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"CAB022085: , CAB025148: , HPA051251: AB_2681407"	"unprognostic (2.05e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.76e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.82e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.59e-2)"	147.5	121.5	35.8	47.4	57.3	68.9	83.2	40.0	51.4	61.1	96.9	68.4	51.4	37.0	9.5	108.4	36.5	170.0	35.8	41.2	42.7	105.2	99.3	81.8	33.6	64.5	44.9	125.8	177.1	1007.1	12.0	70.6	49.6	47.6	39.0	14.1	70.8	60.3	50.2	75.7	282.5	48.4	35.8	21.5	104.2	30.4	53.6	39.7	56.7	33.9	78.1	141.3	96.7	94.0	4.1	6.9	4.2	0.4	51.7	12.9	5.9	76.7	159.4	98.4	79.8	12.2	10.6	13.1	11.3	79.8	48.0	2.5	6.8	12.2	72.0	0.5	3.1	0.6	175.7	9.2	298.1	0.7	6.8	77.3	75.4	96.7	124.3	39.3	167.1	2.3	25.6	192.8	35.6	0.6	1.1	3.0	4.8	20.3	8.3	2.4	8.9	1.5	469.5	1.4	2.2	18.6	241.7	0.7	319.7	43.2	0.5	2.1	373.9	28.8	12.3	176.9	17.1	36.2	358.5	40.3	26.7	12.0	39.5	2.2	43.4	170.2	0.7	24.4	1.6	1.9	1.3	0.8	14.1	1.4	1.6	2.0	91.6	3.6	14.5	0.9	2.5	12.6	35.8	57.3	40.0	51.4	41.2	42.7	64.5	44.9	49.6	35.8	53.6	94.0	346.2	38.5	177.8	34.0	68.0	183.3	133.7	277.3	329.0	12.0	87.1	112.0	28.4	88.6	168.6	68.0	35.5	41.0	27.0	132.2	21.5	81.3	9.6	145.8	73.1	232.1	10.7	14.7	68.2	171.2	33.6	88.8	206.4	483.4	271.8	33.9	353.4	21.9	284.2	0.0	225.7	65.1	91.6	181.3	1238.4	7.7	15.2	492.5	268.6	58.1	29.6	4.6	2.1	270.9	377.7	36.2	123.9	15.8	92.4	51.0	789.1	124.3	61.5	29.3	13.1	43.5	102.9	38.1	10.2	348.1	116.2	579.8	46.9	48.9	36.3	123.8
SIM1	bHLHe14	ENSG00000112246	"SIM bHLH transcription factor 1"	P81133	6	100385009-100464921	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;kidney: 9.9;skeletal muscle: 3.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 20.2;Distal tubular cells: 7.9;Ductal cells: 4.5;Skeletal myocytes: 7.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.8"	"Group enriched"	"Detected in some"	5	"hypothalamus: 4.4;midbrain: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.7;BJ: 16.4;BJ hTERT+: 23.7;BJ hTERT+ SV40 Large T+: 7.2;HDLM-2: 7.3;RPTEC TERT1: 18.4"	"Region enriched"	"Detected in single"	8	"hypothalamus: 5.2"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.1"	HPA024385			Approved	"Nuclear speckles"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"	"Nuclear speckles"		"HPA024385: AB_1856879"	"unprognostic (1.04e-1)"			"unprognostic (4.34e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.76e-2)"		"prognostic favorable (5.32e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.19e-1)"			1.7	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	4.4	9.9	0.3	0.0	0.0	0.0	1.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	9.7	0.0	16.4	23.7	7.2	6.7	0.0	0.0	0.0	0.0	5.2	1.5	0.0	0.0	0.0	6.1	7.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.4	0.0	1.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	20.2	0.0	0.1	0.0	0.0	7.9	4.5	1.8	0.1	0.1	0.1	1.8	0.0	0.1	1.2	0.1	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	7.6	0.3	1.5	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.1
SLC2A4RG	"GEF, HDBP1, Si-1-2, Si-1-2-19"	ENSG00000125520	"SLC2A4 regulator"	Q9NR83	20	63739776-63744050	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 150.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 116.2;Proximal tubular cells: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063050			Approved	"Nuclear speckles"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA063050: AB_2684930"	"unprognostic (2.89e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.07e-3)"	"unprognostic (6.48e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.22e-1)"	59.4	37.9	8.8	3.1	8.6	10.2	45.0	7.3	12.8	42.0	7.7	55.5	1.6	39.2	4.2	47.7	35.0	3.3	60.5	8.3	8.4	67.8	150.6	30.9	5.0	8.4	8.2	45.8	28.4	5.6	23.0	2.8	7.6	50.1	1.5	2.3	27.3	10.5	88.2	60.8	25.6	3.3	8.6	35.5	33.4	24.2	8.2	6.3	32.1	18.7	3.0	50.2	40.6	8.6	20.5	26.4	12.2	11.0	7.6	14.9	11.9	16.6	16.4	43.8	15.2	49.0	34.0	4.3	23.1	12.1	18.9	24.1	6.1	20.0	7.6	13.5	11.0	4.3	19.4	25.8	16.2	10.5	8.9	17.4	29.0	11.8	9.5	8.7	12.8	3.9	15.8	4.7	21.3	37.0	5.9	29.8	5.3	21.9	59.6	29.4	21.8	10.5	17.3	7.8	10.8	19.0	35.4	16.0	4.5	4.6	37.9	33.7	11.0	43.4	22.7	25.2	13.1	12.8	27.0	7.3	18.1	12.4	11.8	0.0	0.0	0.2	0.9	0.0	0.4	0.1	0.9	0.5	0.1	0.0	0.7	0.7	0.0	0.3	0.1	0.2	1.1	0.1	8.8	8.6	7.3	12.8	8.3	8.4	8.4	8.2	7.6	8.6	8.2	8.6	35.9	9.6	21.2	21.5	16.0	24.5	25.0	19.3	19.4	10.1	44.7	61.5	21.3	37.1	11.2	42.3	10.4	30.7	60.1	18.3	78.2	8.2	9.2	16.3	57.1	22.2	2.4	55.4	5.5	10.3	16.6	49.7	12.8	32.4	3.8	52.6	19.6	116.2	14.7	10.1	4.5	17.5	14.2	13.5	12.7	4.3	28.9	14.6	3.6	5.6	11.7	33.5	13.4	8.0	7.1	20.3	7.8	34.6	16.9	14.9	10.5	160.8	6.1	6.5	32.9	26.1	32.9	1.1	6.4	29.3	37.8	8.6	46.3	77.0	15.0	18.3
SMC5	"KIAA0594, SMC5L1"	ENSG00000198887	"Structural maintenance of chromosomes 5"	Q8IY18	9	70258978-70354873	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA054900	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA054900: AB_2682634"	"unprognostic (2.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.72e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.80e-1)"	10.2	7.7	4.3	15.0	4.8	26.0	16.6	10.4	5.0	12.2	9.0	15.0	13.5	15.2	12.8	10.8	12.3	12.9	9.9	4.2	6.1	8.0	14.8	12.8	18.5	5.2	5.7	25.2	19.4	10.4	9.6	14.8	5.7	11.4	16.9	8.3	17.1	8.7	13.8	9.0	13.9	10.7	4.2	12.0	14.5	13.5	4.9	18.2	14.3	8.2	16.1	16.4	11.3	7.8	43.9	10.8	26.6	16.2	15.1	28.3	20.9	29.8	25.8	15.9	17.3	4.1	23.3	43.7	9.5	22.5	13.9	39.3	28.9	19.8	31.7	19.9	10.3	25.5	18.3	13.1	19.2	41.8	25.3	19.9	13.5	21.5	24.5	25.4	16.9	25.8	19.1	17.1	29.9	6.7	55.4	14.7	20.4	33.5	14.9	32.4	43.6	13.7	16.1	21.3	18.9	14.2	29.5	18.7	8.3	19.2	11.2	17.6	18.6	21.3	22.4	29.2	41.2	20.9	29.9	29.9	17.9	21.6	25.9	14.1	5.6	10.4	8.5	6.3	8.0	8.4	7.3	8.1	4.6	8.2	8.0	7.4	3.7	8.1	7.6	8.7	8.4	4.0	4.3	4.8	10.4	5.0	4.2	6.1	5.2	5.7	5.7	4.2	4.9	7.8	48.9	57.7	70.3	61.7	54.6	45.6	102.0	30.3	59.7	26.8	39.2	34.0	34.6	41.5	62.0	20.2	29.2	32.1	65.2	38.8	9.8	61.3	47.9	65.3	58.9	37.6	28.1	29.0	72.2	54.8	37.5	62.1	40.8	89.1	51.8	52.5	16.1	25.9	16.4	38.7	66.4	34.8	20.3	22.9	30.8	15.9	53.4	37.9	24.9	74.0	65.4	17.2	54.6	85.5	94.6	68.3	37.9	59.5	40.6	105.5	23.6	11.7	51.0	35.7	26.3	66.2	52.2	80.0	55.0	52.5	41.9	35.6	56.7	58.4	45.0	105.8
SMIM19	C8orf40	ENSG00000176209	"Small integral membrane protein 19"	Q96E16	8	42541155-42555195	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011145, HPA074830"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA011145: AB_1078360, HPA074830: "	"unprognostic (2.12e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.68e-3)"	"unprognostic (7.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.67e-2)"	"prognostic favorable (1.74e-6)"	"unprognostic (5.10e-2)"	"unprognostic (9.70e-3)"	"unprognostic (9.64e-2)"	"unprognostic (2.93e-3)"	55.2	57.1	34.7	18.4	35.4	32.5	64.9	35.8	44.3	31.9	35.8	41.7	30.0	32.6	80.0	33.2	57.0	27.8	59.6	36.1	35.8	76.9	136.8	31.5	36.9	34.2	34.9	42.2	68.5	36.2	26.8	23.3	35.1	31.9	34.6	21.1	62.6	30.1	121.8	44.8	38.9	25.1	35.7	33.3	46.2	43.9	35.0	36.6	73.5	74.1	33.9	36.4	29.9	37.3	38.9	28.5	61.0	52.6	35.9	43.2	19.9	29.9	40.2	23.4	27.8	6.8	84.4	42.4	12.2	25.1	57.0	27.2	31.8	19.2	24.3	33.8	26.3	35.9	17.9	15.5	73.9	25.7	9.0	35.4	16.1	19.6	62.7	45.3	21.5	49.1	28.8	94.5	23.7	38.0	18.8	39.0	72.1	90.4	19.5	21.1	43.4	72.4	60.7	28.5	12.7	46.0	30.0	32.2	93.1	32.6	68.0	48.2	27.3	14.7	12.5	40.8	19.6	88.7	53.8	56.9	62.2	40.9	39.6	92.2	42.3	31.4	46.3	34.0	56.5	71.3	59.6	57.0	65.1	68.3	55.6	54.3	15.3	80.7	28.8	107.2	78.2	40.0	34.7	35.4	35.8	44.3	36.1	35.8	34.2	34.9	35.1	35.7	35.0	37.3	53.1	22.4	45.9	5.9	43.0	45.8	63.5	89.8	70.6	25.2	89.9	108.8	75.7	88.6	66.2	33.1	6.2	90.1	58.6	36.2	201.5	67.9	183.9	109.6	26.0	43.9	16.3	45.6	12.7	126.8	62.9	65.5	43.3	54.8	40.0	52.3	47.8	142.5	78.3	23.5	13.4	74.4	61.1	45.9	51.0	77.5	69.0	47.3	92.5	11.2	64.0	66.7	42.2	10.6	14.6	85.5	69.5	59.5	29.0	53.3	161.9	228.2	110.9	14.3	26.3	67.6	50.7	131.3	48.6	58.4	49.6	47.2	43.3	76.4	74.8	63.2
SMURF2		ENSG00000108854	"SMAD specific E3 ubiquitin protein ligase 2"	Q9HAU4	17	64542282-64662307	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ: 221.1;HBF TERT88: 157.4;LHCN-M2: 164.1;TIME: 207.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071508	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"		"HPA071508: AB_2686406"	"unprognostic (1.21e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.41e-1)"	6.8	4.3	3.3	6.2	3.9	5.9	5.2	5.3	3.4	7.3	3.4	5.3	6.9	5.9	2.3	4.4	5.8	7.1	4.1	3.1	3.3	7.0	3.8	10.5	5.0	4.6	2.7	4.8	6.5	6.3	3.4	13.3	2.8	7.4	4.8	12.5	6.2	5.2	3.0	5.0	10.1	6.1	3.2	5.4	7.8	13.0	3.6	7.8	8.3	6.2	6.5	7.5	3.2	3.8	67.0	17.8	15.3	9.1	11.0	41.5	7.6	221.1	103.2	88.2	73.4	10.4	45.5	8.6	14.5	38.8	29.9	15.2	16.0	37.2	157.4	4.3	12.9	9.1	10.9	11.8	12.0	12.2	5.5	11.8	16.1	109.5	48.5	52.7	97.0	11.9	13.0	7.5	164.1	13.2	28.3	4.8	9.9	8.8	23.8	6.1	38.4	5.2	20.1	11.1	16.0	17.9	14.4	5.8	10.0	24.6	11.7	8.4	207.6	93.8	44.4	39.2	139.6	10.4	11.7	13.9	23.7	7.3	28.4	1.0	0.6	1.4	1.0	0.4	1.1	0.7	0.8	1.1	0.7	0.9	0.9	0.9	1.4	2.7	0.3	0.6	0.2	0.5	3.3	3.9	5.3	3.4	3.1	3.3	4.6	2.7	2.8	3.2	3.6	3.8	40.2	32.1	26.0	96.3	18.6	43.8	30.8	10.0	25.0	26.4	23.3	18.7	10.3	7.2	16.1	9.2	43.8	13.2	35.4	13.8	9.8	18.1	29.0	29.0	37.2	39.3	17.9	2.5	46.1	10.0	3.6	28.1	12.2	39.7	13.3	21.4	38.2	5.1	13.6	26.9	40.9	11.2	10.2	17.3	25.5	9.2	12.5	22.8	21.4	101.2	13.2	21.4	20.6	101.0	52.8	26.5	24.7	12.0	18.0	25.2	28.0	9.6	14.4	46.7	0.0	37.4	23.3	37.1	21.3	13.7	39.8	7.3	33.5	16.2	13.8	24.6
SNRNP40	"HPRP8BP, PRP8BP, PRPF8BP, SPF38, WDR57"	ENSG00000060688	"Small nuclear ribonucleoprotein U5 subunit 40"	Q96DI7	1	31259568-31296788	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026527, HPA027345"	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"HPA026527: AB_1858814, HPA027345: AB_2239703"	"unprognostic (2.31e-3)"	"unprognostic (5.63e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (4.73e-6)"	"unprognostic (2.14e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.24e-2)"	17.9	18.9	10.7	21.2	14.6	30.0	20.7	15.5	12.6	17.7	10.3	20.6	16.4	20.1	21.7	19.1	22.5	13.1	14.2	10.4	12.5	17.6	19.3	15.8	35.4	14.5	13.3	20.8	13.0	18.0	15.9	22.3	15.4	20.1	22.1	19.1	15.0	20.8	20.9	18.5	17.6	21.7	13.7	21.3	16.6	21.2	12.8	40.3	18.0	18.1	40.2	24.0	16.7	20.1	71.6	53.6	95.5	78.6	46.7	38.4	66.2	58.8	57.4	104.7	101.9	76.7	69.8	91.8	56.4	46.1	53.9	66.4	145.7	69.8	105.9	99.2	109.3	135.2	72.1	83.9	58.4	150.0	59.3	36.2	54.7	102.1	75.6	34.4	86.1	80.2	129.0	52.9	60.5	51.6	111.3	87.9	171.6	71.1	76.5	87.3	134.5	71.1	44.2	57.7	65.1	63.6	92.3	47.4	116.2	88.0	47.2	94.9	59.5	57.9	85.2	81.5	112.9	43.5	57.1	126.1	47.1	139.3	96.4	102.8	75.8	82.3	98.6	97.3	113.1	93.8	95.1	98.2	93.0	82.6	101.1	115.1	16.4	110.5	92.0	78.4	110.2	161.1	10.7	14.6	15.5	12.6	10.4	12.5	14.5	13.3	15.4	13.7	12.8	20.1	44.1	3.2	6.1	14.7	51.5	53.0	50.2	90.8	41.5	15.6	24.4	30.6	16.5	21.5	32.5	16.5	18.8	108.7	35.7	11.9	43.0	42.5	7.1	21.0	27.5	39.4	34.8	80.8	23.7	35.9	91.3	38.1	28.5	13.9	34.3	36.2	28.9	22.3	56.2	10.1	24.3	18.6	69.2	20.7	48.6	5.4	26.8	31.5	42.7	15.0	44.7	23.8	44.3	23.6	49.0	36.4	20.2	34.3	40.6	55.0	17.0	45.0	27.6	22.2	32.9	31.0	35.1	105.5	89.7	39.6	54.8	61.3	52.4	45.9	36.9	40.6
SNURF		ENSG00000273173	"SNRPN upstream reading frame"	Q9Y675	15	24954986-24977850	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 62.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 191.3;U-698: 112.1"									HPA065733			Supported	"Nuclear speckles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA065733: AB_2685548"	"unprognostic (2.08e-1)"	"unprognostic (2.88e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.59e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.39e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.56e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.91e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-2)"	8.1	16.1	3.7	6.9	7.5	12.5	5.3	16.3	16.0	12.1	1.2	14.6	1.9	9.6	54.8	5.3	8.5	13.2	50.7	5.6	11.8	14.6	12.9	9.8	10.2	1.5	2.8	13.7	13.5	19.8	28.5	2.7	2.4	15.2	2.5	25.3	8.4	8.3	62.9	3.7	6.4	3.8	0.5	17.2	11.5	3.3	6.5	8.1	15.5	7.4	7.0	12.8	7.3	8.6	0.1	11.9	61.9	44.1	3.1	4.1	0.1	40.7	3.3	4.2	2.8	7.0	36.4	0.5	21.0	2.7	6.0	15.3	0.0	9.1	3.2	14.1	0.0	74.3	50.2	1.8	11.0	79.2	25.4	10.0	2.3	7.7	0.5	22.1	5.2	22.4	7.3	0.2	8.3	0.0	55.5	0.5	191.3	0.0	1.9	54.7	84.7	0.9	3.3	82.0	37.1	29.1	0.0	3.8	22.3	75.2	38.7	7.1	75.8	27.2	30.2	1.0	8.9	58.8	81.6	112.1	43.9	33.6	24.5	17.7	1.5	6.3	14.9	0.7	31.0	22.3	32.9	28.4	2.7	27.8	41.2	38.1	1.7	22.4	3.1	23.6	35.7	20.1	3.7	7.5	16.3	16.0	5.6	11.8	1.5	2.8	2.4	0.5	6.5	8.6	1.0	3.2	3.7	0.0	2.9	0.5	0.6	1.4	2.2	1.6	1.4	1.1	4.1	0.0	1.1	0.0	0.0	0.0	1.1	0.7	3.9	2.1	0.4	0.7	1.2	0.9	0.0	0.8	0.0	2.4	0.0	1.4	1.5	0.7	1.3	2.0	1.1	0.7	0.3	3.3	0.0	2.7	0.0	0.8	0.4	0.3	0.6	0.6	0.0	0.0	0.7	0.4	0.0	0.0	0.0	2.2	2.8	0.4	2.7	0.6	1.1	0.7	4.1	1.5	0.0	0.9	2.0	0.3	0.8	0.7	0.3	0.0	2.8	1.9	1.2	0.3
SOHLH1	"bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2"	ENSG00000165643	"Spermatogenesis and oogenesis specific basic helix-loop-helix 1"	Q5JUK2	9	135693407-135704498	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 28.9;choroid plexus: 13.1;testis: 16.9"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 78.3"	"Group enriched"	"Detected in some"	5	"cervical cancer: 2.3;endometrial cancer: 0.6;head and neck cancer: 2.3;lung cancer: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 20.9;U-266/84: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA059439			Approved	"Nuclear speckles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA059439: AB_2684017"	"unprognostic (2.93e-1)"			"unprognostic (1.23e-3)"	"unprognostic (9.85e-3)"	"unprognostic (2.84e-2)"		"unprognostic (3.55e-1)"		"unprognostic (2.59e-3)"				"unprognostic (4.98e-3)"	"unprognostic (2.17e-1)"		"unprognostic (1.63e-1)"	0.1	0.0	15.5	0.0	17.0	0.0	0.0	13.9	28.9	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.3	13.7	0.0	0.0	0.0	0.0	17.8	13.7	0.1	0.0	0.1	3.2	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	13.5	0.1	0.1	16.9	13.5	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	17.0	13.9	28.9	16.3	13.7	17.8	13.7	17.8	13.5	13.5	19.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.1	0.0	0.0	15.9	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	0.0	0.0	0.0	0.0	5.1	0.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	78.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SON	"BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP"	ENSG00000159140	"SON DNA and RNA binding protein"	P18583	21	33543038-33577481	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023535, HPA031755, HPA031756"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: AB_2674030"	"unprognostic (1.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-1)"	69.1	62.5	45.6	57.8	52.1	161.9	65.0	56.4	58.6	59.4	71.9	64.1	44.9	66.9	61.5	60.7	68.5	43.2	60.3	43.7	45.7	49.4	60.3	65.2	81.0	49.8	46.8	76.7	63.4	92.8	63.9	60.9	51.3	61.2	56.4	91.8	64.3	52.6	89.4	64.1	67.8	51.1	47.6	71.5	66.8	48.0	47.8	92.8	64.4	53.8	76.2	62.9	55.9	65.8	105.7	59.7	126.1	72.7	108.1	98.3	89.2	77.2	88.1	73.0	69.6	89.5	75.2	163.8	45.9	114.8	86.6	76.4	152.4	113.0	109.7	85.4	77.9	220.0	78.2	111.3	79.3	215.0	110.8	100.6	128.7	88.0	124.5	91.3	110.1	91.2	172.9	150.9	101.1	101.6	121.0	112.9	136.0	108.5	60.7	121.5	133.8	118.1	109.7	102.1	84.1	77.6	124.2	100.3	91.3	103.6	93.6	128.3	116.0	83.4	73.1	66.6	87.0	144.8	143.2	193.9	84.7	172.3	78.9	33.7	20.3	28.7	20.7	18.4	20.8	30.4	22.9	22.1	15.8	28.2	22.7	22.3	37.4	22.3	24.5	38.5	22.1	15.8	45.6	52.1	56.4	58.6	43.7	45.7	49.8	46.8	51.3	47.6	47.8	65.8	374.1	410.3	298.2	201.4	355.2	433.1	312.2	310.6	250.4	389.7	213.1	219.2	351.5	320.3	298.0	301.6	221.0	224.1	423.2	276.8	193.7	209.7	97.0	296.9	412.2	342.1	186.8	375.8	93.1	207.3	164.7	333.4	208.0	335.8	418.2	216.1	304.8	344.6	170.1	455.9	105.8	256.0	219.7	237.2	307.4	66.0	393.9	261.0	218.7	146.1	256.8	335.7	347.1	131.7	162.3	190.0	217.2	393.4	294.4	250.7	198.0	225.7	288.3	372.0	381.3	505.0	399.2	470.1	334.6	197.8	394.2	327.1	378.2	183.2	246.3	226.5
SPINDOC	"C11orf84, SPIN-DOC"	ENSG00000168005	"Spindlin interactor and repressor of chromatin binding"	Q9BUA3	11	63813456-63827716	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 7.2;Breast glandular cells: 6.7;Breast myoepithelial cells: 8.6;Cytotrophoblasts: 13.3;dendritic cells: 9.4;Endometrial stromal cells: 8.0;Granulosa cells: 9.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040128, HPA050313"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA040128: AB_10673027, HPA050313: AB_2681083"	"unprognostic (2.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	11.9	10.4	25.8	12.1	26.3	6.2	8.9	27.9	38.1	16.3	20.7	19.2	5.4	19.1	5.1	10.1	15.3	9.3	15.8	26.0	31.5	13.8	5.2	16.4	15.0	25.4	26.4	16.6	8.0	3.3	17.3	26.4	27.9	18.2	3.6	9.8	9.0	10.4	8.0	6.0	11.3	8.2	22.9	13.9	11.4	38.8	31.4	12.3	13.4	7.2	9.8	18.0	12.3	25.8	34.9	45.7	65.7	57.6	12.5	12.3	24.7	26.6	22.7	47.4	32.9	48.7	23.4	58.1	60.6	15.5	60.8	44.9	60.3	13.7	17.1	55.6	26.4	64.2	46.4	42.0	20.1	36.4	53.6	14.2	14.1	37.2	13.6	24.9	28.5	54.8	36.1	27.6	20.2	48.0	75.7	98.2	112.9	10.0	42.1	100.3	45.5	19.7	16.5	20.2	50.0	63.2	40.6	25.6	55.3	39.7	35.3	43.0	32.2	52.9	60.8	64.0	47.3	40.1	61.9	58.2	27.3	31.8	38.1	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	25.8	26.3	27.9	38.1	26.0	31.5	25.4	26.4	27.9	22.9	31.4	25.8	7.2	3.2	1.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	6.7	8.6	0.0	0.0	0.6	0.0	0.0	13.3	9.4	0.0	0.0	2.2	0.0	5.6	8.0	3.1	0.0	0.0	0.0	1.8	3.0	2.7	0.0	6.5	0.0	9.6	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.4	0.0	0.0	0.7	0.7	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	3.8	2.8	4.0	0.0	0.0
SPTSSB	"ADMP, C3orf57, ssSPTb"	ENSG00000196542	"Serine palmitoyltransferase small subunit B"	Q8NFR3	3	161344792-161372880	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 45.5;stomach 1: 61.4;urinary bladder: 49.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 28.5;Exocrine glandular cells: 46.0;Gastric mucus-secreting cells: 37.2;Melanocytes: 46.2;Prostatic glandular cells: 74.6;Suprabasal keratinocytes: 36.4;Urothelial cells: 65.6"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 24.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	13	"NK-cell: 353.6"	"Lineage enriched"	"Detected in many"	13	"NK-cells: 353.6"	"Group enriched"	"Detected in some"	10	"MCF7: 1167.1;RT4: 304.2"									HPA047712			Uncertain	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 35: Glandular cells - Unknown function"	"Nuclear speckles"		"HPA047712: AB_2680127"	"unprognostic (2.09e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.10e-2)"	"unprognostic (6.37e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.08e-2)"	"unprognostic (5.37e-4)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.51e-3)"	1.9	0.1	3.7	0.6	1.9	0.3	8.3	5.2	7.9	4.8	3.0	0.8	0.3	1.0	0.1	8.7	0.4	1.3	0.4	2.2	1.3	1.2	0.5	0.1	1.2	2.8	5.6	0.2	0.8	0.1	0.4	0.0	4.8	14.7	0.7	2.5	11.4	0.1	0.1	45.5	0.3	0.2	0.2	1.3	61.4	0.0	6.7	0.4	0.3	1.5	2.0	49.5	11.1	3.7	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.9	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.4	0.0	0.0	0.1	0.1	2.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1167.1	0.0	0.0	4.3	71.5	13.4	0.0	0.0	0.5	0.0	304.2	1.9	11.9	0.0	40.6	0.0	0.1	64.7	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.1	0.2	26.2	0.1	0.9	2.5	0.0	0.1	0.3	0.4	0.9	353.6	0.0	0.2	0.0	2.5	3.7	1.9	5.2	7.9	2.2	1.3	2.8	5.6	4.8	0.2	6.7	3.7	0.2	0.0	0.0	4.2	0.1	3.8	16.6	19.6	1.8	1.4	16.6	8.4	0.4	1.5	22.5	3.7	0.0	0.0	3.6	0.1	0.0	1.3	0.0	0.5	0.2	0.8	0.0	0.0	28.5	46.0	0.0	0.7	37.2	1.2	0.0	4.3	0.0	0.0	0.2	0.0	14.2	2.5	6.1	0.0	0.8	0.0	0.0	0.4	46.2	1.0	0.1	0.6	7.2	5.0	1.5	27.6	0.0	0.0	0.4	74.6	0.0	0.0	4.1	1.4	0.0	0.1	2.2	0.0	0.0	6.8	36.4	0.1	3.2	0.0	0.0	65.6
SRRM1	"MGC39488, POP101, SRM160"	ENSG00000133226	"Serine and arginine repetitive matrix 1"	Q8IYB3	1	24631716-24673281	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049941, HPA058612"	Supported		Enhanced	"Nuclear speckles"		NA	NA		20000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA049941: AB_2680962, HPA058612: AB_2683778"	"unprognostic (3.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.83e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.08e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.46e-1)"	43.2	32.8	28.5	30.7	32.9	68.9	45.3	37.2	35.8	62.6	33.8	48.8	27.7	50.7	83.8	37.5	58.4	22.9	40.5	28.3	29.4	31.2	32.1	40.2	40.3	32.6	31.1	79.2	35.7	26.2	37.6	33.3	33.7	53.5	26.9	52.4	40.6	31.9	52.0	54.8	43.2	30.6	27.4	45.7	36.8	39.3	30.7	31.4	39.8	21.5	37.0	41.6	50.3	46.0	52.4	40.4	79.2	74.2	44.4	46.0	78.0	57.7	40.5	59.1	67.4	45.2	88.1	115.0	36.6	50.4	39.2	66.0	82.1	58.2	78.4	39.2	54.3	89.9	83.3	53.0	30.7	101.3	58.5	30.6	34.9	48.4	68.1	66.4	53.7	55.2	92.8	65.5	61.5	44.1	96.3	69.6	139.4	42.9	29.0	89.4	63.3	58.0	52.4	51.6	49.3	43.0	63.5	54.5	45.5	59.8	49.3	50.7	56.7	54.2	53.2	71.4	62.5	54.7	46.0	138.3	58.4	122.4	61.0	32.3	18.1	20.9	21.6	23.3	26.7	19.9	20.4	21.3	20.7	20.0	18.6	21.6	23.2	29.7	27.5	16.8	16.5	16.9	28.5	32.9	37.2	35.8	28.3	29.4	32.6	31.1	33.7	27.4	30.7	46.0	231.5	157.0	165.3	67.9	266.8	302.3	280.8	194.6	271.5	178.4	164.6	188.0	154.8	128.7	172.7	121.4	118.9	152.1	315.1	146.5	199.6	174.1	330.2	211.3	247.6	170.7	118.4	230.1	53.6	147.2	170.0	177.2	142.2	260.0	241.0	148.6	140.7	225.6	149.5	124.5	56.7	174.4	120.1	178.7	311.3	134.1	167.7	205.3	154.7	45.9	286.6	187.1	256.4	58.8	173.2	147.5	149.1	150.8	236.8	329.8	141.8	198.4	145.5	186.9	138.1	252.3	220.3	219.4	223.3	282.5	295.4	241.2	288.6	135.9	194.3	308.9
SRRM2	"Cwc21, KIAA0324, SRL300, SRm300"	ENSG00000167978	"Serine/arginine repetitive matrix 2"	Q9UQ35	16	2752626-2772538	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 150.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041411, HPA066181"	Supported		Enhanced	"Nuclear speckles"		NA	NA		17000	"Cluster 11: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA041411: AB_10796671, HPA066181: AB_2685630"	"unprognostic (8.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (6.77e-4)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (7.39e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.50e-3)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (1.05e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.84e-2)"	195.2	215.4	203.8	115.7	211.0	270.4	193.4	229.1	374.7	255.3	232.5	239.3	127.0	219.7	69.9	222.8	253.9	94.3	246.5	205.6	201.2	212.5	252.5	198.6	125.4	222.7	197.7	265.5	315.1	115.9	171.0	89.2	208.7	217.8	102.8	134.1	243.0	86.9	306.6	224.6	261.5	100.3	180.2	250.7	269.6	146.9	227.5	108.4	231.4	96.9	95.2	211.5	211.7	234.5	108.1	134.7	212.9	147.1	147.1	141.9	125.1	119.8	68.1	105.5	93.5	111.5	123.1	192.2	87.3	134.6	88.2	151.6	170.2	153.6	110.9	139.3	177.5	164.8	284.5	192.9	65.6	171.9	229.6	146.3	145.6	155.0	182.8	210.4	110.5	136.5	187.5	184.1	98.7	186.5	162.6	270.9	196.9	76.4	75.1	286.2	84.0	150.4	136.4	109.7	138.1	120.8	158.1	162.0	98.7	141.7	147.2	137.4	157.1	148.8	150.3	97.9	149.8	161.2	131.6	402.9	51.7	124.0	102.2	150.8	24.0	13.3	8.2	10.6	7.9	15.9	10.4	8.1	5.8	22.9	9.1	12.0	48.2	60.5	10.5	31.9	5.9	3.0	203.8	211.0	229.1	374.7	205.6	201.2	222.7	197.7	208.7	180.2	227.5	234.5	286.4	141.1	232.4	134.8	221.3	310.5	430.1	204.0	178.2	416.5	271.8	283.3	139.0	147.3	180.5	167.3	291.9	179.3	289.0	244.4	66.5	156.3	83.1	285.4	457.7	230.3	189.6	191.6	71.1	179.5	204.8	235.0	296.2	379.3	134.8	273.1	158.8	183.8	157.2	439.1	76.7	245.2	162.8	124.5	238.7	77.2	251.6	208.1	120.9	116.2	160.9	239.8	195.7	94.0	109.6	159.9	188.4	192.2	262.3	352.3	192.5	99.3	146.6	358.1	197.2	366.8	391.0	231.8	253.7	219.2	365.1	276.2	237.5	339.5	236.5	377.8
SRSF11	"NET2, p54, SFRS11"	ENSG00000116754	"Serine and arginine rich splicing factor 11"	Q05519	1	70205682-70253052	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008762	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA008762: AB_1856782"	"unprognostic (7.82e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.30e-3)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.25e-3)"	"prognostic unfavorable (6.53e-6)"	"unprognostic (7.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-2)"	76.4	67.0	39.4	51.4	42.6	136.8	76.9	48.1	64.6	86.6	40.0	73.7	44.7	75.9	70.0	62.1	83.7	45.1	51.9	39.4	46.5	68.8	94.1	70.1	75.8	42.0	40.7	96.3	85.7	43.0	79.8	56.1	43.7	73.7	45.0	57.7	69.5	40.8	66.3	75.9	84.9	39.3	39.7	89.8	72.9	58.4	41.4	75.4	86.2	32.9	64.7	68.5	75.0	47.9	92.8	46.2	118.4	76.2	59.5	79.7	162.4	111.6	57.5	89.0	80.3	81.6	68.0	156.6	74.7	56.5	58.4	77.4	151.5	61.4	120.7	105.9	118.1	159.0	112.4	98.5	71.1	221.0	63.3	64.2	76.0	82.5	83.5	111.3	80.4	79.0	159.1	96.1	88.7	36.4	133.3	163.1	190.9	72.3	76.9	156.1	130.9	99.9	104.3	65.7	99.3	82.1	94.5	101.1	139.8	109.1	80.9	98.1	96.0	97.8	70.4	71.3	102.3	110.4	94.5	169.9	70.2	161.3	87.7	111.7	63.5	103.6	65.7	51.6	74.9	76.3	67.0	65.2	66.1	70.7	72.2	67.8	31.7	85.8	64.6	91.7	80.4	52.7	39.4	42.6	48.1	64.6	39.4	46.5	42.0	40.7	43.7	39.7	41.4	47.9	198.6	211.5	224.9	90.4	208.6	354.0	295.5	229.6	222.5	164.8	166.9	171.7	119.6	115.8	184.5	195.0	118.9	242.0	243.4	123.8	115.4	151.0	64.4	160.0	267.9	186.8	173.8	218.5	219.0	135.3	253.1	228.9	165.6	231.0	194.1	218.1	146.3	152.6	150.4	159.9	183.0	158.3	150.5	124.9	244.4	56.9	255.7	155.4	168.9	126.5	183.1	115.5	145.2	168.9	219.8	144.9	104.7	264.4	234.9	317.8	122.1	101.4	157.8	158.1	170.9	199.1	218.3	270.0	138.0	181.4	353.6	303.7	226.2	195.5	172.9	315.0
SRSF4	"SFRS4, SRP75"	ENSG00000116350	"Serine and arginine rich splicing factor 4"	Q08170	1	29147743-29181900	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050975	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"		"HPA050975: AB_2681296"	"unprognostic (3.26e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (4.26e-4)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.60e-2)"	84.7	61.1	43.4	46.8	45.4	77.5	78.2	47.6	46.6	82.3	44.1	86.7	49.6	79.7	38.6	73.5	71.7	36.4	61.9	43.0	46.9	62.9	95.8	83.5	57.4	44.8	43.7	88.2	61.6	38.7	56.0	57.6	45.6	72.0	35.6	51.8	62.5	39.6	94.1	76.2	73.1	40.6	43.0	81.9	66.7	44.5	45.0	63.2	73.7	51.7	43.4	77.7	76.6	46.1	108.2	63.5	117.0	42.8	83.9	63.0	72.5	87.6	65.5	103.3	88.0	58.6	64.9	122.2	79.9	74.5	66.9	99.0	99.7	81.4	104.5	148.6	118.9	185.7	95.6	92.9	87.2	127.8	114.0	51.1	101.1	87.7	111.8	83.9	86.6	70.2	154.8	95.7	71.1	54.1	162.2	110.4	125.2	64.4	60.0	150.6	126.9	83.3	71.1	110.0	71.3	81.4	107.4	61.5	105.8	103.4	41.0	76.3	84.2	82.9	66.1	91.0	146.4	88.0	70.6	134.5	79.4	161.0	91.9	72.7	45.7	102.2	64.6	55.1	63.3	49.0	59.7	70.5	55.8	53.1	51.0	55.0	89.6	48.4	62.3	43.2	78.9	51.1	43.4	45.4	47.6	46.6	43.0	46.9	44.8	43.7	45.6	43.0	45.0	46.1	142.3	80.1	129.8	23.8	94.2	99.8	179.6	65.0	91.0	70.2	50.2	42.9	51.1	45.8	92.8	51.5	85.5	132.7	100.0	68.4	54.8	64.9	8.2	85.4	98.4	131.0	39.0	114.3	20.1	47.2	124.6	87.8	76.5	99.4	91.7	76.2	101.0	75.9	68.8	57.2	21.1	72.7	59.0	69.8	79.0	11.6	85.7	83.4	55.2	14.0	88.6	74.8	92.7	19.6	19.6	56.3	78.8	89.1	121.4	172.3	83.1	58.3	91.7	108.3	72.3	99.5	97.4	64.7	51.9	95.9	103.3	142.8	105.1	75.9	78.7	210.4
SRSF6	"B52, SFRS6, SRP55"	ENSG00000124193	"Serine and arginine rich splicing factor 6"	Q13247	20	43457893-43466046	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029005, CAB034889"	Supported		Supported	"Nuclear speckles"		NA	NA		50000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"CAB034889: AB_785899, HPA029005: AB_10610424"	"unprognostic (1.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.25e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-3)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.18e-2)"	43.3	53.7	34.0	34.5	37.5	115.9	56.2	41.4	43.8	44.2	52.7	37.8	36.3	52.7	59.7	32.8	47.4	31.4	31.4	33.3	39.6	47.4	50.3	40.3	48.4	34.5	34.7	58.5	66.3	41.8	48.0	39.3	35.6	48.7	43.4	38.7	45.3	30.0	30.5	48.7	45.4	39.7	35.6	55.9	47.4	30.3	35.7	53.7	50.8	18.1	40.8	29.7	30.4	47.3	52.7	79.1	88.7	57.3	50.7	67.7	86.3	79.6	38.3	55.4	47.1	112.9	55.9	95.9	73.9	73.3	45.1	77.6	91.7	116.9	71.7	40.2	85.7	74.6	83.3	94.1	62.3	94.9	78.9	115.7	61.9	51.0	46.2	85.1	52.7	83.8	63.3	54.5	52.6	112.3	144.5	107.6	57.8	87.4	107.4	100.2	54.4	76.9	63.1	93.7	69.0	90.9	89.5	108.7	105.0	61.7	70.4	103.3	54.9	57.9	61.6	49.9	67.3	98.2	67.3	131.4	69.9	67.2	42.8	26.0	19.9	9.7	19.7	33.4	22.4	16.0	20.8	19.1	24.5	15.9	27.3	25.7	10.8	21.2	29.6	20.4	18.7	22.9	34.0	37.5	41.4	43.8	33.3	39.6	34.5	34.7	35.6	35.6	35.7	47.3	78.9	64.1	80.0	49.6	75.8	94.4	61.0	58.5	50.7	48.9	110.7	78.7	28.7	75.8	61.3	46.0	39.6	97.8	103.3	67.8	88.0	60.2	12.3	60.1	87.7	62.3	101.4	71.1	32.1	43.7	108.2	80.0	70.8	79.1	97.0	103.2	60.7	94.7	56.5	32.0	37.2	97.2	46.8	73.2	93.7	14.7	55.0	77.3	101.4	26.2	61.2	45.0	37.0	89.0	79.6	46.2	74.3	44.8	49.3	68.9	66.7	67.7	47.6	46.4	59.2	166.1	99.8	53.8	61.0	51.5	98.3	139.1	76.4	90.7	105.5	55.3
STK19	"D6S60, G11, RP1"	ENSG00000204344	"Serine/threonine kinase 19"	P49842	6	31971091-31982821	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	4	"Proximal tubular cells: 348.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.4;HEL: 1.5;HL-60: 1.6;REH: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031511, HPA068559"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA031511: AB_2673915, HPA068559: AB_2686004"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.10e-1)"	1.5	3.6	0.1	0.2	0.1	0.0	1.3	0.4	0.9	2.1	0.0	2.5	0.0	1.4	0.3	1.9	1.0	0.1	1.2	0.0	0.0	1.5	2.2	1.3	0.0	0.0	0.0	1.1	1.1	0.2	1.4	0.4	0.1	2.1	0.0	0.2	0.9	0.1	1.3	2.5	0.7	0.0	0.0	1.2	1.3	1.5	0.1	0.1	1.2	0.0	0.1	2.0	1.5	0.4	0.0	0.1	0.0	0.4	1.1	0.7	0.0	0.3	0.1	0.2	0.4	0.0	0.7	0.6	0.3	0.5	0.0	0.6	0.0	0.2	0.3	1.4	0.4	1.5	0.3	0.0	0.5	1.6	0.0	0.6	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	1.1	0.4	0.0	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.9	0.0	0.7	0.2	0.0	0.0	1.1	0.0	0.1	0.3	0.2	0.6	0.2	0.0	0.8	0.2	0.3	0.1	0.1	0.3	0.4	0.4	0.0	0.1	0.1	0.1	0.4	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	21.2	9.6	21.5	13.7	16.4	13.0	14.0	23.0	13.6	11.8	26.6	27.6	8.1	18.6	24.6	22.0	20.9	37.2	22.4	13.8	39.2	26.3	85.8	27.8	31.8	20.6	19.3	4.6	8.7	28.3	20.0	23.3	19.4	20.7	9.5	20.1	14.3	21.1	19.3	10.1	8.0	17.3	18.3	8.8	10.0	76.0	20.2	18.3	17.8	11.2	12.5	30.2	13.4	4.5	6.5	23.6	16.4	18.4	11.9	13.2	15.0	348.9	41.8	21.9	32.9	19.6	21.1	39.5	21.0	17.9	18.2	49.7	19.8	45.1	13.1	11.8
SYF2	"CBPIN, DKFZp564O2082, fSAP29, NTC31, p29"	ENSG00000117614	"SYF2 pre-mRNA splicing factor"	O95926	1	25222276-25232502	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018265, HPA070710"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"		"HPA018265: AB_10962002, HPA070710: AB_2686301"	"unprognostic (4.19e-3)"	"unprognostic (1.58e-2)"	"unprognostic (9.98e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-3)"	"unprognostic (7.40e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-3)"	"prognostic favorable (5.72e-4)"	75.3	56.5	37.8	42.6	38.4	147.6	66.9	39.9	48.4	70.1	39.0	71.6	55.4	59.9	72.2	49.3	63.7	40.7	50.0	36.9	41.6	64.0	48.3	46.4	63.8	39.3	38.4	104.5	59.1	67.8	35.3	57.1	40.3	50.3	59.4	29.5	52.0	51.3	89.1	58.5	57.7	47.0	39.2	55.9	61.9	26.9	38.4	77.6	59.0	57.8	76.8	63.2	60.1	41.4	54.0	22.0	54.9	45.4	85.2	109.0	42.4	56.1	91.0	52.7	47.8	13.7	73.0	46.2	75.6	68.1	39.8	47.3	47.6	43.2	76.4	76.2	39.4	52.8	56.1	41.8	86.6	75.9	54.3	79.4	118.2	54.3	75.2	100.4	76.0	61.8	42.0	74.4	75.2	19.8	77.6	104.0	71.7	78.9	32.4	51.3	46.3	78.9	86.9	28.6	47.8	69.5	49.1	44.5	160.5	47.7	38.3	91.5	61.8	45.9	40.6	87.0	46.8	86.7	83.4	48.6	67.6	77.7	45.2	185.5	82.1	222.9	79.1	98.4	95.7	140.0	102.4	99.9	70.0	125.5	108.4	102.0	337.6	111.3	121.6	67.3	129.2	92.7	37.8	38.4	39.9	48.4	36.9	41.6	39.3	38.4	40.3	39.2	38.4	41.4	160.7	128.2	112.8	6.8	176.0	159.3	123.0	238.5	111.5	74.3	134.9	174.1	108.1	147.3	151.3	189.4	83.4	195.7	203.9	211.7	246.5	158.6	78.7	153.2	125.9	137.4	111.4	117.6	10.6	174.2	130.1	121.1	59.1	166.8	232.4	120.9	154.9	131.3	126.4	58.9	10.2	166.0	181.0	231.5	155.4	32.1	214.6	155.4	108.5	3.7	251.8	95.0	217.3	6.0	12.5	154.5	221.1	164.7	83.0	109.5	322.0	273.4	151.0	90.5	164.3	139.5	142.5	98.2	108.8	88.1	171.3	280.6	176.8	95.9	171.8	147.2
TAB1	MAP3K7IP1	ENSG00000100324	"TGF-beta activated kinase 1 (MAP3K7) binding protein 1"	Q15750	22	39399778-39437060	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032328, HPA039988, HPA057104"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear speckles"		"CAB032328: AB_2281637, HPA039988: AB_2676787, HPA057104: AB_2683338"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.73e-3)"	"unprognostic (9.23e-3)"	"unprognostic (4.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	13.1	14.8	18.2	9.0	20.6	9.7	12.9	17.0	19.8	18.2	10.6	18.9	10.7	16.5	6.2	13.8	15.9	7.4	17.0	17.3	16.1	12.4	16.6	11.0	11.1	18.7	19.3	20.5	15.6	10.0	10.5	8.6	17.7	16.7	5.4	12.2	13.7	10.9	19.9	17.4	13.5	8.7	15.8	15.9	14.7	10.2	18.5	11.9	13.3	10.7	7.8	17.9	14.9	20.6	15.0	15.3	15.2	17.5	15.8	13.2	13.5	12.3	15.1	18.4	17.3	14.2	10.6	22.5	9.4	12.0	10.3	18.0	15.5	18.0	7.2	17.6	24.8	9.9	19.0	14.2	13.7	18.8	18.3	13.5	15.7	13.9	15.1	14.0	13.6	13.5	18.4	15.0	9.3	9.7	14.6	15.6	10.6	23.6	15.4	26.0	21.6	22.6	14.4	15.7	13.5	9.9	17.4	21.5	15.4	9.4	17.6	20.4	11.8	12.8	20.2	9.9	10.1	23.6	16.2	16.4	15.1	13.1	12.8	0.8	5.6	4.1	4.3	4.3	3.4	3.3	2.6	3.5	5.0	3.2	4.1	3.9	0.7	3.3	4.5	2.3	2.8	4.3	18.2	20.6	17.0	19.8	17.3	16.1	18.7	19.3	17.7	15.8	18.5	20.6	6.0	3.2	6.7	17.9	7.0	2.0	2.8	4.0	6.8	55.2	5.9	6.9	7.4	8.6	4.1	3.7	18.8	12.4	4.7	4.9	0.0	6.2	1.6	4.5	7.0	5.4	11.4	6.9	9.1	3.8	7.9	6.2	7.1	4.4	5.1	12.5	2.2	4.7	7.1	28.6	12.6	4.8	0.0	6.0	1.0	3.2	7.8	6.4	5.4	9.4	8.6	12.1	8.2	7.5	18.6	5.4	4.1	9.1	8.4	2.8	7.6	5.4	4.7	18.8	6.6	6.4	7.4	8.2	9.1	5.5	3.3	5.6	8.1	10.3	4.9	1.8
TADA2A	"ADA2, ADA2A, hADA2, TADA2L"	ENSG00000276234	"Transcriptional adaptor 2A"		17	37406886-37479725	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 125.0;Late spermatids: 87.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076497			Approved	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA076497: AB_2686801"	"unprognostic (3.49e-1)"	"unprognostic (5.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.13e-3)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-3)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (2.25e-5)"	"unprognostic (4.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.41e-2)"	3.8	3.5	2.8	3.1	3.6	2.6	3.8	5.5	5.3	4.9	1.4	5.0	1.8	5.0	2.6	3.8	4.9	1.5	4.2	2.8	2.9	3.9	4.7	3.3	2.0	2.7	3.1	3.9	5.0	1.2	4.6	1.5	2.9	4.4	2.8	5.0	3.9	1.7	6.2	4.8	5.3	1.5	2.8	5.4	4.3	10.1	3.3	1.7	5.5	1.5	3.2	4.9	4.3	4.1	0.8	6.4	6.2	4.9	3.0	4.3	6.9	4.0	4.0	6.9	5.0	7.8	0.0	12.7	5.9	2.9	9.0	10.0	8.9	4.9	7.6	8.9	7.6	6.6	8.2	4.3	5.3	10.4	4.0	3.2	3.3	7.9	3.9	3.7	6.9	16.3	11.0	3.7	9.0	3.4	19.7	8.5	4.9	3.1	4.5	13.5	19.3	10.4	4.4	6.5	7.2	6.9	5.3	2.8	4.9	6.4	8.9	3.4	5.7	7.9	6.9	5.7	6.2	6.4	6.1	16.6	7.6	4.4	6.8	2.4	3.8	4.5	5.4	4.2	3.9	3.9	3.4	4.5	4.7	7.1	5.3	5.1	0.5	3.1	5.9	8.6	3.2	2.8	2.8	3.6	5.5	5.3	2.8	2.9	2.7	3.1	2.9	2.8	3.3	4.1	6.8	6.4	9.3	8.5	6.1	2.5	6.7	9.7	6.8	15.1	3.9	4.4	7.4	8.6	11.3	9.2	16.7	15.2	11.0	4.3	1.9	7.1	125.0	7.5	9.7	8.2	4.2	9.9	22.9	5.9	9.7	5.5	5.1	6.8	10.1	9.1	5.7	3.9	8.0	23.5	19.7	7.3	4.1	5.5	4.7	87.9	8.1	6.5	1.8	20.6	10.5	11.4	5.2	17.6	21.6	6.6	4.0	7.9	7.1	5.3	6.6	5.1	11.4	21.8	13.1	8.7	10.1	27.3	33.5	4.8	3.3	5.1	6.8	7.4	7.4	4.0
TADA2B	MGC21874	ENSG00000173011	"Transcriptional adaptor 2B"	Q86TJ2	4	7041899-7057952	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 40.4;Rod photoreceptor cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035770	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nuclear speckles"		"HPA035770: AB_10603993"	"unprognostic (1.52e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.17e-11)"	"unprognostic (5.00e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.59e-2)"	"prognostic favorable (1.59e-4)"	10.9	16.3	7.7	13.1	8.1	35.4	10.5	9.3	10.4	10.6	8.3	12.7	13.4	11.8	8.1	14.6	12.2	10.2	20.6	11.0	6.5	12.3	15.7	11.7	17.8	8.7	7.0	19.3	30.2	16.7	9.1	10.8	8.6	12.8	10.3	20.2	24.4	13.0	52.0	12.1	13.0	11.6	6.4	15.3	14.6	15.5	8.2	12.0	16.4	42.4	12.6	11.5	9.2	8.3	11.5	17.2	11.8	14.0	12.8	14.5	11.3	16.5	16.9	20.9	12.8	17.0	16.8	15.2	9.6	18.4	27.8	9.2	16.3	8.7	13.4	9.0	12.5	15.5	10.5	12.9	15.6	17.9	24.3	10.5	18.2	13.9	16.1	14.4	9.8	13.9	17.6	23.9	15.8	11.0	21.8	15.3	14.0	15.3	26.4	14.0	24.1	8.0	19.1	15.9	19.2	13.8	14.2	12.6	16.6	9.5	19.0	26.6	15.3	13.2	10.2	16.1	22.9	21.6	19.5	19.7	10.9	9.7	13.7	0.7	1.3	6.9	2.7	1.7	1.9	2.5	1.7	2.6	1.2	1.7	2.3	1.7	4.4	1.5	2.1	1.3	2.0	1.2	7.7	8.1	9.3	10.4	11.0	6.5	8.7	7.0	8.6	6.4	8.2	8.3	7.1	9.6	15.0	7.2	9.0	4.6	2.7	3.3	0.6	27.1	12.4	8.0	12.7	4.3	9.1	7.3	31.3	3.6	14.2	10.6	5.9	4.5	2.9	8.6	9.0	6.4	7.2	2.1	5.0	9.3	2.9	8.0	8.2	8.7	9.5	6.3	4.2	16.7	5.7	40.4	5.2	9.5	4.1	8.8	4.2	4.8	16.8	7.0	7.2	1.9	8.1	10.4	6.2	5.0	3.7	7.9	7.8	12.8	5.1	5.8	8.7	7.6	7.1	38.3	0.0	12.4	5.2	6.1	4.5	3.6	5.8	4.4	10.1	12.5	6.9	5.4
TARBP1	"TRM3, TRMT3, TRP-185"	ENSG00000059588	"TAR (HIV-1) RNA binding protein 1"	Q13395	1	234391313-234479179	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 209.4;Inhibitory neurons: 161.5;Oligodendrocyte precursor cells: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020810, HPA024632"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"CAB020810: , HPA024632: AB_1857770"	"unprognostic (3.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.44e-3)"	"unprognostic (8.45e-3)"	"unprognostic (5.22e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.14e-10)"	"unprognostic (5.72e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.27e-2)"	4.8	5.2	3.9	7.4	4.0	11.1	9.1	5.5	5.0	4.9	0.1	6.1	6.5	4.9	7.6	6.3	7.6	5.7	3.8	3.7	2.9	5.6	3.9	6.2	10.3	0.4	0.8	2.7	7.7	6.1	6.3	8.3	1.1	7.4	9.0	7.3	9.3	4.5	6.3	7.9	5.8	4.6	0.7	7.5	8.3	4.8	4.3	6.7	6.2	7.1	11.4	3.7	4.2	4.1	18.9	12.9	8.3	9.7	13.6	18.5	17.2	7.9	5.9	10.1	7.4	6.2	12.0	16.3	8.2	6.0	8.7	12.1	9.7	9.9	9.7	16.0	14.9	9.0	14.0	9.1	4.3	39.7	7.6	7.7	8.9	7.3	4.1	7.8	10.5	21.6	11.5	10.2	7.1	3.9	16.5	19.4	17.7	20.1	5.3	28.7	4.9	16.0	6.8	10.8	8.9	10.6	10.8	14.0	12.1	5.5	9.0	39.9	7.1	9.3	1.2	10.4	16.1	27.0	19.0	7.2	6.0	18.3	14.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.0	0.5	0.3	0.0	0.3	0.0	1.1	0.0	0.0	3.9	4.0	5.5	5.0	3.7	2.9	0.4	0.8	1.1	0.7	4.3	4.1	12.4	41.7	22.7	53.8	14.6	6.2	4.1	7.4	7.4	35.1	18.4	18.9	5.8	5.7	13.3	7.3	37.5	20.1	23.3	7.2	1.9	4.7	21.5	13.8	13.6	11.1	11.5	16.4	209.4	5.7	17.6	10.1	16.3	9.9	3.8	13.2	12.1	7.7	9.0	57.2	161.5	12.2	10.2	6.6	9.2	3.6	5.6	11.4	10.6	39.4	8.0	7.7	10.3	115.1	72.3	8.8	6.5	6.0	6.3	6.5	5.8	4.3	27.9	17.1	0.0	12.7	7.8	4.1	8.6	11.5	8.2	11.9	12.8	12.8	19.6	4.8
TATDN2	KIAA0218	ENSG00000157014	"TatD DNase domain containing 2"	Q93075	3	10248023-10281218	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA036822	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA036822: AB_10671972"	"unprognostic (4.51e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.48e-2)"	15.5	15.8	19.8	14.8	20.9	34.4	15.4	18.0	21.4	19.9	17.0	15.5	12.7	17.4	15.5	19.9	15.6	10.3	16.2	20.8	17.3	17.8	14.0	17.3	21.6	17.6	17.2	24.7	19.9	17.9	17.8	9.8	17.3	20.9	14.7	9.0	17.7	12.3	15.0	20.7	18.8	13.5	17.4	23.9	16.7	8.6	19.5	32.5	20.8	10.9	22.1	16.6	18.4	18.3	19.4	32.1	16.9	14.3	21.2	22.9	73.3	23.2	22.5	28.8	18.8	23.6	17.0	45.6	17.0	32.1	30.7	14.3	29.1	20.9	22.5	29.5	36.5	24.3	30.8	24.9	13.7	34.6	24.8	17.6	22.9	40.2	13.6	18.8	23.6	28.3	27.9	40.7	26.4	37.2	45.4	29.6	23.9	25.2	31.9	24.8	18.0	26.5	18.2	26.8	18.7	22.6	19.4	21.8	10.9	15.6	22.2	32.4	18.8	33.1	21.6	28.1	41.6	25.5	43.6	80.6	30.0	35.6	23.1	1.3	0.6	0.5	1.6	1.0	1.6	0.8	1.4	1.3	0.5	1.4	1.4	2.1	0.5	0.9	0.5	1.3	1.7	0.9	19.8	20.9	18.0	21.4	20.8	17.3	17.6	17.2	17.3	17.4	19.5	18.3	6.3	6.4	11.0	4.9	8.2	12.6	4.6	4.8	9.1	4.4	9.4	6.3	6.9	7.2	4.3	11.0	6.2	3.8	9.3	12.7	1.9	5.1	2.0	4.1	7.0	7.9	16.8	6.1	8.8	9.2	4.0	6.8	5.1	5.9	5.1	9.1	7.9	10.2	10.3	5.0	5.9	8.7	2.0	15.6	21.0	1.8	7.2	9.1	14.2	6.5	9.0	5.2	18.6	4.5	5.0	8.6	3.1	7.5	8.8	9.3	8.0	5.4	2.4	2.8	6.6	5.8	4.7	2.1	5.6	6.4	12.4	2.5	10.7	8.7	10.8	7.1
TBX19	"dj747L4.1, TPIT"	ENSG00000143178	"T-box transcription factor 19"	O60806	1	168280877-168314426	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"pituitary gland: 50.2"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 5.5;HDLM-2: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005800, HPA072686"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"HPA005800: AB_1080219, HPA072686: AB_2732209"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.76e-4)"	"unprognostic (1.43e-2)"	"unprognostic (3.09e-2)"	"unprognostic (8.36e-2)"	"unprognostic (7.14e-7)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (8.57e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	1.8	0.8	1.0	0.8	1.2	0.7	1.8	0.8	1.3	2.9	1.0	2.5	0.8	5.0	0.8	1.6	2.7	1.2	1.1	1.1	2.0	1.8	1.1	2.4	1.7	1.5	1.1	3.7	1.1	0.5	50.2	0.6	1.2	2.2	1.0	0.4	1.8	1.0	0.8	2.5	1.6	2.1	1.0	2.3	1.1	1.0	1.5	1.6	1.3	0.8	1.1	1.5	2.1	1.2	1.0	0.0	0.8	3.1	1.4	0.6	1.0	1.6	0.9	0.5	0.8	1.4	1.0	0.8	1.7	0.6	0.8	5.5	0.4	0.4	0.8	5.1	0.7	0.1	1.1	0.4	1.5	1.6	2.0	1.2	1.4	0.2	0.8	1.3	0.7	0.3	1.1	1.3	0.7	0.2	0.8	1.3	0.2	3.3	0.5	1.3	0.4	0.3	1.2	0.4	1.1	1.6	0.9	0.7	1.0	1.3	0.2	1.3	1.2	0.5	1.3	1.1	1.7	1.0	0.8	0.6	0.1	0.4	1.6	0.2	0.7	0.4	1.1	0.5	0.5	0.4	0.8	0.7	0.7	0.5	0.5	0.5	1.0	0.9	1.0	2.4	0.8	0.6	1.0	1.2	0.8	1.3	1.1	2.0	1.5	1.1	1.2	1.0	1.5	1.2	1.4	0.0	0.5	2.3	1.4	2.7	1.3	1.2	2.2	0.0	3.1	3.0	0.4	0.0	0.6	0.0	0.0	0.1	6.1	2.6	0.0	0.6	0.6	3.2	1.8	2.5	1.2	0.8	0.7	0.4	0.4	2.5	0.0	5.6	4.5	1.8	0.4	0.7	1.3	0.0	0.5	0.9	2.0	2.8	8.9	0.7	3.4	4.2	0.0	6.5	3.9	0.4	6.2	0.5	3.1	1.9	0.6	2.6	1.1	4.3	0.7	0.6	1.2	0.0	0.0	0.7	0.9	1.0	1.1	1.9	3.3	0.1	1.6	0.9	0.9	2.7
TCEANC	MGC17403	ENSG00000176896	"Transcription elongation factor A N-terminal and central domain containing"	Q8N8B7	X	13653189-13681964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000337, HPA001013"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear speckles"		"HPA000337: , HPA001013: AB_1079371"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.29e-3)"	"unprognostic (4.03e-2)"	"unprognostic (4.29e-6)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.11e-4)"	1.5	1.2	1.3	1.0	1.4	4.5	2.5	2.0	1.8	1.5	1.2	1.2	1.1	1.5	3.0	0.8	1.8	1.0	1.5	1.4	1.4	1.5	1.7	1.7	2.7	1.5	1.4	2.5	1.5	1.2	1.3	1.2	1.5	1.5	1.5	2.8	1.8	1.2	1.7	1.5	1.4	1.5	1.3	2.5	1.2	1.0	1.6	2.9	2.0	1.5	2.0	1.1	1.1	1.9	0.4	1.1	1.2	2.1	2.5	3.0	0.4	0.3	1.0	1.0	0.4	0.4	0.8	1.3	1.1	0.8	0.6	0.6	1.1	0.6	0.2	1.4	1.5	0.7	0.6	0.6	1.4	1.1	1.3	2.6	1.0	0.6	4.2	1.5	0.3	1.3	1.4	2.2	1.4	0.9	1.8	1.1	1.6	0.6	0.3	1.4	1.1	2.8	0.5	0.7	1.2	1.1	1.1	1.2	1.6	1.5	1.2	1.0	0.5	0.9	0.4	0.8	0.1	1.8	1.1	1.0	1.2	0.6	0.4	7.2	1.6	4.2	2.6	1.4	3.0	3.5	2.8	3.5	1.3	3.6	3.4	3.1	2.1	1.6	1.5	2.3	3.7	1.9	1.3	1.4	2.0	1.8	1.4	1.4	1.5	1.4	1.5	1.3	1.6	1.9	2.9	0.0	1.1	1.6	3.8	0.3	1.0	1.2	1.8	3.5	2.3	2.0	2.6	1.5	2.3	3.7	2.1	2.2	7.3	1.3	3.9	1.5	0.0	2.2	2.6	1.5	2.4	19.0	1.7	0.9	0.8	1.8	1.1	2.0	5.1	2.1	1.8	3.9	2.0	1.7	2.2	2.5	2.0	2.8	2.0	0.2	3.4	1.8	0.0	2.8	3.1	4.9	6.2	0.5	2.5	0.5	1.8	2.2	7.3	1.2	2.7	3.2	2.0	2.3	0.0	1.7	2.6	1.1	1.2	0.9	0.3	3.3	4.8	2.1	1.3	0.9
TCF15	"bHLHa40, EC2, PARAXIS"	ENSG00000125878	"Transcription factor 15"	Q12870	20	603797-610398	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 27.8;skeletal muscle: 13.2;tongue: 9.1"	"Cell type enriched"	"Detected in some"	6	"Adipocytes: 260.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 10.6;HMC-1: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050998, HPA060221"	Approved		Supported	"Nuclear speckles"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"		"HPA050998: AB_2681302, HPA060221: AB_2684225"	"unprognostic (2.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.11e-1)"	"unprognostic (6.99e-2)"	7.0	0.6	1.3	0.1	1.2	0.0	4.6	1.2	1.4	0.2	0.9	1.6	0.1	0.8	0.0	0.3	0.4	0.1	27.8	1.1	1.2	1.5	0.2	0.6	0.1	1.3	1.3	0.2	0.3	0.1	0.4	3.3	1.4	0.3	0.0	0.0	0.6	0.0	13.2	0.2	0.5	0.2	1.3	0.0	0.6	2.0	1.3	0.0	0.5	9.1	0.0	0.9	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.9	10.6	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.5	0.0	1.3	0.0	3.0	0.0	1.4	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	1.2	1.4	1.1	1.2	1.3	1.3	1.4	1.3	1.3	1.2	260.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.6	0.5	0.6	1.0	15.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.7	0.2	0.2	41.2	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.6	0.0	0.1	7.1	0.0	0.1	1.7	0.5	0.0	0.0	0.0	0.4	0.2	0.0	0.5	0.0	2.8	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	13.1	3.7	23.3	2.3	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.0
TCF23	"bHLHa24, OUT"	ENSG00000163792	"Transcription factor 23"	Q7RTU1	2	27149004-27156974	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"endometrium 1: 51.2;fallopian tube: 24.6;ovary: 18.5;smooth muscle: 20.4"	"Cell type enhanced"	"Detected in some"		"Leydig cells: 10.5;Peritubular cells: 29.0;Sertoli cells: 52.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	12	"THP-1: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044596			Approved	"Nuclear speckles"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA044596: AB_10797258"	"unprognostic (1.04e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.41e-5)"	"unprognostic (7.58e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.58e-4)"	"unprognostic (2.64e-2)"	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.5	0.4	4.6	0.2	0.2	0.1	51.2	5.8	0.0	24.6	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.1	18.5	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.5	0.2	0.1	0.1	20.4	0.0	2.3	0.1	2.6	0.2	0.0	0.0	0.0	0.0	0.2	2.9	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.2	0.2	0.1	0.2	0.3	0.3	0.2	0.0	0.4	0.3	0.2	1.1	0.3	0.1	0.4	0.1	0.0	0.2	0.2	0.5	0.4	0.3	0.2	0.1	0.1	0.3	0.0	0.2	0.5	0.1	0.0	2.2	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.3	0.3	0.7	0.0	0.6	0.0	2.1	0.0	0.2	0.1	0.0	0.0	1.7	0.2	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	1.3	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	10.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.7	0.0	0.1	0.0	0.6	52.6	1.0	1.5	0.3	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.6
TCP11L2	MGC40368	ENSG00000166046	"T-complex 11 like 2"	Q8N4U5	12	106301929-106347003	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 98.8;choroid plexus: 79.4"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 111.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 67.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 67.0"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039483, HPA042188"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear speckles"		"HPA039483: AB_10795291, HPA042188: AB_10794415"	"unprognostic (1.41e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (9.52e-4)"	"unprognostic (3.87e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.05e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.67e-1)"	11.5	8.8	16.4	7.9	43.0	30.3	10.3	32.6	24.5	9.2	79.4	7.7	7.5	10.0	4.2	22.9	13.1	9.5	22.6	12.9	22.4	6.7	6.5	16.7	10.2	46.6	33.2	9.0	6.0	10.2	4.8	14.5	43.3	6.7	9.0	10.3	12.1	6.5	17.9	13.9	9.8	8.2	28.4	11.7	12.1	10.6	30.8	13.6	11.6	23.0	16.8	8.5	9.3	98.8	3.3	8.1	1.1	2.3	10.6	12.2	5.0	2.1	10.2	1.3	3.2	1.3	4.3	1.1	3.2	8.1	3.0	15.2	1.0	4.5	2.3	1.7	3.3	0.7	3.4	5.1	10.4	0.3	2.1	15.4	10.2	1.6	7.6	25.1	7.5	5.9	2.0	1.5	1.9	2.4	2.0	1.7	1.4	4.4	5.0	1.0	0.3	3.8	10.1	15.2	5.0	3.6	5.5	1.7	6.0	8.4	4.6	0.3	5.7	1.9	1.6	2.9	0.5	10.0	0.8	3.8	5.3	0.3	1.0	29.6	6.9	11.0	4.8	3.1	3.6	12.4	9.9	5.4	1.7	10.6	12.2	8.3	67.0	4.3	5.3	1.2	12.3	3.8	16.4	43.0	32.6	24.5	12.9	22.4	46.6	33.2	43.3	28.4	30.8	98.8	12.6	12.8	14.4	15.0	23.1	1.1	3.4	4.4	5.7	8.1	3.5	5.5	10.5	0.0	8.6	3.7	22.9	1.5	13.4	4.2	1.9	3.6	6.3	28.6	7.3	12.1	4.2	33.7	7.7	2.6	0.8	10.5	11.2	20.5	2.5	4.3	6.1	1.5	1.2	21.9	23.9	5.0	2.0	3.1	2.0	4.5	5.9	5.2	3.6	12.2	8.0	3.1	10.3	9.0	111.0	3.7	4.8	2.6	9.9	4.0	5.9	1.2	16.7	13.4	13.1	11.8	7.2	4.3	3.0	6.3	2.6	15.1	12.4	8.0	1.2	8.7
THOC1	"HPR1, P84"	ENSG00000079134	"THO complex 1"	Q96FV9	18	214520-268050	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019096, HPA019687"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA019096: AB_1857979, HPA019687: AB_1857980"	"prognostic favorable (8.43e-4)"	"unprognostic (2.06e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.83e-5)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-3)"	"prognostic favorable (2.89e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.42e-1)"	"prognostic favorable (9.62e-4)"	6.0	5.2	8.7	8.1	9.7	7.5	5.8	10.0	12.2	5.5	9.8	6.6	6.3	4.7	4.5	6.5	4.1	4.6	4.6	8.8	8.8	7.5	9.9	4.6	12.3	9.4	9.0	4.7	3.9	6.7	3.7	6.4	9.9	5.1	5.5	5.8	6.9	4.1	6.2	6.3	5.9	5.7	8.8	6.3	5.3	16.8	9.5	12.8	4.7	6.2	11.6	9.5	3.8	10.7	27.0	15.8	32.4	26.1	20.8	15.4	40.2	15.4	14.5	29.8	31.1	30.8	16.1	37.2	11.9	20.0	46.0	17.1	43.0	24.4	36.9	12.3	19.1	22.2	18.4	21.0	16.0	50.5	20.2	10.6	14.4	33.3	21.8	13.6	33.3	34.5	52.3	17.4	27.3	20.5	38.1	29.6	31.5	34.2	21.1	53.3	30.3	33.4	17.2	26.1	21.2	16.6	39.0	19.9	25.3	36.7	14.0	37.1	16.6	26.6	29.9	21.8	48.3	15.9	26.4	54.7	22.2	36.0	22.8	13.4	7.3	6.4	9.8	10.7	14.8	13.3	11.7	12.4	11.9	11.5	13.5	13.4	0.7	11.2	9.4	7.2	12.8	6.6	8.7	9.7	10.0	12.2	8.8	8.8	9.4	9.0	9.9	8.8	9.5	10.7	20.4	19.2	11.7	48.3	21.0	12.9	15.6	16.8	23.9	30.8	13.1	14.1	9.6	2.8	17.9	11.0	20.9	24.7	23.2	6.0	15.6	16.5	67.1	15.0	23.6	16.7	9.5	21.0	45.3	8.2	16.7	19.9	9.2	21.9	27.3	32.4	8.2	10.3	16.1	28.6	51.6	8.7	10.2	6.9	11.1	11.6	19.3	15.0	3.6	32.8	14.3	12.9	10.3	41.7	74.6	12.7	7.0	17.0	15.6	16.7	9.2	10.2	10.5	27.6	6.6	21.6	22.9	73.4	30.5	13.8	9.1	18.7	22.3	17.7	13.4	12.9
THRAP3	"BCLAF2, TRAP150"	ENSG00000054118	"Thyroid hormone receptor associated protein 3"	Q9Y2W1	1	36224432-36305357	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA012041, CAB017472, HPA063765"	Supported		Enhanced	"Nuclear speckles"		NA	NA		59000	"Cluster 6: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"CAB017472: AB_2271759, HPA012041: AB_1857983, HPA063765: AB_2685117"	"unprognostic (8.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (7.56e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.23e-1)"	41.9	40.6	24.0	45.9	24.7	44.6	43.7	28.5	26.3	36.6	31.2	40.2	33.9	39.5	34.9	40.6	39.3	29.6	47.2	24.3	26.2	32.3	45.8	37.4	57.1	25.6	24.6	45.3	35.6	52.0	30.0	40.1	26.7	50.4	38.7	40.9	38.8	31.3	115.3	38.2	35.1	42.1	24.1	48.0	37.8	34.3	25.0	63.1	46.0	64.0	60.8	37.1	36.2	28.1	100.7	63.9	110.1	94.9	88.0	69.7	90.9	104.6	107.4	107.2	109.8	74.7	91.5	187.5	38.5	113.8	73.8	89.1	125.2	106.9	131.3	97.4	70.1	157.7	94.3	85.6	94.6	157.2	102.5	105.7	65.7	107.1	86.7	75.2	118.4	107.5	127.8	93.5	77.6	57.8	180.4	92.7	130.5	64.2	50.4	163.6	133.4	99.4	77.0	125.4	69.6	83.9	117.5	77.0	92.7	108.7	73.1	69.3	122.4	89.2	100.4	82.5	111.6	56.7	80.7	162.4	82.2	109.2	92.7	85.8	36.9	64.7	51.5	43.9	46.0	53.6	43.9	46.5	42.4	61.0	46.4	43.1	80.8	51.2	48.6	46.7	40.7	47.3	24.0	24.7	28.5	26.3	24.3	26.2	25.6	24.6	26.7	24.1	25.0	28.1	101.0	115.4	101.7	32.3	136.1	56.7	94.5	126.9	78.0	98.0	76.4	65.5	113.7	75.8	106.2	47.8	31.3	150.7	151.9	64.3	97.8	155.7	9.7	92.1	114.7	96.2	72.4	114.9	65.6	104.1	147.2	98.3	58.6	106.0	92.9	120.5	80.7	78.8	101.6	87.5	63.2	70.1	89.5	77.1	71.7	12.0	80.2	89.9	72.9	53.4	155.5	129.4	196.7	47.7	53.4	111.5	61.9	83.5	119.7	125.2	51.6	76.0	87.6	93.2	92.1	114.6	116.5	145.9	118.4	89.6	68.5	144.1	129.0	141.0	87.1	86.4
TLCD4	"FLJ31842, TMEM56"	ENSG00000152078	"TLC domain containing 4"	Q96MV1	1	95117355-95197607	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 130.0"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 77.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 22.4;RH-30: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046762			Approved	"Nuclear speckles"		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"		"HPA046762: AB_2679792"	"unprognostic (1.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.82e-3)"	"unprognostic (3.63e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.15e-2)"	5.3	9.9	9.4	2.1	10.6	20.5	2.6	19.5	15.1	2.4	0.0	13.6	5.5	3.4	2.5	2.3	2.4	4.2	25.7	10.6	6.3	5.7	130.0	3.7	0.4	4.9	5.7	1.7	7.4	6.4	3.4	4.4	4.2	5.3	10.2	3.1	8.3	2.9	13.0	1.6	8.5	3.6	6.9	0.7	5.0	4.8	9.9	0.3	7.3	9.7	0.5	4.7	1.3	12.6	22.4	12.6	1.7	2.6	0.8	0.0	2.9	0.8	0.5	2.8	6.5	9.1	10.4	0.0	10.7	0.4	20.0	0.2	7.4	1.1	4.8	15.5	4.1	0.5	9.2	2.0	0.8	0.4	0.6	1.2	0.4	2.1	0.0	4.4	0.0	1.2	19.8	1.2	0.6	1.9	1.3	0.1	1.7	0.7	6.9	0.0	35.7	0.6	12.0	14.4	4.5	3.6	15.6	10.8	6.7	1.8	11.7	0.4	0.2	0.3	9.0	1.1	7.9	3.8	8.0	0.0	1.5	0.1	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.4	10.6	19.5	15.1	10.6	6.3	4.9	5.7	4.2	6.9	9.9	12.6	5.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.9	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.5	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0
TMEM179B		ENSG00000185475	"Transmembrane protein 179B"	Q7Z7N9	11	62787402-62790400	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016585, HPA062068"			Enhanced	"Nuclear speckles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"		"HPA016585: AB_1844357, HPA062068: AB_2684676"	"unprognostic (1.18e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.61e-3)"	"unprognostic (2.76e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.74e-3)"	"unprognostic (3.60e-2)"	52.1	60.3	32.4	22.0	34.7	21.5	55.0	33.7	36.4	50.5	41.8	48.7	34.7	44.4	71.2	47.9	46.7	28.4	34.0	30.8	32.9	54.3	64.3	51.0	26.9	35.3	33.3	39.6	58.7	34.1	31.0	30.0	35.6	45.8	40.1	10.4	59.1	26.4	27.2	58.2	49.8	26.3	33.7	48.1	53.9	41.6	33.0	33.0	55.4	21.6	29.8	43.3	46.0	36.9	35.6	68.8	17.7	35.7	136.3	34.3	22.6	38.2	47.5	29.8	34.2	39.3	82.9	16.5	53.1	78.0	44.2	64.8	33.4	35.4	23.2	48.6	44.9	24.1	29.2	36.3	90.8	30.9	32.2	65.8	55.8	57.1	70.0	60.0	30.3	46.9	33.2	46.3	34.5	81.1	40.2	59.5	26.5	76.8	74.6	26.5	28.8	86.1	57.7	42.6	24.4	26.7	49.3	65.3	70.4	35.8	76.2	37.8	42.2	39.6	29.4	73.3	32.2	51.2	32.5	22.6	57.0	19.0	47.3	302.9	300.4	332.7	149.4	305.0	147.9	169.2	135.5	144.9	198.2	140.6	118.2	117.3	224.3	140.2	305.9	366.1	146.6	282.5	32.4	34.7	33.7	36.4	30.8	32.9	35.3	33.3	35.6	33.7	33.0	36.9	119.6	60.9	59.2	15.3	52.7	68.7	73.9	175.6	86.0	12.4	108.0	122.2	1.3	65.8	121.1	60.7	0.0	174.5	71.7	91.2	37.2	138.1	5.8	75.2	54.5	83.7	65.2	40.4	9.9	149.0	160.5	76.8	54.6	66.5	54.6	43.8	69.9	81.9	133.2	8.4	9.0	103.5	128.1	63.7	83.0	11.0	75.8	76.5	106.7	12.2	98.3	74.4	91.6	16.1	28.1	124.0	137.1	45.9	93.9	97.1	179.4	87.5	122.9	14.7	65.7	50.5	57.8	120.8	100.5	93.2	76.0	185.1	60.0	90.4	94.8	97.5
TRIP12	"KIAA0045, TRIPC, ULF"	ENSG00000153827	"Thyroid hormone receptor interactor 12"	Q14669	2	229763837-229923239	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 251.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036835, HPA045893"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA036835: AB_2675340, HPA045893: AB_2679486"	"unprognostic (1.22e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.33e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.49e-3)"	"unprognostic (4.87e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.01e-2)"	48.2	32.3	20.2	47.1	26.7	53.9	33.6	20.2	31.4	34.8	15.7	40.8	25.6	30.8	33.4	47.6	28.1	33.9	41.5	16.0	25.4	41.3	42.8	33.3	48.2	20.7	20.8	32.7	29.3	45.0	24.8	44.6	22.1	39.9	33.9	34.8	30.2	33.0	81.7	29.3	27.6	38.2	17.9	41.1	39.1	127.7	21.5	60.3	44.5	59.0	56.3	46.3	26.5	30.0	97.1	100.7	96.2	79.0	94.9	106.2	88.3	144.5	103.0	106.9	118.7	80.5	75.3	37.8	96.2	135.6	129.5	76.3	140.5	105.9	159.3	132.4	52.9	264.1	84.4	78.3	76.4	195.8	163.2	88.1	80.3	174.9	108.5	74.9	145.1	88.2	188.2	38.2	122.5	72.5	105.3	68.5	77.0	50.3	47.7	94.8	189.8	33.6	75.7	156.4	94.4	67.5	1.6	51.9	97.7	85.1	48.2	118.3	188.8	133.9	94.7	84.9	115.5	66.4	79.3	119.0	103.8	77.0	116.6	34.0	14.2	23.6	12.9	16.2	13.1	9.6	12.0	12.7	13.4	8.9	9.5	9.7	36.0	13.9	18.7	12.6	19.5	9.8	20.2	26.7	20.2	31.4	16.0	25.4	20.7	20.8	22.1	17.9	21.5	30.0	78.3	89.8	51.2	85.8	43.4	31.0	32.8	36.3	25.6	31.2	41.2	29.8	91.0	34.3	52.8	31.3	52.1	27.0	60.8	57.3	15.6	37.5	119.5	63.5	65.2	59.3	18.6	40.2	147.6	45.1	25.1	43.7	56.6	73.5	39.2	53.1	50.0	54.3	35.1	42.1	130.3	32.5	30.5	89.6	32.2	102.1	34.8	70.8	26.6	122.7	63.9	25.8	56.7	127.2	251.3	57.8	35.0	45.5	52.1	44.7	25.7	34.5	73.1	32.1	19.7	57.5	45.0	137.2	59.3	43.1	36.2	42.4	47.0	60.2	31.9	54.5
UBE4A	"E4, KIAA0126, UBOX2, UFD2"	ENSG00000110344	"Ubiquitination factor E4A"	Q14139	11	118359600-118399211	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055035, HPA064010"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA055035: AB_2682679, HPA064010: AB_2685174"	"unprognostic (1.32e-2)"	"unprognostic (8.15e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.86e-2)"	18.6	14.1	15.9	20.3	17.8	17.7	18.0	25.5	20.5	16.1	15.7	17.4	19.1	18.9	18.6	15.0	15.5	15.6	19.7	15.1	20.2	18.0	27.6	17.0	22.5	18.9	18.1	19.1	19.5	19.0	9.5	17.5	20.2	19.0	20.7	18.4	16.1	14.9	22.1	24.0	20.5	18.1	16.5	19.7	23.9	17.7	19.7	21.3	18.4	15.9	21.6	14.7	12.7	24.4	18.8	17.9	22.4	22.5	38.0	34.9	22.3	27.1	28.1	19.7	24.0	49.7	44.9	39.3	51.0	34.4	26.5	40.3	31.9	25.7	32.6	22.3	14.8	64.5	15.4	25.7	32.6	36.8	47.3	35.4	18.2	40.4	39.3	26.3	33.3	33.9	37.2	35.9	28.7	35.4	31.5	36.5	20.9	37.7	22.7	20.0	32.5	40.2	21.6	43.1	20.3	21.1	39.2	33.5	12.3	24.2	44.8	16.6	34.6	29.0	19.0	25.1	22.8	10.5	13.8	36.4	16.1	41.6	30.4	14.2	9.5	9.7	7.5	10.5	5.8	5.1	5.6	5.4	9.8	3.5	6.0	5.4	9.6	6.5	12.8	5.7	7.0	4.8	15.9	17.8	25.5	20.5	15.1	20.2	18.9	18.1	20.2	16.5	19.7	24.4	28.7	12.8	31.9	45.7	27.5	26.8	22.0	20.4	25.6	19.5	26.3	18.0	18.2	10.0	27.8	14.7	18.8	20.3	30.6	25.5	5.9	19.8	18.0	23.7	35.3	20.9	18.6	26.9	46.2	28.5	19.8	24.2	41.8	31.7	10.8	25.7	19.2	44.6	21.9	16.8	56.3	20.1	30.5	27.9	23.1	15.2	17.1	33.2	24.9	36.5	32.4	20.5	24.7	55.8	80.9	27.0	18.3	21.4	42.0	23.1	29.0	11.5	37.5	16.8	19.7	23.4	23.6	35.3	22.0	30.3	39.2	24.8	31.0	26.0	20.3	26.1
USP22	"KIAA1063, USP3L"	ENSG00000124422	"Ubiquitin specific peptidase 22"	Q9UPT9	17	20999596-21043760	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044980	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA044980: AB_10794503"	"unprognostic (7.24e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.72e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (2.17e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.07e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (1.53e-7)"	"unprognostic (8.95e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.79e-2)"	40.7	66.8	91.2	40.3	93.7	53.0	42.5	72.0	90.5	55.3	44.8	48.8	33.6	63.7	48.2	40.7	57.3	40.0	79.8	93.1	112.3	49.5	44.1	46.3	48.3	71.7	78.1	75.6	48.0	68.2	65.2	39.3	85.8	50.2	35.2	57.1	36.3	48.2	108.6	40.3	39.5	54.0	72.4	45.1	49.8	29.3	120.3	63.9	57.0	81.2	50.2	42.3	35.4	68.4	106.9	189.7	179.9	155.5	102.7	105.9	85.9	120.2	91.8	105.6	89.3	220.0	46.9	145.4	112.5	185.2	71.3	111.7	176.7	143.1	157.1	70.0	122.8	120.8	121.5	107.9	121.3	134.2	101.0	117.4	83.9	119.9	125.1	119.8	134.1	93.3	139.7	51.4	151.6	109.5	189.8	63.7	93.1	125.5	61.9	206.2	284.5	99.2	97.7	153.9	86.3	177.8	154.9	63.5	124.9	488.4	106.4	78.0	171.0	107.4	140.8	111.3	164.1	55.0	79.6	476.2	109.0	70.3	169.4	5.5	9.6	10.0	7.9	7.6	7.9	8.0	8.1	7.8	9.2	9.9	10.7	10.2	9.9	7.1	9.7	7.6	6.1	6.0	91.2	93.7	72.0	90.5	93.1	112.3	71.7	78.1	85.8	72.4	120.3	68.4	46.6	41.7	48.8	31.6	47.9	33.0	43.8	33.8	38.7	97.6	80.3	63.8	23.8	45.8	41.5	60.7	93.8	51.4	36.6	59.3	23.5	51.6	36.0	59.3	75.3	56.1	88.2	43.7	53.1	59.0	37.5	51.0	57.6	68.7	30.4	86.5	76.8	68.5	38.1	117.8	66.0	48.8	30.5	53.8	36.1	51.2	51.0	31.7	35.6	43.1	42.2	55.4	28.8	38.7	50.6	69.6	40.3	71.8	36.6	62.2	33.4	48.9	37.4	59.1	13.1	58.6	52.2	15.9	19.7	49.6	29.1	65.8	33.4	77.9	53.3	53.5
VAX2	DRES93	ENSG00000116035	"Ventral anterior homeobox 2"	Q9UIW0	2	70900576-70965373	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.4;retina: 11.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 9.5;Cone photoreceptor cells: 16.7;Horizontal cells: 11.8;Muller glia cells: 7.6;Rod photoreceptor cells: 19.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 4.7;MCF7: 5.6;RH-30: 4.6;SCLC-21H: 4.6;SH-SY5Y: 5.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 3.2"	HPA009708			Approved	"Nuclear speckles"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nuclear speckles"		"HPA009708: AB_2668261"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.74e-3)"	"unprognostic (6.63e-3)"	"unprognostic (4.65e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.18e-2)"	1.5	0.4	1.8	0.1	1.0	0.0	1.1	5.4	1.6	0.9	0.6	0.6	0.0	1.0	0.0	0.4	0.7	0.0	0.6	1.9	2.6	0.4	0.0	0.5	0.0	0.9	1.0	0.7	1.2	0.2	0.9	0.2	1.0	0.7	0.0	11.1	0.8	0.0	0.5	1.2	0.3	0.3	0.7	0.0	0.2	0.2	1.6	0.0	0.2	0.1	0.0	0.5	0.4	1.0	1.5	3.6	0.8	4.7	1.2	0.7	2.6	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.2	1.8	0.0	0.1	0.0	3.0	0.0	0.0	2.1	0.6	0.0	0.0	1.2	0.0	0.2	0.0	1.3	0.4	0.2	0.0	0.0	1.8	5.6	0.0	0.0	2.0	0.0	0.0	0.0	4.6	0.0	1.5	1.2	4.6	5.6	3.7	0.0	2.1	0.1	2.1	0.2	0.9	2.2	0.5	1.1	0.9	0.0	0.0	0.0	1.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.0	5.4	1.6	1.9	2.6	0.9	1.0	1.0	0.7	1.6	1.0	3.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	9.5	1.4	1.4	0.1	0.0	0.1	0.0	16.7	0.1	0.1	0.2	1.9	1.2	0.1	0.0	0.1	1.5	0.0	0.0	0.6	0.6	0.4	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	11.8	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.8	0.0	4.2	7.6	0.0	2.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	19.5	0.0	0.8	0.8	0.0	0.2	0.0	0.0	0.1	0.1	0.8	0.1	0.0
VPS72	"Swc2, TCFL1, YL-1, YL1"	ENSG00000163159	"Vacuolar protein sorting 72 homolog"	Q15906	1	151176304-151195321	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065709			Approved	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA065709: AB_2685540"	"unprognostic (2.55e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.16e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (4.41e-6)"	"unprognostic (4.10e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.30e-1)"	23.8	21.0	33.3	17.0	34.1	12.9	22.7	35.3	39.7	27.5	30.0	26.8	16.8	28.1	19.0	25.0	23.5	15.0	25.4	32.9	35.9	24.9	17.9	18.7	21.2	34.2	33.6	25.8	21.5	21.2	19.1	22.3	34.6	25.8	16.2	18.2	23.5	18.1	56.3	24.3	20.5	24.2	33.6	23.5	23.8	18.7	34.3	27.9	20.0	32.3	26.3	32.2	23.6	36.5	60.7	41.0	92.8	66.9	40.1	35.0	79.5	64.2	33.8	50.4	36.4	43.7	49.4	60.6	77.3	48.7	35.0	56.0	69.1	41.4	38.0	72.2	75.4	52.3	31.0	30.2	55.7	77.8	46.0	28.5	56.8	57.4	47.5	52.8	66.7	74.3	100.2	44.5	40.3	103.3	67.0	54.8	108.5	107.5	69.2	73.2	52.9	95.3	47.1	30.5	65.5	116.8	44.1	67.6	78.9	86.6	76.5	114.4	63.2	26.5	44.9	42.7	82.3	82.5	124.9	96.4	43.4	52.9	49.9	63.3	48.8	82.4	57.2	47.5	55.4	65.8	50.9	49.3	55.3	53.9	50.3	45.6	35.7	75.3	40.6	35.2	67.5	58.3	33.3	34.1	35.3	39.7	32.9	35.9	34.2	33.6	34.6	33.6	34.3	36.5	23.3	6.4	9.1	7.5	21.9	28.4	28.6	40.0	28.5	13.7	24.8	32.1	15.1	24.3	26.8	23.9	4.2	57.6	19.1	24.6	64.6	49.9	12.2	15.2	18.1	25.2	20.3	30.9	6.3	46.4	53.5	24.3	20.9	17.4	31.7	25.4	25.0	18.1	32.0	15.2	6.9	30.6	63.1	22.9	18.8	9.7	25.1	17.7	42.7	2.8	33.8	32.8	29.9	4.5	9.1	59.8	30.5	24.8	13.5	31.4	28.6	35.4	15.7	12.9	52.6	23.3	40.7	39.5	30.4	23.5	31.7	63.1	24.8	16.1	27.1	35.5
VXN	"C8orf46, MGC33510"	ENSG00000169085	Vexin	Q8TAG6	8	66493520-66518524	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 123.8"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.1;Proximal tubular cells: 3.4;Syncytiotrophoblasts: 1.0"	"Cancer enriched"	"Detected in many"	6	"glioma: 16.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.5;GAMG: 5.4;HBF TERT88: 3.9;LHCN-M2: 4.4;T-47d: 5.8;WM-115: 4.5"	"Group enriched"	"Detected in all"	8	"amygdala: 159.7;basal ganglia: 78.9;cerebral cortex: 298.2;hippocampal formation: 219.3;white matter: 199.5"	"Low region specificity"	"Detected in all"			HPA075134			Approved	"Nuclear speckles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA075134: AB_2686736"	"unprognostic (6.87e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-4)"	"unprognostic (7.87e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.53e-4)"	"unprognostic (1.86e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.91e-2)"	0.3	0.5	61.0	0.3	72.1	0.0	0.5	52.0	87.2	0.9	21.7	1.8	0.0	0.7	1.3	0.0	0.5	0.2	0.3	123.8	47.4	0.6	1.4	0.3	0.0	53.1	56.2	0.3	0.6	0.4	0.4	0.0	56.0	1.5	0.3	0.2	0.1	5.4	0.5	0.2	0.5	1.1	53.4	0.1	1.2	0.3	53.7	0.0	0.2	0.0	0.3	0.3	0.4	84.5	2.7	0.1	1.0	1.3	0.1	0.1	0.0	0.2	0.4	1.2	1.3	0.1	4.5	0.0	0.1	2.9	5.4	0.1	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.1	4.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	1.9	0.1	0.2	0.0	0.1	0.1	3.0	0.1	5.8	0.0	0.0	0.4	0.9	0.0	1.9	2.0	1.1	0.0	1.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.0	72.1	52.0	87.2	123.8	47.4	53.1	56.2	56.0	53.4	53.7	84.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.3	0.0	0.0
WDR17		ENSG00000150627	"WD repeat domain 17"	Q8IZU2	4	176065841-176182818	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 11.5;retina: 28.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 183.1;Cone photoreceptor cells: 64.6;Excitatory neurons: 222.8;Inhibitory neurons: 127.6;Oligodendrocyte precursor cells: 125.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 5.6;SCLC-21H: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042766, HPA054501"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA042766: AB_10806372, HPA054501: AB_2732586"	"unprognostic (3.41e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.43e-7)"	"unprognostic (3.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.39e-3)"	"unprognostic (6.04e-4)"	"unprognostic (3.66e-4)"	"unprognostic (9.25e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.24e-3)"	0.8	2.9	4.5	0.9	7.9	0.6	1.3	2.9	7.6	1.4	0.0	2.5	0.5	1.8	2.4	0.6	1.9	1.1	0.8	8.5	2.5	2.5	0.3	1.4	0.6	0.0	0.0	1.8	2.2	7.0	11.5	0.1	0.8	0.8	1.1	28.6	0.8	0.8	0.2	0.4	1.2	1.0	0.0	1.1	1.3	1.9	2.3	0.3	4.3	0.3	0.5	1.4	1.0	3.4	0.0	2.5	5.6	0.0	0.1	0.4	0.2	0.1	0.0	0.6	1.9	0.2	0.0	3.7	0.0	0.1	3.0	0.0	2.4	1.4	0.5	0.0	2.0	0.0	0.5	0.0	0.2	2.0	2.8	0.8	0.7	0.1	0.3	0.7	0.0	4.3	0.0	0.3	0.5	1.1	2.4	0.1	1.2	0.0	1.4	0.0	2.5	0.0	0.2	0.0	7.6	4.8	0.0	1.4	3.8	0.7	0.4	0.0	0.0	0.8	1.0	0.0	3.4	2.7	1.8	2.3	4.2	0.0	1.4	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.0	0.0	4.5	7.9	2.9	7.6	8.5	2.5	0.0	0.0	0.8	0.0	2.3	3.4	0.3	0.0	5.8	183.1	2.4	0.1	0.5	0.1	3.4	16.9	0.6	0.9	0.9	1.5	1.3	0.0	64.6	0.0	0.0	0.1	1.9	0.3	1.5	0.5	0.6	0.7	4.8	1.7	222.8	0.6	0.0	2.0	0.0	0.0	3.8	0.1	2.2	0.1	0.2	21.9	127.6	0.1	0.0	0.6	0.6	1.5	0.9	1.3	1.8	23.4	0.6	10.2	0.0	125.2	40.0	0.2	0.0	1.5	0.2	0.4	0.0	11.6	7.7	36.6	0.0	3.0	1.9	2.7	5.2	0.4	0.0	0.0	0.3	1.4	0.1	0.3
WDR90	"C16orf15, C16orf16, C16orf17, C16orf18, C16orf19, FLJ36483, KIAA1924, POC16"	ENSG00000161996	"WD repeat domain 90"	Q96KV7	16	649311-667833	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 61.2"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 32.3;Respiratory ciliated cells: 57.6;Rod photoreceptor cells: 34.7;Spermatocytes: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA049362, HPA061785"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"		"HPA049362: AB_2680728, HPA061785: AB_2684606"	"unprognostic (1.97e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.34e-3)"	"unprognostic (3.89e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (2.67e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.55e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.84e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.48e-2)"	8.1	16.3	8.7	3.4	8.8	11.5	10.9	9.5	12.3	17.0	9.9	11.4	5.9	13.3	3.2	10.5	22.1	3.6	9.7	8.9	8.7	16.4	10.9	10.0	4.0	9.2	9.3	21.5	15.7	4.4	25.9	2.5	8.9	15.1	2.2	4.6	9.5	5.5	4.6	9.9	9.3	2.2	8.5	7.4	11.7	61.2	9.1	5.1	22.2	1.4	2.0	10.0	10.5	9.4	10.2	14.1	7.8	18.8	2.9	1.9	0.5	7.4	2.8	5.4	6.3	18.2	14.0	8.8	5.7	2.3	0.1	22.0	3.8	6.0	1.2	15.0	13.7	2.9	57.2	16.9	0.8	15.7	13.4	3.8	4.7	10.8	2.5	2.0	4.0	13.7	1.0	21.9	2.4	7.4	12.5	15.0	7.6	8.4	4.4	34.7	3.1	14.6	6.0	9.4	14.6	15.3	6.8	13.9	1.6	0.5	28.7	12.9	4.3	13.0	13.1	14.3	9.8	22.0	10.4	9.7	3.8	8.5	8.6	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	8.7	8.8	9.5	12.3	8.9	8.7	9.2	9.3	8.9	8.5	9.1	9.4	4.5	0.0	9.1	10.4	1.1	3.4	2.8	4.5	3.4	9.4	9.7	10.4	4.9	14.3	6.9	9.2	14.6	2.8	0.7	10.1	0.0	5.4	5.6	32.3	6.5	4.3	1.2	2.5	5.0	3.8	2.6	5.9	12.2	9.9	0.0	15.1	1.8	4.5	2.7	11.8	5.5	6.9	0.0	0.8	2.5	4.0	6.2	2.2	3.6	5.6	0.3	5.6	0.0	1.5	2.6	4.5	3.1	4.5	1.3	2.7	3.0	2.1	57.6	34.7	6.6	8.3	5.1	34.2	20.7	3.0	2.3	2.5	1.5	8.3	10.8	2.0
WRN	"RECQ3, RECQL2"	ENSG00000165392	"WRN RecQ like helicase"	Q14191	8	31033788-31176138	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 74.7;Early spermatids: 116.3;Oligodendrocytes: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028661	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA028661: AB_10602255"	"unprognostic (8.73e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.66e-1)"	3.0	3.6	1.7	3.2	1.7	8.2	4.8	4.1	2.4	3.0	2.6	3.5	1.5	6.4	3.2	2.7	2.9	2.4	1.7	1.6	1.7	2.1	2.5	2.4	2.5	1.8	2.1	5.2	2.6	2.0	2.1	3.6	1.8	3.5	2.9	4.4	3.5	2.6	2.1	4.1	2.5	4.2	1.2	3.1	2.3	3.0	1.9	3.2	3.2	2.2	3.0	2.6	2.3	3.1	4.4	5.9	10.8	5.3	6.7	9.8	5.0	4.7	4.9	6.4	6.6	2.7	1.5	10.0	4.6	4.3	4.4	2.4	6.4	3.8	9.7	3.3	4.3	9.6	4.9	4.4	5.4	8.7	4.3	7.1	3.7	3.6	6.2	3.9	7.7	6.1	14.5	5.0	6.8	2.0	17.5	6.6	7.7	5.1	3.2	7.5	7.5	6.7	2.9	4.4	3.3	5.2	6.9	2.7	3.8	4.9	2.9	5.3	9.1	6.2	3.8	3.1	4.9	1.4	3.0	14.6	5.5	3.8	4.2	0.8	0.2	0.3	0.3	0.1	0.4	0.5	0.5	0.3	0.2	0.5	0.3	0.4	0.3	1.1	0.1	0.1	0.3	0.1	1.7	1.7	4.1	2.4	1.6	1.7	1.8	2.1	1.8	1.2	1.9	3.1	17.5	9.6	10.6	74.7	15.1	13.5	11.7	5.3	18.8	14.5	14.7	10.5	7.5	15.7	8.8	16.5	22.9	7.1	18.0	5.3	1.9	6.7	116.3	15.8	32.3	12.5	2.4	49.2	59.7	9.8	5.7	15.2	21.9	17.1	2.5	18.5	7.1	9.7	5.3	15.2	54.9	13.8	8.2	5.3	6.6	12.8	19.0	7.8	10.6	51.5	6.9	14.3	4.1	61.3	88.6	9.1	4.2	14.3	16.6	15.3	3.9	2.7	10.0	19.8	6.6	20.2	15.3	10.9	19.2	10.1	10.2	5.6	13.0	15.2	7.7	11.0
WTAP	"KIAA0105, MGC3925, Mum2"	ENSG00000146457	"WT1 associated protein"	Q15007	6	159725585-159756319	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 560.1;Suprabasal keratinocytes: 455.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010550	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA010550: AB_1858866"	"unprognostic (9.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (3.01e-5)"	"unprognostic (7.92e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.32e-2)"	86.2	63.7	35.3	62.3	35.7	245.1	74.9	40.0	41.3	71.7	41.3	54.6	34.9	64.7	65.1	65.0	64.2	52.2	54.3	35.0	42.5	54.8	50.7	68.6	77.5	38.2	38.3	70.5	63.3	53.2	49.8	61.8	39.4	65.1	55.2	35.6	62.0	44.6	179.7	72.5	61.6	51.5	36.9	67.0	58.5	34.9	40.1	89.7	57.4	67.4	80.7	102.6	65.1	41.2	55.5	51.1	115.8	100.2	136.5	147.7	67.1	86.2	299.4	108.7	145.4	95.7	49.0	126.8	50.8	92.6	238.4	70.4	112.2	94.3	138.1	70.0	71.9	135.0	46.7	144.2	108.4	116.1	75.4	172.0	94.7	120.0	155.0	82.6	81.6	130.7	149.1	114.2	116.0	53.5	170.5	165.0	91.9	88.6	44.2	107.4	74.3	94.4	114.0	62.6	104.5	74.5	158.2	83.5	45.7	77.5	41.3	152.6	72.6	70.0	81.4	100.1	125.0	83.9	109.6	206.5	67.8	120.9	76.8	46.6	24.5	31.0	28.1	31.7	31.7	33.1	33.9	34.3	29.1	27.5	29.9	31.4	42.9	32.1	38.3	24.3	40.2	20.2	35.3	35.7	40.0	41.3	35.0	42.5	38.2	38.3	39.4	36.9	40.1	41.2	131.1	35.3	57.3	31.3	138.1	419.0	198.0	52.9	113.8	30.0	144.2	123.6	58.1	74.4	39.9	60.7	35.5	107.3	138.5	61.2	86.1	128.1	47.1	86.4	125.5	118.8	61.6	59.3	41.5	81.4	126.7	226.9	97.9	171.9	40.0	56.7	58.2	90.5	75.4	37.0	36.6	65.7	24.4	99.7	560.1	50.7	65.3	168.6	243.7	33.7	113.7	49.7	88.6	44.7	57.0	75.8	59.7	50.8	111.5	307.5	49.6	106.5	35.3	36.2	72.3	222.2	124.5	93.8	73.9	113.0	455.3	149.3	138.6	54.7	74.0	150.9
XYLB	"FLJ10343, FLJ12539"	ENSG00000093217	Xylulokinase	O75191	3	38346760-38421348	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Xylose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 33.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 39.3;Hepatocytes: 49.3;Inhibitory neurons: 35.9;Proximal tubular cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037863, HPA038415"	Uncertain		Approved	"Nuclear speckles"		NA	NA		12000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA037863: AB_10672729, HPA038415: AB_10672592"	"unprognostic (2.48e-1)"	"unprognostic (9.72e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.37e-2)"	1.4	2.3	1.3	1.5	1.0	2.2	3.0	5.4	2.0	1.6	0.0	4.1	5.8	1.9	0.8	1.9	1.1	1.6	0.5	0.9	0.7	11.4	33.4	0.7	1.0	0.9	0.2	2.2	2.5	1.1	0.8	0.9	1.1	1.6	4.6	2.1	5.3	0.9	0.6	1.5	6.4	1.4	0.0	1.0	3.5	1.0	0.9	1.6	0.7	0.5	0.8	1.2	1.3	0.6	3.5	6.4	2.8	6.7	4.2	4.3	6.3	5.9	2.0	4.5	4.4	8.2	3.6	3.7	1.4	7.6	5.4	2.5	8.1	2.5	5.6	5.0	6.2	7.5	5.0	24.1	2.2	10.1	7.7	3.0	5.2	5.8	2.7	1.9	4.7	8.5	18.0	6.2	5.0	2.4	8.3	1.4	3.8	8.9	7.9	4.2	5.5	5.0	0.6	6.3	3.6	3.2	3.7	16.0	12.7	2.4	7.2	6.1	2.6	9.0	7.3	15.6	2.5	3.5	6.6	8.5	5.4	9.1	7.2	1.4	0.9	2.0	0.6	1.6	0.5	0.2	0.5	0.3	1.7	0.3	0.6	0.6	1.9	0.5	1.4	0.6	1.5	0.4	1.3	1.0	5.4	2.0	0.9	0.7	0.9	0.2	1.1	0.0	0.9	0.6	1.0	0.0	1.3	14.0	0.9	0.9	2.1	1.8	6.8	3.2	3.0	3.4	1.1	2.8	1.5	0.0	0.0	4.3	1.7	3.8	1.9	1.0	0.5	0.4	3.5	1.8	0.0	3.4	39.3	3.0	3.8	2.3	8.6	1.0	0.0	1.3	1.1	49.3	4.0	0.0	35.9	5.7	2.0	1.0	3.7	1.0	1.5	2.0	0.0	17.8	1.0	0.4	0.0	17.1	17.7	1.3	5.8	1.9	1.6	1.7	13.0	31.7	1.3	5.1	0.0	2.4	1.4	0.5	2.7	4.1	0.9	1.4	0.8	1.8	5.1	2.1
ZC3H11A	"KIAA0663, ZC3HDC11A"	ENSG00000058673	"Zinc finger CCCH-type containing 11A"	O75152	1	203795623-203854999	"Predicted intracellular proteins"	"mRNA transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA026439, HPA028490, HPA028526"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533"	"unprognostic (8.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.41e-1)"	14.9	15.6	8.3	20.9	12.3	28.8	15.5	11.5	11.7	14.2	13.1	14.7	20.4	18.7	12.8	16.8	16.1	15.2	13.9	8.2	9.6	16.6	16.2	14.5	26.2	9.4	8.9	18.9	15.5	19.8	5.6	17.4	10.0	16.2	17.7	20.2	19.4	13.2	23.4	26.2	22.5	16.6	5.6	23.1	20.4	22.9	9.7	33.4	22.6	23.1	25.5	16.1	6.5	15.5	29.7	23.8	45.2	28.8	28.7	22.9	49.7	33.6	24.0	27.0	30.2	32.7	36.2	37.6	19.9	35.7	22.0	41.0	35.8	19.7	37.2	56.6	25.8	36.3	39.3	16.5	15.4	50.9	62.3	19.1	23.5	29.0	28.2	34.2	25.5	40.4	74.0	51.6	24.0	24.2	56.2	20.3	42.6	20.8	19.4	40.1	52.1	24.7	19.1	50.0	33.1	31.4	33.8	27.5	29.8	51.7	29.5	38.1	39.2	39.2	34.7	33.1	32.3	36.8	37.3	58.5	25.2	29.1	30.7	15.6	3.6	5.5	5.2	3.5	7.2	5.0	4.7	4.8	4.2	3.5	5.9	4.4	7.9	5.1	5.8	2.3	5.0	4.2	8.3	12.3	11.5	11.7	8.2	9.6	9.4	8.9	10.0	5.6	9.7	15.5	2.4	12.8	22.5	105.8	49.2	101.5	61.7	50.6	112.7	46.2	1.1	0.9	54.2	58.6	38.4	0.0	45.9	31.1	18.2	43.6	0.0	0.3	54.7	3.1	2.9	49.9	46.7	67.1	71.9	0.2	27.3	51.5	53.0	3.9	25.3	0.9	54.7	70.0	32.5	84.1	69.0	64.2	28.5	54.6	60.8	14.3	60.3	37.2	48.0	82.4	31.7	40.5	41.2	103.0	169.4	0.6	42.2	67.4	64.1	104.0	52.1	0.3	43.9	49.8	78.9	83.3	42.1	63.6	40.2	84.5	111.5	51.0	41.4	0.5	52.1	114.2
ZC3H11B	ZC3HDC11B	ENSG00000215817	"Zinc finger CCCH-type containing 11B"	A0A1B0GTU1	1	219608010-219613145	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"testis: 5.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.3;Cardiomyocytes: 1.5;Collecting duct cells: 1.8;monocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA026439, HPA028490, HPA028526"	Uncertain		Approved	"Nuclear speckles"		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533"	"unprognostic (1.75e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.87e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.87e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.0	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.3	0.4	0.2	0.1	0.0	0.2	0.2	5.1	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.4	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.1	0.3	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.2	0.2	0.1	0.3	0.2	0.1	0.3	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.3	1.5	0.0	0.0	1.8	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.6	0.8	0.3	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0
ZC3H18	NHN1	ENSG00000158545	"Zinc finger CCCH-type containing 18"	Q86VM9	16	88570403-88631964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040847, HPA041327"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA040847: AB_10794865, HPA041327: AB_10795005"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (1.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.07e-3)"	"prognostic favorable (3.68e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.01e-1)"	14.1	11.0	10.7	18.7	11.3	25.5	13.6	14.4	14.2	14.3	5.7	16.1	14.9	17.4	4.3	14.5	14.2	8.8	14.3	10.6	11.4	10.9	12.0	13.1	18.4	10.1	9.6	14.1	13.7	12.3	10.1	11.9	9.2	11.5	8.1	9.0	13.6	8.2	22.8	15.3	15.6	10.1	7.5	17.4	14.5	25.3	10.2	19.1	13.1	10.1	12.3	15.3	13.7	12.1	45.3	59.6	42.6	42.8	20.7	17.7	68.3	44.5	24.1	40.8	18.5	58.8	38.3	55.1	36.9	21.1	27.3	53.0	40.3	33.7	25.6	32.5	51.2	36.6	29.2	50.6	26.2	28.5	30.7	16.1	25.2	43.3	20.8	16.9	25.5	37.8	101.4	17.8	20.4	87.4	91.6	50.5	66.7	35.3	35.5	111.0	29.3	40.4	18.5	28.3	44.9	38.7	85.2	23.5	25.2	24.8	53.3	38.1	35.1	43.6	45.2	32.0	45.5	39.5	67.2	130.8	38.6	65.7	47.0	2.3	2.0	2.0	2.5	2.3	2.8	2.3	2.4	2.7	1.9	1.9	2.1	1.7	3.4	3.1	5.4	2.8	3.3	2.1	10.7	11.3	14.4	14.2	10.6	11.4	10.1	9.6	9.2	7.5	10.2	12.1	24.9	28.9	24.2	11.1	29.6	16.8	17.0	11.1	13.1	26.6	13.8	14.4	10.2	20.0	23.9	16.5	35.5	24.1	45.6	30.1	7.9	16.5	76.2	21.9	28.7	21.3	25.0	28.6	12.0	16.6	22.1	18.7	22.4	32.1	20.8	26.6	16.4	12.9	18.2	28.6	11.9	18.5	10.2	20.1	21.1	10.0	21.8	30.5	14.2	12.2	23.9	18.1	46.4	7.1	15.7	17.5	21.7	17.0	35.5	20.5	20.3	8.4	13.1	44.0	6.6	28.8	19.5	41.4	37.5	19.6	22.3	25.2	39.2	25.1	24.7	16.6
ZCWPW2	ZCW2	ENSG00000206559	"Zinc finger CW-type and PWWP domain containing 2"	Q504Y3	3	28348721-28538122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 35.6;Early spermatids: 95.0;Excitatory neurons: 33.7;Inhibitory neurons: 34.9;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 31.7;Spermatocytes: 68.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035035, HPA039839"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA035035: AB_10602256, HPA039839: AB_2676708"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.59e-3)"	"unprognostic (6.53e-2)"	"unprognostic (6.09e-4)"	"unprognostic (3.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-4)"	"unprognostic (1.06e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.38e-2)"	1.5	1.7	1.8	0.9	1.5	0.8	1.8	1.6	1.9	1.4	0.2	1.4	1.2	2.1	2.1	1.3	1.0	2.0	2.7	1.7	1.1	1.6	1.2	1.3	1.2	0.8	1.0	2.4	1.9	1.5	1.2	1.2	1.0	2.2	1.1	1.6	2.3	1.1	6.2	1.9	0.9	1.0	0.8	1.1	1.8	9.9	1.2	0.6	2.5	4.5	1.0	0.8	0.8	1.6	0.3	0.2	0.8	0.3	1.2	2.8	1.2	1.1	0.8	0.3	0.3	0.2	0.9	0.7	0.5	0.6	0.8	0.4	0.2	0.2	0.3	0.4	0.4	0.3	1.1	0.3	0.6	0.5	0.6	1.2	0.5	0.3	0.5	1.3	0.5	1.5	0.3	1.0	1.5	0.3	0.2	0.6	0.3	0.1	1.1	0.3	0.3	0.6	1.2	0.1	0.3	0.9	0.2	0.4	0.7	0.8	0.4	2.6	1.0	0.8	0.4	0.7	0.6	0.3	0.2	0.3	2.8	0.5	1.0	1.0	0.7	1.1	0.3	0.7	0.2	0.1	0.3	0.2	0.3	0.2	0.5	0.7	1.0	0.2	0.2	0.4	0.3	0.2	1.8	1.5	1.6	1.9	1.7	1.1	0.8	1.0	1.0	0.8	1.2	1.6	1.6	0.0	2.0	35.6	0.4	0.6	2.7	3.7	1.2	3.0	1.6	2.7	13.6	0.0	4.3	0.0	0.0	2.4	0.1	0.4	5.9	0.5	95.0	1.2	1.2	1.0	1.2	0.0	33.7	0.9	1.4	4.3	0.0	0.6	2.5	0.8	1.4	0.5	1.3	3.3	34.9	1.9	8.2	0.6	0.7	17.7	4.7	1.3	0.0	13.1	0.7	3.7	1.0	32.2	31.7	0.6	0.3	4.9	0.3	1.1	0.6	2.6	1.7	2.0	0.0	4.4	4.5	68.7	5.8	1.1	1.6	1.2	0.6	1.3	0.7	1.3
ZFP14	"KIAA1559, ZNF531"	ENSG00000142065	"ZFP14 zinc finger protein"	Q9HCL3	19	36334453-36379201	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 63.2;Rod photoreceptor cells: 105.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030637	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA030637: AB_10602353"	"unprognostic (1.89e-1)"	"unprognostic (3.80e-2)"	"unprognostic (9.61e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.75e-5)"	1.8	2.6	4.0	2.5	5.2	1.1	4.1	6.2	4.7	2.9	6.9	2.3	2.8	3.3	5.2	1.6	3.1	1.9	1.7	3.8	5.4	3.2	2.0	1.9	3.7	4.3	4.5	4.2	1.9	4.7	3.8	2.1	4.7	3.0	2.0	9.0	2.2	3.0	1.5	3.2	2.5	2.2	3.7	3.6	2.5	1.1	4.4	3.9	4.4	1.5	3.5	2.4	2.4	8.6	1.5	2.5	5.1	4.7	4.3	2.1	1.2	0.7	2.2	1.4	2.2	1.7	1.2	4.2	1.8	1.0	1.1	0.5	2.1	0.3	1.5	1.6	1.6	3.7	2.5	1.4	1.4	3.0	3.8	0.9	0.9	0.6	0.1	2.6	1.9	4.8	1.1	0.0	2.2	1.0	4.8	1.2	3.8	2.2	1.1	3.8	2.9	1.2	1.5	2.9	2.8	4.2	2.6	0.8	1.5	2.6	1.6	2.4	1.3	1.4	3.2	1.5	0.7	1.1	1.9	2.1	0.2	0.4	2.5	5.6	2.8	4.1	4.1	3.4	4.4	8.1	4.7	5.6	2.8	6.0	6.5	6.6	1.7	4.5	2.9	4.2	4.8	1.3	4.0	5.2	6.2	4.7	3.8	5.4	4.3	4.5	4.7	3.7	4.4	8.6	12.0	0.0	5.3	17.9	25.5	3.2	6.7	4.5	8.0	63.2	8.5	6.1	6.5	20.0	5.9	12.9	52.1	8.2	18.5	8.2	7.9	8.9	2.8	6.5	7.9	11.2	13.2	10.3	32.9	4.5	2.4	9.3	7.7	4.6	13.3	22.1	12.5	4.3	8.6	47.1	39.5	8.3	6.1	8.5	4.6	0.8	15.5	8.8	3.6	17.8	15.6	16.9	44.3	41.2	56.2	4.9	13.0	19.5	4.9	7.0	13.9	12.4	11.3	105.3	32.9	10.4	9.1	7.9	8.3	3.0	2.6	2.5	17.3	15.2	7.7	7.2
ZNF217	ZABC1	ENSG00000171940	"Zinc finger protein 217"	O75362	20	53567071-53609907	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 129.1;Glandular and luminal cells: 154.8;Squamous epithelial cells: 118.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 148.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051857	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA051857: AB_2681641"	"unprognostic (4.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.52e-2)"	15.0	4.2	4.0	20.5	3.8	31.1	22.0	4.0	3.8	17.9	9.6	18.1	12.8	11.8	8.3	13.1	11.1	15.1	5.4	3.2	3.9	11.0	14.5	12.2	29.6	6.0	6.0	9.7	10.1	17.3	4.8	19.0	5.4	16.5	17.5	0.8	18.9	8.2	3.4	16.9	13.5	8.9	4.7	29.2	17.9	22.1	5.9	26.0	10.9	6.4	23.7	21.8	11.6	5.0	28.7	33.4	27.5	40.3	25.1	28.5	60.1	31.3	31.8	34.8	17.1	21.5	31.2	27.5	32.9	38.4	44.9	27.5	22.3	33.0	40.1	19.9	6.3	8.9	14.3	37.8	19.5	14.5	36.7	15.6	31.1	18.6	51.4	27.4	20.1	28.2	19.8	126.9	26.4	113.8	50.1	31.9	29.2	16.2	32.8	38.9	23.0	32.3	20.3	62.8	2.8	7.6	29.2	148.2	30.5	34.6	44.3	60.3	14.2	69.7	25.6	36.0	38.9	52.4	62.4	23.0	25.4	16.0	22.8	9.1	6.1	10.9	3.2	7.4	4.1	5.6	3.4	4.1	4.9	4.3	3.8	3.8	23.3	6.8	15.8	5.0	3.6	3.1	4.0	3.8	4.0	3.8	3.2	3.9	6.0	6.0	5.4	4.7	5.9	5.0	18.7	0.0	8.0	7.5	30.6	129.1	40.3	25.3	71.7	0.6	41.7	22.5	8.2	20.0	26.1	18.4	0.0	16.4	43.7	58.5	9.8	27.5	39.1	76.2	34.4	21.6	6.0	24.4	0.5	16.7	17.7	21.7	42.8	154.8	12.0	24.8	14.6	26.8	16.1	0.0	0.5	32.0	22.4	43.6	52.3	25.9	6.8	39.6	21.4	22.5	43.0	1.8	20.6	3.0	3.4	22.2	39.8	5.3	31.7	65.8	13.8	11.0	30.4	0.5	0.0	13.3	22.7	8.0	23.3	118.8	106.8	45.1	40.5	12.3	24.7	87.1
ZNF382	"FLJ14686, KS1"	ENSG00000161298	"Zinc finger protein 382"	Q96SR6	19	36604817-36634114	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.1;retina: 18.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 23.8;Early spermatids: 23.3;Excitatory neurons: 19.1;Horizontal cells: 50.5;Late spermatids: 20.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049259	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear speckles"		"HPA049259: AB_2680694"	"unprognostic (5.43e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.68e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.85e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.76e-5)"	"unprognostic (8.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.22e-2)"	1.7	2.8	2.6	1.9	4.2	0.9	1.6	12.1	4.3	1.9	0.1	2.8	0.6	2.3	2.0	1.5	2.7	1.4	4.0	3.7	1.9	1.8	0.7	1.3	2.7	0.2	0.2	2.1	1.3	2.2	5.4	2.3	0.0	1.7	0.8	18.0	1.5	1.4	0.9	0.6	1.6	2.1	0.0	2.9	1.1	3.8	4.3	3.2	2.8	2.6	3.2	1.8	1.0	3.9	0.2	0.1	4.5	6.4	1.8	2.5	1.5	2.0	0.6	5.9	6.0	0.1	0.3	4.0	4.2	2.5	2.5	0.1	5.8	0.1	3.7	11.3	2.6	6.6	0.3	1.6	5.0	0.9	7.6	3.4	0.2	3.3	0.1	5.9	0.7	7.8	0.1	0.2	3.9	0.6	9.3	2.1	2.9	0.0	2.2	0.4	1.9	1.8	1.6	0.1	0.5	8.6	0.3	0.3	3.7	6.5	2.7	0.7	0.1	1.4	0.3	0.3	5.9	9.9	0.8	0.4	0.0	0.1	3.5	2.4	0.5	3.3	5.2	0.6	7.7	9.0	7.7	5.4	2.1	5.3	6.3	7.3	0.9	4.4	0.6	2.2	4.9	2.6	2.6	4.2	12.1	4.3	3.7	1.9	0.2	0.2	0.0	0.0	4.3	3.9	2.4	3.2	0.0	7.5	3.5	0.1	0.9	0.5	2.2	23.8	1.7	2.0	13.2	1.5	1.0	3.7	10.4	2.0	1.3	0.1	5.9	3.2	23.3	3.5	2.3	2.4	0.0	4.8	19.1	0.4	1.0	1.7	0.5	1.9	0.0	6.8	2.5	0.3	2.9	50.5	16.0	0.1	0.0	0.8	0.8	20.5	0.6	1.2	1.8	1.9	0.7	4.3	0.0	8.0	8.5	0.2	0.3	1.2	0.3	0.4	0.0	1.8	2.6	13.7	0.0	2.6	2.7	6.5	3.0	0.5	0.0	0.1	3.5	2.9	0.0	0.3
ZNF441	FLJ38637	ENSG00000197044	"Zinc finger protein 441"	Q8N8Z8	19	11767000-11784078	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 19.0;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA063338			Approved	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA063338: AB_2684989"	"unprognostic (1.97e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.42e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.70e-3)"	3.3	2.9	3.4	3.0	3.9	0.9	5.9	6.9	4.0	3.6	2.3	3.4	2.3	4.6	6.1	1.7	3.9	2.1	3.8	3.6	3.3	6.4	4.4	3.5	4.9	2.7	3.1	6.4	3.4	7.2	7.1	3.2	3.0	4.5	3.2	7.1	3.8	4.9	3.6	3.1	4.2	3.2	3.1	4.6	3.2	2.7	3.0	3.6	7.1	2.7	4.4	3.9	2.5	3.9	2.1	0.0	2.5	2.1	3.0	3.2	2.7	5.0	2.8	3.7	3.6	2.3	0.7	4.4	2.6	3.2	1.8	1.5	1.6	3.0	4.2	0.0	1.8	2.0	1.7	3.7	2.7	0.0	3.6	3.9	3.3	2.6	2.0	2.5	2.1	1.8	3.3	0.0	5.8	0.0	4.7	1.3	0.4	0.9	3.6	1.7	5.0	1.3	3.0	3.4	1.9	3.0	3.3	1.0	1.8	2.4	3.3	4.5	1.0	8.0	1.9	7.0	3.4	4.4	6.9	1.9	0.4	0.0	3.2	0.0	0.3	0.8	1.0	0.3	0.7	1.4	1.1	1.5	0.6	1.6	1.4	1.6	0.5	0.9	1.6	0.4	0.8	0.6	3.4	3.9	6.9	4.0	3.6	3.3	2.7	3.1	3.0	3.1	3.0	3.9	5.6	16.0	8.7	8.5	9.5	0.4	0.8	1.2	0.6	11.7	2.7	2.3	14.5	0.0	4.5	11.0	14.6	2.1	5.1	1.9	3.9	1.7	0.2	2.5	3.8	5.3	0.0	1.7	12.3	1.2	0.6	3.6	1.1	1.8	2.5	6.4	3.6	1.9	0.8	6.7	9.5	1.6	2.0	0.8	1.2	0.8	2.5	2.2	3.6	2.8	1.8	7.0	8.2	4.0	4.2	1.1	1.5	7.2	1.9	0.9	1.5	3.0	0.9	19.0	19.7	6.7	6.2	7.6	6.0	1.4	0.0	0.8	3.4	4.9	0.8	0.4
ZNF446	"FLJ20626, ZKSCAN20, ZSCAN52"	ENSG00000083838	"Zinc finger protein 446"	Q9NWS9	19	58474017-58481230	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052786, HPA078262"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA052786: , HPA078262: "	"unprognostic (1.52e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.94e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.94e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.91e-3)"	6.0	7.2	8.0	3.4	7.7	3.0	6.8	9.4	8.5	9.7	7.2	8.7	3.3	9.4	4.6	5.9	9.9	3.2	6.6	7.8	8.0	9.4	10.8	4.8	4.0	8.5	7.9	11.5	9.3	7.7	12.5	2.3	7.5	10.9	2.2	3.7	6.2	5.5	6.4	9.1	6.5	3.3	7.2	6.6	7.9	13.2	7.6	4.9	9.5	3.1	2.5	8.7	6.5	8.6	4.4	8.8	6.0	6.2	5.8	10.1	5.6	2.6	7.9	2.4	2.8	4.3	4.1	4.0	3.8	3.8	10.2	6.4	2.6	3.5	0.9	5.9	27.7	4.8	6.7	3.9	8.6	2.6	6.9	9.4	6.3	4.0	4.0	8.7	5.2	7.0	2.9	2.8	3.5	5.2	7.0	3.0	2.2	4.1	5.5	6.1	4.2	5.5	4.8	8.0	7.4	6.8	4.9	7.3	4.5	3.3	5.3	3.6	3.7	11.4	3.8	2.4	5.7	9.6	13.2	2.6	5.7	1.4	4.9	2.9	2.1	2.3	2.8	3.1	1.8	2.3	3.3	1.8	3.0	2.8	2.2	2.9	2.6	1.7	5.2	1.9	2.8	1.9	8.0	7.7	9.4	8.5	7.8	8.0	8.5	7.9	7.5	7.2	7.6	8.6	4.8	3.2	3.2	7.8	4.6	2.0	2.3	7.0	4.0	8.9	7.3	8.3	1.0	14.3	5.6	5.5	8.4	5.6	2.2	8.3	3.9	7.9	5.5	14.4	5.7	4.2	10.7	5.7	7.8	5.1	3.8	4.5	6.1	5.8	8.2	6.7	2.2	3.1	4.5	8.4	9.7	6.6	10.2	3.3	2.3	5.2	7.2	2.4	3.6	3.7	2.1	10.8	7.2	5.5	9.5	4.9	4.8	5.3	3.4	1.9	6.8	6.3	11.8	8.5	0.0	6.8	4.8	40.0	21.1	4.1	3.7	3.4	3.4	8.8	5.3	1.5
ZNF572	FLJ38002	ENSG00000180938	"Zinc finger protein 572"	Q7Z3I7	8	124973295-124979389	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 3.9;Inhibitory neurons: 2.5;Microglial cells: 2.8;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.7;Spermatogonia: 2.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 4.1"					"Low region specificity"	"Detected in all"			HPA066838	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles"		"HPA066838: AB_2685734"	"unprognostic (8.65e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.37e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.95e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.82e-1)"	"unprognostic (6.17e-2)"	0.6	0.3	0.9	1.0	1.3	0.1	1.8	1.0	1.2	1.1	0.7	1.0	0.9	1.4	2.2	0.5	1.5	0.7	0.9	0.8	1.0	1.7	0.9	0.7	1.9	1.4	1.1	2.3	1.0	0.6	0.4	1.5	1.1	1.4	1.3	1.9	1.3	1.5	0.2	0.8	0.9	0.8	1.1	1.5	1.4	3.6	1.1	1.9	1.8	0.2	1.9	1.1	0.8	1.6	1.0	0.5	1.1	0.0	1.5	1.7	0.0	0.3	0.1	1.3	0.7	1.4	0.7	2.5	1.6	0.4	0.2	1.9	0.6	0.0	1.1	0.0	0.5	0.0	0.7	1.7	1.2	0.0	1.2	1.3	1.6	1.3	0.0	0.3	0.8	0.0	1.5	0.0	1.7	4.1	0.0	0.0	0.0	2.4	0.0	1.6	2.8	0.3	0.7	0.7	2.5	2.4	1.5	2.4	2.6	2.1	1.0	1.6	0.5	1.5	1.7	0.4	0.0	0.0	1.4	1.1	0.3	0.0	0.1	0.0	0.1	0.3	0.2	0.3	0.4	0.6	0.2	0.1	0.1	0.6	0.8	0.5	0.0	0.7	0.2	0.0	0.0	0.1	0.9	1.3	1.0	1.2	0.8	1.0	1.4	1.1	1.1	1.1	1.1	1.6	0.2	0.0	0.0	3.9	0.8	0.1	0.2	0.0	0.0	1.0	0.3	0.4	0.6	0.0	0.6	0.0	0.0	0.9	0.2	0.2	1.9	0.3	0.5	0.9	0.5	0.4	0.0	0.4	1.3	0.2	0.3	0.4	0.0	0.3	0.0	1.6	0.4	0.3	0.4	0.0	2.5	0.1	0.0	0.3	0.0	0.4	0.0	0.2	0.0	2.8	0.6	2.3	1.0	2.5	2.7	0.0	0.1	1.2	0.0	0.1	0.1	1.0	0.9	0.6	0.0	0.1	0.2	2.4	2.8	0.3	0.0	0.3	0.3	0.5	0.6	0.1
ZNF584	FLJ39899	ENSG00000171574	"Zinc finger protein 584"	Q8IVC4	19	58401504-58418327	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 49.8"					"Low region specificity"	"Detected in all"			"HPA043408, HPA048075"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"		"HPA043408: AB_2678466, HPA048075: AB_2680251"	"unprognostic (6.06e-2)"	"unprognostic (3.27e-3)"	"unprognostic (3.76e-3)"	"unprognostic (8.15e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.04e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.90e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.36e-2)"	5.7	6.7	4.6	2.9	4.5	1.8	5.0	5.4	5.5	5.6	6.0	6.6	3.5	6.9	3.8	5.8	6.8	2.3	8.9	5.1	4.3	5.3	6.6	4.3	2.5	5.3	4.6	6.1	4.9	8.4	6.7	2.7	4.6	5.0	2.6	5.1	4.7	5.7	9.8	9.0	3.5	5.1	4.0	3.3	5.6	4.7	4.5	3.2	4.7	10.9	3.4	6.1	5.0	4.1	11.7	16.7	11.2	14.7	10.8	10.7	4.5	8.9	15.8	5.4	6.7	2.7	3.5	5.8	7.0	14.7	14.2	6.5	12.1	14.6	6.1	7.5	49.8	15.7	9.6	3.5	18.3	17.3	4.3	11.1	10.4	16.5	22.8	11.9	10.9	9.5	15.8	5.4	8.9	8.3	14.4	5.4	2.8	7.6	23.2	10.4	8.4	9.0	7.6	13.7	9.0	9.5	19.5	5.6	7.4	2.9	3.7	8.6	7.0	21.2	6.5	8.9	14.3	5.0	9.5	1.3	15.2	6.0	7.1	0.0	2.2	0.8	3.2	2.1	5.2	2.1	4.3	4.5	3.4	3.3	2.3	3.6	0.7	3.2	3.5	2.9	5.1	2.7	4.6	4.5	5.4	5.5	5.1	4.3	5.3	4.6	4.6	4.0	4.5	4.1	4.2	3.2	3.9	1.0	2.3	11.2	3.2	5.6	6.2	4.1	4.8	4.3	12.8	5.7	2.1	9.2	4.2	1.0	5.9	1.6	13.7	5.6	9.6	8.1	6.1	4.6	6.7	9.5	2.0	5.1	1.5	5.6	3.6	1.8	2.5	5.5	6.8	4.7	2.6	3.3	2.2	2.3	4.1	2.4	3.3	7.8	5.3	2.1	1.8	0.0	1.3	6.1	2.1	0.5	1.6	4.9	2.8	6.4	2.6	4.2	2.1	5.5	10.2	9.2	6.6	4.4	6.3	8.1	3.7	4.3	15.9	0.4	4.0	12.3	3.2	2.0
ZNF621	FLJ45246	ENSG00000172888	"Zinc finger protein 621"	Q6ZSS3	3	40524878-40574685	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA065518, HPA071440"			Enhanced	"Nuclear speckles"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA065518: AB_2685501, HPA071440: AB_2686395"	"unprognostic (1.09e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.52e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.04e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.33e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.01e-3)"	13.0	10.0	15.7	5.9	18.9	7.1	12.9	15.0	16.5	12.7	13.4	11.2	5.3	11.2	8.1	9.5	11.5	5.7	9.4	13.2	17.1	15.2	12.4	13.2	6.2	19.4	16.3	12.0	12.2	7.7	14.6	5.5	19.4	14.4	5.7	7.4	12.1	6.9	7.2	10.0	11.7	6.1	17.0	12.7	10.7	7.6	17.5	5.5	13.2	5.6	6.1	11.0	11.5	21.0	8.9	5.0	12.2	12.0	7.8	13.4	6.9	9.5	11.1	11.7	11.6	11.1	4.8	3.7	6.9	12.4	8.8	3.1	12.2	7.2	13.7	14.9	15.1	12.4	20.8	10.1	13.6	11.6	11.8	10.4	14.9	12.2	19.0	12.7	9.9	4.4	13.3	10.8	10.1	5.6	2.9	13.8	7.7	3.5	10.2	1.1	8.2	4.4	6.1	11.0	4.3	10.9	10.2	6.9	12.0	11.7	11.4	9.4	13.1	20.2	9.8	10.2	13.4	16.1	17.4	8.3	9.9	8.6	12.5	2.5	1.0	0.9	1.3	1.3	0.8	2.3	1.3	1.8	0.9	3.3	1.6	1.2	1.2	1.8	0.7	1.3	1.3	0.7	15.7	18.9	15.0	16.5	13.2	17.1	19.4	16.3	19.4	17.0	17.5	21.0	13.2	9.6	12.3	22.5	9.6	1.5	5.2	2.3	9.1	13.8	6.3	5.0	12.1	10.0	7.7	11.0	12.5	5.5	9.5	4.9	5.9	7.7	10.8	11.1	16.4	12.0	10.2	12.4	4.1	5.6	3.5	9.0	7.7	12.2	3.8	15.0	5.0	5.6	3.7	15.2	4.2	7.1	4.1	8.1	3.0	7.9	7.5	6.9	3.6	11.2	9.4	7.1	10.3	19.1	26.1	7.5	4.9	12.0	8.8	6.6	6.7	3.2	4.6	16.7	0.0	13.6	9.1	10.6	6.3	7.5	1.8	5.5	8.1	12.9	5.8	4.4
ZNF695	SBZF3	ENSG00000197472	"Zinc finger protein 695"	Q8IW36	1	246945547-247008093	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 3.2;Extravillous trophoblasts: 4.7;Spermatocytes: 3.5;Spermatogonia: 2.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA024743	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"		"Cluster 28: BEWO - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"HPA024743: AB_1859419"	"unprognostic (8.46e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-5)"	"unprognostic (7.42e-4)"	"unprognostic (2.81e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.05e-9)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.87e-1)"	0.0	0.0	0.2	0.1	0.2	0.8	0.3	0.1	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.2	7.1	0.8	4.2	10.7	0.1	0.1	11.1	2.4	0.1	3.2	4.3	7.3	0.4	5.6	4.4	1.2	2.8	2.2	12.2	0.6	3.7	0.0	4.0	3.8	1.5	4.5	0.0	0.0	1.4	0.2	0.0	3.6	2.9	0.9	1.3	7.3	5.2	0.0	3.4	2.7	8.2	4.1	7.8	6.8	4.3	4.5	9.7	0.0	0.8	3.8	3.7	6.5	3.4	2.8	1.2	4.0	3.0	5.2	0.6	0.5	6.0	3.2	0.0	0.7	2.2	0.1	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.6	0.0	0.8	1.1	0.5	0.0	0.0	0.0	0.0	3.2	0.0	0.4	0.0	0.3	0.9	0.9	0.5	0.3	0.0	2.1	0.0	0.0	4.7	0.4	1.5	1.4	0.0	2.0	0.4	0.2	1.4	0.0	0.0	2.1	0.0	0.8	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.5	3.5	2.8	2.0	0.1	1.1	0.0	0.3	1.7	0.2
ZSCAN5A	"MGC4161, ZNF495, ZSCAN5"	ENSG00000131848	"Zinc finger and SCAN domain containing 5A"	Q9BUG6	19	56219670-56368383	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 128.5;Late spermatids: 88.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041263, HPA043123, HPA046836, HPA060667"	Uncertain		Uncertain	"Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear speckles"		"HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: "	"unprognostic (1.72e-1)"	"unprognostic (3.19e-3)"	"unprognostic (8.22e-4)"	"unprognostic (1.65e-2)"	"unprognostic (2.05e-3)"	"unprognostic (6.99e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.67e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.70e-2)"	"unprognostic (6.15e-3)"	"unprognostic (3.99e-3)"	3.1	3.2	3.5	3.6	4.0	2.5	2.8	3.3	3.4	3.4	5.3	3.8	3.9	3.7	2.0	3.0	7.1	2.6	4.1	3.6	3.6	3.6	2.6	3.1	2.8	3.7	4.0	3.5	2.6	3.8	3.3	2.0	3.8	3.0	4.5	2.3	3.2	2.4	4.1	4.3	3.4	3.9	3.3	2.8	2.6	25.1	3.6	4.5	3.2	3.5	3.4	3.7	3.2	3.4	5.9	5.0	7.1	8.6	5.7	3.6	10.4	3.4	7.2	10.3	6.1	10.1	3.4	10.6	2.7	6.0	6.1	7.0	9.2	7.3	9.2	3.0	19.4	13.0	3.4	10.2	4.5	14.5	14.0	2.8	11.0	10.1	4.6	2.1	7.5	8.2	5.3	4.7	3.2	7.2	3.5	8.0	12.8	5.2	13.1	5.5	10.7	6.1	4.3	10.9	6.9	6.9	9.1	6.9	3.6	4.0	3.0	13.2	4.1	8.9	8.9	4.7	11.4	7.7	21.1	7.2	11.5	14.2	3.5	3.7	6.5	4.4	4.2	7.2	6.4	3.3	4.4	3.2	7.5	1.9	5.7	3.0	0.5	1.3	4.5	9.3	1.2	3.7	3.5	4.0	3.3	3.4	3.6	3.6	3.7	4.0	3.8	3.3	3.6	3.4	3.3	0.0	4.2	2.3	5.3	4.8	5.8	6.0	6.2	4.9	6.4	5.0	17.4	0.0	5.0	0.0	8.4	3.0	5.6	4.3	11.7	5.0	128.5	10.5	3.4	4.1	7.8	5.5	0.6	5.1	3.5	5.5	5.1	4.9	2.5	2.8	4.6	6.8	6.5	3.3	0.3	4.0	8.2	7.3	3.0	88.5	2.5	5.2	0.0	0.0	3.0	7.8	2.1	0.5	0.3	4.4	1.0	2.6	4.0	4.5	4.5	6.0	12.4	10.8	0.0	6.5	3.3	14.7	16.5	4.2	3.7	7.0	3.4	3.3	5.2	3.3
ZSCAN5B	"ZNF371, ZNF495B"	ENSG00000197213	"Zinc finger and SCAN domain containing 5B"	A6NJL1	19	56189570-56197920	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 1.3"	"Cell type enriched"	"Detected in single"	8	"Spermatogonia: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043123, HPA046836, HPA059494, HPA060667"	Uncertain		Uncertain	"Nuclear speckles"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA043123: AB_2678328, HPA046836: AB_2679832, HPA059494: AB_2684038, HPA060667: "	"unprognostic (4.73e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.15e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.83e-2)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZSCAN5C	"ZNF495C, ZSCAN5CP"	ENSG00000204532	"Zinc finger and SCAN domain containing 5C"	A6NGD5	19	56202273-56209200	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041263, HPA043123, HPA046836, HPA060667"	Uncertain		Uncertain	"Nuclear speckles"		NA	NA							"Nuclear speckles"		"HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: "	"unprognostic (3.74e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.56e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.53e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZSWIM5	KIAA1511	ENSG00000162415	"Zinc finger SWIM-type containing 5"	Q9P217	1	45016399-45306209	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"Astrocytes: 96.9;Excitatory neurons: 84.3;Granulosa cells: 36.3;Inhibitory neurons: 133.8;Microglial cells: 54.4;Oligodendrocyte precursor cells: 144.8;Oligodendrocytes: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 5.2;Hep G2: 6.1;SCLC-21H: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018211	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"		"HPA018211: AB_1859502"	"unprognostic (1.86e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.12e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.16e-1)"	1.0	12.1	2.8	0.9	3.4	0.2	1.7	5.4	3.1	2.2	0.9	4.1	4.4	3.0	2.4	1.3	2.4	1.1	1.5	2.6	3.3	2.9	0.6	2.1	1.1	3.0	3.2	8.0	2.9	6.0	6.0	0.9	2.9	3.1	4.9	8.5	2.9	2.3	1.2	1.5	6.8	3.0	2.2	1.6	1.9	3.0	3.5	0.7	4.1	1.1	0.9	2.6	1.3	2.5	0.4	1.3	3.1	5.2	0.4	0.1	0.7	0.1	4.2	0.8	0.6	0.4	0.5	0.3	0.1	0.1	2.3	0.1	2.2	0.0	0.9	2.2	3.9	0.2	4.6	6.1	0.0	0.6	0.6	0.1	0.1	0.2	0.0	0.4	0.9	1.0	0.2	0.2	0.1	1.8	0.4	0.2	2.8	3.7	1.5	1.4	0.1	0.2	0.0	1.0	7.2	3.7	2.0	0.7	0.3	0.9	1.5	0.1	0.2	0.7	0.4	0.2	0.8	1.4	0.2	0.1	2.8	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.8	3.4	5.4	3.1	2.6	3.3	3.0	3.2	2.9	2.2	3.5	2.5	0.3	0.0	3.1	96.9	0.4	0.5	0.5	0.1	1.2	9.3	1.5	1.4	1.4	2.8	1.3	0.0	10.4	0.1	0.2	5.7	1.9	0.3	1.2	0.4	0.7	1.9	6.7	0.0	84.3	1.3	0.0	1.0	1.5	0.7	0.0	36.3	1.8	0.3	0.1	8.4	133.8	3.9	0.0	0.0	0.3	1.5	0.3	0.2	0.0	54.4	0.6	1.8	0.0	144.8	106.1	0.8	3.7	1.5	0.2	0.5	6.1	1.8	0.7	4.9	0.0	1.1	1.1	1.3	2.3	0.5	0.9	0.1	0.9	0.7	4.4	0.3